
<html lang="en"     class="pb-page"  data-request-id="15c367e8-f3f0-4a63-9438-c3f85d479945"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b01536;issue:issue:10.1021/jmcmar.2019.62.issue-2;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology" /></meta><meta name="dc.Creator" content="Vishnu&#xA;C.  Damalanka" /></meta><meta name="dc.Creator" content="Zhenfu  Han" /></meta><meta name="dc.Creator" content="Partha  Karmakar" /></meta><meta name="dc.Creator" content="Anthony J.  O’Donoghue" /></meta><meta name="dc.Creator" content="Florencia  La Greca" /></meta><meta name="dc.Creator" content="Tommy  Kim" /></meta><meta name="dc.Creator" content="Shishir M.  Pant" /></meta><meta name="dc.Creator" content="Jonathan  Helander" /></meta><meta name="dc.Creator" content="Juha  Klefström" /></meta><meta name="dc.Creator" content="Charles S.  Craik" /></meta><meta name="dc.Creator" content="James W.  Janetka" /></meta><meta name="dc.Description" content="Matriptase and hepsin belong to the family of type II transmembrane serine proteases (TTSPs). Increased activity of these and the plasma protease, hepatocyte growth factor activator (HGFA), is asso..." /></meta><meta name="Description" content="Matriptase and hepsin belong to the family of type II transmembrane serine proteases (TTSPs). Increased activity of these and the plasma protease, hepatocyte growth factor activator (HGFA), is asso..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 20, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01536" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01536" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01536" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01536" /></link>
        
    
    

<title>Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01536" /></meta><meta property="og:title" content="Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0007.jpeg" /></meta><meta property="og:description" content="Matriptase and hepsin belong to the family of type II transmembrane serine proteases (TTSPs). Increased activity of these and the plasma protease, hepatocyte growth factor activator (HGFA), is associated with unregulated cell signaling and tumor progression through increased MET and RON kinase signaling pathways. These proteases are highly expressed in multiple solid tumors and hematological malignancies. Herein, we detail the synthesis and structure–activity relationships (SAR) of a dipeptide library bearing Arg α-ketobenozothiazole (kbt) warheads as novel inhibitors of HGFA, matriptase, and hepsin. We elucidated the substrate specificity for HGFA using positional scanning of substrate combinatorial libraries (PS-SCL), which was used to discover selective inhibitors of matriptase and hepsin. Using these selective inhibitors, we have clarified the specific role of hepsin in maintaining epithelial cell membrane integrity, known to be lost in breast cancer progression. These selective compounds are useful as chemical biology tools and for future drug discovery efforts." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01536"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01536">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01536&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01536&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01536&amp;href=/doi/10.1021/acs.jmedchem.8b01536" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 480-490</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01561" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00973" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Vishnu C. Damalanka</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vishnu C. Damalanka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vishnu%0AC.++Damalanka">Vishnu C. Damalanka</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhenfu Han</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhenfu Han</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhenfu++Han">Zhenfu Han</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Partha Karmakar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Partha Karmakar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Partha++Karmakar">Partha Karmakar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anthony J. O’Donoghue</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anthony J. O’Donoghue</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, University of California, San Francisco, California, 94158, United States</div><div class="loa-info-affiliations-info">Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, California, 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+J.++O%E2%80%99Donoghue">Anthony J. O’Donoghue</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5695-0409" title="Orcid link">http://orcid.org/0000-0001-5695-0409</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Florencia La Greca</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Florencia La Greca</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, University of California, San Francisco, California, 94158, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Florencia++La+Greca">Florencia La Greca</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tommy Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tommy Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tommy++Kim">Tommy Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shishir M. Pant</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shishir M. Pant</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology & Medicum, University of Helsinki, P.O. Box 63, Haartmaninkatu 8, 00014 Helsinki, Finland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shishir+M.++Pant">Shishir M. Pant</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jonathan Helander</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jonathan Helander</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan++Helander">Jonathan Helander</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Juha Klefström</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Juha Klefström</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology & Medicum, University of Helsinki, P.O. Box 63, Haartmaninkatu 8, 00014 Helsinki, Finland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Juha++Klefstr%C3%B6m">Juha Klefström</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Charles S. Craik</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Charles S. Craik</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, University of California, San Francisco, California, 94158, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Charles+S.++Craik">Charles S. Craik</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7704-9185" title="Orcid link">http://orcid.org/0000-0001-7704-9185</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">James W. Janetka</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James W. Janetka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, 63110, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: 314-362-0509. Fax: 314-362-7183. E-mail: <a href="/cdn-cgi/l/email-protection#e88289868d9c838982a89f9d9b9c84c68d8c9d"><span class="__cf_email__" data-cfemail="7e141f101b0a151f143e090b0d0a12501b1a0b">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James+W.++Janetka">James W. Janetka</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9888-5411" title="Orcid link">http://orcid.org/0000-0002-9888-5411</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01536&amp;href=/doi/10.1021%2Facs.jmedchem.8b01536" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 480–490</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 20, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 October 2018</li><li><span class="item_label"><b>Published</b> online</span>20 December 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 January 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01536" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01536</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D480%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DVishnu%250AC.%2BDamalanka%252C%2BZhenfu%2BHan%252C%2BPartha%2BKarmakar%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D2%26contentID%3Dacs.jmedchem.8b01536%26title%3DDiscovery%2Bof%2BSelective%2BMatriptase%2Band%2BHepsin%2BSerine%2BProtease%2BInhibitors%253A%2BUseful%2BChemical%2BTools%2Bfor%2BCancer%2BCell%2BBiology%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D490%26publicationDate%3DJanuary%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01536"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1951</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01536" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Vishnu\nC.&quot;,&quot;last_name&quot;:&quot;Damalanka&quot;},{&quot;first_name&quot;:&quot;Zhenfu&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Partha&quot;,&quot;last_name&quot;:&quot;Karmakar&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;J. O’Donoghue&quot;},{&quot;first_name&quot;:&quot;Florencia&quot;,&quot;last_name&quot;:&quot;La Greca&quot;},{&quot;first_name&quot;:&quot;Tommy&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Shishir&quot;,&quot;last_name&quot;:&quot;M. Pant&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;Helander&quot;},{&quot;first_name&quot;:&quot;Juha&quot;,&quot;last_name&quot;:&quot;Klefström&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;S. Craik&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;W. Janetka&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;480-490&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01536&quot;},&quot;abstract&quot;:&quot;Matriptase and hepsin belong to the family of type II transmembrane serine proteases (TTSPs). Increased activity of these and the plasma protease, hepatocyte growth factor activator (HGFA), is associated with unregulated cell signaling and tumor progression through increased MET and RON kinase signaling pathways. These proteases are highly expressed in multiple solid tumors and hematological malignancies. Herein, we detail the synthesis and structure–activity relationships (SAR) of a dipeptide library bearing Arg α-ketobenozothiazole (kbt) warheads as novel inhibitors of HGFA, matriptase, and hepsin. We elucidated the substrate specificity for HGFA using positional scanning of substrate combinatorial libraries (PS-SCL), which was used to discover selective inhibitors of matriptase and hepsin. Using these selective inhibitors, we have clarified the specific role of hepsin in maintaining epithelial cell membrane integrity, known to be lost in breast cancer progression. These selective compounds are useful as ch&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01536&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01536" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01536&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01536" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01536&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01536" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01536&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01536&amp;href=/doi/10.1021/acs.jmedchem.8b01536" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01536" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01536" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01536%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DDamalanka%26date%3D2019%26atitle%3DDiscovery%2Bof%2BSelective%2BMatriptase%2Band%2BHepsin%2BSerine%2BProtease%2BInhibitors%253A%2BUseful%2BChemical%2BTools%2Bfor%2BCancer%2BCell%2BBiology%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D2%26spage%3D480%26epage%3D490%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/jmcmar.2019.62.issue-2/20190124/jmcmar.2019.62.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/medium/jm-2018-01536m_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01536&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Matriptase and hepsin belong to the family of type II transmembrane serine proteases (TTSPs). Increased activity of these and the plasma protease, hepatocyte growth factor activator (HGFA), is associated with unregulated cell signaling and tumor progression through increased MET and RON kinase signaling pathways. These proteases are highly expressed in multiple solid tumors and hematological malignancies. Herein, we detail the synthesis and structure–activity relationships (SAR) of a dipeptide library bearing Arg α-ketobenozothiazole (kbt) warheads as novel inhibitors of HGFA, matriptase, and hepsin. We elucidated the substrate specificity for HGFA using positional scanning of substrate combinatorial libraries (PS-SCL), which was used to discover selective inhibitors of matriptase and hepsin. Using these selective inhibitors, we have clarified the specific role of hepsin in maintaining epithelial cell membrane integrity, known to be lost in breast cancer progression. These selective compounds are useful as chemical biology tools and for future drug discovery efforts.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Proteolytic regulation of growth factors, cytokines, and cell-surface receptors are important processes in normal physiology but often becomes dysregulated in disease.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9">(1−9)</a> The aberrant activity of the trypsin-like S1 serine proteases matriptase,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> hepsin,<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> and hepatocyte growth factor activator (HGFA)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> in cancer leads to increased proteolysis of the growth factors HGF and macrophage stimulating protein (MSP) among others. HGF is the activating ligand for the oncogene MET and MSP is the ligand for RON. MET and RON are structurally related receptor tyrosine kinases (RTKs) which when activated promote downstream effects including cell proliferation, survival, motility, and epithelial to mesenchymal transition (EMT). Increased HGF/MET<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18 ref19">(14−19)</a> and MSP/RON<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20−22)</a> signaling, prompted by deregulated HGFA, matriptase, and hepsin activity<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> in the tumor microenvironment,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> has been clearly associated with oncogenesis,<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> tumor progression,<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31">(27−31)</a> and resistance to targeted therapy in cancer.<a onclick="showRef(event, 'ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43 ref44 ref45">(32−45)</a> Loss of epithelial integrity is a diagnostic hallmark of all advanced epithelial cancers.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> In healthy epithelial tissue, the integrity is maintained by complex network of cell–cell junctions, which include tight junctions, adhesion junctions, and desmosomes as well as cell contacts to surrounding basement membrane.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The desmosomal localization of hepsin and disruption of desmosomal junction upon hepsin expression suggest an important role for hepsin in regulation of epithelial integrity and tumor invasive processes.<a onclick="showRef(event, 'ref49 ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51 ref52">(49−52)</a> Therefore, inhibitors of these proteases offer a novel therapeutic strategy<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> for targeting these signaling pathways and associated cross-talk for the treatment of cancer and the prevention of tumor progression.</div><div class="NLM_p">The growth factors HGF and MSP are secreted as single-chain zymogens, proHGF and proMSP, which are incapable of activating their respective receptors, MET and RON. Matriptase, hepsin, and HGFA are the three most efficient activators of HGF and MSP.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Proteolytic processing of proHGF and proMSP occurs by peptide bond hydrolysis between an Arg and Val residue.</div><div class="NLM_p">Subsequent disulfide bond formation leads to an active two-chain protein which can bind to and activate the receptor. This processing is the rate-limiting step in MET and RON kinase signaling. Normally, the activity of these proteases is regulated by the endogenous polypeptide inhibitors, HAI-1 and HAI-2,<a onclick="showRef(event, 'ref55 ref56 ref57 ref58 ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref55 ref56 ref57 ref58 ref59 ref60">(55−60)</a> which are both selective for HGFA, matriptase, and hepsin. In multiple tumor types, especially of advanced disease, HAI-1 and/or HAI-2 are either downregulated or silenced through transcription, leaving protease activity unchecked and dysregulated.<a onclick="showRef(event, 'ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref61 ref62 ref63">(61−63)</a> We have recently reported on substrate-based<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64,65)</a> covalent (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) and small molecule benzamidine<a onclick="showRef(event, 'ref38 ref66 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref38 ref66 ref67 ref68">(38,66−68)</a> triplex inhibitors of HGFA, matriptase, and hepsin. We have demonstrated these novel inhibitors display anticancer properties in breast,<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> prostate,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> colon,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> and lung<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> cancer cells. In this present article, we have discovered new and smaller molecular weight dipeptides which contain a P1 arginine (R) ketobenzothiazole (kbt) warhead that are not triplex inhibitors of HGFA, matriptase, and hepsin but rather selective inhibitors of each of the proteases matriptase and hepsin alone. These selective inhibitors were used as discriminating chemical tools to study the individual roles of HGFA, hepsin, and matriptase in the regulation of epithelial cell membrane integrity in breast cancer cells.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/medium/jm-2018-01536m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Previously reported pro-HGF and pro-MSP substrate-based triplex ketobenzothiazole (kbt) inhibitors of HGFA, matriptase, and hepsin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01536&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27121" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27121" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Previously, we conducted several structure–activity relationship (SAR) studies based on the tetrapeptide inhibitors Ac-KQLR-kbt (1) and Ac-SKLR-kbt (2) shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> The significance of these two peptide sequences is that they correspond to the N-terminal portion of the pro-HGF and pro-MSP substrate cleavage sites for HGFA, matriptase, and hepsin. To date, our SAR studies have shown that hepsin and HGFA prefer a Leu in the P2 site adjacent to the essential P1 Arg. Other groups have found a preference for a P2 is Leu in hepsin by screening combinatorial substrate libraries using positional scanning of substrate combinatorial libraries/PS-SCL.<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69,70)</a> Published reports on PS-SCL on matriptase substrates<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71,72)</a> and synthetic studies of inhibitors<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a> have produced confusing results, indicating that matriptase prefers small P2 hydrophobic sidechains, while others, like ours, indicated other side chains were also tolerated. For example, the ketothiazole inhibitor Ac-KQFR-kt<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> and ketobenzothiazole inhibitor RQYR-kbt<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> were shown to have <i>K</i><sub>i</sub>* of 0.69 and 0.18 nM, respectively, for matriptase.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">A.  Substrate Specificity of HGFA</h3><div class="NLM_p">To more fully understand the substrate specificity for HGFA and to enable the design of more selective inhibitors for not only HGFA but also of matriptase and hepsin, we performed positional scanning of substrate combinatorial libraries (PS-SCL) on a recombinant form of the HGFA serine protease domain (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The PS-SCL method and the same libraries have been utilized extensively in the determination of the substrate specificities of other proteases including matriptase and hepsin. Four compound libraries (P1, P2, P3, P4) were screened where one of the 20 amino acids (Cys is substituted with norleucine) is held constant while the other three positions are an isokinetic mixture of the same 20 amino acids (see Experimental Section for details). In this study, we found that HGFA clearly prefers Arg in the P1 position, which is consistent with other S1 trypsin-like serine proteases. From the subsequent results of screening the P2, P3, and P4 positions, we found HGFA discriminates substrate preference mainly in the S2 pocket, strongly preferring Leu, then Met and norleucine (n), followed by Phe, Thr, and Val. These data support the substrate cleavage of pro-HGF and pro-MSP by HGFA, as both pro-protein activation sites contain Leu in the P2 position. The P3 position of pro-HGF and pro-MSP are Gln and Lys, respectively, however, HGFA hydrolyzes fluorescent substrates with P3-Lys 3-fold faster than substrates with P3-Gln. This might suggest HGFA is a more efficient activator of pro-MSP versus pro-HGF. Finally, it appears that HGFA is promiscuous in discerning selectivity at the P4 position, but it is apparent that acidic residues (Glu and Asp) are not preferred in the S4 pocket.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/medium/jm-2018-01536m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. PS-SCL evaluation of HGFA substrate specificity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01536&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">B.  Synthesis and Evaluation of a Dipeptide Library of P2-Arg-Kbt Inhibitors</h3><div class="NLM_p">To validate the results from PS-SCL studies on all three proteases HGFA, matriptase, and hepsin in the P2 position and solidify our SAR for this position of HGFA, matriptase, and hepsin inhibitors, we set out to create a comprehensive synthetic inhibitor library of dipeptides consisting of an Arg-kbt warhead in the P1 position and all of the naturally occurring amino acids except Cys in the P2 position. Shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, we employed a simple, high-yielding two-step synthetic strategy (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B) to prepare the dipeptide inhibitor library (<b>6</b>) where the side chain protected Arg-kbt (<b>4</b>), synthesized as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> was reacted with the side chain protected Fmoc-amino acids (<b>5</b>) using standard coupling conditions in solution phase followed by global deprotection of the side chains and purification by HPLC.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/medium/jm-2018-01536m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Matriptase, Hepsin, and HGFA Inhibitor Library of P1 Arg Dipeptide kbts<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01536&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HCl·HN(Me)OMe, HATU, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, DMF, RT; (b) benzothiazole, nBuLi in hexane, THF, −78 °C, 1.5 h, then <b>3</b>, −78 °C, 2 h; (c) 4 M HCl in dioxane, RT; (d) HATU, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, DMF, RT; (e) TFA/thioanisole/H<sub>2</sub>O (95:2.5:2.5 v/v/v), RT, 4 h.</p></p></figure><div class="NLM_p">Using the fluorogenic protease substrates, Boc-QLR-AMC (HGFA) or Boc-QAR-AMC (matriptase and hepsin) in previously published kinetic enzyme assays.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Briefly, 11 different concentrations of compound were preincubated with protease followed by the addition of the substrate. Inhibition of substrate proteolysis derived fluorescence was monitored kinetically over a period of one hour. We experimentally determined the IC<sub>50</sub> values and then calculated<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> apparent inhibition constants (<i>K</i><sub>i</sub> *) of each dipeptide for their inhibition of HGFA, matriptase, and hepsin. Interestingly, none of the Fmoc dipeptides showed good potency against HGFA (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), with Fmoc-LR-kbt (<b>6l</b>), Fmoc-MR-kbt (<b>6i</b>), and Fmoc-FR-kt (<b>6r</b>) showing the highest activity with <i>K</i><sub>i</sub>*s of 468, 1208, and 963 nM, respectively. This observation is supported by our results from PS-SCL, molecular modeling, and previous SAR that additional amino acid side chains at the P3 and P4 positions are necessary for effective HGFA binding and enzyme inhibition.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Enzyme Activity<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> and Selectivity Data for Inhibitors against HGA, Matriptase, and Hepsin</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">structure</th><th class="colsep0 rowsep0" align="center" char=".">matriptase <i>K</i><sub>i</sub>* (nM)</th><th class="colsep0 rowsep0" align="center" char=".">hepsin <i>K</i><sub>i</sub>* (nM)</th><th class="colsep0 rowsep0" align="center" char=".">HGFA<i>K</i><sub>i</sub>* (nM)</th><th class="colsep0 rowsep0" align="center" char=".">matriptase selectivity</th><th class="colsep0 rowsep0" align="center" char=".">hepsin selectivity</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">Ac-KQLR-kbt</td><td class="colsep0 rowsep0" align="char" char=".">0.55</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="center">Ac-SKLR-kbt</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="center">Fmoc-RR kbt</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">102</td><td class="colsep0 rowsep0" align="char" char=".">8634</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="center">Fmoc-GR kbt</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">831</td><td class="colsep0 rowsep0" align="char" char=".">9375</td><td class="colsep0 rowsep0" align="char" char=".">6392</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="center">Fmoc-KR kbt</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">104</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">473</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6d</b></td><td class="colsep0 rowsep0" align="center">Fmoc-AR kbt</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">240</td><td class="colsep0 rowsep0" align="char" char=".">7984</td><td class="colsep0 rowsep0" align="char" char=".">667</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6e</b></td><td class="colsep0 rowsep0" align="center">Fmoc-QR kbt</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="char" char=".">116</td><td class="colsep0 rowsep0" align="char" char=".">6827</td><td class="colsep0 rowsep0" align="char" char=".">179</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6f</b></td><td class="colsep0 rowsep0" align="center">Fmoc-ER kbt</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char=".">372</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6g</b></td><td class="colsep0 rowsep0" align="center">Fmoc-HR kbt</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">226</td><td class="colsep0 rowsep0" align="char" char=".">6122</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6h</b></td><td class="colsep0 rowsep0" align="center">Fmoc-PR kbt</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="char" char=".">391</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">782</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6i</b></td><td class="colsep0 rowsep0" align="center">Fmoc-MR kbt</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">227</td><td class="colsep0 rowsep0" align="char" char=".">1208</td><td class="colsep0 rowsep0" align="char" char=".">42</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6j</b></td><td class="colsep0 rowsep0" align="center">Fmoc-SR kbt</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">555</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">113</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6k</b></td><td class="colsep0 rowsep0" align="center">Fmoc-NR kbt</td><td class="colsep0 rowsep0" align="char" char=".">106</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">4771</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6l</b></td><td class="colsep0 rowsep0" align="center">Fmoc-LR kbt</td><td class="colsep0 rowsep0" align="char" char=".">253</td><td class="colsep0 rowsep0" align="char" char=".">67</td><td class="colsep0 rowsep0" align="char" char=".">468</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6m</b></td><td class="colsep0 rowsep0" align="center">Fmoc-DR kbt</td><td class="colsep0 rowsep0" align="char" char=".">294</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6n</b></td><td class="colsep0 rowsep0" align="center">Fmoc-YR kbt</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">256</td><td class="colsep0 rowsep0" align="char" char=".">2961</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6o</b></td><td class="colsep0 rowsep0" align="center">Fmoc-IR kbt</td><td class="colsep0 rowsep0" align="char" char=".">486</td><td class="colsep0 rowsep0" align="char" char=".">228</td><td class="colsep0 rowsep0" align="char" char=".">4303</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6p</b></td><td class="colsep0 rowsep0" align="center">Fmoc-WR kbt</td><td class="colsep0 rowsep0" align="char" char=".">294</td><td class="colsep0 rowsep0" align="char" char=".">302</td><td class="colsep0 rowsep0" align="char" char=".">3197</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6q</b></td><td class="colsep0 rowsep0" align="center">Fmoc-TR kbt</td><td class="colsep0 rowsep0" align="char" char=".">271</td><td class="colsep0 rowsep0" align="char" char=".">180</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6r</b></td><td class="colsep0 rowsep0" align="center">Fmoc-FR kbt</td><td class="colsep0 rowsep0" align="char" char=".">188</td><td class="colsep0 rowsep0" align="char" char=".">764</td><td class="colsep0 rowsep0" align="char" char=".">963</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6s</b></td><td class="colsep0 rowsep0" align="center">Fmoc-VR-kbt</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">125</td><td class="colsep0 rowsep0" align="char" char=".">4634</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last"><i>K</i><sub>i</sub>* values were calculated using the Cheng and Prusoff equation<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> (<i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [S]/<i>K</i><sub>m</sub>).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Values are an average of three experiments with ± 10% standard deviation.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">C.  TTSP Selectivity and Structure–Activity Relationships (SAR)</h3><div class="NLM_p">In contrast to HGFA, multiple members of this dipeptide library are potent inhibitors of matriptase and hepsin. The dipeptides <b>6a</b>–<b>6j</b> and <b>6n</b> display high potency for matriptase and >10-fold selectivity over hepsin. In contrast, the dipeptides <b>6k</b>–<b>6m</b> and <b>6o</b> are more potent and selective for hepsin over matriptase. In general, the analogues with the highest potency against matriptase are more potent than the most potent hepsin inhibitors. For example, the most potent inhibitor of matriptase is Fmoc-GR-kbt (<b>6b</b>), with a <i>K</i><sub>i</sub>* of 0.13 nM, while the most potent for hepsin is Fmoc-NR-kbt (<b>6k</b>), with a <i>K</i><sub>i</sub>* of 1.7 nM. To better understand the selectivity of these compounds against these three proteases, virtual docking was employed to identify key interactions. Generally, these compounds adopt similar conformations, with the expected P1 and P2 binding sites occupied by the conserved Arg and then the variable second side chain, respectively. The Fmoc group was observed to form π–π interactions with the conserved Trp215 (chymotrypsin numbering) in the P4 pocket.</div><div class="NLM_p">First, we sought to understand the good affinity of compound <b>6a</b> for matriptase. A salt bridge of the P2 Arg with Asp96 (chymotrypsin numbering; Asp101 in matriptase), in addition to the proximity of the Fmoc group by three aromatic residues (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A,B), provides favorable binding interactions in matriptase. Docking of <b>6a</b> in hepsin indicates the guanidine of the P2 Arg side chain can form hydrogen bonds (H-bonds) with the side chain of Asn99 and the backbone carbonyls of both Ser97 and Pro96 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C,D; chymotrypsin numbering, 254, 251, and 249, respectively, for hepsin). However, this orientation requires Asn99 to occupy a space directly above the Trp215 residue, which disrupts hydrophobic π–π interactions with the Fmoc group, thus the hydrophobic interactions in the P4 pocket and hydrophilic interactions in the P2 pocket are both highly favorable for compound <b>6a</b> in matriptase but in hepsin require a tradeoff between these two pocket’s ability to simultaneously and favorably interact with this ligand, otherwise known as cooperativity. These interactions are likely mimicked with compound <b>6c</b>, which could potentially form a salt bridge with Asp96 as well but with the amine unable to form the extensive H-bonding network observed with the guanidyl group and the hepsin backbone, thus explaining the increased selectivity seen with the Lys side chain (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/medium/jm-2018-01536m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docking model and binding orientations of <b>6a</b> to matriptase (A, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NCL">3NCL</a>, protein in light blue, ligand in gold) and hepsin (C, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z8G">1Z8G</a> protein in tan, ligand in green) with respective ligand interaction diagrams (B, matriptase numbering; D, hepsin numbering).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01536&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a more general analysis, the relationship of the inhibitor selectivity profile with the size, branching, charge, and H-bond donor ability of the side chain of the P2 amino acid was investigated. When the P2 is changed from Glu (compound <b>6f</b>) to Gln (compound <b>6e</b>), the matriptase selectivity increased over 3-fold over hepsin, with a 10-fold increase in potency (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). This increase in activity from carboxylic acid to amide is also observed in <b>6m</b>–<b>6k</b>. However, both <b>6m</b> and <b>6k</b> are selective for hepsin over matriptase. To understand this result, <b>6k</b> was docked into hepsin (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A,C) which indicated a dual H-bond of the P2 Asn side chain with Asn99 (chymotrypsin numbering, Asn254 in hepsin). This H-bonding capability is disrupted in matriptase, where the homologous Phe99 (chymotrypsin numbering, Phe104 in matriptase) overlaps with this required positioning of the P2 Asn amide (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Additionally, HGFA is unable to facilitate this H-bonding due to the homologous Ser pointing away from the ligand.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/medium/jm-2018-01536m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Docking model of <b>6k</b> bound to hepsin. (A) H-Bond capabilities of <b>6k</b> (cyan) with Asn99 of hepsin (tan, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z8G">1Z8G</a>). (B) Overlap of matriptase (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NCL">3NCL</a>) Phe99 and the inability of HGFA (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WUC">2WUC</a>) Ser99 indicate a greatly diminished ability to form favorable interactions in the S2 pocket when P2 is Asn. (C) Surface view of hepsin-bound <b>6k</b> with the P2 Asn residue fitting into the S2 pocket. This amide–amide interaction is likely weakened or lost in hepsin when introducing another carbon linker (Gln); see <b>6e</b> and <b>6f</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01536&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The smallest side chain of Ala at the P2 position (<b>6d</b>) showed excellent selectivity for matriptase over hepsin. This preference increases to over 9-fold when the P2 side chain is removed altogether with Gly, as in compound <b>6b</b>, the most potent (<i>K</i><sub>i</sub>* 0.13 nM) and selective (6400-fold over hepsin) inhibitor we identified for matriptase. The preference for small amino acids in P2 is known for matriptase. and here its selectivity over hepsin and HGFA can be explained by the diverse S2 amino acid residues. For example, the S2 pocket of matriptase is disrupted in the crystal structure of PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NCL">3NCL</a> by Phe99 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,C), potentially introducing steric clashes with large amino acids in the P2 position. However, hydrophobic interaction between the α-carbon of glycine and Phe99 would be present in this case. In contrast, hepsin has a larger pocket which is left unfilled with the simple Gly residue at this location (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). Interestingly, <b>6h</b> (Fmoc-PR-kbt) is incredibly the second most selective inhibitor for matriptase also indicating small sidechains are preferred.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/medium/jm-2018-01536m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking model of <b>6b</b> to (A) matriptase (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NCL">3NCL</a>, blue) surface view with <b>6b</b> (purple) with the P2 position indicated with red circle. (B) Hepsin (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z8G">1Z8G</a>, tan) surface view with docked compo <b>6b</b> (green) and P2 position with clear pocket indicated with red circle. (C) Overlay of matriptase (blue ribbon, residues) and hepsin (tan ribbons, residues) showing the important Phe99 (chymotrypsin numbering) occupying the P2 pocket for matriptase, homologous residue Asn99 of Hepsin pointed away, to the left. (D) Ligand interaction diagram of <b>6b</b> with hepsin (residue numbering for hepsin).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01536&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>6d</b> (Fmoc-AR-kbt) is the third most selective and potent inhibitor for matriptase and with a <i>K</i><sub>i</sub>* of 0.36 nM. It is noteworthy that another group<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> previously identified AR-kbt without the Fmoc group as a potent inhibitor of matriptase with a <i>K</i><sub>i</sub>* of 1.4 nM. Compound <b>6l</b> with Leu at P2 (Fmoc-LR-kbt) is the second most potent hepsin inhibitor we found (<i>K</i><sub>i</sub>* of 67 nM). This result is consistent with that reported by another group<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> who showed Ac-LR-kbt was 60-fold more selective for hepsin over matriptase. The effect of branching at the C3 carbon of the side chain in selectivity was also demonstrated because when the P2 amino acid was changed from Ser (compound <b>6j</b>) to Thr (compound <b>6q</b>), the selectivity was altered considerably (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) going from 113-fold selectivity for matriptase to almost a 2-fold preference for hepsin.</div><div class="NLM_p last">Overall, the selectivity strongly favoring hepsin and matriptase over HGFA is difficult to interpret using our models because several analogues dock well into the active site and subpockets of HGFA. Because our previously reported tetrapeptides (compounds <b>1</b> and <b>2</b>) show excellent activity against HGFA, it may be indicative of the inability for HGFA to adopt a favorable conformation in the P4 pocket to allow the Fmoc favorable interactions (e.g., with the conserved Trp215). In our development of nonpeptide benzamidine inhibitors of matriptase, hepsin, and HGFA,<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> we also observe a similar trend where we can achieve excellent matriptase and hepsin potency and selectivity but not for HGFA. Further biochemical and biophysical studies are in progress to help understand these surprising results but will be reported elsewhere.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">D.  Selective Hepsin Inhibitor <b>6k</b> Inhibits Cellular Proteolytic Activity of Hepsin and Prevents Hepsin-Mediated Loss of Desmosomal Junctions in Breast Cancer Cells</h3><div class="NLM_p">Loss of epithelial integrity is a defining feature during tumor progression, and recently it has been realized that the endogenous inhibitors of HGFA, matriptase, and hepsin, HAI-1 and HAI-2 may play a vital role.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> It is known that hepsin colocalizes with desmosomes in epithelial cells and elevated oncogenic levels of hepsin disrupt the desmosomal junction.<a onclick="showRef(event, 'ref52 ref77'); return false;" href="javascript:void(0);" class="ref ref52 ref77">(52,77)</a> Herein, we asked if selective hepsin inhibitor <b>6k</b> could intervene the desmosome degrading action of hepsin overexpression. We first show that our potent and selective hepsin inhibitor <b>6k</b> inhibits the cellular-mediated proteolysis of the fluorogenic hepsin substrate Boc-QRR-AMC<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> (<i>K</i><sub>m</sub> is >3-fold lower than Boc-QAR-AMC) in modified doxycycline inducible MCF10A mammary epithelial cells (MCF10A-Indu20-hepsin) with an IC<sub>50</sub> of 92 nM (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A), while the matriptase selective inhibitor <b>6b</b> has an IC<sub>50</sub> > 10 μM. In this assay, hepsin is membrane-bound on the extracellular surface of MCF10A cells in contrast to the biochemical enzyme assay described earlier, which uses a soluble recombinant form of hepsin. It is important to note that hepsin, the substrate and inhibitors are all functioning outside the cell and not expected to have any cellular permeability.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/medium/jm-2018-01536m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0010.jpeg" id="GRAPHIC-d7e1476-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibition of cell-based hepsin activity by <b>6k</b> and <b>6b</b>. (A) Inhibition of Boc-QRR-AMC cleavage in MCF10A cells with doxycycline inducible hepsin (MCF10A-Indu20-hepsin) by matriptase inhibitor <b>6b</b> and hepsin inhibitor <b>6k</b>. (B) Inhibition of hepsin-mediated loss of desmosomal cadherin desmoglein 2 by <b>6b</b> and <b>6k</b>. Representative confocal immunofluorescence microscopy images of MCF10A-indu20-hepsin cells without (−DOX) or with (+DOX) induction of hepsin and pretreated with indicated inhibitors. Asterisks denote cells with at least two sides bordering the neighboring cells staining positive for desmoglein 2. Scale bar is 10 μm. (C) Quantitation of desmosomal integrity. Cells expressing pericellular desmoglein 2 staining in at least two sides were counted positive from the immunofluorescent images. Cells were counted from 10 field of views per treatment from three biological repeats and shown as a percentage. Student’s <i>t</i> test was used for statistical analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01536&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Next, we demonstrated that the hepsin selective inhibitor <b>6k</b> was able to rescue pericellular expression of desmoglein 2, thus indicating inhibition of desmosome degradation in these cells at a concentration of 1 μM (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). In contrast, the selective matriptase inhibitor <b>6b</b> had no effect in this assay. This significant finding shows that epithelial integrity damaging actions of oncogenic hepsin can be inhibited by selective hepsin inhibitor but not by matriptase inhibitor. Taken together, these results suggest a critical role for hepsin alone and not matriptase or HGFA in epithelial integrity damage and interventional strategy to inhibit transition of in situ tumors to invasive cancer.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15862" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15862" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have developed a small library of small but selective and potent dipeptide inhibitors of hepsin and matriptase based on PS-SCL screening of HGFA combined with the previously reported data for matriptase and hepsin. The SAR analysis validates these PS-SCL data and indicates that selectivity is highly dependent on the size, branching, charge, and H-bond donor ability of the side chain at P2 position of the dipeptides. When combined with computational docking results, we show that the S2 pocket encompasses differential residue interactions that could be further targeted for further optimization. Small residues such as Gly, Pro, and Ala as well as basic residues produce selective and potent ligands for matriptase, while the intermediate size residues such as Asn are the most potent for hepsin. We hypothesize from our models that the Fmoc group introduces steric bulk that cannot be accommodated by the S4 pocket of HGFA. Finally, we demonstrated the selective matriptase and hepsin inhibitors, <b>6b</b> and <b>6k</b>, respectively, are useful tools for chemical biology studies. To that end, we have provided strong evidence that hepsin alone and not matriptase or HGFA plays a key role in diminishing epithelial cell membrane integrity through degradation of desmogelin-2 in breast cancer cells. The low molecular weight, high potency and selectivity, as well as the facile synthesis enable these new inhibitors as exciting leads for further optimization as matriptase and hepsin TTSP serine protease small molecule inhibitor-based therapeutics and chemical tools.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04056" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04056" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Synthesis, Purification, and Analytical Chemistry Procedures</h3><div class="NLM_p">Starting materials, reagents, and solvents were purchased from commercial vendors unless otherwise noted. <sup>1</sup>H NMR spectra were measured on a Varian 400 MHz NMR instrument. The chemical shifts were reported as δ ppm relative to TMS using residual solvent peak as the reference unless otherwise noted. The following abbreviations were used to express the multiplicities: s = singlet; d = doublet; t = triplet; q = quartet; m = multiplet; br = broad. High-performed liquid chromatography (HPLC) was carried out on GILSON GX-281 using Waters C18 5 μM, 4.6 mm × 50 mm and Waters Prep C18 5 μM, 19 mm × 150 mm reverse phase columns, eluted with a gradient system of 5:95 to 95:5 acetonitrile:water, with a buffer consisting of 0.05% TFA. Mass spectra (MS) were performed on HPLC/MSD using electrospray ionization (ESI) for detection. All reactions were monitored by thin layer chromatography (TLC) carried out on Merck silica gel plates (0.25 mm thick, 60F254), visualized by using UV (254 nm) or dyes such as KMnO<sub>4</sub>, <i>p</i>-anisaldehyde, and cerium ammonium molybdate (CAMA or Hanessian’s Stain). Silica gel chromatography was carried out on a Teledyne ISCO CombiFlash purification system using prepacked silica gel columns (12–330 g sizes). All compounds used for biological assays are greater than 95% purity based on NMR and HPLC by absorbance at 220 and 254 nm wavelengths.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Substrate Specificity Profiling of HGFA</h4><div class="NLM_p last">PS-SCL is a combinatorial peptide library used to uncover the nonprime substrate specificity of proteases. It consists of four sublibraries of fluorogenic substrates with the general structure acetyl-P4-P3-P2-P1-ACC, where ACC corresponds to amino-4-carbamoyl-methylcoumarin. In each sublibrary, one position is fixed, whereas the remaining positions contain an isokinetic mixture of 20 amino acids with cysteine omitted and norleucine included. Synthesis of this library has been described previously.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> When protease mediated cleavage occurs between the P1 amino acid and ACC, a quantitative increase in fluorescence takes place. HGFA (500 nM) was assayed with each sublibrary in 25 mM Tris-HCl, pH 8.0, 150 mM NaCl, 5 mM CaCl<sub>2</sub>, and 0.01% Triton X-100 for 1 h at 25 °C. All reactions were run in triplicate in Costar black 96-well round-bottom plates (Corning, NY) using a BioTek Synergy H4 hybrid multi-mode microplate reader with λex = 380 nm and λem = 460 nm and the photomultiplier tube set to a gain of 63. Initial velocity in relative fluorescence units per second (RFU/s) was calculated using a linear fit of the progress curves with Gen5 software v.2.03.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> General Docking Protocol of Dipeptides into Hepsin, HGFA, and Matriptase</h4><div class="NLM_p last">Receptor grid files were prepared using Schrödinger’s (<i>Schrödinger Release 2018-1, Glide</i>; Schrödinger, LLC: New York, 2018) Protein Preparation Wizard and theGlide module (ref: <a href="https://pubs.acs.org/doi/abs/10.1021/jm051256o" class="extLink">https://pubs.acs.org/doi/abs/10.1021/jm051256o</a>). For all grid files, two constraints were applied: an H-bond requirement to the conserved Asp189 (chymotrypsin numbering), and a sulfur atom (as in the benzothiazole ring) within 4 Å radius of the His57 and Ser195 (chymotrypsin numbering). Ligands were prepared using Schrödinger’s Ligprep module and docking using Glide in SP mode with enhanced conformational sampling. Protonation states of the acidic and basic amino acid side chain residues are those which exist at pH 7.4. Subsequent ligand interactions were generated in the Maestro UI of Schrödinger. Surface and ribbon views were generated using UCSF Chimera (ref: <a href="https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.20084" class="extLink">https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.20084</a>)</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> General Procedure for the Preparation of Dipeptides (<b>6</b>)</h4><div class="NLM_p">Arg (Mtr)-kbt HCl (<b>4</b>, 02 mmol) was coupled with 19 of the natural Fmoc-<span class="smallcaps smallerCapital">l</span>-amino acids (Fmoc-X) with standard protecting groups (<b>5</b>, 0.02 mmol) using HATU (0.02 mmol) as coupling reagent in presence of <sup><i>i</i></sup>Pr<sub>2</sub>NEt (0.1 mmol) in DMF (0.5 mL) under a nitrogen atmosphere. After stirring for 4 h at RT, the reaction was concentrated in vacuo and deprotection of the crude product was accomplished by stirring in 0.3 mL of a TFA–thioanisole–water mixture (95:2.5:2.5) for 4–5 h. After concentrating in vacuo, the crude material was dissolved in DMSO and purified using reverse phase HPLC (0.05% TFA/acetonitrile/water gradient). The pure fractions were pooled, frozen, and lyophilized to give the pure dipeptides, Fmoc-XR-kbt (<b>6</b>) as white powders.</div><div id="sec4_1_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i16" class="anchor-spacer"></div><h5 class="article-section__title" id="_i16"> Fmoc-RR kbt (<b>6a</b>)</h5><div class="NLM_p last">Yield 75%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.20 (d, <i>J</i> = 7.83 Hz, 1 H), 8.11 (d, <i>J</i> = 7.43 Hz, 1 H), 7.79 (d, <i>J</i> = 7.43 Hz, 2 H) 7.53–7.69 (m, 6 H), 7.22–7.43 (m, 2 H), 5.70 (d, <i>J</i> = 8.61 Hz, 1 H), 4.36 (dd, <i>J</i> = 13.89, 6.85 Hz, 3 H), 4.10–4.27 (m, 3 H), 3.05–3.25 (m, 6 H), 2.19 (br s, 1 H), 2.04 (br s, 1 H), 1.51–1.89 (m, 9 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 669.3, found 670.5 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i17" class="anchor-spacer"></div><h5 class="article-section__title" id="_i17"> Fmoc-GR kbt (<b>6b</b>)</h5><div class="NLM_p last">Yield 75%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.02–8.26 (m, 2 H), 7.50–7.84 (m, 6 H), 7.19–7.46 (m, 4 H), 5.70–5.81 (m, 1 H), 4.17–4.39 (m, 3 H), 3.72–3.94 (m, 2 H), 3.24 (br s, 2 H), 2.18 (br s, 1 H), 1.65–1.87 (m, 3 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 570.2, found 571.4 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> Fmoc-KR kbt (<b>6c</b>)</h5><div class="NLM_p last">Yield 84%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.98–8.09 (m, 1 H), 7.92–7.99 (m, 1 H), 7.63–7.67 (m, 3 H), 7.41–7.53 (m, 3 H), 7.13–7.33 (m, 2 H), 6.93–7.09 (m, 2 H), 4.95 (q, <i>J</i> = 7.30 Hz, 2 H), 4.83 (m, 1 H), 4.58–4.72 (m, 2 H), 3.15–3.17 (m, 2 H), 2.49–2.52 (m, 2 H), 2.17 (br s, 2 H), 1.84–1.91 (m, 4 H), 1.15 (br s, 2 H), 1.09 (t, <i>J</i> = 7.24 Hz, 2 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 641.3, found 642.5 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> Fmoc-AR kbt (<b>6d</b>)</h5><div class="NLM_p last">Yield 65%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.19 (d, <i>J</i> = 7.83 Hz, 1 H), 8.10 (d, <i>J</i> = 7.43 Hz, 1 H), 7.78 (d, <i>J</i> = 7.43 Hz, 2 H), 7.61 (dd, <i>J</i> = 15.46, 6.46 Hz, 4 H), 7.22–7.42 (m, 4 H), 5.68 (d, <i>J</i> = 9.00 Hz, 1 H), 5.44 (d, <i>J</i> = 12.91 Hz, 1 H), 4.69 (br s, 2 H), 4.10–4.38 (m, 2 H), 3.87 (br s, 1 H), 3.14 (br s, 3 H), 1.78 (br s, 2 H), 1.33 (d, <i>J</i> = 7.04 Hz, 2 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 584.2, found 585.4 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> Fmoc-QR kbt (<b>6e</b>)</h5><div class="NLM_p last">Yield 65%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.04–8.24 (m, 2 H), 7.78 (d, <i>J</i> = 7.04 Hz, 2 H), 7.49–7.68 (m, 4 H), 7.21–7.44 (m, 4 H), 5.63–5.74 (m, 1 H), 4.05–4.42 (m, 3 H), 3.34–3.48 (m, 1 H), 3.08–3.24 (m, 2 H), 2.26–2.40 (m, 2 H), 2.00–2.23 (m, 2 H), 1.64–1.96 (m, 4 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 641.2, found 642.5 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> Fmoc-ER kbt (<b>6f</b>)</h5><div class="NLM_p last">Yield 65%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.03–8.24 (m, 2 H), 7.79 (br s, 2 H), 7.62 (dd, <i>J</i> = 14.28, 5.28 Hz, 4 H), 7.20–7.45 (m, 4 H), 5.67 (br s, 1 H), 4.11–4.41 (m, 5 H), 3.24 (br s, 2 H), 2.40 (br s, 2 H), 2.00–2.25 (m, 2 H), 1.65–1.96 (m, 4 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 642.2, found 643.5 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> Fmoc-HR kbt (<b>6g</b>)</h5><div class="NLM_p last">Yield 70%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.76 (br s, 2 H), 8.03–8.26 (m, 2 H), 7.50–7.85 (m, 6 H), 7.15–7.44 (m, 4 H), 5.71 (br s, 1 H), 4.26–4.57 (m, 3 H), 4.18 (br s, 2 H), 2.96–3.25 (m, 4 H), 2.19 (br s, 2 H), 1.77 (br s, 2 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 650.2, found 651.5 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> Fmoc-PR kbt (<b>6h</b>)</h5><div class="NLM_p last">Yield 70%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.19 (m, 1 H), 8.12 (m, 1 H), 7.82 (m, 2 H), 7.64 (m, 3 H), 7.57 (m, 1 H), 7.41 (m., 1 H), 7.16–7.37 (m, 3 H), 5.69 (m, 1 H), 4.18–4.48 (m, 4 H), 4.09 (m, 1 H), 3.58 (m, 2 H), 3.13 (m, 1 H), 2.31 (m, 1 H), 2.22 (m, 2 H), 1.92 (m, 2 H), 1.82 (m, 2 H), 1.67 (m, 1 H). LCMS (ESI+): expected <i>m</i>/<i>z</i> 610.2, found 611.5 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> Fmoc-MR kbt (<b>6i</b>)</h5><div class="NLM_p last">Yield 70%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.03–8.23 (m, 2 H), 7.78 (d, <i>J</i> = 7.04 Hz, 2 H), 7.53–7.68 (m, 4 H), 7.22–7.44 (m, 4 H), 5.67 (br s, 1 H), 4.12–4.44 (m, 4 H), 3.24 (d, <i>J</i> = 7.04 Hz, 2 H), 2.51 (d, <i>J</i> = 6.26 Hz, 2 H), 2.18 (br s, 2 H), 2.02 (s, 3 H), 1.67–1.92 (m, 4 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 644.2, found 645.5 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> Fmoc-SR kbt (<b>6j</b>)</h5><div class="NLM_p last">Yield 70%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.00–8.30 (m, 2 H), 7.81 (br s, 2 H), 7.65 (d, <i>J</i> = 16.04 Hz, 4 H), 7.15–7.46 (m, 4 H), 5.70 −5.81 (m, 1 H), 4.05–4.53 (m, 4 H), 3.80 (br s, 2 H), 3.13 (br s, 2 H), 1.78 (br s, 2 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 600.2, found 601.5 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> Fmoc-NR kbt (<b>6k</b>)</h5><div class="NLM_p last">Yield 80%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.15–8.25 (m, 1 H), 8.03–8.16 (m, 1 H), 7.79 (d, <i>J</i> = 7.43 Hz, 2 H), 7.52–7.69 (m, 4 H), 7.21–7.44 (m, 4 H), 5.64–5.78 (m, 1 H), 4.53–4.67 (m, 1 H), 4.29 (d, <i>J</i> = 7.43 Hz, 2 H), 4.12 −4.24 (m, 1 H), 3.17–3.30 (m, 2 H), 2.68–2.85 (m, 2 H), 2.10–2.27 (m, 2 H), 1.63–1.96 (m, 4 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 627.2, found 628.4 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> Fmoc-LR kbt (<b>6l</b>)</h5><div class="NLM_p last">Yield 70%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.04–8.24 (m, 2 H), 7.78 (d, <i>J</i> = 7.43 Hz, 2 H), 7.54–7.69 (m, 4 H), 7.22–7.45 (m, 4 H), 5.65 (br s, 1 H), 4.13–4.41 (m, 5 H), 3.33–3.50 (m, 2 H), 3.23 (br s, 2 H), 2.17 (br s, 1 H), 1.44–1.90 (m, 4 H), 0.79–0.97 (m, 6 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 626.3, found 627.5 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> Fmoc-DR kbt (<b>6m</b>)</h5><div class="NLM_p last">Yield 70%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.19 (d, <i>J</i> = 7.43 Hz, 1 H), 8.03–8.12 (m, 1 H), 7.78 (d, <i>J</i> = 6.65 Hz, 2 H), 7.50–7.69 (m, 4 H), 7.20–7.44 (m, 4 H), 5.66 (d, <i>J</i> = 4.70 Hz, 1 H), 4.55 (d, <i>J</i> = 5.87 Hz, 1 H), 4.12–4.42 (m, 3 H), 3.46 (br s, 1 H), 3.22 (br s, 2 H), 2.61–2.95 (m, 2 H), 2.17 (br s, 1 H), 1.65–1.93 (m, 3 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 628.2, found 629.4 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> Fmoc-YR kbt (<b>6n</b>)</h5><div class="NLM_p last">Yield (70%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.16−8.25 (m, 1 H), 8.06−8.16 (m, 1 H), (br. s., 4 H), 7.58 (br. s., 4 H), 7.12−7.43 (m, 2 H), 6.87−7.11 (m, 2 H), 6.54−6.66 (m, 2 H), 5.61−5.75 (m, 1 H), 4.22−4.44 (m, 2 H), 4.15 (br. s., 1 H), 2.84−3.07 (m, 2 H), 2.66−2.84 (m, 2 H), 1.96−2.24 (m, 2 H), 1.58−1.90 (m, 2 H). LCMS (ESI+), calculated <i>m</i>/<i>z</i> 676.2, found 677.5 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> Fmoc-IR kbt (<b>6o</b>)</h5><div class="NLM_p last">Yield 70%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.04–8.23 (m, 2 H), 7.79 (d, <i>J</i> = 7.04 Hz, 2 H), 7.51–7.68 (m, 4 H), 7.22–7.43 (m, 4 H), 5.69 (d, <i>J</i> = 5.09 Hz, 1 H), 4.11–4.42 (m, 4 H), 3.98 (d, <i>J</i> = 7.83 Hz, 1 H), 3.16–3.24 (m, 2 H), 2.16 (m, 1 H), 1.65–1.86 (m, 3 H), 1.09–1.23 (m, 1 H), 0.77–0.97 (m, 8 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 626.3, found 627.5 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Fmoc-WR kbt (<b>6p</b>)</h5><div class="NLM_p last">Yield 70%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.06–8.24 (m, 3 H), 7.70–7.87 (m, 4 H), 7.59 (d, <i>J</i> = 8.61 Hz, 2 H), 7.17–7.43 (m, 4H), 7.03–7.14 (m, 2 H), 6.81–6.95 (m, 2 H), 5.54–5.68 (m, 1 H), 5.05–5.22 (m, 1 H), 4.39–4.60 (m, 2 H), 4.26–4.39 (m, 1 H), 4.06–4.25 (m,1 H), 3.20 (d, <i>J</i> = 4.70 Hz, 2 H), 1.93–2.17 (m, 2 H), 1.50–1.86 (m, 2 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 699.3, found 700.5 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Fmoc-TR kbt (<b>6q</b>)</h5><div class="NLM_p last">Yield 70%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.17–8.27 (m, 1 H), 8.07–8.14 (m, 1 H), 7.74–7.86 (m, 1 H), 7.54–7.70 (m, 2 H), 7.19–7.44 (m, 3 H), 5.71–5.83 (m, 1 H), 4.05–4.54 (m, 4 H), 2.12–2.28 (m, 2 H), 1.64–1.95 (m, 2 H), 1.49–1.56 (m, 2 H), 1.19 (d, 3 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 614.2, found 615.5 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Fmoc-FR kbt (<b>6r</b>)</h5><div class="NLM_p last">Yield 70%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.04–8.25 (m, 2 H), 7.50–7.83 (m, 7 H), 7.04–7.45 (m, 9 H), 5.66 (br s, 1 H), 4.04–4.49 (m, 5 H), 3.46 (br s, 2 H), 2.80–3.24 (m, 4 H), 1.72 (br s, 2 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 660.2, found 661.5 (M + H<sup>+</sup>).</div></div><div id="sec4_1_3_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> Fmoc-VR-kbt (<b>6s</b>)</h5><div class="NLM_p last">Yield 70%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.16–8.27 (m, 1 H), 8.03–8.13 (m, 1 H), 7.80 (s, 2 H), 7.65 (br s, 4 H), 7.25–7.46 (m, 4 H), 5.66–5.78 (m, 1 H), 4.33–4.44 (m, 1 H), 4.14–4.32 (m, 2 H), 3.91–4.04 (m, 2 H), 2.12–2.27 (m, 1 H), 1.96–2.10 (m, 1 H), 1.65–1.94 (m, 4 H), 0.84–1.07 (m, 6 H). LCMS (ESI+): calculated <i>m</i>/<i>z</i> 612.2, found 613.5 (M + H<sup>+</sup>).</div></div></div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Fluorescent Kinetic Enzyme Inhibitor Assays of HGFA, Matriptase, and Hepsin</h3><div class="NLM_p last">Inhibitors were serially diluted to 11 concentrations (0–20 μM final concentration in reaction) in DMSO (2% DMSO final concentration) and then mixed with either recombinant catalytic domains of HGFA,<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> matriptase (3946-SEB, R&D Systems) or hepsin* (4776-SE, R&D Systems) in black 384-well plates (Corning no. 3575, Corning, NY). The final assay concentration for HGFA, matriptase, and hepsin 7.5, 0.2, and 0.3 nM, respectively, in TNC buffer (25 mM Tris, 150 mM NaCl, 5 mM CaCl<sub>2</sub>, 0.01% Triton X-100, pH 8). After 30 min incubation at room temperature, Boc-QLR-AMC substrate (<i>K</i><sub>m</sub> = 37 μM) was added to the HGFA assays and Boc-QAR-AMC substrate was added to the matriptase (<i>K</i><sub>m</sub> = 93 μM) and hepsin (<i>K</i><sub>m</sub> = 156 μM) assays. The final substrate concentrations for all assays were at the <i>K</i><sub>m</sub> for the respective enzymes. Changes in fluorescence (excitation at 380 nm and emission at 460 nm) were measured at room temperature over time in a Biotek Synergy 2 plate reader (Winnoski, VT). Using GraphPad Prism version 6.04 software program, (GraphPad Software, San Diego, CA, <a href="http://www.graphpad.com" class="extLink">www.graphpad.com</a>), a four-parameter curve fit was used to determine the inhibitor IC<sub>50</sub>s from a plot of the mean reaction velocity versus the inhibitor concentration. The IC<sub>50</sub> values represent the average of three separate experimental determinations. <i>K</i><sub>i</sub>* values were calculated using the Cheng and Prusoff equation<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> (<i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [S]/<i>K</i><sub>m</sub>).</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> *Hepsin Activation</h3><div class="NLM_p last">Recombinant hepsin (10 μg, 0.44 mg/mL) was diluted to 2.4 μM in TNC buffer (25 mM Tris, 150 mM NaCl, 5 mM CaCl<sub>2</sub>, 0.01% Triton X-100, pH 8) and incubated at 37 °C. After 24 h, the hepsin was diluted in glycerol to 50%. This stock hepsin (1.2 μM) was stored in a −20 °C freezer and diluted in TNC buffer for use in assays.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Cell Lines</h3><div class="NLM_p last">MCF10A cells were obtained from ATCC (Manassas, VA, USA) and maintained in low passages and regularly tested for mycoplasma contamination. Culture protocols for MCF10A have been described in Partanen et al. 2013. Generation and characterization of doxycycline inducible hepsin in MCF10A cells (MCF10A-Indu20-hepsin) is described in Tervonen et al.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Cell-Based Activity Assay</h3><div class="NLM_p last">Fluorogenic peptide substrate for hepsin, Boc-QRR-AMC (no. 4017093, Bachem) was used to analyze the proteolytic activity of hepsin in a cell-based assay. The 50000 MCF10A-indu20-hepsin cells were seeded per well in 96-well plates and incubated for 24 h at the cell. Hepsin was induced by adding 100 ng/mL doxycycline and incubated for additional 24 h. MCF10A-Indu20-hepsin cells were pretreated with either DMSO or increasing concentration of inhibitors for 30 min, followed by the addition of 30 μM substrate. The amount of peptide cleavage was then detected by using FLUOstar Omega (BMG Labtech) at 350<sup>em</sup>/450<sup>ex</sup> nm. The amount of substrate cleaved was expressed in terms of % activity with respect to the DMSO control. Inhibitors IC<sub>50</sub>s were determined using a four-parameter curve fit in GraphPad Inc. Prism software (Tervonen et al.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and Pant et al.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a>).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Immunofluorescence Staining Protocols, Confocal Fluorescence Microscopy</h3><div class="NLM_p last">The immunofluorescence staining and confocal fluorescence microscopy protocols are described in Tervonen et al.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> For immunostaining, cells were cultured in 2D monolayer on coverslips. The cells were fixed and permeabilized with ice-cold 100% methanol for 5 min at room temperature (RT). Cells were then washed once with PBS and blocked with in 0.1% bovine serum albumin (BSA) in PBS for 30 min in RT. Cell were then incubated in primary antibodies hepsin (Cayman Chemicals) and desmoglein 2 (Abcam) followed by three washes before incubation with secondary antibodies (Alexa-488/546-conjugated secondary antibodies, Invitrogen) for 45 min at RT. Nuclei were counterstained with Hoechst 33258 (Sigma). Coverslips were mounted on objective glasses with Immu-Mount (Thermo Scientific). For quantitative analysis of immunostained cells, digital images were acquired with confocal microscopes Leica TCS SP8 CARS. Contrast and brightness for images were optimized with uniform settings across single experiment using Adobe Photoshop CS5.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01536" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70366" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70366" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01536" class="ext-link">10.1021/acs.jmedchem.8b01536</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H NMR, HPLC purity and MS spectral data for all compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01536/suppl_file/jm8b01536_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01536/suppl_file/jm8b01536_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01536/suppl_file/jm8b01536_si_001.pdf">jm8b01536_si_001.pdf (2.37 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01536/suppl_file/jm8b01536_si_002.csv">jm8b01536_si_002.csv (2.36 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01536" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20844" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20844" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James W. Janetka</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, 63110, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9888-5411" title="Orcid link">http://orcid.org/0000-0002-9888-5411</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#345e555a51405f555e7443414740581a515041"><span class="__cf_email__" data-cfemail="412b202f24352a202b01363432352d6f242534">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vishnu
C. Damalanka</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, 63110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhenfu Han</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, 63110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Partha Karmakar</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, 63110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony J. O’Donoghue</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, University
of California, San Francisco, California, 94158, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Skaggs
School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, California, 92093, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5695-0409" title="Orcid link">http://orcid.org/0000-0001-5695-0409</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florencia La Greca</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, University
of California, San Francisco, California, 94158, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tommy Kim</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, 63110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shishir M. Pant</span> - <span class="hlFld-Affiliation affiliation">Cancer
Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer
Biology & Medicum, University of Helsinki, P.O. Box 63, Haartmaninkatu 8, 00014 Helsinki, Finland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan Helander</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, 63110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juha Klefström</span> - <span class="hlFld-Affiliation affiliation">Cancer
Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer
Biology & Medicum, University of Helsinki, P.O. Box 63, Haartmaninkatu 8, 00014 Helsinki, Finland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles S. Craik</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, University
of California, San Francisco, California, 94158, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7704-9185" title="Orcid link">http://orcid.org/0000-0001-7704-9185</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73345" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73345" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Funding for this work was generously provided by the Alvin J. Siteman Cancer Research Fund (Washington University School of Medicine), Susan G. Komen for the Cure Foundation grants CCR12222792 and CCR499051, and the Academy of Finland and Finnish Cancer Organization.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">TTSPs</td><td class="NLM_def"><p class="first last">type-II transmembrane serine proteases</p></td></tr><tr><td class="NLM_term">HGFA</td><td class="NLM_def"><p class="first last">hepatocyte growth factor activator</p></td></tr><tr><td class="NLM_term">HGF</td><td class="NLM_def"><p class="first last">hepatocyte growth factor</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">kbt</td><td class="NLM_def"><p class="first last">α-ketobenozothiazole</p></td></tr><tr><td class="NLM_term">PS-SCL</td><td class="NLM_def"><p class="first last">positional scanning of substrate combinatorial libraries</p></td></tr><tr><td class="NLM_term">MSP</td><td class="NLM_def"><p class="first last">macrophage stimulating protein</p></td></tr><tr><td class="NLM_term">TRKs</td><td class="NLM_def"><p class="first last">receptor tyrosine kinases</p></td></tr><tr><td class="NLM_term">EMT</td><td class="NLM_def"><p class="first last">epithelial to mesenchymal transition</p></td></tr><tr><td class="NLM_term">HAI-1</td><td class="NLM_def"><p class="first last">hepatocyte growth factor activator inhibitor type-1</p></td></tr><tr><td class="NLM_term">HAI-2</td><td class="NLM_def"><p class="first last">hepatocyte growth factor activator inhibitor type-2</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 79 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Otin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bond, J. S.</span></span> <span> </span><span class="NLM_article-title">Proteases: multifunctional enzymes in life and disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">30433</span>– <span class="NLM_lpage">30437</span>, <span class="refDoi"> DOI: 10.1074/jbc.R800035200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1074%2Fjbc.R800035200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=30433-30437&author=C.+Lopez-Otinauthor=J.+S.+Bond&title=Proteases%3A+multifunctional+enzymes+in+life+and+disease&doi=10.1074%2Fjbc.R800035200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R800035200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R800035200%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Otin%26aufirst%3DC.%26aulast%3DBond%26aufirst%3DJ.%2BS.%26atitle%3DProteases%253A%2520multifunctional%2520enzymes%2520in%2520life%2520and%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D30433%26epage%3D30437%26doi%3D10.1074%2Fjbc.R800035200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menssen, R.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of cell regulation–proteolysis, the big surprise</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>592</i></span>,  <span class="NLM_fpage">2515</span>– <span class="NLM_lpage">2524</span>, <span class="refDoi"> DOI: 10.1002/1873-3468.13109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1002%2F1873-3468.13109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=592&publication_year=2018&pages=2515-2524&author=D.+H.+Wolfauthor=R.+Menssen&title=Mechanisms+of+cell+regulation%E2%80%93proteolysis%2C+the+big+surprise&doi=10.1002%2F1873-3468.13109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2F1873-3468.13109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1873-3468.13109%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DD.%2BH.%26aulast%3DMenssen%26aufirst%3DR.%26atitle%3DMechanisms%2520of%2520cell%2520regulation%25E2%2580%2593proteolysis%252C%2520the%2520big%2520surprise%26jtitle%3DFEBS%2520Lett.%26date%3D2018%26volume%3D592%26spage%3D2515%26epage%3D2524%26doi%3D10.1002%2F1873-3468.13109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman-Vaughan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, J. V.</span></span> <span> </span><span class="NLM_article-title">Regulated intramembrane proteolysis: emergent role in cell signalling pathways</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1185</span>– <span class="NLM_lpage">1202</span>, <span class="refDoi"> DOI: 10.1042/BST20170002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1042%2FBST20170002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29079648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2jsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=1185-1202&author=A.+J.+McCarthyauthor=C.+Coleman-Vaughanauthor=J.+V.+McCarthy&title=Regulated+intramembrane+proteolysis%3A+emergent+role+in+cell+signalling+pathways&doi=10.1042%2FBST20170002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Regulated intramembrane proteolysis: emergent role in cell signalling pathways</span></div><div class="casAuthors">McCarthy, Aonghus J.; Coleman-Vaughan, Caroline; McCarthy, Justin V.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1185-1202</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Receptor signalling events including those initiated following activation of cytokine and growth factor receptors and the well-characterised death receptors (tumor necrosis factor receptor, type 1, FasR and TRAIL-R1/2) are initiated at the cell surface through the recruitment and formation of intracellular multiprotein signalling complexes that activate divergent signalling pathways.  Over the past decade, research studies reveal that many of these receptor-initiated signalling events involve the sequential proteolysis of specific receptors by membrane-bound proteases and the γ-secretase protease complexes.  Proteolysis enables the liberation of sol. receptor ectodomains and the generation of intracellular receptor cytoplasmic domain fragments.  The combined and sequential enzymic activity has been defined as regulated intramembrane proteolysis and is now a fundamental signal transduction process involved in the termination or propagation of receptor signalling events.  In this review, we discuss emerging evidence for a role of the γ-secretase protease complexes and regulated intramembrane proteolysis in cell- and immune-signalling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGPwlWk4YWfrVg90H21EOLACvtfcHk0lhz4TLUxlGNkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2jsr%252FL&md5=0197606bd89179c5d071039b92e58f96</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1042%2FBST20170002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20170002%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarthy%26aufirst%3DA.%2BJ.%26aulast%3DColeman-Vaughan%26aufirst%3DC.%26aulast%3DMcCarthy%26aufirst%3DJ.%2BV.%26atitle%3DRegulated%2520intramembrane%2520proteolysis%253A%2520emergent%2520role%2520in%2520cell%2520signalling%2520pathways%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2017%26volume%3D45%26spage%3D1185%26epage%3D1202%26doi%3D10.1042%2FBST20170002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achen, M. G.</span></span> <span> </span><span class="NLM_article-title">The proteolytic activation of angiogenic and lymphangiogenic growth factors in cancer–its potential relevance for therapeutics and diagnostics</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1821</span>– <span class="NLM_lpage">1842</span>, <span class="refDoi"> DOI: 10.2174/0929867321666131217144550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.2174%2F0929867321666131217144550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=24350854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmt1Gqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1821-1842&author=N.+C.+Harrisauthor=M.+G.+Achen&title=The+proteolytic+activation+of+angiogenic+and+lymphangiogenic+growth+factors+in+cancer%E2%80%93its+potential+relevance+for+therapeutics+and+diagnostics&doi=10.2174%2F0929867321666131217144550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The Proteolytic Activation of Angiogenic and Lymphangiogenic Growth Factors in Cancer - Its Potential Relevance for Therapeutics and Diagnostics</span></div><div class="casAuthors">Harris, Nicole C.; Achen, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1821-1842</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The growth of blood vessels (angiogenesis) and lymphatic vessels (lymphangiogenesis) in and around solid tumors is central to the growth and metastatic spread of cancer.  The therapeutic targeting of angiogenesis has become an established modality of cancer treatment, however, more comprehensive targeting of angiogenic signaling pathways may be required to enhance the clin. benefits of this approach.  Angiogenesis and lymphangiogenesis are driven, or modulated, by a range of secreted glycoproteins including vascular endothelial growth factors, platelet-derived growth factors, and transforming growth factor-β.  These key regulatory growth factors are subject to proteolytic activation, involving highly specific cleavage events, which can occur at the cell surface or in the extracellular milieu.  These cleavage events are catalyzed by a variety of enzymes including proprotein convertases.  This proteolysis can regulate the activity of these growth factors by enhancing binding affinities for cell surface receptors and co-receptors, or by altering their interactions with heparan sulfate proteoglycans, thereby modulating bioavailability.  The proteolytic processing of these growth factors complicates strategies for targeting them for diagnostic and/or therapeutic purposes in cancer, as processing can generate various forms with distinct biol. properties.  Hence it has been important to det. which forms are biol. active for promoting angiogenesis and lymphangiogenesis in cancer, so as to indicate clin. relevance.  Here we review the regulation of tumor angiogenesis and lymphangiogenesis by proteolytic activation of growth factors, and the potential therapeutic and diagnostic strategies arising from our understanding of this process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8Dz41WYYQHbVg90H21EOLACvtfcHk0lihI1qW7NKTtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmt1Gqtr8%253D&md5=dc55abec7e0f1b1476809d96008471f9</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F0929867321666131217144550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666131217144550%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DN.%2BC.%26aulast%3DAchen%26aufirst%3DM.%2BG.%26atitle%3DThe%2520proteolytic%2520activation%2520of%2520angiogenic%2520and%2520lymphangiogenic%2520growth%2520factors%2520in%2520cancer%25E2%2580%2593its%2520potential%2520relevance%2520for%2520therapeutics%2520and%2520diagnostics%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1821%26epage%3D1842%26doi%3D10.2174%2F0929867321666131217144550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eatemadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiyelabegan, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negahdari, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazlomi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daraee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daraee, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eatemadi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadroddiny, E.</span></span> <span> </span><span class="NLM_article-title">Role of protease and protease inhibitors in cancer pathogenesis and treatment</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2016.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.biopha.2016.12.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=28006747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFWltrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2017&pages=221-231&author=A.+Eatemadiauthor=H.+T.+Aiyelabeganauthor=B.+Negahdariauthor=M.+A.+Mazlomiauthor=H.+Daraeeauthor=N.+Daraeeauthor=R.+Eatemadiauthor=E.+Sadroddiny&title=Role+of+protease+and+protease+inhibitors+in+cancer+pathogenesis+and+treatment&doi=10.1016%2Fj.biopha.2016.12.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Role of protease and protease inhibitors in cancer pathogenesis and treatment</span></div><div class="casAuthors">Eatemadi, Ali; Aiyelabegan, Hammed T.; Negahdari, Babak; Mazlomi, Mohammad Ali; Daraee, Hadis; Daraee, Nasim; Eatemadi, Razieh; Sadroddiny, Esmaeil</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">221-231</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Cancer is the second cause of death in 2015, and it has been estd. to surpass heart diseases as the leading cause of death in the next few years.  Several mechanisms are involved in cancer pathogenesis.  Studies have indicated that proteases are also implicated in tumor growth and progression which is highly dependent on nutrient and oxygen supply.  On the other hand, protease inhibitors could be considered as a potent strategy in cancer therapy.  On the basis of the type of the key amino acid in the active site of the protease and the mechanism of peptide bond cleavage, proteases can be classified into six groups: cysteine, serine, threonine, glutamic acid, aspartate proteases, as well as matrix metalloproteases.  In this review, we focus on the role of different types of proteases and protease inhibitors in cancer pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAT3oJ_gif8rVg90H21EOLACvtfcHk0lihI1qW7NKTtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFWltrfL&md5=decfade2ecb7c383ba1de1535d25c3be</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2016.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2016.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DEatemadi%26aufirst%3DA.%26aulast%3DAiyelabegan%26aufirst%3DH.%2BT.%26aulast%3DNegahdari%26aufirst%3DB.%26aulast%3DMazlomi%26aufirst%3DM.%2BA.%26aulast%3DDaraee%26aufirst%3DH.%26aulast%3DDaraee%26aufirst%3DN.%26aulast%3DEatemadi%26aufirst%3DR.%26aulast%3DSadroddiny%26aufirst%3DE.%26atitle%3DRole%2520of%2520protease%2520and%2520protease%2520inhibitors%2520in%2520cancer%2520pathogenesis%2520and%2520treatment%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2017%26volume%3D86%26spage%3D221%26epage%3D231%26doi%3D10.1016%2Fj.biopha.2016.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mason, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, J. A.</span></span> <span> </span><span class="NLM_article-title">Proteolytic networks in cancer</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2010.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.tcb.2010.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=21232958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1Gnt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=228-237&author=S.+D.+Masonauthor=J.+A.+Joyce&title=Proteolytic+networks+in+cancer&doi=10.1016%2Fj.tcb.2010.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic networks in cancer</span></div><div class="casAuthors">Mason, Steven D.; Joyce, Johanna A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">228-237</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Proteases are important for multiple processes during malignant progression, including tumor angiogenesis, invasion and metastasis.  Recent evidence reveals that tumor-promoting proteases function as part of an extensive multidirectional network of proteolytic interactions, in contrast to the unidirectional caspase cascade.  These networks involve different constituents of the tumor microenvironment and key proteases, such as cathepsin B, urokinase-type plasminogen activator and several matrix metalloproteinases, occupy central nodes for amplifying proteolytic signals passing through the network.  The proteolytic network interacts with other important signaling pathways in tumor biol., involving chemokines, cytokines, and kinases.  Viewing these proteolytic interactions as a system of activating and inhibiting reactions provides insight into tumor biol. and reveals relevant pharmaceutical targets.  This review examines recent advances in understanding proteases in cancer and summarizes how the network of activity is co-opted to promote tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtZN81nyg0grVg90H21EOLACvtfcHk0lihI1qW7NKTtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1Gnt78%253D&md5=60909797ce77bd59bed67d8b8dcfde87</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2010.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2010.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DS.%2BD.%26aulast%3DJoyce%26aufirst%3DJ.%2BA.%26atitle%3DProteolytic%2520networks%2520in%2520cancer%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2011%26volume%3D21%26spage%3D228%26epage%3D237%26doi%3D10.1016%2Fj.tcb.2010.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sevenich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, J. A.</span></span> <span> </span><span class="NLM_article-title">Pericellular proteolysis in cancer</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2331</span>– <span class="NLM_lpage">2347</span>, <span class="refDoi"> DOI: 10.1101/gad.250647.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1101%2Fgad.250647.114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=2331-2347&author=L.+Sevenichauthor=J.+A.+Joyce&title=Pericellular+proteolysis+in+cancer&doi=10.1101%2Fgad.250647.114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1101%2Fgad.250647.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.250647.114%26sid%3Dliteratum%253Aachs%26aulast%3DSevenich%26aufirst%3DL.%26aulast%3DJoyce%26aufirst%3DJ.%2BA.%26atitle%3DPericellular%2520proteolysis%2520in%2520cancer%26jtitle%3DGenes%2520Dev.%26date%3D2014%26volume%3D28%26spage%3D2331%26epage%3D2347%26doi%3D10.1101%2Fgad.250647.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eftekhari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lima, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saifeddine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noorbakhsh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarisbrick, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenberg, M. D.</span></span> <span> </span><span class="NLM_article-title">Microenvironment proteinases, proteinase-activated receptor regulation, cancer and inflammation</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>399</i></span>,  <span class="NLM_fpage">1023</span>– <span class="NLM_lpage">1039</span>, <span class="refDoi"> DOI: 10.1515/hsz-2018-0001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1515%2Fhsz-2018-0001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=2018&pages=1023-1039&author=R.+Eftekhariauthor=S.+G.+de+Limaauthor=Y.+Liuauthor=K.+Miharaauthor=M.+Saifeddineauthor=F.+Noorbakhshauthor=I.+A.+Scarisbrickauthor=M.+D.+Hollenberg&title=Microenvironment+proteinases%2C+proteinase-activated+receptor+regulation%2C+cancer+and+inflammation&doi=10.1515%2Fhsz-2018-0001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2018-0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2018-0001%26sid%3Dliteratum%253Aachs%26aulast%3DEftekhari%26aufirst%3DR.%26aulast%3Dde%2BLima%26aufirst%3DS.%2BG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMihara%26aufirst%3DK.%26aulast%3DSaifeddine%26aufirst%3DM.%26aulast%3DNoorbakhsh%26aufirst%3DF.%26aulast%3DScarisbrick%26aufirst%3DI.%2BA.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26atitle%3DMicroenvironment%2520proteinases%252C%2520proteinase-activated%2520receptor%2520regulation%252C%2520cancer%2520and%2520inflammation%26jtitle%3DBiol.%2520Chem.%26date%3D2018%26volume%3D399%26spage%3D1023%26epage%3D1039%26doi%3D10.1515%2Fhsz-2018-0001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oikonomopoulou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamandis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenberg, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandran, V.</span></span> <span> </span><span class="NLM_article-title">Proteinases and their receptors in inflammatory arthritis: an overview</span>. <i>Nat. Rev. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1038/nrrheum.2018.17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1038%2Fnrrheum.2018.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29416136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=170-180&author=K.+Oikonomopoulouauthor=E.+P.+Diamandisauthor=M.+D.+Hollenbergauthor=V.+Chandran&title=Proteinases+and+their+receptors+in+inflammatory+arthritis%3A+an+overview&doi=10.1038%2Fnrrheum.2018.17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Proteinases and their receptors in inflammatory arthritis: an overview</span></div><div class="casAuthors">Oikonomopoulou, Katerina; Diamandis, Eleftherios P.; Hollenberg, Morley D.; Chandran, Vinod</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Rheumatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">170-180</span>CODEN:
                <span class="NLM_cas:coden">NRRACB</span>;
        ISSN:<span class="NLM_cas:issn">1759-4790</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Proteinases are enzymes with established roles in physiol. and pathol. processes such as digestion and the homeostasis, destruction and repair of tissues.  Over the past few years, the hormone-like properties of circulating proteinases have become increasingly appreciated.  Some proteolytic enzymes trigger cell signalling via proteinase-activated receptors, a family of G protein-coupled receptors that have been implicated in inflammation and pain in inflammatory arthritis.  Proteinases can also regulate ion flux owing to the cross-sensitization of transient receptor potential cation channel subfamily V members 1 and 4, which are assocd. with mechanosensing and pain.  In this Review, the idea that proteinases have the potential to orchestrate inflammatory signals by interacting with receptors on cells within the synovial microenvironment of an inflamed joint is revisited in three arthritic diseases: osteoarthritis, spondyloarthritis and rheumatoid arthritis.  Unanswered questions are highlighted and the therapeutic potential of modulating this proteinase-receptor axis for the management of disease in patients with these types of arthritis is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyh0isavyOy7Vg90H21EOLACvtfcHk0lhrrTjL-TaGkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKjs70%253D&md5=2b5b3abfd42385c916651acaea15efcb</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrrheum.2018.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrrheum.2018.17%26sid%3Dliteratum%253Aachs%26aulast%3DOikonomopoulou%26aufirst%3DK.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DChandran%26aufirst%3DV.%26atitle%3DProteinases%2520and%2520their%2520receptors%2520in%2520inflammatory%2520arthritis%253A%2520an%2520overview%26jtitle%3DNat.%2520Rev.%2520Rheumatol.%26date%3D2018%26volume%3D14%26spage%3D170%26epage%3D180%26doi%3D10.1038%2Fnrrheum.2018.17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanabe, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">List, K.</span></span> <span> </span><span class="NLM_article-title">The role of type II transmembrane serine protease-mediated signaling in cancer</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">1421</span>– <span class="NLM_lpage">1436</span>, <span class="refDoi"> DOI: 10.1111/febs.13971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1111%2Ffebs.13971" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2017&pages=1421-1436&author=L.+M.+Tanabeauthor=K.+List&title=The+role+of+type+II+transmembrane+serine+protease-mediated+signaling+in+cancer&doi=10.1111%2Ffebs.13971"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13971%26sid%3Dliteratum%253Aachs%26aulast%3DTanabe%26aufirst%3DL.%2BM.%26aulast%3DList%26aufirst%3DK.%26atitle%3DThe%2520role%2520of%2520type%2520II%2520transmembrane%2520serine%2520protease-mediated%2520signaling%2520in%2520cancer%26jtitle%3DFEBS%2520J.%26date%3D2017%26volume%3D284%26spage%3D1421%26epage%3D1436%26doi%3D10.1111%2Ffebs.13971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Owen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilpatrick, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, V.</span></span> <span> </span><span class="NLM_article-title">Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>426</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1042/BJ20091448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1042%2FBJ20091448" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2010&pages=219-228&author=K.+A.+Owenauthor=D.+Y.+Qiuauthor=J.+Alvesauthor=A.+M.+Schumacherauthor=L.+M.+Kilpatrickauthor=J.+Liauthor=J.+L.+Harrisauthor=V.+Ellis&title=Pericellular+activation+of+hepatocyte+growth+factor+by+the+transmembrane+serine+proteases+matriptase+and+hepsin%2C+but+not+by+the+membrane-associated+protease+uPA&doi=10.1042%2FBJ20091448"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1042%2FBJ20091448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20091448%26sid%3Dliteratum%253Aachs%26aulast%3DOwen%26aufirst%3DK.%2BA.%26aulast%3DQiu%26aufirst%3DD.%2BY.%26aulast%3DAlves%26aufirst%3DJ.%26aulast%3DSchumacher%26aufirst%3DA.%2BM.%26aulast%3DKilpatrick%26aufirst%3DL.%2BM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DJ.%2BL.%26aulast%3DEllis%26aufirst%3DV.%26atitle%3DPericellular%2520activation%2520of%2520hepatocyte%2520growth%2520factor%2520by%2520the%2520transmembrane%2520serine%2520proteases%2520matriptase%2520and%2520hepsin%252C%2520but%2520not%2520by%2520the%2520membrane-associated%2520protease%2520uPA%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D426%26spage%3D219%26epage%3D228%26doi%3D10.1042%2FBJ20091448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolumam, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarus, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhuri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchhofer, D.</span></span> <span> </span><span class="NLM_article-title">Proteolytic activation of pro-macrophage-stimulating protein by hepsin</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1186</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-11-0004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1158%2F1541-7786.MCR-11-0004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=21875933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKntb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=1175-1186&author=R.+Ganesanauthor=G.+A.+Kolumamauthor=S.+J.+Linauthor=M.+H.+Xieauthor=L.+Santellauthor=T.+D.+Wuauthor=R.+A.+Lazarusauthor=A.+Chaudhuriauthor=D.+Kirchhofer&title=Proteolytic+activation+of+pro-macrophage-stimulating+protein+by+hepsin&doi=10.1158%2F1541-7786.MCR-11-0004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic Activation of Pro-Macrophage-Stimulating Protein by Hepsin</span></div><div class="casAuthors">Ganesan, Rajkumar; Kolumam, Ganesh A.; Lin, S. Jack; Xie, Ming-Hong; Santell, Lydia; Wu, Thomas D.; Lazarus, Robert A.; Chaudhuri, Amitabha; Kirchhofer, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1175-1186</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Macrophage-stimulating protein (MSP) is a plasminogen-related growth factor and ligand for the receptor tyrosine kinase RON.  The MSP/RON system promotes wound healing and invasive tumor growth and suppresses proinflammatory immune response.  MSP binding to RON requires proteolytic conversion of the inactive single-chain form (pro-MSP) into the disulfide-linked α/β heterodimer.  The pro-MSP cleavage sequence (Ser-Lys-Leu-Arg483↓Val484) closely matches the substrate recognition sequences of hepsin, a type II transmembrane serine protease, that is overexpressed in several cancers.  Here, we show that recombinant hepsin cleaves pro-MSP at the consensus site Arg483-Val484 with superior efficiency compared with the known activators MT-SP1 and hepatocyte growth factor activator (HGFA).  At least 50% of pro-MSP was processed within 1 h at a hepsin concn. of 2.4 nmol/L and at a molar enzyme to substrate ratio of 1:500.  An uncleavable single-chain variant of MSP weakly bound to a RON-Fc fusion protein, whereas hepsin-cleaved MSP bound with a KD of 10.3 nmol/L, suggesting that the high-affinity binding site in MSP β-chain was properly formed.  LNCaP prostate cancer cells overexpressing hepsin on the cell surface efficiently activated pro-MSP, which was blocked by a specific anti-hepsin antibody.  Incubation of pro-MSP with hepsin led to robust RON-mediated phosphorylation of mitogen-activated protein kinase, ribosomal S6 protein, and Akt in human A2780 ovarian carcinoma cells stably expressing RON protein.  In macrophages, pro-MSP with hepsin induced chemotaxis and attenuated lipopolysaccharide-dependent prodn. of nitric oxide.  These findings suggest that the MSP/RON signaling pathway may be regulated by hepsin in tissue homeostasis and in disease pathologies, such as in cancer and immune disorders.  Mol Cancer Res; 9(9); 1175-86.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmBj9IV-D-j7Vg90H21EOLACvtfcHk0lgEpAyq8En7XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKntb%252FM&md5=86805e168be676e7776550a0d817082d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-11-0004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-11-0004%26sid%3Dliteratum%253Aachs%26aulast%3DGanesan%26aufirst%3DR.%26aulast%3DKolumam%26aufirst%3DG.%2BA.%26aulast%3DLin%26aufirst%3DS.%2BJ.%26aulast%3DXie%26aufirst%3DM.%2BH.%26aulast%3DSantell%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DT.%2BD.%26aulast%3DLazarus%26aufirst%3DR.%2BA.%26aulast%3DChaudhuri%26aufirst%3DA.%26aulast%3DKirchhofer%26aufirst%3DD.%26atitle%3DProteolytic%2520activation%2520of%2520pro-macrophage-stimulating%2520protein%2520by%2520hepsin%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2011%26volume%3D9%26spage%3D1175%26epage%3D1186%26doi%3D10.1158%2F1541-7786.MCR-11-0004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, H.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of hepatocyte growth factor activation in cancer tissues</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1890</span>– <span class="NLM_lpage">1904</span>, <span class="refDoi"> DOI: 10.3390/cancers6041890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.3390%2Fcancers6041890" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1890-1904&author=M.+Kawaguchiauthor=H.+Kataoka&title=Mechanisms+of+hepatocyte+growth+factor+activation+in+cancer+tissues&doi=10.3390%2Fcancers6041890"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3390%2Fcancers6041890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers6041890%26sid%3Dliteratum%253Aachs%26aulast%3DKawaguchi%26aufirst%3DM.%26aulast%3DKataoka%26aufirst%3DH.%26atitle%3DMechanisms%2520of%2520hepatocyte%2520growth%2520factor%2520activation%2520in%2520cancer%2520tissues%26jtitle%3DCancers%26date%3D2014%26volume%3D6%26spage%3D1890%26epage%3D1904%26doi%3D10.3390%2Fcancers6041890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherle, P. A.</span></span> <span> </span><span class="NLM_article-title">Development of c-MET pathway inhibitors</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1241</span>, <span class="refDoi"> DOI: 10.1517/13543784.2011.600687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1517%2F13543784.2011.600687" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=1225-1241&author=X.+D.+Liuauthor=R.+C.+Newtonauthor=P.+A.+Scherle&title=Development+of+c-MET+pathway+inhibitors&doi=10.1517%2F13543784.2011.600687"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F13543784.2011.600687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2011.600687%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%2BD.%26aulast%3DNewton%26aufirst%3DR.%2BC.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26atitle%3DDevelopment%2520of%2520c-MET%2520pathway%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26spage%3D1225%26epage%3D1241%26doi%3D10.1517%2F13543784.2011.600687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J. J.</span></span> <span> </span><span class="NLM_article-title">Targeting receptor tyrosine kinase MET in cancer: small molecule inhibitors and clinical progress</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4427</span>– <span class="NLM_lpage">4453</span>, <span class="refDoi"> DOI: 10.1021/jm401427c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401427c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4427-4453&author=J.+J.+Cui&title=Targeting+receptor+tyrosine+kinase+MET+in+cancer%3A+small+molecule+inhibitors+and+clinical+progress&doi=10.1021%2Fjm401427c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress</span></div><div class="casAuthors">Cui, J. Jean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4427-4453</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The HGF/MET signaling pathway is crit. in mediating a wide range of normal physiol. functions including embryol. development, wound healing, and tissue regeneration.  Aberrant activation of the pathway has frequently been found in human cancers via protein overexpression, mutation, gene amplification, and also paracrine or autocrine up-regulation.  In addn., the activation of HGF/MET signaling confers resistance to the effects of cancer treatments.  Therefore, inhibition of the HGF/MET signaling pathway has great potential for therapeutic intervention in cancer.  Currently, there are three approaches toward modulating HGF/MET signaling in human clin. studies of cancer: anti-HGF monoclonal antibodies, MET monoclonal antibodies, and small mol. MET inhibitors.  Preliminary clin. benefit from inhibition of HGF or MET has been reported.  This Perspective will provide an overview of the HGF/MET signaling pathway in cancer and then will review the development of small mol. MET inhibitors and their progress in clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoARAsEnH4X5rVg90H21EOLACvtfcHk0lgEpAyq8En7XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltbvE&md5=534fd1c6fd8b83be41251d0d556903d1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm401427c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401427c%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520receptor%2520tyrosine%2520kinase%2520MET%2520in%2520cancer%253A%2520small%2520molecule%2520inhibitors%2520and%2520clinical%2520progress%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4427%26epage%3D4453%26doi%3D10.1021%2Fjm401427c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span> <span> </span><span class="NLM_article-title">Hepatocyte growth factor and Met in drug discovery</span>. <i>J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1093/jb/mvv027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1093%2Fjb%2Fmvv027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=25770121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVOgtLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2015&pages=271-284&author=K.+Sakaiauthor=S.+Aokiauthor=K.+Matsumoto&title=Hepatocyte+growth+factor+and+Met+in+drug+discovery&doi=10.1093%2Fjb%2Fmvv027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor and Met in drug discovery</span></div><div class="casAuthors">Sakai, Katsuya; Aoki, Shunsuke; Matsumoto, Kunio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">271-284</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Activation of the hepatocyte growth factor (HGF) -Met pathway evokes dynamic biol. responses that support the morphogenesis, regeneration and survival of cells and tissues.  A characterization of conditional Met knockout mice indicates that the HGF-Met pathway plays important roles in the regeneration, protection and homeostasis of cells such as hepatocytes, renal tubular cells and neurons.  Preclin. studies in disease models have indicated that recombinant HGF protein and expression plasmid for HGF are biol. drug candidates for the treatment of patients with diseases or injuries that involve impaired tissue function.  The phase-I and phase-I/II clin. trials of the intrathecal administration of HGF protein for the treatment of patients with amyotrophic lateral sclerosis and spinal cord injury, resp., are ongoing.  Biol. actions of HGF that promote the dynamic movement, morphogenesis and survival of cells also closely participate in invasion-metastasis and resistance to the mol.-targeted drugs in tumor cells.  Different types of HGF-Met pathway inhibitors are now in clin. trials for treatment of malignant tumors.  Basic research on HGF and Met has lead to drug discoveries in regenerative medicine and tumor biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquPM_j6_c6trVg90H21EOLACvtfcHk0lg2N7b5gFVKtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVOgtLvK&md5=ad81f392981d02d76934cce53ac4d2f8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvv027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvv027%26sid%3Dliteratum%253Aachs%26aulast%3DSakai%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DS.%26aulast%3DMatsumoto%26aufirst%3DK.%26atitle%3DHepatocyte%2520growth%2520factor%2520and%2520Met%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Biochem.%26date%3D2015%26volume%3D157%26spage%3D271%26epage%3D284%26doi%3D10.1093%2Fjb%2Fmvv027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. S.</span></span> <span> </span><span class="NLM_article-title">Progress in cancer therapy targeting c-Met signaling pathway</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1007/s12272-012-0402-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1007%2Fs12272-012-0402-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=22553051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVGlu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=595-604&author=K.+H.+Jungauthor=B.+H.+Parkauthor=S.+S.+Hong&title=Progress+in+cancer+therapy+targeting+c-Met+signaling+pathway&doi=10.1007%2Fs12272-012-0402-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in cancer therapy targeting c-Met signaling pathway</span></div><div class="casAuthors">Jung, Kyung Hee; Park, Byung Hee; Hong, Soon-Sun</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">595-604</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  A primary hurdle in developing anticancer therapeutics is to selectively target cancer cells while sparing normal tissues.  Oncogenic protein kinases represent a class of biol. important targets for cancer intervention.  Among them, c-Met is a receptor tyrosine kinase (RTK) that has low activity in normal tissues but is dysregulated in many tumor types.  The c-Met is the prototype member of a subfamily of RTKs, which includes Ron, which is structurally distinct from other RTK families.  It is the only known high-affinity receptor for hepatocyte growth factor, also known as scatter factor.  HGF and c-Met are both required for normal mammalian development.  In adults, both are widely expressed in a variety of tissues; however, their expression is normally very low and is involved mainly in tissue damage, repair and regeneration.  The results of in vitro and in vivo expts. have shown that this receptor-growth factor pair is involved in multiple physiol. cellular responses, including cell proliferation, survival, differentiation, motility, and invasion.  Here, as well as presenting the biol. aspects of c-Met signaling regulation, we consider recent findings that have provided new knowledge at the mol., cellular, and animal study.  Also, we describe how the c-Met pathway is tuned by the functional cooperation between various signal transducers.  We then discuss the progress in the development of agents that target the c-Met pathway, with an emphasis on small mols. of c-Met kinase inhibitors.  Finally, we provide our perspective in terms of possible future trends and limitation in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2BhXJADEW8rVg90H21EOLACvtfcHk0lg2N7b5gFVKtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVGlu74%253D&md5=b3f70ac7f90458023abce87edc758396</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs12272-012-0402-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-012-0402-6%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DK.%2BH.%26aulast%3DPark%26aufirst%3DB.%2BH.%26aulast%3DHong%26aufirst%3DS.%2BS.%26atitle%3DProgress%2520in%2520cancer%2520therapy%2520targeting%2520c-Met%2520signaling%2520pathway%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2012%26volume%3D35%26spage%3D595%26epage%3D604%26doi%3D10.1007%2Fs12272-012-0402-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parikh, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghate, M. D.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the discovery of small molecule c-Met kinase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">1103</span>– <span class="NLM_lpage">1138</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.08.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.ejmech.2017.08.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29157685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVKitLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2018&pages=1103-1138&author=P.+K.+Parikhauthor=M.+D.+Ghate&title=Recent+advances+in+the+discovery+of+small+molecule+c-Met+kinase+inhibitors&doi=10.1016%2Fj.ejmech.2017.08.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the discovery of small molecule c-Met Kinase inhibitors</span></div><div class="casAuthors">Parikh, Palak K.; Ghate, Manjunath D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1103-1138</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">C-Met is a prototype member of a subfamily of heterodimeric receptor tyrosine kinases (RTKs) and is the receptor for hepatocyte growth factor (HGF).  Binding of HGF to its receptor c-Met, initiates a wide range of cellular signalling, including those involved in proliferation, motility, migration and invasion.  Importantly, dysregulated HGF/c-Met signalling is a driving factor for numerous malignancies and promotes tumor growth, invasion, dissemination and/or angiogenesis.  Dysregulated HGF/c-Met signalling has also been assocd. with poor clin. outcomes and resistance acquisition to some approved targeted therapies.  Thus, c-Met kinase has emerged as a promising target for cancer drug development.  Different therapeutic approaches targeting the HGF/c-Met signalling pathway are under development for targeted cancer therapy, among which small mol. inhibitors of c-Met kinase constitute the largest effort within the pharmaceutical industry.  The review is an effort to summarize recent advancements in medicinal chem. development of small mol. c-Met kinase inhibitors as potential anti-cancer agents which would certainly help future researchers to bring further developments in the discovery of small mol. c-Met kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcQHNqZtWRPLVg90H21EOLACvtfcHk0lg2N7b5gFVKtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVKitLbO&md5=d598a6ad21532adab52bff67a8bd8e01</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.08.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.08.044%26sid%3Dliteratum%253Aachs%26aulast%3DParikh%26aufirst%3DP.%2BK.%26aulast%3DGhate%26aufirst%3DM.%2BD.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520small%2520molecule%2520c-Met%2520kinase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D143%26spage%3D1103%26epage%3D1138%26doi%3D10.1016%2Fj.ejmech.2017.08.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Silva, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottaro, D. P.</span></span> <span> </span><span class="NLM_article-title">Targeting the hepatocyte growth factor/Met pathway in cancer</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">855</span>– <span class="NLM_lpage">870</span>, <span class="refDoi"> DOI: 10.1042/BST20160132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1042%2FBST20160132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=28673936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlaktbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=855-870&author=D.+M.+De%0ASilvaauthor=A.+Royauthor=T.+Katoauthor=F.+Cecchiauthor=Y.+H.+Leeauthor=K.+Matsumotoauthor=D.+P.+Bottaro&title=Targeting+the+hepatocyte+growth+factor%2FMet+pathway+in+cancer&doi=10.1042%2FBST20160132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the hepatocyte growth factor/Met pathway in cancer</span></div><div class="casAuthors">De Silva, Dinuka M.; Roy, Arpita; Kato, Takashi; Cecchi, Fabiola; Lee, Young H.; Matsumoto, Kunio; Bottaro, Donald P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">855-870</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Hepatocyte growth factor (HGF)-induced activation of its cell surface receptor, the Met tyrosine kinase, drives mitogenesis, motogenesis and morphogenesis in a wide spectrum of target cell types and embryol., developmental and homeostatic contexts.  Typical paracrine HGF/Met signaling is regulated by HGF activation at target cell surfaces, HGF binding-induced receptor activation, internalization and degrdn.  Despite these controls, HGF/Met signaling contributes to oncogenesis, tumor angiogenesis and invasiveness, and tumor metastasis in many types of cancer, leading to the rapid growth of pathway-targeted anticancer drug development programs.  We review here HGF and Met structure and function, basic properties of HGF/Met pathway antagonists now in clin. development, and recent clin. trial results.  Presently, the main challenges facing the effective use of HGF/Met-targeted antagonists for cancer treatment include optimal patient selection, diagnostic and pharmacodynamic biomarker development, and the identification and testing of effective therapy combinations.  The wealth of basic information, anal. reagents and model systems available regarding normal and oncogenic HGF/Met signaling will continue to be invaluable in meeting these challenges and moving expeditiously toward more effective cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqANiimskGdsrVg90H21EOLACvtfcHk0lg2N7b5gFVKtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlaktbbF&md5=8582f3c75774ccd2ca73db8869a9b347</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1042%2FBST20160132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20160132%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BSilva%26aufirst%3DD.%2BM.%26aulast%3DRoy%26aufirst%3DA.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DCecchi%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DY.%2BH.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DBottaro%26aufirst%3DD.%2BP.%26atitle%3DTargeting%2520the%2520hepatocyte%2520growth%2520factor%252FMet%2520pathway%2520in%2520cancer%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2017%26volume%3D45%26spage%3D855%26epage%3D870%26doi%3D10.1042%2FBST20160132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. H.</span></span> <span> </span><span class="NLM_article-title">MSP-RON signalling in cancer: pathogenesis and therapeutic potential</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">481</span>, <span class="refDoi"> DOI: 10.1038/nrc3545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1038%2Fnrc3545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=23792360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVykur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=466-481&issue=7&author=H.+P.+Yaoauthor=Y.+Q.+Zhouauthor=R.+Zhangauthor=M.+H.+Wang&title=MSP-RON+signalling+in+cancer%3A+pathogenesis+and+therapeutic+potential&doi=10.1038%2Fnrc3545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">MSP-RON signalling in cancer: pathogenesis and therapeutic potential</span></div><div class="casAuthors">Yao, Hang-Ping; Zhou, Yong-Qing; Zhang, Ruiwen; Wang, Ming-Hai</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">466-481</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the discovery of MSP (macrophage-stimulating protein; also known as MST1 and hepatocyte growth factor-like (HGFL)) as the ligand for the receptor tyrosine kinase RON (also known as MST1R) in the early 1990s, the roles of this signalling axis in cancer pathogenesis has been extensively studied in various model systems.  Both in vitro and in vivo evidence has revealed that MSP-RON signalling is important for the invasive growth of different types of cancers.  Currently, small-mol. inhibitors and antibodies blocking RON signalling are under investigation.  Substantial responses have been achieved in human tumor xenograft models, laying the foundation for clin. validation.  In this Review, we discuss recent advances that demonstrate the importance of MSP-RON signalling in cancer and its potential as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxZ7BjkQx6l7Vg90H21EOLACvtfcHk0ljIunV_4i1A0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVykur8%253D&md5=e903663a2613485f0091e83611c3766a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrc3545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3545%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DH.%2BP.%26aulast%3DZhou%26aufirst%3DY.%2BQ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DM.%2BH.%26atitle%3DMSP-RON%2520signalling%2520in%2520cancer%253A%2520pathogenesis%2520and%2520therapeutic%2520potential%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2013%26volume%3D13%26issue%3D7%26spage%3D466%26epage%3D481%26doi%3D10.1038%2Fnrc3545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H. P.</span></span> <span> </span><span class="NLM_article-title">Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addiction</span>. <i>J Biomed. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.7555/JBR.27.20130038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.7555%2FJBR.27.20130038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=24086167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvFamu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=345-356&author=M.+H.+Wangauthor=R.+Zhangauthor=Y.+Q.+Zhouauthor=H.+P.+Yao&title=Pathogenesis+of+RON+receptor+tyrosine+kinase+in+cancer+cells%3A+activation+mechanism%2C+functional+crosstalk%2C+and+signaling+addiction&doi=10.7555%2FJBR.27.20130038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addiction</span></div><div class="casAuthors">Wang, Minghai; Zhang, Ruiwen; Zhou, Yongqing; Yao, Hangping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomedical Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">345-356</span>CODEN:
                <span class="NLM_cas:coden">JBROEZ</span>;
        ISSN:<span class="NLM_cas:issn">1674-8301</span>.
    
            (<span class="NLM_cas:orgname">Editorial Dep. of Journal of Biomedical Research</span>)
        </div><div class="casAbstract">A review.  The RON receptor tyrosine kinase, a member of the MET proto-oncogene family, is a pathogenic factor implicated in tumor malignancy.  Specifically, aberrations in RON signaling result in increased cancer cell growth, survival, invasion, angiogenesis, and drug resistance.  Biochem. events such as ligand binding, receptor overexpression, generation of structure-defected variants, and point mutations in the kinase domain contribute to RON signaling activation.  Recently, functional crosstalk between RON and signaling proteins such as MET and EFGR has emerged as an addnl. mechanism for RON activation, which is crit. for tumorigenic development.  The RON signaling crosstalk acts either as a regulatory feedback loop that strengthens or enhances tumorigenic phenotype of cancer cells or serves as a signaling compensatory pathway providing a growth/survival advantage for cancer cells to escape targeted therapy.  Moreover, viral oncoproteins derived from Friend leukemia or Epstein-Barr viruses interact with RON to drive viral oncogenesis.  In cancer cells, RON signaling is integrated into cellular signaling network essential for cancer cell growth and survival.  These activities provide the mol. basis of targeting RON for cancer treatment.  In this review, we will discuss recent data that uncover the mechanisms of RON activation in cancer cells, review evidence of RON signaling crosstalk relevant to cancer malignancy, and emphasize the significance of the RON signaling addiction by cancer cells for tumor therapy.  Understanding aberrant RON signaling will not only provide insight into the mechanisms of tumor pathogenesis, but also lead to the development of novel strategies for molecularly targeted cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS3TWJA95rurVg90H21EOLACvtfcHk0ljIunV_4i1A0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvFamu7g%253D&md5=905b8c4a4c6e162d02d33b064d517ccb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.7555%2FJBR.27.20130038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7555%252FJBR.27.20130038%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%2BH.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DY.%2BQ.%26aulast%3DYao%26aufirst%3DH.%2BP.%26atitle%3DPathogenesis%2520of%2520RON%2520receptor%2520tyrosine%2520kinase%2520in%2520cancer%2520cells%253A%2520activation%2520mechanism%252C%2520functional%2520crosstalk%252C%2520and%2520signaling%2520addiction%26jtitle%3DJ%2520Biomed.%2520Res.%26date%3D2013%26volume%3D27%26spage%3D345%26epage%3D356%26doi%3D10.7555%2FJBR.27.20130038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padhye, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Potential therapeutics specific to c-MET/RON receptor tyrosine kinases for molecular targeting in cancer therapy</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1181</span>– <span class="NLM_lpage">1188</span>, <span class="refDoi"> DOI: 10.1038/aps.2010.106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1038%2Faps.2010.106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=1181-1188&author=M.+H.+Wangauthor=S.+S.+Padhyeauthor=S.+Guinauthor=Q.+Maauthor=Y.+Q.+Zhou&title=Potential+therapeutics+specific+to+c-MET%2FRON+receptor+tyrosine+kinases+for+molecular+targeting+in+cancer+therapy&doi=10.1038%2Faps.2010.106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Faps.2010.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2010.106%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%2BH.%26aulast%3DPadhye%26aufirst%3DS.%2BS.%26aulast%3DGuin%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DY.%2BQ.%26atitle%3DPotential%2520therapeutics%2520specific%2520to%2520c-MET%252FRON%2520receptor%2520tyrosine%2520kinases%2520for%2520molecular%2520targeting%2520in%2520cancer%2520therapy%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2010%26volume%3D31%26spage%3D1181%26epage%3D1188%26doi%3D10.1038%2Faps.2010.106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Webb, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W. G.</span></span> <span> </span><span class="NLM_article-title">Type II transmembrane serine protease (TTSP) deregulation in cancer</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">552</span>, <span class="refDoi"> DOI: 10.2741/3704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.2741%2F3704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=21196187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVyltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=539-552&author=S.+L.+Webbauthor=A.+J.+Sandersauthor=M.+D.+Masonauthor=W.+G.+Jiang&title=Type+II+transmembrane+serine+protease+%28TTSP%29+deregulation+in+cancer&doi=10.2741%2F3704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Type II transmembrane serine protease (TTSP) deregulation in cancer</span></div><div class="casAuthors">Webb, Siobhan L.; Sanders, Andrew J.; Mason, Malcolm D.; Jiang, Wen G.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience, Landmark Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">539-552</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  The Type II transmembrane serine proteases (TTSP) are a relatively newly identified family of proteolytic enzymes that have become the subject of intense scrutiny in the field of cancer research.  Advances in genome screening technol. have enabled the identification of putative members and the further characterization of existing members.  The TTSPs are involved in a diverse range of physiol. functions and new roles continue to be discovered.  A large majority of these proteases appear to play crucial roles in the development of disease, esp. cancer development and progression.  This review presents the current knowledge of the biol. role of those TTSPs that have been identified in the development and progression of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5vmYxuDq1y7Vg90H21EOLACvtfcHk0ljIunV_4i1A0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVyltrk%253D&md5=d8f0bc72ad393fc20c0c149d15681f79</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2741%2F3704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3704%26sid%3Dliteratum%253Aachs%26aulast%3DWebb%26aufirst%3DS.%2BL.%26aulast%3DSanders%26aufirst%3DA.%2BJ.%26aulast%3DMason%26aufirst%3DM.%2BD.%26aulast%3DJiang%26aufirst%3DW.%2BG.%26atitle%3DType%2520II%2520transmembrane%2520serine%2520protease%2520%2528TTSP%2529%2520deregulation%2520in%2520cancer%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2011%26volume%3D16%26spage%3D539%26epage%3D552%26doi%3D10.2741%2F3704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Owusu, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galemmo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klampfer, L.</span></span> <span> </span><span class="NLM_article-title">Hepatocyte Growth factor, a key tumor-promoting factor in the tumor microenvironment</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">35</span>, <span class="refDoi"> DOI: 10.3390/cancers9040035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.3390%2Fcancers9040035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=35&author=B.+Y.+Owusuauthor=R.+Galemmoauthor=J.+Janetkaauthor=L.+Klampfer&title=Hepatocyte+Growth+factor%2C+a+key+tumor-promoting+factor+in+the+tumor+microenvironment&doi=10.3390%2Fcancers9040035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3390%2Fcancers9040035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers9040035%26sid%3Dliteratum%253Aachs%26aulast%3DOwusu%26aufirst%3DB.%2BY.%26aulast%3DGalemmo%26aufirst%3DR.%26aulast%3DJanetka%26aufirst%3DJ.%26aulast%3DKlampfer%26aufirst%3DL.%26atitle%3DHepatocyte%2520Growth%2520factor%252C%2520a%2520key%2520tumor-promoting%2520factor%2520in%2520the%2520tumor%2520microenvironment%26jtitle%3DCancers%26date%3D2017%26volume%3D9%26spage%3D35%26doi%3D10.3390%2Fcancers9040035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, W.</span></span> <span> </span><span class="NLM_article-title">Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">45</span>, <span class="refDoi"> DOI: 10.1186/s12943-018-0796-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1186%2Fs12943-018-0796-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29455668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitF2nt7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=45&author=Y.+Zhangauthor=M.+Xiaauthor=K.+Jinauthor=S.+Wangauthor=H.+Weiauthor=C.+Fanauthor=Y.+Wuauthor=X.+Liauthor=X.+Liauthor=G.+Liauthor=Z.+Zengauthor=W.+Xiong&title=Function+of+the+c-Met+receptor+tyrosine+kinase+in+carcinogenesis+and+associated+therapeutic+opportunities&doi=10.1186%2Fs12943-018-0796-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities</span></div><div class="casAuthors">Zhang, Yazhuo; Xia, Mengfang; Jin, Ke; Wang, Shufei; Wei, Hang; Fan, Chunmei; Wu, Yingfen; Li, Xiaoling; Li, Xiayu; Li, Guiyuan; Zeng, Zhaoyang; Xiong, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45/1-45/14</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">C-Met is a receptor tyrosine kinase belonging to the MET (MNNG HOS transforming gene) family, and is expressed on the surfaces of various cells.  Hepatocyte growth factor (HGF) is the ligand for this receptor.  The binding of HGF to c-Met initiates a series of intracellular signals that mediate embryogenesis and wound healing in normal cells.  However, in cancer cells, aberrant HGF/c-Met axis activation, which is closely related to c-Met gene mutations, overexpression, and amplification, promotes tumor development and progression by stimulating the PI3K/AKT, Ras/MAPK, JAK/STAT, SRC, Wnt/β-catenin, and other signaling pathways.  Thus, c-Met and its assocd. signaling pathways are clin. important therapeutic targets.  In this review, we elaborate on the mol. structure of c-Met and HGF and the mechanism through which their interaction activates the PI3K/AKT, Ras/MAPK, and Wnt signaling pathways.  We also summarize the connection between c-Met and RON and EGFR, which are also receptor tyrosine kinases.  Finally, we introduce the current therapeutic drugs that target c-Met in primary tumors, and their use in clin. research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxr1VpZ-qwwbVg90H21EOLACvtfcHk0lhiBEWgWTrW9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitF2nt7nE&md5=23db43661c4a23160dbed1ee1c26f8db</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1186%2Fs12943-018-0796-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12943-018-0796-y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DXiong%26aufirst%3DW.%26atitle%3DFunction%2520of%2520the%2520c-Met%2520receptor%2520tyrosine%2520kinase%2520in%2520carcinogenesis%2520and%2520associated%2520therapeutic%2520opportunities%26jtitle%3DMol.%2520Cancer%26date%3D2018%26volume%3D17%26spage%3D45%26doi%3D10.1186%2Fs12943-018-0796-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span>; <span class="NLM_string-name">Benson, R.</span></span> <i>Extracellular Targeting of Cell Signaling in Cancer: Strategies Directed at MET and RON Receptor Tyrosine Kinases</i>, <span class="NLM_edition">1st</span> ed.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2018</span>; p pages cm.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1002%2F9781119300229" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+W.+Janetka&author=R.+Benson&title=Extracellular+Targeting+of+Cell+Signaling+in+Cancer%3A+Strategies+Directed+at+MET+and+RON+Receptor+Tyrosine+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2F9781119300229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781119300229%26sid%3Dliteratum%253Aachs%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26btitle%3DExtracellular%2520Targeting%2520of%2520Cell%2520Signaling%2520in%2520Cancer%253A%2520Strategies%2520Directed%2520at%2520MET%2520and%2520RON%2520Receptor%2520Tyrosine%2520Kinases%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamibeppu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukino, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamoto, T.</span></span> <span> </span><span class="NLM_article-title">Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression</span>. <i>Hum. Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1007/s13577-015-0123-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1007%2Fs13577-015-0123-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=26250899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCjs7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=22-29&author=S.+Sugieauthor=S.+Mukaiauthor=K.+Yamasakiauthor=T.+Kamibeppuauthor=H.+Tsukinoauthor=T.+Kamoto&title=Plasma+macrophage-stimulating+protein+and+hepatocyte+growth+factor+levels+are+associated+with+prostate+cancer+progression&doi=10.1007%2Fs13577-015-0123-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression</span></div><div class="casAuthors">Sugie, Satoru; Mukai, Shoichiro; Yamasaki, Koji; Kamibeppu, Toyoharu; Tsukino, Hiromasa; Kamoto, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Human Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-29</span>CODEN:
                <span class="NLM_cas:coden">HUCEE7</span>;
        ISSN:<span class="NLM_cas:issn">1749-0774</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Hepatocyte growth factor (HGF) is a well-known multifunctional growth factor, and evidence has accumulated indicating that the HGF/MET (HGF receptor) signaling axis is involved in the progression of cancer.  Macrophage-stimulating protein (MSP) is also known as a growth factor which activates not only macrophages but also cancer cells and osteoclasts through the activation of the specific Receptor d'origine nantais (RON).  Pro-HGF and pro-MSP lack biol. activity and, therefore, require proteolytic activation for conversion to an active two-chain form by HGF activator (HGFA).  Although, there are several studies on HGF/MET signaling with castration-resistant prostate cancer (CRPC) and bone metastasis, reports on plasma protein are rare.  In addn., the MSP/RON signaling axis in PC is not well understood.  Here, we analyzed assocns. between PC progression and plasma HGF and MSP levels.  We tested plasma samples from 58 patients with PC: 36 with castration-resistant (CR) PC and 22 with pretreatment for PC as control.  We used ELISA (ELISA) kit to det. plasma levels of HGF, MSP and HGFA, and examd. correlations with clinicopathol. characteristics such as Gleason grade and bone metastasis.  PCR was used to evaluate HGF and MSP-related mols. in PC cell lines.  Plasma levels of HGF, MSP and HGFA in the CRPC group were higher than in the control group (HGF: P < 0.001; MSP: P = 0.008; HGFA: P < 0.001).  HGF and MSP levels were significantly correlated (P = 0.003).  In the CRPC group, plasma HGF and MSP levels and Gleason score were not correlated; however, high plasma MSP level correlated with bone metastasis.  (P = 0.016). In cell lines, PC3 expressed significantly more HGF, MET and RON than did LNCaP (P < 0.001), and both cell lines expressed MSP.  Plasma concns. of HGF, MSP and HGFA are significantly elevated in patients with CRPC.  Also, as plasma MSP levels are significantly assocd. with bone metastasis in CRPC patients, MSP may be a candidate for serum marker of bone metastasis.  Our results show the importance of the HGF/MET and MSP/RON signaling systems in CRPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogVts6n7zstrVg90H21EOLACvtfcHk0lhiBEWgWTrW9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCjs7jE&md5=27f51149484567eb0a3b70c8d5209667</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs13577-015-0123-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13577-015-0123-5%26sid%3Dliteratum%253Aachs%26aulast%3DSugie%26aufirst%3DS.%26aulast%3DMukai%26aufirst%3DS.%26aulast%3DYamasaki%26aufirst%3DK.%26aulast%3DKamibeppu%26aufirst%3DT.%26aulast%3DTsukino%26aufirst%3DH.%26aulast%3DKamoto%26aufirst%3DT.%26atitle%3DPlasma%2520macrophage-stimulating%2520protein%2520and%2520hepatocyte%2520growth%2520factor%2520levels%2520are%2520associated%2520with%2520prostate%2520cancer%2520progression%26jtitle%3DHum.%2520Cell%26date%3D2016%26volume%3D29%26spage%3D22%26epage%3D29%26doi%3D10.1007%2Fs13577-015-0123-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Q. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S. T.</span></span> <span> </span><span class="NLM_article-title">c-Met and RON expression levels in endometrial adenocarcinoma tissue and their relationship with prognosis</span>. <i>Eur. J. Gynaecol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=26189249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FkslajsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=255-259&author=X.+P.+Zhuangauthor=W.+W.+Jinauthor=X.+D.+Tengauthor=Z.+Z.+Yuanauthor=Q.+Q.+Linauthor=S.+T.+Xu&title=c-Met+and+RON+expression+levels+in+endometrial+adenocarcinoma+tissue+and+their+relationship+with+prognosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">c-Met and RON expression levels in endometrial adenocarcinoma tissue and their relationship with prognosis</span></div><div class="casAuthors">Zhuang X P; Jin W W; Teng X D; Yuan Z Z; Lin Q Q; Xu S T</div><div class="citationInfo"><span class="NLM_cas:title">European journal of gynaecological oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-9</span>
        ISSN:<span class="NLM_cas:issn">0392-2936</span>.
    </div><div class="casAbstract">OBJECTIVE:  To investigate the potential relevance of c-Met and RON gene expression in patients with adenocarcinoma of the endometrium and analyze the relationships among the c-Met and RON expression, clinicopathological characteristics, and patient survival.  MATERIALS AND METHODS:  The study included 60 cases diagnosed with endometrial adenocarcinoma with more than five-years follow-up.  Total RNA from formalin-fixed paraffin-embedded tissues of 60 adenocarcinomas of the endometrium and normal endometrium tissues were isolated for c-Met and RON quantitative analysis by real-time real-time polymerase chain reaction (RT-PCR).  RESULTS:  The c-Met and RON expression in endometrial adenocarcinoma was significantly higher than that in normal endometrial tissues (p < 0.01), with average up-regulated levels of 3.94 ± 1.88 and 2.74 ± 0.88, respectively.  Moreover, high c-Met expression was significantly correlated with the histological stage (p = 0.017), and high RON expression was related to histological stage (p = 0.035), muscle invasion (p = 0.006), and lymph node metastasis (p = 0.018).  Multivariate Cox regression analysis revealed that the co-expression of c-Met and RON was an independent prognostic factor for adenocarcinoma of the endometrium and was significantly associated with decreased overall survival (HR = 3.571, p = 0.014).  CONCLUSION:  The co-expression of c-Met and RON is associated with a poor prognosis in endometrial adenocarcinoma and is an independent prognostic marker for endometrioid adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTH_GNAkXtkKyA3UY9EwTNrfW6udTcc2eZHD5mtx0xRmrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FkslajsA%253D%253D&md5=68430e788aa8f1ca8eaa088c56cd153f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DX.%2BP.%26aulast%3DJin%26aufirst%3DW.%2BW.%26aulast%3DTeng%26aufirst%3DX.%2BD.%26aulast%3DYuan%26aufirst%3DZ.%2BZ.%26aulast%3DLin%26aufirst%3DQ.%2BQ.%26aulast%3DXu%26aufirst%3DS.%2BT.%26atitle%3Dc-Met%2520and%2520RON%2520expression%2520levels%2520in%2520endometrial%2520adenocarcinoma%2520tissue%2520and%2520their%2520relationship%2520with%2520prognosis%26jtitle%3DEur.%2520J.%2520Gynaecol.%2520Oncol.%26date%3D2015%26volume%3D36%26spage%3D255%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karnad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, J. W.</span></span> <span> </span><span class="NLM_article-title">Roles of c-Met and RON kinases in tumor progression and their potential as therapeutic targets</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">3507</span>– <span class="NLM_lpage">3518</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.3420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.18632%2Foncotarget.3420" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=3507-3518&author=K.+Changauthor=A.+Karnadauthor=S.+Zhaoauthor=J.+W.+Freeman&title=Roles+of+c-Met+and+RON+kinases+in+tumor+progression+and+their+potential+as+therapeutic+targets&doi=10.18632%2Foncotarget.3420"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.3420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.3420%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DK.%26aulast%3DKarnad%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DFreeman%26aufirst%3DJ.%2BW.%26atitle%3DRoles%2520of%2520c-Met%2520and%2520RON%2520kinases%2520in%2520tumor%2520progression%2520and%2520their%2520potential%2520as%2520therapeutic%2520targets%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D3507%26epage%3D3518%26doi%3D10.18632%2Foncotarget.3420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maggiora, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fracchioli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagnaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arisio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsaros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massobrio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comoglio, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Renzo, M. F.</span></span> <span> </span><span class="NLM_article-title">The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1016/S0014-4827(03)00250-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2FS0014-4827%2803%2900250-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=12915129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1ehu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2003&pages=382-389&author=P.+Maggioraauthor=A.+Lorenzatoauthor=S.+Fracchioliauthor=B.+Costaauthor=M.+Castagnaroauthor=R.+Arisioauthor=D.+Katsarosauthor=M.+Massobrioauthor=P.+M.+Comoglioauthor=M.+F.+Di+Renzo&title=The+RON+and+MET+oncogenes+are+co-expressed+in+human+ovarian+carcinomas+and+cooperate+in+activating+invasiveness&doi=10.1016%2FS0014-4827%2803%2900250-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness</span></div><div class="casAuthors">Maggiora, Piera; Lorenzato, Annalisa; Fracchioli, Stefano; Costa, Barbara; Castagnaro, Massimo; Arisio, Riccardo; Katsaros, Dionyssios; Massobrio, Marco; Comoglio, Paolo M.; Flavia Di Renzo, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">382-389</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">RON is a member of the receptor tyrosine kinase gene family that includes the MET oncogene, whose germline mutations have been causally related to human tumorigenesis.  In vitro, RON and MET receptors cross-talk, synergize in intracellular signaling, and cooperate in inducing morphogenic responses.  Here the authors show that the RON and MET oncogenes were expressed in 55% and 56% of human ovarian carcinomas, resp., and were significantly coexpressed in 42% (P < 0.001).  In ovarian carcinoma samples and cell lines the authors did not find mutations in RON and MET gene kinase domain, nor coexpression of RON and MET receptor ligands (MSP and HGF, resp.).  We show that motility and invasiveness of ovarian cancer cells coexpressing MET and RON receptors were elicited by HGF and, to a lesser extent, by MSP.  More interestingly, invasion of both reconstituted basement membrane and collagen gel was greatly enhanced by the simultaneous addn. of the 2 ligands.  These data suggest that coexpression of the MET and RON receptors confer a selective advantage to ovarian cancer cells and might promote ovarian cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCY6UIVChzy7Vg90H21EOLACvtfcHk0lifmzi6GunZxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1ehu7w%253D&md5=b1905acc66d6f2dbaabd79870a33172b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0014-4827%2803%2900250-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-4827%252803%252900250-7%26sid%3Dliteratum%253Aachs%26aulast%3DMaggiora%26aufirst%3DP.%26aulast%3DLorenzato%26aufirst%3DA.%26aulast%3DFracchioli%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DB.%26aulast%3DCastagnaro%26aufirst%3DM.%26aulast%3DArisio%26aufirst%3DR.%26aulast%3DKatsaros%26aufirst%3DD.%26aulast%3DMassobrio%26aufirst%3DM.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3DDi%2BRenzo%26aufirst%3DM.%2BF.%26atitle%3DThe%2520RON%2520and%2520MET%2520oncogenes%2520are%2520co-expressed%2520in%2520human%2520ovarian%2520carcinomas%2520and%2520cooperate%2520in%2520activating%2520invasiveness%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2003%26volume%3D288%26spage%3D382%26epage%3D389%26doi%3D10.1016%2FS0014-4827%2803%2900250-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Z.</span></span> <span> </span><span class="NLM_article-title">RON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">3209</span>– <span class="NLM_lpage">3218</span>, <span class="refDoi"> DOI: 10.3892/or.2017.5585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.3892%2For.2017.5585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=28440432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOiu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=3209-3218&author=B.+Yinauthor=Z.+Liuauthor=Y.+Wangauthor=X.+Wangauthor=W.+Liuauthor=P.+Yuauthor=X.+Duanauthor=C.+Liuauthor=Y.+Chenauthor=Y.+Zhangauthor=X.+Panauthor=H.+Yaoauthor=Z.+Liaoauthor=Z.+Tao&title=RON+and+c-Met+facilitate+metastasis+through+the+ERK+signaling+pathway+in+prostate+cancer+cells&doi=10.3892%2For.2017.5585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">RON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells</span></div><div class="casAuthors">Yin, Binbin; Liu, Zhenping; Wang, Yiyun; Wang, Xuchu; Liu, Weiwei; Yu, Pan; Duan, Xiuzhi; Liu, Chunhua; Chen, Yuhua; Zhang, Yurong; Pan, Xiaoyan; Yao, Hangping; Liao, Zhaoping; Tao, Zhihua</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3209-3218</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1791-2431</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Prostate cancer (PCa) is a metastatic malignant cancer driven by complex pathol. mechanisms and characterized by poor long-term prognosis.  Metastasis is the main cause of death of PCa patients, yet the mol. mechanisms of this process are poorly understood.  In the present study, pos. co-expression of RON and c-Met was obsd. in human clin. PCa tissues (biopsy material), as detected by immunohistochem. staining and quant. real-time PCR.  We investigated this further in PCa cells, demonstrating that the inhibition of RON and c-Met with foretinib (GSK1363089) suppressed metastasis and promoted the reversal of the epithelial-to-mesenchymal transition (EMT) in PCa cells.  Furthermore, the invasion and migration of PCa cells were enhanced by the exogenous activation of RON with MSP and c-Met with HGF, whereas silencing of RON and c-Met attenuated the invasion and metastasis of the PCa cells.  Our data also demonstrated that HGF/c-Met, but not the MSP-RON signaling pathway may be the dominant mechanism for PCa EMT.  We further revealed that RON and c-Met facilitate metastasis via ERK1/2 signaling.  These findings indicate that RON and c-Met facilitate metastasis through ERK1/2 signaling and that targeting RON and c-Met with foretinib may be an attractive therapeutic option for suppressing PCa metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdySGcGmt017Vg90H21EOLACvtfcHk0lifmzi6GunZxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOiu7jI&md5=cda4b24641558f38f259f5f9a8bfc589</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3892%2For.2017.5585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2017.5585%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DDuan%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DLiao%26aufirst%3DZ.%26aulast%3DTao%26aufirst%3DZ.%26atitle%3DRON%2520and%2520c-Met%2520facilitate%2520metastasis%2520through%2520the%2520ERK%2520signaling%2520pathway%2520in%2520prostate%2520cancer%2520cells%26jtitle%3DOncol.%2520Rep.%26date%3D2017%26volume%3D37%26spage%3D3209%26epage%3D3218%26doi%3D10.3892%2For.2017.5585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1864</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2017.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.bbadis.2017.12.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29253515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVegtrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1864&publication_year=2018&pages=793-803&author=Y.+Yiauthor=S.+Zengauthor=Z.+Wangauthor=M.+Wuauthor=Y.+Maauthor=X.+Yeauthor=B.+Zhangauthor=H.+Liu&title=Cancer-associated+fibroblasts+promote+epithelial-mesenchymal+transition+and+EGFR-TKI+resistance+of+non-small+cell+lung+cancers+via+HGF%2FIGF-1%2FANXA2+signaling&doi=10.1016%2Fj.bbadis.2017.12.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling</span></div><div class="casAuthors">Yi, Yanmei; Zeng, Shanshan; Wang, Zhaotong; Wu, Minhua; Ma, Yuanhuan; Ye, Xiaoxia; Zhang, Biao; Liu, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1864</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">793-803</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The involvement of the tumor stromal cells in acquired resistance of non-small cell lung cancers (NSCLCs) to tyrosine kinase inhibitors (TKIs) has previously been reported, but the precise mechanism remains unclear.  In the present study, we investigated the role and mechanism underlying Cancer-assocd. fibroblasts (CAFs) in TKI resistance of NSCLCs.  In vitro and in vivo expts. showed that HCC827 and PC9 cells, non-small cell lung cancer cells with EGFR-activating mutations, became resistant to the EGFR-TKI gefitinib when cultured with CAFs isolated from NSCLC tissues.  Moreover, we showed that CAFs could induce epithelial-mesenchymal transition (EMT) phenotype of HCC827 and PC9 cells, with an assocd. change in the expression of epithelial to mesenchymal transition markers.  Using proteomics-based method, we identified that CAFs significantly increased the expression of the Annexin A2 (ANXA2).  More importantly, knockdown of ANXA2 completely reversed EMT phenotype and gefitinib resistance induced by CAFs.  Furthermore, we found that CAFs increased the expression and phosphorylation of ANXA2 by secretion of growth factors HGF and IGF-1 and by activation of the corresponding receptors c-met and IGF-1R.  Dual inhibition of HGF/c-met and IGF-1/IGF-1R pathways could significantly suppress ANXA2, and markedly reduced CAFs-induced EMT and gefitinib resistance.  Taken together, these findings indicate that CAFs promote EGFR-TKIs resistance through HGF/IGF-1/ANXA2/EMT signaling and may be an ideal therapeutic target in NSCLCs with EGFR-activating mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcSKkW5LtfQ7Vg90H21EOLACvtfcHk0lgvAhvn6KHCeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVegtrzI&md5=5ce2254fbb4f8a8a7f91bda6b81190cc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2017.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2017.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DYi%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DCancer-associated%2520fibroblasts%2520promote%2520epithelial-mesenchymal%2520transition%2520and%2520EGFR-TKI%2520resistance%2520of%2520non-small%2520cell%2520lung%2520cancers%2520via%2520HGF%252FIGF-1%252FANXA2%2520signaling%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2018%26volume%3D1864%26spage%3D793%26epage%3D803%26doi%3D10.1016%2Fj.bbadis.2017.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sa, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joo, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, D. H.</span></span> <span> </span><span class="NLM_article-title">Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma</span>. <i>Neuro. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_fpage">noy105</span>, <span class="refDoi"> DOI: 10.1093/neuonc/noy105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1093%2Fneuonc%2Fnoy105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=noy105&author=J.+K.+Saauthor=S.+H.+Kimauthor=J.+K.+Leeauthor=H.+J.+Choauthor=Y.+J.+Shinauthor=H.+Shinauthor=H.+Kooauthor=D.+Kimauthor=M.+Leeauthor=W.+Kangauthor=S.+H.+Hongauthor=J.+Y.+Kimauthor=Y.+W.+Parkauthor=S.+W.+Songauthor=S.+J.+Leeauthor=K.+M.+Jooauthor=D.+H.+Nam&title=Identification+of+genomic+and+molecular+traits+that+present+therapeutic+vulnerability+to+HGF-targeted+therapy+in+glioblastoma&doi=10.1093%2Fneuonc%2Fnoy105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnoy105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnoy105%26sid%3Dliteratum%253Aachs%26aulast%3DSa%26aufirst%3DJ.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BK.%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DShin%26aufirst%3DY.%2BJ.%26aulast%3DShin%26aufirst%3DH.%26aulast%3DKoo%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DKang%26aufirst%3DW.%26aulast%3DHong%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DPark%26aufirst%3DY.%2BW.%26aulast%3DSong%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DJoo%26aufirst%3DK.%2BM.%26aulast%3DNam%26aufirst%3DD.%2BH.%26atitle%3DIdentification%2520of%2520genomic%2520and%2520molecular%2520traits%2520that%2520present%2520therapeutic%2520vulnerability%2520to%2520HGF-targeted%2520therapy%2520in%2520glioblastoma%26jtitle%3DNeuro.%2520Oncol.%26date%3D2018%26spage%3Dnoy105%26doi%3D10.1093%2Fneuonc%2Fnoy105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oba, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedo, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carapeto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKean, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Arnam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eterovic, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kale, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haymaker, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routbort, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydu, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernatchez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazar, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimm, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodman, S. E.</span></span> <span> </span><span class="NLM_article-title">Targeting the HGF/MET axis counters primary resistance to KIT inhibition in KIT-mutant melanoma</span>. <i>JCO Precis. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_fpage">55</span>, <span class="refDoi"> DOI: 10.1200/PO.18.00055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1200%2FPO.18.00055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=55&author=J.+Obaauthor=S.+H.+Kimauthor=W.+L.+Wangauthor=M.+P.+Macedoauthor=F.+Carapetoauthor=M.+A.+McKeanauthor=J.+Van+Arnamauthor=A.+K.+Eterovicauthor=S.+Senauthor=C.+R.+Kaleauthor=X.+Yuauthor=C.+L.+Haymakerauthor=M.+Routbortauthor=L.+E.+Hayduauthor=C.+Bernatchezauthor=A.+J.+Lazarauthor=E.+A.+Grimmauthor=D.+S.+Hongauthor=S.+E.+Woodman&title=Targeting+the+HGF%2FMET+axis+counters+primary+resistance+to+KIT+inhibition+in+KIT-mutant+melanoma&doi=10.1200%2FPO.18.00055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1200%2FPO.18.00055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FPO.18.00055%26sid%3Dliteratum%253Aachs%26aulast%3DOba%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DWang%26aufirst%3DW.%2BL.%26aulast%3DMacedo%26aufirst%3DM.%2BP.%26aulast%3DCarapeto%26aufirst%3DF.%26aulast%3DMcKean%26aufirst%3DM.%2BA.%26aulast%3DVan%2BArnam%26aufirst%3DJ.%26aulast%3DEterovic%26aufirst%3DA.%2BK.%26aulast%3DSen%26aufirst%3DS.%26aulast%3DKale%26aufirst%3DC.%2BR.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DHaymaker%26aufirst%3DC.%2BL.%26aulast%3DRoutbort%26aufirst%3DM.%26aulast%3DHaydu%26aufirst%3DL.%2BE.%26aulast%3DBernatchez%26aufirst%3DC.%26aulast%3DLazar%26aufirst%3DA.%2BJ.%26aulast%3DGrimm%26aufirst%3DE.%2BA.%26aulast%3DHong%26aufirst%3DD.%2BS.%26aulast%3DWoodman%26aufirst%3DS.%2BE.%26atitle%3DTargeting%2520the%2520HGF%252FMET%2520axis%2520counters%2520primary%2520resistance%2520to%2520KIT%2520inhibition%2520in%2520KIT-mutant%2520melanoma%26jtitle%3DJCO%2520Precis.%2520Oncol.%26date%3D2018%26spage%3D55%26doi%3D10.1200%2FPO.18.00055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knauf, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luckett, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voza, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Socci, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghossein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagin, J. A.</span></span> <span> </span><span class="NLM_article-title">Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">4086</span>– <span class="NLM_lpage">4097</span>, <span class="refDoi"> DOI: 10.1172/JCI120966</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1172%2FJCI120966" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2018&pages=4086-4097&author=J.+A.+Knaufauthor=K.+A.+Luckettauthor=K.+Y.+Chenauthor=F.+Vozaauthor=N.+D.+Socciauthor=R.+Ghosseinauthor=J.+A.+Fagin&title=Hgf%2FMet+activation+mediates+resistance+to+BRAF+inhibition+in+murine+anaplastic+thyroid+cancers&doi=10.1172%2FJCI120966"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1172%2FJCI120966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI120966%26sid%3Dliteratum%253Aachs%26aulast%3DKnauf%26aufirst%3DJ.%2BA.%26aulast%3DLuckett%26aufirst%3DK.%2BA.%26aulast%3DChen%26aufirst%3DK.%2BY.%26aulast%3DVoza%26aufirst%3DF.%26aulast%3DSocci%26aufirst%3DN.%2BD.%26aulast%3DGhossein%26aufirst%3DR.%26aulast%3DFagin%26aufirst%3DJ.%2BA.%26atitle%3DHgf%252FMet%2520activation%2520mediates%2520resistance%2520to%2520BRAF%2520inhibition%2520in%2520murine%2520anaplastic%2520thyroid%2520cancers%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2018%26volume%3D128%26spage%3D4086%26epage%3D4097%26doi%3D10.1172%2FJCI120966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1864</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2017.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.bbadis.2017.12.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29253515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVegtrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1864&publication_year=2018&pages=793-803&author=Y.+Yiauthor=S.+Zengauthor=Z.+Wangauthor=M.+Wuauthor=Y.+Maauthor=X.+Yeauthor=B.+Zhangauthor=H.+Liu&title=Cancer-associated+fibroblasts+promote+epithelial-mesenchymal+transition+and+EGFR-TKI+resistance+of+non-small+cell+lung+cancers+via+HGF%2FIGF-1%2FANXA2+signaling&doi=10.1016%2Fj.bbadis.2017.12.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling</span></div><div class="casAuthors">Yi, Yanmei; Zeng, Shanshan; Wang, Zhaotong; Wu, Minhua; Ma, Yuanhuan; Ye, Xiaoxia; Zhang, Biao; Liu, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1864</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">793-803</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The involvement of the tumor stromal cells in acquired resistance of non-small cell lung cancers (NSCLCs) to tyrosine kinase inhibitors (TKIs) has previously been reported, but the precise mechanism remains unclear.  In the present study, we investigated the role and mechanism underlying Cancer-assocd. fibroblasts (CAFs) in TKI resistance of NSCLCs.  In vitro and in vivo expts. showed that HCC827 and PC9 cells, non-small cell lung cancer cells with EGFR-activating mutations, became resistant to the EGFR-TKI gefitinib when cultured with CAFs isolated from NSCLC tissues.  Moreover, we showed that CAFs could induce epithelial-mesenchymal transition (EMT) phenotype of HCC827 and PC9 cells, with an assocd. change in the expression of epithelial to mesenchymal transition markers.  Using proteomics-based method, we identified that CAFs significantly increased the expression of the Annexin A2 (ANXA2).  More importantly, knockdown of ANXA2 completely reversed EMT phenotype and gefitinib resistance induced by CAFs.  Furthermore, we found that CAFs increased the expression and phosphorylation of ANXA2 by secretion of growth factors HGF and IGF-1 and by activation of the corresponding receptors c-met and IGF-1R.  Dual inhibition of HGF/c-met and IGF-1/IGF-1R pathways could significantly suppress ANXA2, and markedly reduced CAFs-induced EMT and gefitinib resistance.  Taken together, these findings indicate that CAFs promote EGFR-TKIs resistance through HGF/IGF-1/ANXA2/EMT signaling and may be an ideal therapeutic target in NSCLCs with EGFR-activating mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcSKkW5LtfQ7Vg90H21EOLACvtfcHk0lgct2U2FRKTVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVegtrzI&md5=5ce2254fbb4f8a8a7f91bda6b81190cc</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2017.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2017.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DYi%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DCancer-associated%2520fibroblasts%2520promote%2520epithelial-mesenchymal%2520transition%2520and%2520EGFR-TKI%2520resistance%2520of%2520non-small%2520cell%2520lung%2520cancers%2520via%2520HGF%252FIGF-1%252FANXA2%2520signaling%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2018%26volume%3D1864%26spage%3D793%26epage%3D803%26doi%3D10.1016%2Fj.bbadis.2017.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locatelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stammberger, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scagliotti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.</span></span> <span> </span><span class="NLM_article-title">Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer?</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2017.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.ctrv.2017.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29121501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGht7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=70-81&author=Y.+L.+Wuauthor=R.+A.+Sooauthor=G.+Locatelliauthor=U.+Stammbergerauthor=G.+Scagliottiauthor=K.+Park&title=Does+c-Met+remain+a+rational+target+for+therapy+in+patients+with+EGFR+TKI-resistant+non-small+cell+lung+cancer%3F&doi=10.1016%2Fj.ctrv.2017.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer?</span></div><div class="casAuthors">Wu, Yi-Long; Soo, Ross Andrew; Locatelli, Giuseppe; Stammberger, Uz; Scagliotti, Giorgio; Park, Keunchil</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">70-81</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Non-small cell lung cancer (NSCLC) inevitably develops resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) treatment.  In 5-20% of cases, this can be attributed to aberrant c-Met activity, providing a clear rationale for the use of c-Met inhibitors in these patients.  EGFR TKI-resistant tumors often remain sensitive to EGFR signaling, such that c-Met inhibitors are likely to be most effective when combined with continued EGFR TKI therapy.  The phase III trials of the c-Met inhibitors onartuzumab and tivantinib, which failed to demonstrate significant benefit in patients with NSCLC but excluded patients with EGFR TKI-resistant disease, do not allow c-Met to be dismissed as a rational target in EGFR TKI-resistant NSCLC.  Selective c-Met TKIs exhibit more favorable properties, targeting both hepatocyte growth factor (HGF)-dependent and -independent c-Met activity, with a reduced risk of toxicity compared to non-selective c-Met TKIs.  Phase Ib/II trials of the selective c-Met TKIs capmatinib and tepotinib have shown encouraging signs of efficacy.  Factors affecting the success of ongoing and future trials of c-Met inhibitors in patients with EGFR TKI-resistant, c-Met-pos. NSCLC are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpAvtCcmYXzLVg90H21EOLACvtfcHk0lgct2U2FRKTVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGht7rJ&md5=88a27ba738f83f5933cf1de113406414</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2017.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2017.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%2BL.%26aulast%3DSoo%26aufirst%3DR.%2BA.%26aulast%3DLocatelli%26aufirst%3DG.%26aulast%3DStammberger%26aufirst%3DU.%26aulast%3DScagliotti%26aufirst%3DG.%26aulast%3DPark%26aufirst%3DK.%26atitle%3DDoes%2520c-Met%2520remain%2520a%2520rational%2520target%2520for%2520therapy%2520in%2520patients%2520with%2520EGFR%2520TKI-resistant%2520non-small%2520cell%2520lung%2520cancer%253F%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2017%26volume%3D61%26spage%3D70%26epage%3D81%26doi%3D10.1016%2Fj.ctrv.2017.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Owusu, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venukadasula, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galemmo, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klampfer, L.</span></span> <span> </span><span class="NLM_article-title">Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">63014</span>– <span class="NLM_lpage">63025</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.18260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.18632%2Foncotarget.18260" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=63014-63025&author=B.+Y.+Owusuauthor=S.+Thomasauthor=P.+Venukadasulaauthor=Z.+Hanauthor=J.+W.+Janetkaauthor=R.+A.+Galemmoauthor=L.+Klampfer&title=Targeting+the+tumor-promoting+microenvironment+in+MET-amplified+NSCLC+cells+with+a+novel+inhibitor+of+pro-HGF+activation&doi=10.18632%2Foncotarget.18260"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.18260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.18260%26sid%3Dliteratum%253Aachs%26aulast%3DOwusu%26aufirst%3DB.%2BY.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DVenukadasula%26aufirst%3DP.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26aulast%3DKlampfer%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520tumor-promoting%2520microenvironment%2520in%2520MET-amplified%2520NSCLC%2520cells%2520with%2520a%2520novel%2520inhibitor%2520of%2520pro-HGF%2520activation%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D63014%26epage%3D63025%26doi%3D10.18632%2Foncotarget.18260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ko, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadgeel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, B.</span></span> <span> </span><span class="NLM_article-title">MET/HGF pathway activation as a paradigm of resistance to targeted therapies</span>. <i>Ann. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">4</span>, <span class="refDoi"> DOI: 10.21037/atm.2016.12.09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.21037%2Fatm.2016.12.09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=28164089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVGqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=4&author=B.+Koauthor=T.+Heauthor=S.+Gadgeelauthor=B.+Halmos&title=MET%2FHGF+pathway+activation+as+a+paradigm+of+resistance+to+targeted+therapies&doi=10.21037%2Fatm.2016.12.09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">MET/HGF pathway activation as a paradigm of resistance to targeted therapies</span></div><div class="casAuthors">Ko, Brian; He, Tianfang; Gadgeel, Shirish; Halmos, Balazs</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Translational Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4/1-4/16</span>CODEN:
                <span class="NLM_cas:coden">ATMNDX</span>;
        ISSN:<span class="NLM_cas:issn">2305-5847</span>.
    
            (<span class="NLM_cas:orgname">AME Publishing Co.</span>)
        </div><div class="casAbstract">Resistance to targeted therapeutics is a key issue limiting the long-term utility of these medications in the management of molecularly selected subsets of cancer patients, including patients with non-small cell lung cancer harboring oncogenic alterations affecting EGFR, ALK and other genes.  Bypass resistance mediated by activation of MET kinase has emerged as a frequent, validated and pivotal resistance mechanism in multiple types of cancers.  Biochem. understanding is accumulating to explain the unique role of MET in such bypass pathways, providing alternate downstream activation opportunities and intricate interactions during epithelial-mesenchymal transitions.  Multiple diagnostic testing platforms have become available for selecting appropriate patients for MET targeting in a variety of settings.  Importantly, in light of the failures of several earlier clin. studies of MET targeting agents, a large array of recent and current MET-focused trials are incorporating stricter patient selection and more robust predictive biomarkers providing hope for validation of MET targeting as a clin. impactful strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZmcMfkcO3dbVg90H21EOLACvtfcHk0liTL5sT6_wIpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVGqsrc%253D&md5=481e6d34488004735582f9ebdf308f27</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.21037%2Fatm.2016.12.09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.21037%252Fatm.2016.12.09%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DGadgeel%26aufirst%3DS.%26aulast%3DHalmos%26aufirst%3DB.%26atitle%3DMET%252FHGF%2520pathway%2520activation%2520as%2520a%2520paradigm%2520of%2520resistance%2520to%2520targeted%2520therapies%26jtitle%3DAnn.%2520Transl.%2520Med.%26date%3D2017%26volume%3D5%26spage%3D4%26doi%3D10.21037%2Fatm.2016.12.09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friese-Hamim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bladt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locatelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stammberger, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaukat, A.</span></span> <span> </span><span class="NLM_article-title">The selective c-Met inhibitor tepotinib can overcome epidermal growth factor receptor inhibitor resistance mediated by aberrant c-Met activation in NSCLC models</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">972</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=28469968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFOntLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=962-972&author=M.+Friese-Hamimauthor=F.+Bladtauthor=G.+Locatelliauthor=U.+Stammbergerauthor=A.+Blaukat&title=The+selective+c-Met+inhibitor+tepotinib+can+overcome+epidermal+growth+factor+receptor+inhibitor+resistance+mediated+by+aberrant+c-Met+activation+in+NSCLC+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The selective c-Met inhibitor tepotinib can overcome epidermal growth factor receptor inhibitor resistance mediated by aberrant c-Met activation in NSCLC models</span></div><div class="casAuthors">Friese-Hamim, Manja; Bladt, Friedhelm; Locatelli, Giuseppe; Stammberger, Uz; Blaukat, Andree</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">962-972</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Non-small cell lung cancer (NSCLC) sensitive to first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) often acquires resistance through secondary EGFR mutations, including the T790M mutation, aberrant c-Met receptor activity, or both.  We assessed the ability of the highly selective c-Met inhibitor tepotinib to overcome EGFR TKI resistance in various xenograft models of NSCLC.  In models with EGFR-activating mutations and low c-Met expression (patient explant-derived LU342, cell line PC-9), EGFR TKIs caused tumors to shrink, but growth resumed upon cessation of treatment.  Tepotinib combined with EGFR TKIs delayed tumor regrowth, while tepotinib alone was ineffective.  In patient explant-derived LU858, which has an EGFR-activating mutation and expresses high levels of c-Met/HGF, EGFR TKIs had no effect on tumor growth.  Tepotinib combined with EGFR TKIs caused complete tumor regression and tepotinib alone caused tumor stasis.  In cell line DFCI081 (activating EGFR mutation, c-Met amplification), EGFR TKIs were ineffective, whereas tepotinib alone induced com- plete tumor regression.  Finally, in a 'double resistant' EGFR T790M-pos., high c-Met model (cell line HCC827-GR- T790M), the EGFR TKIs erlotinib, afatinib, and rociletinib, as well as tepotinib as a single agent or in combination with erlotinib or afatinib, slowed tumor growth, but only tepotinib in combination with rociletinib induced complete tumor regression.  We conclude that tepotinib can overcome acquired resistance to EGFR TKIs.  Based on these data, clin. trials of tepotinib in combination with EGFR TKIs in patients with NSCLC with acquired resistance to first-generation EGFR TKIs are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzmtl8W9HgD7Vg90H21EOLACvtfcHk0liTL5sT6_wIpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFOntLbI&md5=332fbd51f81c57cfefb0aa301d1ebd73</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriese-Hamim%26aufirst%3DM.%26aulast%3DBladt%26aufirst%3DF.%26aulast%3DLocatelli%26aufirst%3DG.%26aulast%3DStammberger%26aufirst%3DU.%26aulast%3DBlaukat%26aufirst%3DA.%26atitle%3DThe%2520selective%2520c-Met%2520inhibitor%2520tepotinib%2520can%2520overcome%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitor%2520resistance%2520mediated%2520by%2520aberrant%2520c-Met%2520activation%2520in%2520NSCLC%2520models%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2017%26volume%3D7%26spage%3D962%26epage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cascone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howells, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddad, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanrahan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortez, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giri, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saigal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jüergensmeier, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbst, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wistuba, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heymach, J. V.</span></span> <span> </span><span class="NLM_article-title">The HGF/c-MET pathway is a driver and biomarker of VEGFR-inhibitor resistance and vascular remodeling in non-small cell lung cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5489</span>– <span class="NLM_lpage">5501</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-3216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1158%2F1078-0432.CCR-16-3216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=28559461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsV2mu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=5489-5501&author=T.+Casconeauthor=L.+Xuauthor=H.+Y.+Linauthor=W.+Liuauthor=H.+T.+Tranauthor=Y.+Liuauthor=K.+Howellsauthor=V.+Haddadauthor=E.+Hanrahanauthor=M.+B.+Nilssonauthor=M.+A.+Cortezauthor=U.+Giriauthor=H.+Kadaraauthor=B.+Saigalauthor=Y.+Y.+Parkauthor=W.+Pengauthor=J.+S.+Leeauthor=A.+J.+Ryanauthor=J.+M.+J%C3%BCergensmeierauthor=R.+S.+Herbstauthor=J.+Wangauthor=R.+R.+Langleyauthor=I.+I.+Wistubaauthor=J.+J.+Leeauthor=J.+V.+Heymach&title=The+HGF%2Fc-MET+pathway+is+a+driver+and+biomarker+of+VEGFR-inhibitor+resistance+and+vascular+remodeling+in+non-small+cell+lung+cancer&doi=10.1158%2F1078-0432.CCR-16-3216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non-Small Cell Lung Cancer</span></div><div class="casAuthors">Cascone, Tina; Xu, Li; Lin, Heather Y.; Liu, Wenbin; Tran, Hai T.; Liu, Yuan; Howells, Kathryn; Haddad, Vincent; Hanrahan, Emer; Nilsson, Monique B.; Cortez, Maria A.; Giri, Uma; Kadara, Humam; Saigal, Babita; Park, Yun-Yong; Peng, Weiyi; Lee, Ju-Seog; Ryan, Anderson J.; Juergensmeier, Juliane M.; Herbst, Roy S.; Wang, Jing; Langley, Robert R.; Wistuba, Ignacio I.; Lee, Jack J.; Heymach, John V.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5489-5501</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Resistance to VEGFR inhibitors is a major obstacle in the treatment of non-small cell lung cancer (NSCLC).  We investigated the cellular mechanisms mediating resistance of NSCLCs to VEGFR tyrosine kinase inhibitors.  Exptl. Design: We generated murine models of human NSCLC and performed targeted inhibition studies with the VEGFR TKIs cediranib and vandetanib.  We used species-specific hybridization of microarrays to compare cancer (human) and stromal (mouse) cell transcriptomes of TKI-sensitive and -resistant tumors.  We measured tumor microvascular d. and vessel tortuosity to characterize the effects of therapy on the tumor vascular bed.  Circulating cytokine and angiogenic factor levels in patients enrolled in VEGFR TKI trials were correlated with clin. outcomes.  Results: Murine xenograft models of human lung adenocarcinoma were initially sensitive to VEGFR TKIs, but developed resistance to treatment.  Species-specific microarray anal. identified increased expression of stromal-derived hepatocyte growth factor (HGF) as a candidate mediator of TKI resistance and its receptor, c-MET, was activated in cancer cells and tumor-assocd. stroma.  A transient increase in hypoxia-regulated mols. in the initial response phase was followed by adaptive changes resulting in a more tortuous vasculature.  Forced HGF expression in cancer cells reduced tumor sensitivity to VEGFR TKIs and produced tumors with tortuous blood vessels.  Dual VEGFR/c-MET signaling inhibition delayed the onset of the resistant phenotype and prevented the vascular morphol. alterations.  In patients with cancer receiving VEGFR TKIs, high pretreatment HGF plasma levels correlated with poorer survival.  Conclusions: HGF/c-MET pathway mediates VEGFR inhibitor resistance and vascular remodeling in NSCLC.  Clin Cancer Res; 23(18); 5489-501. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxqt2NPffHZrVg90H21EOLACvtfcHk0liTL5sT6_wIpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2mu7bN&md5=9fe1f48d84c2087476122e0ea83fff39</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-3216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-3216%26sid%3Dliteratum%253Aachs%26aulast%3DCascone%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DH.%2BY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DTran%26aufirst%3DH.%2BT.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHowells%26aufirst%3DK.%26aulast%3DHaddad%26aufirst%3DV.%26aulast%3DHanrahan%26aufirst%3DE.%26aulast%3DNilsson%26aufirst%3DM.%2BB.%26aulast%3DCortez%26aufirst%3DM.%2BA.%26aulast%3DGiri%26aufirst%3DU.%26aulast%3DKadara%26aufirst%3DH.%26aulast%3DSaigal%26aufirst%3DB.%26aulast%3DPark%26aufirst%3DY.%2BY.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DRyan%26aufirst%3DA.%2BJ.%26aulast%3DJ%25C3%25BCergensmeier%26aufirst%3DJ.%2BM.%26aulast%3DHerbst%26aufirst%3DR.%2BS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLangley%26aufirst%3DR.%2BR.%26aulast%3DWistuba%26aufirst%3DI.%2BI.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DHeymach%26aufirst%3DJ.%2BV.%26atitle%3DThe%2520HGF%252Fc-MET%2520pathway%2520is%2520a%2520driver%2520and%2520biomarker%2520of%2520VEGFR-inhibitor%2520resistance%2520and%2520vascular%2520remodeling%2520in%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26spage%3D5489%26epage%3D5501%26doi%3D10.1158%2F1078-0432.CCR-16-3216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W. H.</span></span> <span> </span><span class="NLM_article-title">Increased HGF expression induces resistance to c-MET tyrosine kinase inhibitors in gastric cancer</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1127</span>– <span class="NLM_lpage">1138</span>, <span class="refDoi"> DOI: 10.21873/anticanres.11426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.21873%2Fanticanres.11426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=28314274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlWqt7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=1127-1138&author=S.+Y.+Ahnauthor=J.+Kimauthor=M.+A.+Kimauthor=J.+Choiauthor=W.+H.+Kim&title=Increased+HGF+expression+induces+resistance+to+c-MET+tyrosine+kinase+inhibitors+in+gastric+cancer&doi=10.21873%2Fanticanres.11426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Increased HGF expression induces resistance to c-MET tyrosine kinase inhibitors in gastric cancer</span></div><div class="casAuthors">Ahn, So Yeong; Kim, Jin; Kim, Min A.; Choi, Jiwoon; Kim, Woo Ho</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1127-1138</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: Increased expression of hepatocyte growth factor (HGF) and MET proto-oncogene (c-MET) is assocd. with poor prognosis in various cancer types.  Recently, it was reported that the expression of HGF induces resistance to tyrosine kinase inhibitors (TKIs) targeting epidermal growth factor receptor, human epidermal receptor receptor 2, and b-raf proto-oncogene.  Here, we investigated the effects of HGF overexpression in gastric cancer cells in the absence or presence of c-MET TKIs.  Materials and Methods: The effects of c-MET TKIs in gastric cancer cells with and without c-MET overexpression were detd. in gastric cancer cell lines with various cell biol. methods.  Results: Compared to the control, cells with induced expression of HGF showed increase in anchorage-independent colony formation (p<0.001).  The c-MET TKIs inhibited HGF/c-MET downstream signaling, cell proliferation, migration and invasion, and triggered cell-cycle arrest in Hs746T cells.  However, HGF-transfected cells were less affected.  Conclusion: c-MET TKIs had inhibitory effects only on cells overexpressing c-MET.  Furthermore, overexpression of HGF resulted in resistance to c-MET TKIs through an autocrine manner in gastric cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEL-NHb_Qbz7Vg90H21EOLACvtfcHk0lgVmbGJFgvNaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlWqt7bE&md5=c8b178dfc8fa4c2102a5f54aa025fabb</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.21873%2Fanticanres.11426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.21873%252Fanticanres.11426%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DM.%2BA.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DW.%2BH.%26atitle%3DIncreased%2520HGF%2520expression%2520induces%2520resistance%2520to%2520c-MET%2520tyrosine%2520kinase%2520inhibitors%2520in%2520gastric%2520cancer%26jtitle%3DAnticancer%2520Res.%26date%3D2017%26volume%3D37%26spage%3D1127%26epage%3D1138%26doi%3D10.21873%2Fanticanres.11426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwasa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashima, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamaguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, Y.</span></span> <span> </span><span class="NLM_article-title">Serum level of hepatocyte growth factor is a novel marker of predicting the outcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">4925</span>– <span class="NLM_lpage">4938</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.6753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.18632%2Foncotarget.6753" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=4925-4938&author=N.+Takahashiauthor=K.+Furutaauthor=H.+Taniguchiauthor=Y.+Sasakiauthor=H.+Shojiauthor=Y.+Honmaauthor=S.+Iwasaauthor=N.+Okitaauthor=A.+Takashimaauthor=K.+Katoauthor=T.+Hamaguchiauthor=Y.+Shimadaauthor=Y.+Yamada&title=Serum+level+of+hepatocyte+growth+factor+is+a+novel+marker+of+predicting+the+outcome+and+resistance+to+the+treatment+with+trastuzumab+in+HER2-positive+patients+with+metastatic+gastric+cancer&doi=10.18632%2Foncotarget.6753"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.6753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.6753%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DFuruta%26aufirst%3DK.%26aulast%3DTaniguchi%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DShoji%26aufirst%3DH.%26aulast%3DHonma%26aufirst%3DY.%26aulast%3DIwasa%26aufirst%3DS.%26aulast%3DOkita%26aufirst%3DN.%26aulast%3DTakashima%26aufirst%3DA.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DHamaguchi%26aufirst%3DT.%26aulast%3DShimada%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DY.%26atitle%3DSerum%2520level%2520of%2520hepatocyte%2520growth%2520factor%2520is%2520a%2520novel%2520marker%2520of%2520predicting%2520the%2520outcome%2520and%2520resistance%2520to%2520the%2520treatment%2520with%2520trastuzumab%2520in%2520HER2-positive%2520patients%2520with%2520metastatic%2520gastric%2520cancer%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D4925%26epage%3D4938%26doi%3D10.18632%2Foncotarget.6753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koseki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marubashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, H.</span></span> <span> </span><span class="NLM_article-title">c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1892</span>– <span class="NLM_lpage">1898</span>, <span class="refDoi"> DOI: 10.3892/ol.2018.8793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.3892%2Fol.2018.8793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=30008881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252Fot1Oitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=1892-1898&author=K.+Noguchiauthor=M.+Konnoauthor=H.+Eguchiauthor=K.+Kawamotoauthor=R.+Mukaiauthor=N.+Nishidaauthor=J.+Kosekiauthor=H.+Wadaauthor=H.+Akitaauthor=T.+Satohauthor=S.+Marubashiauthor=H.+Naganoauthor=Y.+Dokiauthor=M.+Moriauthor=H.+Ishii&title=c-Met+affects+gemcitabine+resistance+during+carcinogenesis+in+a+mouse+model+of+pancreatic+cancer&doi=10.3892%2Fol.2018.8793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer</span></div><div class="casAuthors">Noguchi Kozo; Eguchi Hidetoshi; Kawamoto Koichi; Mukai Ryouta; Wada Hiroshi; Akita Hirofumi; Marubashi Shigeru; Nagano Hiroaki; Doki Yuichiro; Mori Masaki; Noguchi Kozo; Konno Masamitsu; Nishida Naohiro; Satoh Taroh; Ishii Hideshi; Koseki Jun; Ishii Hideshi</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1892-1898</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">Pancreatic adenocarcinoma is thought to develop from histologically identifiable intraductal lesions known as pancreatic intraepithelial neoplasias (PanINs), which exhibit similar morphological and genetic features to pancreatic ductal adenocarcinoma (PDAC).  Therefore, a better understanding of the biological features underlying the progression of PanIN is essential to development more effective therapeutic interventions for PDAC.  In recent years, numerous studies have reported that MET proto-oncogene receptor tyrosine kinase (c-MET) is a potential marker of pancreatic cancer stem cells (CSCs).  CSCs have been revealed to initiate and propagate tumors in vitro and in vivo, and are associated with a chemoresistant phenotype.  However, in vivo models using a xenograft approach are limited.  In the present study, the morphological phenotype, molecular alteration and biological behavior of neoplasia in Pdx-1Cre/+, KrasLSL-G12D/+ and Metflox/flox and wild-type mice was analyzed.  The results demonstrated that while oncogenic KrasLSL-G12D/+ increased PanIN initiation and significantly decreased survival rate compared with wild-type mice, no additive effect of c-Met receptor signaling on PanIN progression or prognosis was observed.  Following gemcitabine administration, c-Met inhibition in Kras LSL-G12D/+ mice significantly decreased the total surface area of PanIN lesions and the number of anti-proliferation marker protein Ki-67 positive cells occupying PanIN lesions compared with Met+/+ mice.  In conclusion, complete inhibition of the c-Met signaling pathway with chemotherapy may be useful for the treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfpOBgcGQpVV1C8OJBvdfbfW6udTcc2eY6v2V1vu0cw7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252Fot1Oitg%253D%253D&md5=15a5e95a6c508b521637baf730cccd9f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3892%2Fol.2018.8793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2018.8793%26sid%3Dliteratum%253Aachs%26aulast%3DNoguchi%26aufirst%3DK.%26aulast%3DKonno%26aufirst%3DM.%26aulast%3DEguchi%26aufirst%3DH.%26aulast%3DKawamoto%26aufirst%3DK.%26aulast%3DMukai%26aufirst%3DR.%26aulast%3DNishida%26aufirst%3DN.%26aulast%3DKoseki%26aufirst%3DJ.%26aulast%3DWada%26aufirst%3DH.%26aulast%3DAkita%26aufirst%3DH.%26aulast%3DSatoh%26aufirst%3DT.%26aulast%3DMarubashi%26aufirst%3DS.%26aulast%3DNagano%26aufirst%3DH.%26aulast%3DDoki%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DH.%26atitle%3Dc-Met%2520affects%2520gemcitabine%2520resistance%2520during%2520carcinogenesis%2520in%2520a%2520mouse%2520model%2520of%2520pancreatic%2520cancer%26jtitle%3DOncol.%2520Lett.%26date%3D2018%26volume%3D16%26spage%3D1892%26epage%3D1898%26doi%3D10.3892%2Fol.2018.8793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Della
Corte, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papaccio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciardiello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgillo, F.</span></span> <span> </span><span class="NLM_article-title">Role of HGF-MET signaling in primary and acquired resistance to targeted therapies in cancer</span>. <i>Biomedicines</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.3390/biomedicines2040345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.3390%2Fbiomedicines2040345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=28548075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A280%3ADC%252BC1cnhs1Cqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=345-358&author=C.+M.+Della%0ACorteauthor=M.+Fasanoauthor=F.+Papaccioauthor=F.+Ciardielloauthor=F.+Morgillo&title=Role+of+HGF-MET+signaling+in+primary+and+acquired+resistance+to+targeted+therapies+in+cancer&doi=10.3390%2Fbiomedicines2040345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Role of HGF-MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer</span></div><div class="casAuthors">Della Corte Carminia Maria; Fasano Morena; Papaccio Federica; Ciardiello Fortunato; Morgillo Floriana</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicines</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">345-358</span>
        ISSN:<span class="NLM_cas:issn">2227-9059</span>.
    </div><div class="casAbstract">The Hepatocyte growth factor (HGF)-mesenchymal-epithelial transition (MET) pathway is deregulated in several cancers and is associated with aggressive phenotype and worse prognosis.  MET, a tyrosine kinase receptor activated by HGF, plays a physiological role in embryogenesis, promoting cell growth, survival and motility.  HGF-MET aberrant activation in tumorigenesis acts through various mechanisms: paracrine/autocrine HGF production, MET overexpression, MET germ-line and sporadic mutations and cross-talk with other growth factor receptors.  In addition, MET activation could represent a mechanism of escape from other targeted therapies, through receptor amplification or over-stimulation by the ligand, as demonstrated in non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) models with acquired resistance to epidermal growth factor receptor (EGFR) inhibitors and also in models of melanoma resistant to the BRAF inhibitor vemurafenib.  As a consequence, a lot of molecules targeting MET signaling are under clinical investigation as single agent or in combination with other targeted drugs.  Patient selection, based on MET expression on tumor samples (eventually, by re-biopsy of new metastatic sites), and pharmacokinetic/pharmacodynamic markers are needed.  Authors review the latest data on the role of MET and the molecular mechanism underlying primary or acquired resistance to biological agents, focusing on NSCLC, CRC and melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTv7dhNFbIrIpSWdIdmEou5fW6udTcc2eZvrDwzO0W8grntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnhs1Cqsw%253D%253D&md5=bbb1bd966dfe08f4a790b264ad3402b4</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.3390%2Fbiomedicines2040345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiomedicines2040345%26sid%3Dliteratum%253Aachs%26aulast%3DDella%2BCorte%26aufirst%3DC.%2BM.%26aulast%3DFasano%26aufirst%3DM.%26aulast%3DPapaccio%26aufirst%3DF.%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DMorgillo%26aufirst%3DF.%26atitle%3DRole%2520of%2520HGF-MET%2520signaling%2520in%2520primary%2520and%2520acquired%2520resistance%2520to%2520targeted%2520therapies%2520in%2520cancer%26jtitle%3DBiomedicines%26date%3D2014%26volume%3D2%26spage%3D345%26epage%3D358%26doi%3D10.3390%2Fbiomedicines2040345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of cancer: the next generation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+the+next+generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0lgtIWR_x9TGqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520the%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Partanen, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tervonen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klefstrom, J.</span></span> <span> </span><span class="NLM_article-title">Breaking the epithelial polarity barrier in cancer: the strange case of LKB1/PAR-4</span>. <i>Philos. Trans. R. Soc., B</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">20130111</span>, <span class="refDoi"> DOI: 10.1098/rstb.2013.0111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1098%2Frstb.2013.0111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=24062587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslarsr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2013&pages=20130111&author=J.+I.+Partanenauthor=T.+A.+Tervonenauthor=J.+Klefstrom&title=Breaking+the+epithelial+polarity+barrier+in+cancer%3A+the+strange+case+of+LKB1%2FPAR-4&doi=10.1098%2Frstb.2013.0111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Breaking the epithelial polarity barrier in cancer: the strange case of LKB1/PAR-4</span></div><div class="casAuthors">Partanen, Johanna I.; Tervonen, Topi A.; Klefstrom, Juha</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical Transactions of the Royal Society, B: Biological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">1629</span>),
    <span class="NLM_cas:pages">20130111/1-20130111/12</span>CODEN:
                <span class="NLM_cas:coden">PTRBAE</span>;
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">A review.  The PAR clan of polarity regulating genes was initially discovered in a genetic screen searching for genes involved in asym. cell divisions in the Caenorhabditis elegans embryo.  Today, investigations in worms, flies and mammals have established PAR proteins as conserved and fundamental regulators of animal cell polarization in a broad range of biol. phenomena requiring cellular asymmetries.  The human homolog of invertebrate PAR-4, a serine-threonine kinase LKB1/STK11, has caught attention as a gene behind Peutz-Jeghers polyposis syndrome and as a bona fide tumor suppressor gene commonly mutated in sporadic cancer.  LKB1 functions as a master regulator of AMP-activated protein kinase (AMPK) and 12 other kinases referred to as the AMPK-related kinases, including four human homologues of PAR-1.  The role of LKB1 as part of the energy sensing LKB1-AMPK module has been intensively studied, whereas the polarity function of LKB1, in the context of homoeostasis or cancer, has gained less attention.  Here, we focus on the PAR-4 identity of LKB1, discussing the wt. of evidence indicating a role for LKB1 in regulation of cell polarity and epithelial integrity across species and highlight recent investigations providing new insight into the old question: does the PAR-4 identity of LKB1 matter in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohoudKDkyUQbVg90H21EOLACvtfcHk0lgtIWR_x9TGqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslarsr%252FF&md5=c0e81854cdbf072069df76fb4bc5013d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1098%2Frstb.2013.0111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2013.0111%26sid%3Dliteratum%253Aachs%26aulast%3DPartanen%26aufirst%3DJ.%2BI.%26aulast%3DTervonen%26aufirst%3DT.%2BA.%26aulast%3DKlefstrom%26aufirst%3DJ.%26atitle%3DBreaking%2520the%2520epithelial%2520polarity%2520barrier%2520in%2520cancer%253A%2520the%2520strange%2520case%2520of%2520LKB1%252FPAR-4%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2013%26volume%3D368%26spage%3D20130111%26doi%3D10.1098%2Frstb.2013.0111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gumbiner, B. M.</span></span> <span> </span><span class="NLM_article-title">Cell adhesion: the molecular basis of tissue architecture and morphogenesis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81279-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2FS0092-8674%2800%2981279-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=8608588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADyaK28XhtFWqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1996&pages=345-357&author=B.+M.+Gumbiner&title=Cell+adhesion%3A+the+molecular+basis+of+tissue+architecture+and+morphogenesis&doi=10.1016%2FS0092-8674%2800%2981279-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Cell adhesion: the molecular basis of tissue architecture and morphogenesis</span></div><div class="casAuthors">Gumbiner, Barry M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-57</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with 73 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyBq4qZqr6ArVg90H21EOLACvtfcHk0lgtIWR_x9TGqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtFWqtr4%253D&md5=4bea75fb17918173afdbc25ca896e523</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981279-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981279-9%26sid%3Dliteratum%253Aachs%26aulast%3DGumbiner%26aufirst%3DB.%2BM.%26atitle%3DCell%2520adhesion%253A%2520the%2520molecular%2520basis%2520of%2520tissue%2520architecture%2520and%2520morphogenesis%26jtitle%3DCell%26date%3D1996%26volume%3D84%26spage%3D345%26epage%3D357%26doi%3D10.1016%2FS0092-8674%2800%2981279-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Effing, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourbeau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vercoulen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coultas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palen, J.</span></span> <span> </span><span class="NLM_article-title">Self-management programmes for COPD: moving forward</span>. <i>Chron. Resp. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1177/1479972311433574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1177%2F1479972311433574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=22308551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A280%3ADC%252BC383gsFOmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=27-35&author=T.+W.+Effingauthor=J.+Bourbeauauthor=J.+Vercoulenauthor=A.+J.+Apterauthor=D.+Coultasauthor=P.+Meekauthor=P.+Valkauthor=M.+R.+Partridgeauthor=J.+Palen&title=Self-management+programmes+for+COPD%3A+moving+forward&doi=10.1177%2F1479972311433574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Self-management programmes for COPD: moving forward</span></div><div class="casAuthors">Effing Tanja W; Bourbeau Jean; Vercoulen Jan; Apter Andrea J; Coultas David; Meek Paula; Valk Paul van der; Partridge Martyn R; Palen Job van der</div><div class="citationInfo"><span class="NLM_cas:title">Chronic respiratory disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Self-management is of increasing importance in chronic obstructive pulmonary disease (COPD) management.  However, there is confusion over what processes are involved, how the value of self-management should be determined, and about the research priorities.  To gain more insight into and agreement about the content of programmes, outcomes, and future directions of COPD self-management, a group of interested researchers and physicians, all of whom had previously published on this subject and who had previously collaborated on other projects, convened a workshop.  This article summarises their initial findings.  Self-management programmes aim at structural behaviour change to sustain treatment effects after programmes have been completed.  The programmes should include techniques aimed at behavioural change, be tailored individually, take the patient's perspective into account, and may vary with the course of the patient's disease and co-morbidities.  Assessment should include process variables.  This report is a step towards greater conformity in the field of self-management.  To enhance clarity regarding effectiveness, future studies should clearly describe their intervention, be properly designed and powered, and include outcomes that focus more on the acquisition and practice of new skills.  In this way more evidence and a better comprehension on self-management programmes will be obtained, and more specific formulation of guidelines on self-management made possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSlsoHkMF-1VWyYR5VtavbzfW6udTcc2eZaxjWDMIvlRrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383gsFOmsg%253D%253D&md5=e14a1c60a1b360cf1dcd93beef57225c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1177%2F1479972311433574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1479972311433574%26sid%3Dliteratum%253Aachs%26aulast%3DEffing%26aufirst%3DT.%2BW.%26aulast%3DBourbeau%26aufirst%3DJ.%26aulast%3DVercoulen%26aufirst%3DJ.%26aulast%3DApter%26aufirst%3DA.%2BJ.%26aulast%3DCoultas%26aufirst%3DD.%26aulast%3DMeek%26aufirst%3DP.%26aulast%3DValk%26aufirst%3DP.%26aulast%3DPartridge%26aufirst%3DM.%2BR.%26aulast%3DPalen%26aufirst%3DJ.%26atitle%3DSelf-management%2520programmes%2520for%2520COPD%253A%2520moving%2520forward%26jtitle%3DChron.%2520Resp.%2520Dis.%26date%3D2012%26volume%3D9%26spage%3D27%26epage%3D35%26doi%3D10.1177%2F1479972311433574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ergel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singavarapu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orsulic, S.</span></span> <span> </span><span class="NLM_article-title">Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">2041</span>– <span class="NLM_lpage">2047</span>, <span class="refDoi"> DOI: 10.1002/ijc.23726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1002%2Fijc.23726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=18726901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Chs73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2008&pages=2041-2047&author=J.+Miaoauthor=D.+Muauthor=B.+Ergelauthor=R.+Singavarapuauthor=Z.+Duanauthor=S.+Powersauthor=E.+Olivaauthor=S.+Orsulic&title=Hepsin+colocalizes+with+desmosomes+and+induces+progression+of+ovarian+cancer+in+a+mouse+model&doi=10.1002%2Fijc.23726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model</span></div><div class="casAuthors">Miao, Jiangyong; Mu, David; Ergel, Burce; Singavarapu, Rajasekhar; Duan, Zhenfeng; Powers, Scott; Oliva, Esther; Orsulic, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2041-2047</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Hepsin is a serine protease that is widely expressed in different tissues and cell types, most prominently in the normal liver and kidney.  Overexpression of hepsin has been assocd. with prostate cancers, ovarian cancers and renal cell carcinomas.  The physiol. functions of hepsin in normal tissues and tumors are poorly understood.  To gain insight into its function in ovarian cancer, we analyzed the expression and subcellular localization of hepsin protein in ovarian cancer cell lines and tumors.  We showed that the membrane-assocd. hepsin protein is present at desmosomal junctions, where it colocalizes with its putative proteolytic substrate hepatocyte growth factor.  Consistent with the growing evidence that desmosomal junctions and their constituents play a role in cancer progression, we demonstrated that overexpression of hepsin promotes ovarian tumor growth in a mouse model.  The ability of ectopic hepsin to induce tumor growth in mice is abrogated by the mutation of 3 crit. residues in the catalytic domain, thus implicating the enzymic activity of hepsin in promoting tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLAGCqOpssILVg90H21EOLACvtfcHk0lhs4oQwdzbW3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Chs73E&md5=3b7b8ce6c7458011cc1a685e21050f2e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fijc.23726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.23726%26sid%3Dliteratum%253Aachs%26aulast%3DMiao%26aufirst%3DJ.%26aulast%3DMu%26aufirst%3DD.%26aulast%3DErgel%26aufirst%3DB.%26aulast%3DSingavarapu%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DZ.%26aulast%3DPowers%26aufirst%3DS.%26aulast%3DOliva%26aufirst%3DE.%26aulast%3DOrsulic%26aufirst%3DS.%26atitle%3DHepsin%2520colocalizes%2520with%2520desmosomes%2520and%2520induces%2520progression%2520of%2520ovarian%2520cancer%2520in%2520a%2520mouse%2520model%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2008%26volume%3D123%26spage%3D2041%26epage%3D2047%26doi%3D10.1002%2Fijc.23726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klezovitch, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevillet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirosevich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matusik, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasioukhin, V.</span></span> <span> </span><span class="NLM_article-title">Hepsin promotes prostate cancer progression and metastasis</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2004.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.ccr.2004.07.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=185-195&author=O.+Klezovitchauthor=J.+Chevilletauthor=J.+Mirosevichauthor=R.+L.+Robertsauthor=R.+J.+Matusikauthor=V.+Vasioukhin&title=Hepsin+promotes+prostate+cancer+progression+and+metastasis&doi=10.1016%2Fj.ccr.2004.07.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2004.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2004.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DKlezovitch%26aufirst%3DO.%26aulast%3DChevillet%26aufirst%3DJ.%26aulast%3DMirosevich%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DR.%2BL.%26aulast%3DMatusik%26aufirst%3DR.%2BJ.%26aulast%3DVasioukhin%26aufirst%3DV.%26atitle%3DHepsin%2520promotes%2520prostate%2520cancer%2520progression%2520and%2520metastasis%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26spage%3D185%26epage%3D195%26doi%3D10.1016%2Fj.ccr.2004.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tervonen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belitskin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pant, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englund, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ala-Hongisto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevalaita, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sihto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heikkila, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leidenius, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moilanen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joensuu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovanen, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klefstrom, J.</span></span> <span> </span><span class="NLM_article-title">Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1832</span>– <span class="NLM_lpage">1846</span>, <span class="refDoi"> DOI: 10.1038/onc.2015.248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1038%2Fonc.2015.248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=26165838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsFSru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=1832-1846&author=T.+A.+Tervonenauthor=D.+Belitskinauthor=S.+M.+Pantauthor=J.+I.+Englundauthor=E.+Marquesauthor=H.+Ala-Hongistoauthor=L.+Nevalaitaauthor=H.+Sihtoauthor=P.+Heikkilaauthor=M.+Leideniusauthor=K.+Hewitsonauthor=M.+Ramachandraauthor=A.+Moilanenauthor=H.+Joensuuauthor=P.+E.+Kovanenauthor=A.+Posoauthor=J.+Klefstrom&title=Deregulated+hepsin+protease+activity+confers+oncogenicity+by+concomitantly+augmenting+HGF%2FMET+signalling+and+disrupting+epithelial+cohesion&doi=10.1038%2Fonc.2015.248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion</span></div><div class="casAuthors">Tervonen, T. A.; Belitskin, D.; Pant, S. M.; Englund, J. I.; Marques, E.; Ala-Hongisto, H.; Nevalaita, L.; Sihto, H.; Heikkila, P.; Leidenius, M.; Hewitson, K.; Ramachandra, M.; Moilanen, A.; Joensuu, H.; Kovanen, P. E.; Poso, A.; Klefstrom, J.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1832-1846</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepsin belongs to a family of cell-surface serine proteases, which have sparked interest as therapeutic targets because of the accessibility of extracellular protease domain for inhibitors.  Hepsin is frequently amplified and/or overexpressed in epithelial cancers, but it is not clear how enhanced hepsin expression confers a potential for oncogenicity.  The authors show that hepsin is consistently overexpressed in more than 40% of examd. breast cancers, including all major biol. subtypes.  The effects of doxycycline-induced hepsin overexpression were examd. in mammary epithelial organoids, and the authors found that induced hepsin acutely downmodulates its cognate inhibitor, hepatocyte growth factor (HGF) activator inhibitor type 1 (HAI-1).  Hepsin-induced depletion of cellular HAI-1 led to a sharp increase in pericellular serine protease activity.  The derepressed hepsin proteolytically activated downstream serine proteases, augmented HGF/MET signaling and caused deterioration of desmosomes and hemidesmosomes; structures important for cell cohesion and cell-basement membrane interaction.  Moreover, chronic induction of hepsin considerably shortened the latency of Myc-dependent tumorigenesis in the mouse mammary gland.  The serine protease and uPA system inhibitor WX-UK1, identified as a micromolar range hepsin inhibitor, prevented hepsin from augmenting HGF/MET signaling and disrupting desmosomes and hemidesmosomes.  The findings suggest that the oncogenic activity of hepsin arises not only from elevated expression level but also from depletion of HAI-1, events which together trigger gain-of-function activity impacting HGF/MET signaling and epithelial cohesion.  Thus, hepsin overexpression is a major oncogenic conferrer to a serine protease activity involved in breast cancer dissemination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8Y0QR91QE0rVg90H21EOLACvtfcHk0lhs4oQwdzbW3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsFSru7w%253D&md5=76153fb74378464915e3a22e60c2c152</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.248%26sid%3Dliteratum%253Aachs%26aulast%3DTervonen%26aufirst%3DT.%2BA.%26aulast%3DBelitskin%26aufirst%3DD.%26aulast%3DPant%26aufirst%3DS.%2BM.%26aulast%3DEnglund%26aufirst%3DJ.%2BI.%26aulast%3DMarques%26aufirst%3DE.%26aulast%3DAla-Hongisto%26aufirst%3DH.%26aulast%3DNevalaita%26aufirst%3DL.%26aulast%3DSihto%26aufirst%3DH.%26aulast%3DHeikkila%26aufirst%3DP.%26aulast%3DLeidenius%26aufirst%3DM.%26aulast%3DHewitson%26aufirst%3DK.%26aulast%3DRamachandra%26aufirst%3DM.%26aulast%3DMoilanen%26aufirst%3DA.%26aulast%3DJoensuu%26aufirst%3DH.%26aulast%3DKovanen%26aufirst%3DP.%2BE.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DKlefstrom%26aufirst%3DJ.%26atitle%3DDeregulated%2520hepsin%2520protease%2520activity%2520confers%2520oncogenicity%2520by%2520concomitantly%2520augmenting%2520HGF%252FMET%2520signalling%2520and%2520disrupting%2520epithelial%2520cohesion%26jtitle%3DOncogene%26date%3D2016%26volume%3D35%26spage%3D1832%26epage%3D1846%26doi%3D10.1038%2Fonc.2015.248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raghav, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loree, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopetz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holla, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yap, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salgia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, D.</span></span> <span> </span><span class="NLM_article-title">Untying the gordion knot of targeting MET in cancer</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2018.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.ctrv.2018.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29730462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXoslSit7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2018&pages=95-103&author=K.+Raghavauthor=A.+M.+Baileyauthor=J.+M.+Loreeauthor=S.+Kopetzauthor=V.+Hollaauthor=T.+A.+Yapauthor=F.+Wangauthor=K.+Chenauthor=R.+Salgiaauthor=D.+Hong&title=Untying+the+gordion+knot+of+targeting+MET+in+cancer&doi=10.1016%2Fj.ctrv.2018.04.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Untying the gordion knot of targeting MET in cancer</span></div><div class="casAuthors">Raghav, Kanwal; Bailey, Ann Marie; Loree, Jonathan M.; Kopetz, Scott; Holla, Vijaykumar; Yap, Timothy Anthony; Wang, Fang; Chen, Ken; Salgia, Ravi; Hong, David</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95-103</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Despite compelling evidence backing the crucial role of a dysregulated MET axis in cancer and a myriad of agents targeting this pathway in active clin. development, the therapeutic value of MET inhibition in cancer oncol. remains to be established.  Although a series of disappointing clin. trials, at first, lessened fervor for targeting this pathway, investigations continue unabated with a no. of novel active compds. entering clin. trials.  Suboptimal designs which lacked biomarker selection have been the main reason for these early failures and this has stimulated a more biomarker enriched approach lately.  Fresh insights into the mechanics of diverse MET aberrations (amplifications and mutations) have allowed trial enrichment for appropriate patients in appropriate disease settings.  Development of MET inhibition as a therapeutic strategy in cancer has been a lesson in itself reflecting the challenging opportunities enclosed in the genetic landscape of cancer.  Here, we will review the status of MET targeted therapy in development as it stands today, discuss emerging paradigms in MET inhibition and theorize on concepts for future development.  We venture to propose that in spite of early disappointments, the future of this therapeutic strategy is promising with use of appropriate predictive biomarker in the right clin. context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpszv9uz_eUgrVg90H21EOLACvtfcHk0ligtCiCL9C91A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXoslSit7c%253D&md5=8769ec4cc88cafb61f8f58a1a7647ae4</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2018.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2018.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DRaghav%26aufirst%3DK.%26aulast%3DBailey%26aufirst%3DA.%2BM.%26aulast%3DLoree%26aufirst%3DJ.%2BM.%26aulast%3DKopetz%26aufirst%3DS.%26aulast%3DHolla%26aufirst%3DV.%26aulast%3DYap%26aufirst%3DT.%2BA.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DSalgia%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DD.%26atitle%3DUntying%2520the%2520gordion%2520knot%2520of%2520targeting%2520MET%2520in%2520cancer%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2018%26volume%3D66%26spage%3D95%26epage%3D103%26doi%3D10.1016%2Fj.ctrv.2018.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Owen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilpatrick, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, V.</span></span> <span> </span><span class="NLM_article-title">Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>426</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1042/BJ20091448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1042%2FBJ20091448" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2010&pages=219-228&author=K.+A.+Owenauthor=D.+Qiuauthor=J.+Alvesauthor=A.+M.+Schumacherauthor=L.+M.+Kilpatrickauthor=J.+Liauthor=J.+L.+Harrisauthor=V.+Ellis&title=Pericellular+activation+of+hepatocyte+growth+factor+by+the+transmembrane+serine+proteases+matriptase+and+hepsin%2C+but+not+by+the+membrane-associated+protease+uPA&doi=10.1042%2FBJ20091448"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1042%2FBJ20091448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20091448%26sid%3Dliteratum%253Aachs%26aulast%3DOwen%26aufirst%3DK.%2BA.%26aulast%3DQiu%26aufirst%3DD.%26aulast%3DAlves%26aufirst%3DJ.%26aulast%3DSchumacher%26aufirst%3DA.%2BM.%26aulast%3DKilpatrick%26aufirst%3DL.%2BM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DJ.%2BL.%26aulast%3DEllis%26aufirst%3DV.%26atitle%3DPericellular%2520activation%2520of%2520hepatocyte%2520growth%2520factor%2520by%2520the%2520transmembrane%2520serine%2520proteases%2520matriptase%2520and%2520hepsin%252C%2520but%2520not%2520by%2520the%2520membrane-associated%2520protease%2520uPA%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D426%26spage%3D219%26epage%3D228%26doi%3D10.1042%2FBJ20091448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimomura, T.</span></span> <span> </span><span class="NLM_article-title">Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2): Emerging key players in epithelial integrity and cancer</span>. <i>Pathol. Int.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1111/pin.12647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1111%2Fpin.12647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29431273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvVKqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2018&pages=145-158&author=H.+Kataokaauthor=M.+Kawaguchiauthor=T.+Fukushimaauthor=T.+Shimomura&title=Hepatocyte+growth+factor+activator+inhibitors+%28HAI-1+and+HAI-2%29%3A+Emerging+key+players+in+epithelial+integrity+and+cancer&doi=10.1111%2Fpin.12647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2): Emerging key players in epithelial integrity and cancer</span></div><div class="casAuthors">Kataoka, Hiroaki; Kawaguchi, Makiko; Fukushima, Tsuyoshi; Shimomura, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Pathology International</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">145-158</span>CODEN:
                <span class="NLM_cas:coden">PITEES</span>;
        ISSN:<span class="NLM_cas:issn">1320-5463</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The growth, survival, and metabolic activities of multicellular organisms at the cellular level are regulated by intracellular signaling, systemic homeostasis and the pericellular microenvironment.  Pericellular proteolysis has a crucial role in processing bioactive mols. in the microenvironment and thereby has profound effects on cellular functions.  Hepatocyte growth factor activator inhibitor type 1 (HAI-1) and HAI-2 are type I transmembrane serine protease inhibitors expressed by most epithelial cells.  They regulate the pericellular activities of circulating hepatocyte growth factor activator and cellular type II transmembrane serine proteases (TTSPs), proteases required for the activation of hepatocyte growth factor (HGF)/scatter factor (SF).  Activated HGF/SF transduces pleiotropic signals through its receptor tyrosine kinase, MET (coded by the proto-oncogene MET), which are necessary for cellular migration, survival, growth and triggering stem cells for accelerated healing.  HAI-1 and HAI-2 are also required for normal epithelial functions through regulation of TTSP-mediated activation of other proteases and protease-activated receptor 2, and also through suppressing excess degrdn. of epithelial junctional proteins.  This review summarizes current knowledge regarding the mechanism of pericellular HGF/SF activation and highlights emerging roles of HAIs in epithelial development and integrity, as well as tumorigenesis and progression of transformed epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYGfh8FgAOz7Vg90H21EOLACvtfcHk0ligtCiCL9C91A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvVKqsLw%253D&md5=f828322366d79c101fea4f6508f34ba6</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fpin.12647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpin.12647%26sid%3Dliteratum%253Aachs%26aulast%3DKataoka%26aufirst%3DH.%26aulast%3DKawaguchi%26aufirst%3DM.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DShimomura%26aufirst%3DT.%26atitle%3DHepatocyte%2520growth%2520factor%2520activator%2520inhibitors%2520%2528HAI-1%2520and%2520HAI-2%2529%253A%2520Emerging%2520key%2520players%2520in%2520epithelial%2520integrity%2520and%2520cancer%26jtitle%3DPathol.%2520Int.%26date%3D2018%26volume%3D68%26spage%3D145%26epage%3D158%26doi%3D10.1111%2Fpin.12647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J.</span></span> <span> </span><span class="NLM_article-title">Hepatocyte growth factor activator inhibitor type1 in cancer: Advances and perspectives (Review)</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2779</span>– <span class="NLM_lpage">2785</span>, <span class="refDoi"> DOI: 10.3892/mmr.2014.2628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.3892%2Fmmr.2014.2628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=25310042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWnsbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=2779-2785&author=Q.+Zhengauthor=H.+Wuauthor=J.+Caoauthor=J.+Ye&title=Hepatocyte+growth+factor+activator+inhibitor+type1+in+cancer%3A+Advances+and+perspectives+%28Review%29&doi=10.3892%2Fmmr.2014.2628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor activator inhibitor type-1 in cancer: advances and perspectives (Review)</span></div><div class="casAuthors">Zheng, Qiaoli; Wu, Haijian; Cao, Jiang; Ye, Jingjia</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2779-2785</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-2997</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Cancer is one of the most common diseases, with high morbidity and mortality rates.  Large-scale efforts have been made to understand the pathogenesis of the disease, particularly in the advanced stages, in order to develop effective therapeutic approaches.  Hepatocyte growth factor activator inhibitor type-1 (HAI-1), also known as serine protease inhibitor Kunitz type 1, inhibits the activity of several trypsin-like serine proteases.  In particular, HAI-1 suppresses hepatocyte growth factor (HGF) activator and matriptase, resulting in subsequent inhibition of HGF/scatter factor and macrophage-stimulating protein (MSP).  HGF and MSP are involved in cancer development and progression, via the receptors Met receptor tyrosine kinase (RTK) and Ron RTK, resp.  Therefore, HAI-1-mediated downregulation of HGF and MSP signaling may suppress tumorigenesis and progression in certain types of cancers.  Abnormal HAI-1 expression levels have been obsd. in various types of human cancer.  The exact function of HAI-1 in cancer pathogenesis, however, has not been fully elucidated.  In this review, the focus is on the potential impact of aberrant HAI-1 expression levels on tumorigenesis and progression, the underlying mechanisms, and areas that require further investigation to clarify the precise role of HAI-1 in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfCZdhwYJ70LVg90H21EOLACvtfcHk0lhmAE6gQY218w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWnsbfP&md5=93e1e489eed74d2bae545a9e22d0012e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2014.2628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2014.2628%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DJ.%26atitle%3DHepatocyte%2520growth%2520factor%2520activator%2520inhibitor%2520type1%2520in%2520cancer%253A%2520Advances%2520and%2520perspectives%2520%2528Review%2529%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2014%26volume%3D10%26spage%3D2779%26epage%3D2785%26doi%3D10.3892%2Fmmr.2014.2628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. Y.</span></span> <span> </span><span class="NLM_article-title">Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0120489</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0120489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1371%2Fjournal.pone.0120489" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=H.+H.+Changauthor=Y.+Xuauthor=H.+Laiauthor=X.+Yangauthor=C.+C.+Tsengauthor=Y.+J.+Laiauthor=Y.+Panauthor=E.+Zhouauthor=M.+D.+Johnsonauthor=J.+K.+Wangauthor=C.+Y.+Lin&title=Differential+subcellular+localization+renders+HAI-2+a+matriptase+inhibitor+in+breast+cancer+cells+but+not+in+mammary+epithelial+cells&doi=10.1371%2Fjournal.pone.0120489"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0120489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0120489%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DH.%2BH.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DTseng%26aufirst%3DC.%2BC.%26aulast%3DLai%26aufirst%3DY.%2BJ.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DM.%2BD.%26aulast%3DWang%26aufirst%3DJ.%2BK.%26aulast%3DLin%26aufirst%3DC.%2BY.%26atitle%3DDifferential%2520subcellular%2520localization%2520renders%2520HAI-2%2520a%2520matriptase%2520inhibitor%2520in%2520breast%2520cancer%2520cells%2520but%2520not%2520in%2520mammary%2520epithelial%2520cells%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0120489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Generali, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berruti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brizzi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allevi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonardi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguggini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bersiga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogliotti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span> <span> </span><span class="NLM_article-title">Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">550</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-1266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1158%2F1078-0432.CCR-06-1266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=17255277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslSksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=550-558&author=D.+Generaliauthor=S.+B.+Foxauthor=A.+Berrutiauthor=J.+W.+Mooreauthor=M.+P.+Brizziauthor=N.+Patelauthor=G.+Alleviauthor=S.+Bonardiauthor=S.+Agugginiauthor=A.+Bersigaauthor=L.+Campoauthor=L.+Dogliottiauthor=A.+Bottiniauthor=A.+L.+Harris&title=Regulation+of+hepatocyte+growth+factor+activator+inhibitor+2+by+hypoxia+in+breast+cancer&doi=10.1158%2F1078-0432.CCR-06-1266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Hepatocyte Growth Factor Activator Inhibitor 2 by Hypoxia in Breast Cancer</span></div><div class="casAuthors">Generali, Daniele; Fox, Stephen B.; Berruti, Alfredo; Moore, John W.; Brizzi, Maria Pia; Patel, Nilay; Allevi, Giovanni; Bonardi, Simone; Aguggini, Sergio; Bersiga, Alessandra; Campo, Leticia; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2, Pt. 1</span>),
    <span class="NLM_cas:pages">550-558</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The in vitro regulation of hepatocyte growth factor activator inhibitor type 2 (HAI-2) in breast cancer cells and the in vivo predictive role for the efficacy of chemoendocrine primary therapy in patients with breast cancer were examd.  HAI-2 regulation was studied in a panel of breast cancer cell lines comparing normoxia to hypoxia.  The effect of HIF-1α RNAi on HAI-2 expression was evaluated in these cells.  HAI-2 was examd. in breast cancer using in situ hybridization and immunohistochem.  The HAI-2 predictive role was assessed in T2-4 N0-1 breast cancers (n = 177) enrolled in a neoadjuvant randomized trial comparing epirubicin vs. epirubicin + tamoxifen.  HAI-2 mRNA and protein were regulated by hypoxia in the c-erbB2-pos. cell lines, SKBR3 and BT474, and controlled by HIF-1α in these cells.  Immunohistochem. confirmed this profile with high expression of HAI-2 in c-erbB2-pos. breast cancer.  HAI-2 was correlated with T status (P < 0.004), node involvement (P = 0.01), and c-erbB2 expression (P = 0.05).  HAI-2 also correlated with hypoxia markers such as carbonic anhydrase IX expression (P = 0.01) and HIF-1α.  Addnl., high levels of HAI-2 were a significant predictor for poor clin. complete response to preoperative epirubicin in univariate (P = 0.01) and multivariate analyses (P = 0.016).  No correlation with disease-free survival and survival was obsd.  HAI-2 expression in breast cancer correlated with tumor aggressiveness in vivo.  It is a HIF target in c-erbB2-pos. cells and it is an independent neg. predictive factor of efficacy of anthracycline therapy.  The interaction of HAI-2 with the hepatocyte growth factor activation pathway may be a useful site for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4iW5ipIu3fbVg90H21EOLACvtfcHk0lhmAE6gQY218w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslSksQ%253D%253D&md5=01b6c32e957161f0a1566a7cb8b65339</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1266%26sid%3Dliteratum%253Aachs%26aulast%3DGenerali%26aufirst%3DD.%26aulast%3DFox%26aufirst%3DS.%2BB.%26aulast%3DBerruti%26aufirst%3DA.%26aulast%3DMoore%26aufirst%3DJ.%2BW.%26aulast%3DBrizzi%26aufirst%3DM.%2BP.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DAllevi%26aufirst%3DG.%26aulast%3DBonardi%26aufirst%3DS.%26aulast%3DAguggini%26aufirst%3DS.%26aulast%3DBersiga%26aufirst%3DA.%26aulast%3DCampo%26aufirst%3DL.%26aulast%3DDogliotti%26aufirst%3DL.%26aulast%3DBottini%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DRegulation%2520of%2520hepatocyte%2520growth%2520factor%2520activator%2520inhibitor%25202%2520by%2520hypoxia%2520in%2520breast%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D550%26epage%3D558%26doi%3D10.1158%2F1078-0432.CCR-06-1266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W. G.</span></span> <span> </span><span class="NLM_article-title">Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">1176</span>– <span class="NLM_lpage">1183</span>, <span class="refDoi"> DOI: 10.1002/ijc.21881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1002%2Fijc.21881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=16557597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1Cmsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2006&pages=1176-1183&author=C.+Parrauthor=W.+G.+Jiang&title=Hepatocyte+growth+factor+activation+inhibitors+%28HAI-1+and+HAI-2%29+regulate+HGF-induced+invasion+of+human+breast+cancer+cells&doi=10.1002%2Fijc.21881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells</span></div><div class="casAuthors">Parr, Christian; Jiang, Wen G.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1176-1183</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Hepatocyte growth factor (HGF) plays a plethora of roles in cancer metastasis and tumor growth.  The interaction between tumor cells and their surrounding stromal environment is a crucial factor regulating tumor invasion and metastasis.  Stromal fibroblasts are the main source of HGF in the body, and release HGF as an inactive precursor (pro-HGF).  HGF activator (HGFA), matriptase, urokinase-type plasminogen activator and hepsin are the main factors responsible for converting pro-HGF into active HGF.  HAI-1 and HAI-2 are 2 novel Kunitz-type serine protease inhibitors that regulate HGF activity through inhibition of HGFA, matriptase and hepsin action.  Recent studies demonstrate that HAI-1 and HAI-2 may also potently inhibit a no. of other pro-metastatic serine proteases and therefore have direct bearing on the spread of tumors.  Our study examd. the potential of these HAI's to suppress the influence of HGF and regulate cancer metastasis.  We generated a retroviral expression system that induced HAI expression in a human fibroblast cell line.  Forced expression of either HAI-1 or HAI-2 in these fibroblasts resulted in a dramatic decrease in the prodn. of bioactive hepatocyte growth factor (HGF).  This redn. in HGF activity subsequently suppressed HGF's metastatic influence on breast cancer cells.  To further assess the anti-cancer properties of HAI-1 and HAI-2 we generated recombinant HAI proteins.  These recombinant HAI proteins possessed the ability to potently quench HGF activity.  We also demonstrate that these recombinant HAI's suppressed fibroblast-mediated breast cancer invasion.  An addnl. ribozyme transgenes study revealed that elimination of HAI-1 and HAI-2 expression, in an MDA-MB-231 breast cancer cell line, significantly enhanced the migratory, proliferative and invasive nature of these breast cancer cells.  Overall, our data demonstrates the important roles of HAI-1 and HAI-2 in cancer metastasis, and reveals that these serine protease inhibitors display strong therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqmM4Gs-NQurVg90H21EOLACvtfcHk0lhmAE6gQY218w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1Cmsbg%253D&md5=e38f295a24311b5c976aacb7912575f9</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Fijc.21881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.21881%26sid%3Dliteratum%253Aachs%26aulast%3DParr%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DW.%2BG.%26atitle%3DHepatocyte%2520growth%2520factor%2520activation%2520inhibitors%2520%2528HAI-1%2520and%2520HAI-2%2529%2520regulate%2520HGF-induced%2520invasion%2520of%2520human%2520breast%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2006%26volume%3D119%26spage%3D1176%26epage%3D1183%26doi%3D10.1002%2Fijc.21881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansel, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W. G.</span></span> <span> </span><span class="NLM_article-title">The hepatocyte growth factor regulatory factors in human breast cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-0553-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1158%2F1078-0432.CCR-0553-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=14734471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvF2mtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=202-211&author=C.+Parrauthor=G.+Watkinsauthor=R.+E.+Manselauthor=W.+G.+Jiang&title=The+hepatocyte+growth+factor+regulatory+factors+in+human+breast+cancer&doi=10.1158%2F1078-0432.CCR-0553-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">The Hepatocyte Growth Factor Regulatory Factors in Human Breast Cancer</span></div><div class="casAuthors">Parr, Christian; Watkins, Gareth; Mansel, Robert E.; Jiang, Wen G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1, Pt. 1</span>),
    <span class="NLM_cas:pages">202-211</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hepatocyte growth factor (HGF) stimulates tumor cell-cell interactions, matrix adhesion, migration, invasion, and angiogenesis.  This factor is produced as an inactive precursor called pro-HGF, which requires proteolytic conversion, by HGF activator (HGFA) and matriptase, to evoke a biol. response.  Two new HGFA inhibitors, HAI-1 and HAI-2, inhibit the generation of biol. active HGF, through their interaction with HGFA.  This study detd. the expression of this HGF regulatory system in breast cancer.  We examd. HGF, the HGF receptor (c-Met), HGFA, matriptase, and the activation inhibitors (HAI-1 and HAI-2), tissues from patients with breast cancer.  Breast cancer tissue (n = 100) and normal background tissue (n = 20) was obtained immediately after surgery.  The median follow-up for the patients was 72 mo.  HGF, c-Met, HGFA, matriptase-1, HAI-1, and HAI-2 expression was quantified using real-time quant. PCR.  The distribution of these factors in mammary tissues was also examd. through immunohistochem.  The breast cancer specimens expressed a significantly higher level of HGF, c-Met, HGFA, HAI-1, and HAI-2, but not matriptase, compared with the normal background tissues.  Tumor tissues from node-pos. patients expressed a higher level of HGFA than from the patients without nodal involvement.  Interestingly, HAI-2 was expressed to a lower degree in pos. nodes than that of the node-neg. breast cancer tissues.  HAI-1 and HAI-2 were both significantly reduced in grade 3 tumors compared with the well-differentiated tumors.  In addn., on comparison of Tumor-Node-Metastasis (TNM) classification groups, HAI-2 was also found to be statistically lower in the TNM 3 breast cancer group when compared with TNM groups 1 and 2, thus assocd. with a poor prognosis.  This study shows that there are aberrant levels of HGF, c-Met, HGFA, HAI-1, and HAI-2 expressed in breast cancer tissues compared with background breast tissue.  HAI-1 and HAI-2 are expressed to a significantly lower level in poorly differentiated breast tumors, and HAI-2 is also inversely correlated with nodal involvement and tumor spread.  Overall a low level of HAI-2 in the breast cancer tissues was assocd. with an overall poor outlook.  Therefore, the HGF regulatory system may have an important role in the progression of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJFpNGyq1zVrVg90H21EOLACvtfcHk0lgVCumQNVAG0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvF2mtg%253D%253D&md5=6d08f437f0917d61960a028a60cc8c64</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-0553-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-0553-3%26sid%3Dliteratum%253Aachs%26aulast%3DParr%26aufirst%3DC.%26aulast%3DWatkins%26aufirst%3DG.%26aulast%3DMansel%26aufirst%3DR.%2BE.%26aulast%3DJiang%26aufirst%3DW.%2BG.%26atitle%3DThe%2520hepatocyte%2520growth%2520factor%2520regulatory%2520factors%2520in%2520human%2520breast%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D202%26epage%3D211%26doi%3D10.1158%2F1078-0432.CCR-0553-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haruyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanemaru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, H.</span></span> <span> </span><span class="NLM_article-title">Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1111/cas.12306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1111%2Fcas.12306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=24147538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1emt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2014&pages=44-51&author=J.+J.+Yeauthor=M.+Kawaguchiauthor=Y.+Haruyamaauthor=A.+Kanemaruauthor=T.+Fukushimaauthor=K.+Yamamotoauthor=C.+Y.+Linauthor=H.+Kataoka&title=Loss+of+hepatocyte+growth+factor+activator+inhibitor+type+1+participates+in+metastatic+spreading+of+human+pancreatic+cancer+cells+in+a+mouse+orthotopic+transplantation+model&doi=10.1111%2Fcas.12306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model</span></div><div class="casAuthors">Ye, Jingjia; Kawaguchi, Makiko; Haruyama, Yukihiro; Kanemaru, Ai; Fukushima, Tsuyoshi; Yamamoto, Koji; Lin, Chen-Yong; Kataoka, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-51</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is a membrane-bound serine protease inhibitor that is expressed on the surface of epithelial and carcinoma cells.  On the cell surface, HAI-1 regulates membrane-anchored serine proteases, with matriptase being the most crit. target.  Matriptase is involved in pericellular processing of biol. active mols., including protease-activated receptor-2 (PAR-2).  Previously we reported that S2-CP8 cells, a metastatic variant of the SUIT-2 human pancreatic adenocarcinoma cell line, showed markedly decreased HAI-1 expression.  To assess the significance of HAI-1 loss in invasion and spontaneous metastasis of S2-CP8 cells, we established stable S2-CP8 sublines that expressed HAI-1 under the control of a tetracycline-regulated promoter.  In vitro migration and invasion assays revealed inhibitory effects of HAI-1 on S2-CP8 cell migration and invasion.  Matriptase activity was suppressed by the expression of HAI-1.  As the enhanced invasiveness in the absence of HAI-1 was alleviated by knockdown of matriptase by 81% and of PAR-2 completely, and PAR-2 antagonist also suppressed the invasion, matriptase-mediated PAR-2 activation is involved in HAI-1 loss-induced invasion of S2-CP8 cells.  We then analyzed the effect of HAI-1 expression on metastasis of S2-CP8 cells in vivo using a nude mouse orthotopic xenograft model.  Although approx. 50% of the control mice developed distant metastasis, mice treated with doxycycline to induce HAI-1 expression did not develop metastasis.  These data indicate that HAI-1 loss contributes to invasion and dissemination of a highly metastatic subline of SUIT-2, suggesting crucial roles for the balance of pericellular serine proteases/inhibitors in pancreatic cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQkXcHG-e_arVg90H21EOLACvtfcHk0lgVCumQNVAG0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1emt7Y%253D&md5=2f31be04c86b90c559d5036dd74ebca3</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1111%2Fcas.12306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.12306%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DJ.%2BJ.%26aulast%3DKawaguchi%26aufirst%3DM.%26aulast%3DHaruyama%26aufirst%3DY.%26aulast%3DKanemaru%26aufirst%3DA.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DC.%2BY.%26aulast%3DKataoka%26aufirst%3DH.%26atitle%3DLoss%2520of%2520hepatocyte%2520growth%2520factor%2520activator%2520inhibitor%2520type%25201%2520participates%2520in%2520metastatic%2520spreading%2520of%2520human%2520pancreatic%2520cancer%2520cells%2520in%2520a%2520mouse%2520orthotopic%2520transplantation%2520model%26jtitle%3DCancer%2520Sci.%26date%3D2014%26volume%3D105%26spage%3D44%26epage%3D51%26doi%3D10.1111%2Fcas.12306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span> <span> </span><span class="NLM_article-title">Down-regulation of HAI-1 is associated with poor-differentiation status of colorectal cancer</span>. <i>Hum. Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1007/s13577-013-0074-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1007%2Fs13577-013-0074-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=23979832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyitLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2013&pages=162-169&author=J.+J.+Yeauthor=H.+X.+Chengauthor=Y.+Wangauthor=J.+Cao&title=Down-regulation+of+HAI-1+is+associated+with+poor-differentiation+status+of+colorectal+cancer&doi=10.1007%2Fs13577-013-0074-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Down-regulation of HAI-1 is associated with poor-differentiation status of colorectal cancer</span></div><div class="casAuthors">Ye, Jingjia; Cheng, Haixia; Wang, Yi; Cao, Jiang</div><div class="citationInfo"><span class="NLM_cas:title">Human Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">162-169</span>CODEN:
                <span class="NLM_cas:coden">HUCEE7</span>;
        ISSN:<span class="NLM_cas:issn">1749-0774</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is a Kunitz-type serine protease inhibitor which is widely expressed in epithelial cells.  The purpose of this study is to investigate the relationship between HAI-1 expression and differentiation status of colorectal epithelia.  The expression of HAI-1 in clin. samples of both cancerous and normal colorectal tissues was evaluated by immunohistochem. staining.  An in vitro epithelial differentiation model of Caco-2 cell was established, and the characteristics of differentiation of Caco-2 cells were obsd. by transmission electron microscopy.  The expression of HAI-1 in Caco-2 cells at different differentiation stages was examd. by western blot.  Immunohistochem. staining of 52 human colorectal cancer tissues showed a definite correlation between HAI-1 expression and differentiation status: IHC score (mean ± SE) of HAI-1 was higher for well- or moderately-differentiated colorectal cancer tissues than for poorly-differentiated colorectal cancer tissues, with significant differences in HAI-1 pos. rate (P < 0.01 and P < 0.05 for well-differentiated vs. poorly-differentiated and moderately-differentiated vs. poorly-differentiated, resp.).  Immunohistochem. staining of normal colorectal tissues showed pos. HAI-1 expression in well-differentiated epithelial cells whereas the under-differentiated crypt cells showed very weak HAI-1 staining signals.  The result of western blot also showed the gradual increasing of HAI-1 expression during the process of Caco-2 differentiation in vitro.  HAI-1 expression correlates with the differentiation status of colorectal epithelia and could serve as a differentiation marker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVUtCI3pt1ZbVg90H21EOLACvtfcHk0lgVCumQNVAG0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyitLbE&md5=c13038b3998ef114e9f946f1cab22e63</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2Fs13577-013-0074-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13577-013-0074-7%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DJ.%2BJ.%26aulast%3DCheng%26aufirst%3DH.%2BX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DJ.%26atitle%3DDown-regulation%2520of%2520HAI-1%2520is%2520associated%2520with%2520poor-differentiation%2520status%2520of%2520colorectal%2520cancer%26jtitle%3DHum.%2520Cell%26date%3D2013%26volume%3D26%26spage%3D162%26epage%3D169%26doi%3D10.1007%2Fs13577-013-0074-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaieda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takezaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeshima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, H.</span></span> <span> </span><span class="NLM_article-title">Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>109</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2970</span>– <span class="NLM_lpage">2979</span>, <span class="refDoi"> DOI: 10.1111/cas.13732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1111%2Fcas.13732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29987920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFanu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2018&pages=2970-2979&issue=9&author=T.+Fukushimaauthor=M.+Kawaguchiauthor=K.+Yamamotoauthor=F.+Yamashitaauthor=A.+Izumiauthor=T.+Kaiedaauthor=Y.+Takezakiauthor=H.+Itohauthor=H.+Takeshimaauthor=H.+Kataoka&title=Aberrant+methylation+and+silencing+of+the+SPINT2+gene+in+high-grade+gliomas&doi=10.1111%2Fcas.13732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas</span></div><div class="casAuthors">Fukushima, Tsuyoshi; Kawaguchi, Makiko; Yamamoto, Koji; Yamashita, Fumiki; Izumi, Aya; Kaieda, Takashi; Takezaki, Yuka; Itoh, Hiroshi; Takeshima, Hideo; Kataoka, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2970-2979</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Hepatocyte growth factor activator inhibitor type 2 (HAI-2), encoded by the SPINT2 gene, is a membrane-anchored protein that inhibits proteases involved in the activation of hepatocyte growth factor (HGF), a ligand of MET receptor.  Epigenetic silencing of the SPINT2 gene has been reported in a human glioblastoma cell line (U87) and glioblastoma-derived cancer stem cells.  However, the incidence of SPINT2 methylation in tumor tissues obtained from glioma patients is unknown.  In this study, we analyzed the methylation status of the SPINT2 gene of eight human glioblastoma cell lines and surgically resected glioma tissues of different grades (II, III, and IV) by bisulfite sequence anal. and methylation-specific PCR.  Most glioblastoma lines (7/8) showed methylation of the SPINT2 gene with a significantly reduced level of SPINT2mRNA compared to cultured astrocytes and normal brain tissues.  However, all glioblastoma lines expressed mRNA for HGF activator (HGFAC), a target protease of HAI-2/SPINT2.  Forced expression of SPINT2 reduced MET phosphorylation of U87 glioblastoma cells both in vitro and in intracranial xenografts in nude mice.  Methylation-specific PCR anal. of the resected glioma tissues indicated notable methylation of the SPINT2 gene in 33.3% (2/6), 71.4% (10/14), and 74.3% (26/35) of grade II, III, and IV gliomas, resp.  Anal. of RNA sequencing data in a public database indicated an increased HGFAC/SPINT2 expression ratio in high-grade compared to low-grade gliomas (P = .01).  In summary, aberrant methylation of the SPINT2 gene is frequently obsd. in high-grade gliomas and might confer MET signaling in the glioma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmUH_ACH3-nbVg90H21EOLACvtfcHk0lhElujr_gwDPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFanu7rF&md5=fd5319e9bdd89a003b1488addc55bb5b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1111%2Fcas.13732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13732%26sid%3Dliteratum%253Aachs%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DKawaguchi%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DYamashita%26aufirst%3DF.%26aulast%3DIzumi%26aufirst%3DA.%26aulast%3DKaieda%26aufirst%3DT.%26aulast%3DTakezaki%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DH.%26aulast%3DTakeshima%26aufirst%3DH.%26aulast%3DKataoka%26aufirst%3DH.%26atitle%3DAberrant%2520methylation%2520and%2520silencing%2520of%2520the%2520SPINT2%2520gene%2520in%2520high-grade%2520gliomas%26jtitle%3DCancer%2520Sci.%26date%3D2018%26volume%3D109%26issue%3D9%26spage%3D2970%26epage%3D2979%26doi%3D10.1111%2Fcas.13732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karmakar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owusu, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klampfer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span> <span> </span><span class="NLM_article-title">alpha-Ketobenzothiazole serine protease inhibitors of aberrant HGF/c-MET and MSP/RON kinase pathway signaling in cancer</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">599</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1002%2Fcmdc.201500600" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=585-599&author=Z.+Hanauthor=P.+K.+Harrisauthor=P.+Karmakarauthor=T.+Kimauthor=B.+Y.+Owusuauthor=S.+A.+Wildmanauthor=L.+Klampferauthor=J.+W.+Janetka&title=alpha-Ketobenzothiazole+serine+protease+inhibitors+of+aberrant+HGF%2Fc-MET+and+MSP%2FRON+kinase+pathway+signaling+in+cancer&doi=10.1002%2Fcmdc.201500600"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500600%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DHarris%26aufirst%3DP.%2BK.%26aulast%3DKarmakar%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DT.%26aulast%3DOwusu%26aufirst%3DB.%2BY.%26aulast%3DWildman%26aufirst%3DS.%2BA.%26aulast%3DKlampfer%26aufirst%3DL.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3Dalpha-Ketobenzothiazole%2520serine%2520protease%2520inhibitors%2520of%2520aberrant%2520HGF%252Fc-MET%2520and%2520MSP%252FRON%2520kinase%2520pathway%2520signaling%2520in%2520cancer%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D585%26epage%3D599%26doi%3D10.1002%2Fcmdc.201500600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chugani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of HGFA, matriptase, and hepsin serine proteases: a nonkinase strategy to block cell signaling in cancer</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1219</span>– <span class="NLM_lpage">1224</span>, <span class="refDoi"> DOI: 10.1021/ml500254r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500254r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1219-1224&author=Z.+Hanauthor=P.+K.+Harrisauthor=D.+E.+Jonesauthor=R.+Chuganiauthor=T.+Kimauthor=M.+Agarwalauthor=W.+Shenauthor=S.+A.+Wildmanauthor=J.+W.+Janetka&title=Inhibitors+of+HGFA%2C+matriptase%2C+and+hepsin+serine+proteases%3A+a+nonkinase+strategy+to+block+cell+signaling+in+cancer&doi=10.1021%2Fml500254r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fml500254r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500254r%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DHarris%26aufirst%3DP.%2BK.%26aulast%3DJones%26aufirst%3DD.%2BE.%26aulast%3DChugani%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DT.%26aulast%3DAgarwal%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DWildman%26aufirst%3DS.%2BA.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DInhibitors%2520of%2520HGFA%252C%2520matriptase%252C%2520and%2520hepsin%2520serine%2520proteases%253A%2520a%2520nonkinase%2520strategy%2520to%2520block%2520cell%2520signaling%2520in%2520cancer%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1219%26epage%3D1224%26doi%3D10.1021%2Fml500254r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Franco, F.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvis, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span> <span> </span><span class="NLM_article-title">Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: evaluation of potency and selectivity derived from distinct binding pockets</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2328</span>– <span class="NLM_lpage">2343</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.03.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.bmc.2015.03.072" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2328-2343&author=F.%0AM.+Francoauthor=D.+E.+Jonesauthor=P.+K.+Harrisauthor=Z.+Hanauthor=S.+A.+Wildmanauthor=C.+M.+Jarvisauthor=J.+W.+Janetka&title=Structure-based+discovery+of+small+molecule+hepsin+and+HGFA+protease+inhibitors%3A+evaluation+of+potency+and+selectivity+derived+from+distinct+binding+pockets&doi=10.1016%2Fj.bmc.2015.03.072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.03.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.03.072%26sid%3Dliteratum%253Aachs%26aulast%3DFranco%26aufirst%3DF.%2BM.%26aulast%3DJones%26aufirst%3DD.%2BE.%26aulast%3DHarris%26aufirst%3DP.%2BK.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DWildman%26aufirst%3DS.%2BA.%26aulast%3DJarvis%26aufirst%3DC.%2BM.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DStructure-based%2520discovery%2520of%2520small%2520molecule%2520hepsin%2520and%2520HGFA%2520protease%2520inhibitors%253A%2520evaluation%2520of%2520potency%2520and%2520selectivity%2520derived%2520from%2520distinct%2520binding%2520pockets%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D2328%26epage%3D2343%26doi%3D10.1016%2Fj.bmc.2015.03.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venukadasula, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owusu, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobrath, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truss, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stackhouse, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messick, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klampfer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galemmo, R. A.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of nonpeptide inhibitors of hepatocyte growth factor activation</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00357</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00357" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=177-181&author=P.+K.+Venukadasulaauthor=B.+Y.+Owusuauthor=N.+Bansalauthor=L.+J.+Rossauthor=J.+V.+Hobrathauthor=D.+Baoauthor=J.+W.+Trussauthor=M.+Stackhouseauthor=T.+E.+Messickauthor=L.+Klampferauthor=R.+A.+Galemmo&title=Design+and+synthesis+of+nonpeptide+inhibitors+of+hepatocyte+growth+factor+activation&doi=10.1021%2Facsmedchemlett.5b00357"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00357%26sid%3Dliteratum%253Aachs%26aulast%3DVenukadasula%26aufirst%3DP.%2BK.%26aulast%3DOwusu%26aufirst%3DB.%2BY.%26aulast%3DBansal%26aufirst%3DN.%26aulast%3DRoss%26aufirst%3DL.%2BJ.%26aulast%3DHobrath%26aufirst%3DJ.%2BV.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DTruss%26aufirst%3DJ.%2BW.%26aulast%3DStackhouse%26aufirst%3DM.%26aulast%3DMessick%26aufirst%3DT.%2BE.%26aulast%3DKlampfer%26aufirst%3DL.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520nonpeptide%2520inhibitors%2520of%2520hepatocyte%2520growth%2520factor%2520activation%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D177%26epage%3D181%26doi%3D10.1021%2Facsmedchemlett.5b00357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Owusu, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venukadasula, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messick, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galemmo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klampfer, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">29492</span>– <span class="NLM_lpage">29506</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.8785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.18632%2Foncotarget.8785" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=29492-29506&author=B.+Y.+Owusuauthor=N.+Bansalauthor=P.+K.+Venukadasulaauthor=L.+J.+Rossauthor=T.+E.+Messickauthor=S.+Goelauthor=R.+A.+Galemmoauthor=L.+Klampfer&title=Inhibition+of+pro-HGF+activation+by+SRI31215%2C+a+novel+approach+to+block+oncogenic+HGF%2FMET+signaling&doi=10.18632%2Foncotarget.8785"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8785%26sid%3Dliteratum%253Aachs%26aulast%3DOwusu%26aufirst%3DB.%2BY.%26aulast%3DBansal%26aufirst%3DN.%26aulast%3DVenukadasula%26aufirst%3DP.%2BK.%26aulast%3DRoss%26aufirst%3DL.%2BJ.%26aulast%3DMessick%26aufirst%3DT.%2BE.%26aulast%3DGoel%26aufirst%3DS.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26aulast%3DKlampfer%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520pro-HGF%2520activation%2520by%2520SRI31215%252C%2520a%2520novel%2520approach%2520to%2520block%2520oncogenic%2520HGF%252FMET%2520signaling%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D29492%26epage%3D29506%26doi%3D10.18632%2Foncotarget.8785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piper, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaron, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriele, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meininger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, R. J.</span></span> <span> </span><span class="NLM_article-title">Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>390</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1042/BJ20041955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1042%2FBJ20041955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=15839837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntFGmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2005&pages=125-136&author=S.+Herterauthor=D.+E.+Piperauthor=W.+Aaronauthor=T.+Gabrieleauthor=G.+Cutlerauthor=P.+Caoauthor=A.+S.+Bhattauthor=Y.+Choeauthor=C.+S.+Craikauthor=N.+Walkerauthor=D.+Meiningerauthor=T.+Hoeyauthor=R.+J.+Austin&title=Hepatocyte+growth+factor+is+a+preferred+in+vitro+substrate+for+human+hepsin%2C+a+membrane-anchored+serine+protease+implicated+in+prostate+and+ovarian+cancers&doi=10.1042%2FBJ20041955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers</span></div><div class="casAuthors">Herter, Sylvia; Piper, Derek E.; Aaron, Wade; Gabriele, Timothy; Cutler, Gene; Cao, Ping; Bhatt, Ami S.; Choe, Youngchool; Craik, Charles S.; Walker, Nigel; Meininger, David; Hoey, Timothy; Austin, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">390</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-136</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Hepsin is a membrane-anchored, trypsin-like serine protease with prominent expression in the human liver and tumors of the prostate and ovaries.  To better understand the biol. functions of hepsin, we identified macromol. substrates employing a tetrapeptide PS-SCL (positional scanning-synthetic combinatorial library) screen that rapidly dets. the P1-P4 substrate specificity.  Hepsin exhibited strong preference at the P1 position for arginine over lysine, and favored threonine, leucine or asparagine at the P2, glutamine or lysine at the P3, and proline or lysine at the P4 position.  The relative activity of hepsin toward individual AMC (7-amino-4-methylcoumarin)-tetrapeptides was generally consistent with the overall peptide profiling results derived from the PC-SCL screen.  The most active tetrapeptide substrate Ac (acetyl)-KQLR-AMC matched with the activation cleavage site of the hepatocyte growth factor precursor s.c.-HGF (single-chain HGF), KQLR↓VVNG (where ↓ denotes the cleavage site), as identified by a database anal. of trypsin-like precursors.  X-ray crystallog. studies with KQLR chloromethylketone showed that the KQLR peptide fits well into the substrate-binding cleft of hepsin.  This hepsin-processed HGF induced c-Met receptor tyrosine phosphorylation in SKOV-3 ovarian cancer cells, indicating that the hepsin-cleaved HGF is biol. active.  Activation cleavage site mutants of s.c.-HGF with predicted non-preferred sequences, DPGR↓VVNG or KQLQ↓VVNG, were not processed, illustrating that the P4-P1 residues can be important determinants for substrate specificity.  In addn. to finding macromol. hepsin substrates, the extracellular inhibitors of the HGF activator, HAI-1 and HAI-2, were potent inhibitors of hepsin activity (IC50 4±0.2 nM and 12±0.5 nM resp.).  Together, our findings suggest that the HGF precursor is a potential in vivo substrate for hepsin in tumors, where hepsin expression is dysregulated and may influence tumorigenesis through inappropriate activation and/or regulation of HGF receptor (c-Met) functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra-Cmy0jAqULVg90H21EOLACvtfcHk0ljXDgXiN-FGIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntFGmsrg%253D&md5=2ac65cd9f3bcdb72bfdd9856e005f415</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1042%2FBJ20041955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20041955%26sid%3Dliteratum%253Aachs%26aulast%3DHerter%26aufirst%3DS.%26aulast%3DPiper%26aufirst%3DD.%2BE.%26aulast%3DAaron%26aufirst%3DW.%26aulast%3DGabriele%26aufirst%3DT.%26aulast%3DCutler%26aufirst%3DG.%26aulast%3DCao%26aufirst%3DP.%26aulast%3DBhatt%26aufirst%3DA.%2BS.%26aulast%3DChoe%26aufirst%3DY.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DWalker%26aufirst%3DN.%26aulast%3DMeininger%26aufirst%3DD.%26aulast%3DHoey%26aufirst%3DT.%26aulast%3DAustin%26aufirst%3DR.%2BJ.%26atitle%3DHepatocyte%2520growth%2520factor%2520is%2520a%2520preferred%2520in%2520vitro%2520substrate%2520for%2520human%2520hepsin%252C%2520a%2520membrane-anchored%2520serine%2520protease%2520implicated%2520in%2520prostate%2520and%2520ovarian%2520cancers%26jtitle%3DBiochem.%2520J.%26date%3D2005%26volume%3D390%26spage%3D125%26epage%3D136%26doi%3D10.1042%2FBJ20041955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beliveau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desilets, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span> <span> </span><span class="NLM_article-title">Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">2213</span>– <span class="NLM_lpage">2226</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.06950.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1111%2Fj.1742-4658.2009.06950.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=2213-2226&author=F.+Beliveauauthor=A.+Desiletsauthor=R.+Leduc&title=Probing+the+substrate+specificities+of+matriptase%2C+matriptase-2%2C+hepsin+and+DESC1+with+internally+quenched+fluorescent+peptides&doi=10.1111%2Fj.1742-4658.2009.06950.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.06950.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.06950.x%26sid%3Dliteratum%253Aachs%26aulast%3DBeliveau%26aufirst%3DF.%26aulast%3DDesilets%26aufirst%3DA.%26aulast%3DLeduc%26aufirst%3DR.%26atitle%3DProbing%2520the%2520substrate%2520specificities%2520of%2520matriptase%252C%2520matriptase-2%252C%2520hepsin%2520and%2520DESC1%2520with%2520internally%2520quenched%2520fluorescent%2520peptides%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D2213%26epage%3D2226%26doi%3D10.1111%2Fj.1742-4658.2009.06950.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhatt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farady, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasquez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">5771</span>– <span class="NLM_lpage">5776</span>, <span class="refDoi"> DOI: 10.1073/pnas.0606514104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1073%2Fpnas.0606514104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=5771-5776&author=A.+S.+Bhattauthor=A.+Welmauthor=C.+J.+Faradyauthor=M.+Vasquezauthor=K.+Wilsonauthor=C.+S.+Craik&title=Coordinate+expression+and+functional+profiling+identify+an+extracellular+proteolytic+signaling+pathway&doi=10.1073%2Fpnas.0606514104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0606514104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0606514104%26sid%3Dliteratum%253Aachs%26aulast%3DBhatt%26aufirst%3DA.%2BS.%26aulast%3DWelm%26aufirst%3DA.%26aulast%3DFarady%26aufirst%3DC.%2BJ.%26aulast%3DVasquez%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DK.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DCoordinate%2520expression%2520and%2520functional%2520profiling%2520identify%2520an%2520extracellular%2520proteolytic%2520signaling%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D5771%26epage%3D5776%26doi%3D10.1073%2Fpnas.0606514104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barre, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhard, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappelhoff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beliveau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span> <span> </span><span class="NLM_article-title">Cleavage specificity analysis of six type II transmembrane serine proteases (TTSPs) using PICS with proteome-derived peptide libraries</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e105984</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0105984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1371%2Fjournal.pone.0105984" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=O.+Barreauthor=A.+Dufourauthor=U.+Eckhardauthor=R.+Kappelhoffauthor=F.+Beliveauauthor=R.+Leducauthor=C.+M.+Overall&title=Cleavage+specificity+analysis+of+six+type+II+transmembrane+serine+proteases+%28TTSPs%29+using+PICS+with+proteome-derived+peptide+libraries&doi=10.1371%2Fjournal.pone.0105984"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0105984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0105984%26sid%3Dliteratum%253Aachs%26aulast%3DBarre%26aufirst%3DO.%26aulast%3DDufour%26aufirst%3DA.%26aulast%3DEckhard%26aufirst%3DU.%26aulast%3DKappelhoff%26aufirst%3DR.%26aulast%3DBeliveau%26aufirst%3DF.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26atitle%3DCleavage%2520specificity%2520analysis%2520of%2520six%2520type%2520II%2520transmembrane%2520serine%2520proteases%2520%2528TTSPs%2529%2520using%2520PICS%2520with%2520proteome-derived%2520peptide%2520libraries%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0105984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duchene, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desilets, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boudreault, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najmanovich, R.</span></span> <span> </span><span class="NLM_article-title">Analysis of subpocket selectivity and identification of potent selective inhibitors for matriptase and matriptase-2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10198</span>– <span class="NLM_lpage">10204</span>, <span class="refDoi"> DOI: 10.1021/jm5015633</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5015633" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2nt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10198-10204&author=D.+Ducheneauthor=E.+Colomboauthor=A.+Desiletsauthor=P.+L.+Boudreaultauthor=R.+Leducauthor=E.+Marsaultauthor=R.+Najmanovich&title=Analysis+of+subpocket+selectivity+and+identification+of+potent+selective+inhibitors+for+matriptase+and+matriptase-2&doi=10.1021%2Fjm5015633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of Subpocket Selectivity and Identification of Potent Selective Inhibitors for Matriptase and Matriptase-2</span></div><div class="casAuthors">Duchene, Dominic; Colombo, Eloic; Desilets, Antoine; Boudreault, Pierre-Luc; Leduc, Richard; Marsault, Eric; Najmanovich, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10198-10204</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We studied the factors affecting the selectivity of peptidomimetic inhibitors of the highly homologous proteases matriptase (also known as ST-14, for suppressor of tumorigenicity 14 protein) and matriptase-2 (also known as TMPRSS6) across subpockets using docking simulations.  We obsd. that the farther away a subpocket is located from the catalytic site, the more pronounced its role in selectivity.  As a result of our exhaustive virtual screening, we biochem. validated novel potent and selective inhibitors of both enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJgZtgEt4i17Vg90H21EOLACvtfcHk0lgtR27rgq_3fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2nt7vI&md5=3e33bc97debaddf8129c04d722c3ea11</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm5015633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5015633%26sid%3Dliteratum%253Aachs%26aulast%3DDuchene%26aufirst%3DD.%26aulast%3DColombo%26aufirst%3DE.%26aulast%3DDesilets%26aufirst%3DA.%26aulast%3DBoudreault%26aufirst%3DP.%2BL.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DMarsault%26aufirst%3DE.%26aulast%3DNajmanovich%26aufirst%3DR.%26atitle%3DAnalysis%2520of%2520subpocket%2520selectivity%2520and%2520identification%2520of%2520potent%2520selective%2520inhibitors%2520for%2520matriptase%2520and%2520matriptase-2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10198%26epage%3D10204%26doi%3D10.1021%2Fjm5015633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desilets, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duchene, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chagnon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najmanovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, E.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of potent, selective inhibitors of matriptase</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">530</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1021/ml3000534</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3000534" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1OntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=530-534&author=E.+Colomboauthor=A.+Desiletsauthor=D.+Ducheneauthor=F.+Chagnonauthor=R.+Najmanovichauthor=R.+Leducauthor=E.+Marsault&title=Design+and+synthesis+of+potent%2C+selective+inhibitors+of+matriptase&doi=10.1021%2Fml3000534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Potent, Selective Inhibitors of Matriptase</span></div><div class="casAuthors">Colombo, Eloic; Desilets, Antoine; Duchene, Dominic; Chagnon, Felix; Najmanovich, Rafael; Leduc, Richard; Marsault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">530-534</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Matriptase is a member of the type II transmembrane serine protease family.  Several studies have reported deregulated matriptase expression in several types of epithelial cancers, suggesting that matriptase constitutes a potential target for cancer therapy.  We report herein a new series of slow, tight-binding inhibitors of matriptase, which mimic the P1-P4 substrate recognition sequence of the enzyme.  Preliminary structure-activity relationships indicate that this benzothiazole-contg. RQAR-peptidomimetic is a very potent inhibitor and possesses a good selectivity for matriptase vs. other serine proteases.  A mol. model was generated to elucidate the key contacts between inhibitor (I) and matriptase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlqkegeO0GdbVg90H21EOLACvtfcHk0lgtR27rgq_3fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1OntrY%253D&md5=560a72862038f32c57c829618fdd28aa</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fml3000534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3000534%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DE.%26aulast%3DDesilets%26aufirst%3DA.%26aulast%3DDuchene%26aufirst%3DD.%26aulast%3DChagnon%26aufirst%3DF.%26aulast%3DNajmanovich%26aufirst%3DR.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DMarsault%26aufirst%3DE.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%252C%2520selective%2520inhibitors%2520of%2520matriptase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D530%26epage%3D534%26doi%3D10.1021%2Fml3000534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28K1%29+and+the+concentration+of+inhibitor+which+causes+50%25+inhibition+%28I50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lgtR27rgq_3fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528K1%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byun, Y.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis, and biological evaluation of Leu-Arg dipeptide analogs as novel hepsin inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.bmcl.2015.12.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=310-314&author=H.+Kwonauthor=Y.+Kimauthor=K.+Parkauthor=S.+A.+Choiauthor=S.-H.+Sonauthor=Y.+Byun&title=Structure-based+design%2C+synthesis%2C+and+biological+evaluation+of+Leu-Arg+dipeptide+analogs+as+novel+hepsin+inhibitors&doi=10.1016%2Fj.bmcl.2015.12.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DS.%2BA.%26aulast%3DSon%26aufirst%3DS.-H.%26aulast%3DByun%26aufirst%3DY.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520Leu-Arg%2520dipeptide%2520analogs%2520as%2520novel%2520hepsin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D310%26epage%3D314%26doi%3D10.1016%2Fj.bmcl.2015.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ergel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singavarapu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orsulic, S.</span></span> <span> </span><span class="NLM_article-title">Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">2041</span>– <span class="NLM_lpage">2047</span>, <span class="refDoi"> DOI: 10.1002/ijc.23726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1002%2Fijc.23726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=18726901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Chs73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2008&pages=2041-2047&author=J.+Miaoauthor=D.+Muauthor=B.+Ergelauthor=R.+Singavarapuauthor=Z.+Duanauthor=S.+Powersauthor=E.+Olivaauthor=S.+Orsulic&title=Hepsin+colocalizes+with+desmosomes+and+induces+progression+of+ovarian+cancer+in+a+mouse+model&doi=10.1002%2Fijc.23726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model</span></div><div class="casAuthors">Miao, Jiangyong; Mu, David; Ergel, Burce; Singavarapu, Rajasekhar; Duan, Zhenfeng; Powers, Scott; Oliva, Esther; Orsulic, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2041-2047</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Hepsin is a serine protease that is widely expressed in different tissues and cell types, most prominently in the normal liver and kidney.  Overexpression of hepsin has been assocd. with prostate cancers, ovarian cancers and renal cell carcinomas.  The physiol. functions of hepsin in normal tissues and tumors are poorly understood.  To gain insight into its function in ovarian cancer, we analyzed the expression and subcellular localization of hepsin protein in ovarian cancer cell lines and tumors.  We showed that the membrane-assocd. hepsin protein is present at desmosomal junctions, where it colocalizes with its putative proteolytic substrate hepatocyte growth factor.  Consistent with the growing evidence that desmosomal junctions and their constituents play a role in cancer progression, we demonstrated that overexpression of hepsin promotes ovarian tumor growth in a mouse model.  The ability of ectopic hepsin to induce tumor growth in mice is abrogated by the mutation of 3 crit. residues in the catalytic domain, thus implicating the enzymic activity of hepsin in promoting tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLAGCqOpssILVg90H21EOLACvtfcHk0lhiE7Yvt9w3SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Chs73E&md5=3b7b8ce6c7458011cc1a685e21050f2e</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Fijc.23726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.23726%26sid%3Dliteratum%253Aachs%26aulast%3DMiao%26aufirst%3DJ.%26aulast%3DMu%26aufirst%3DD.%26aulast%3DErgel%26aufirst%3DB.%26aulast%3DSingavarapu%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DZ.%26aulast%3DPowers%26aufirst%3DS.%26aulast%3DOliva%26aufirst%3DE.%26aulast%3DOrsulic%26aufirst%3DS.%26atitle%3DHepsin%2520colocalizes%2520with%2520desmosomes%2520and%2520induces%2520progression%2520of%2520ovarian%2520cancer%2520in%2520a%2520mouse%2520model%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2008%26volume%3D123%26spage%3D2041%26epage%3D2047%26doi%3D10.1002%2Fijc.23726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhukov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellman, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">IngelmanSundberg, M.</span></span> <span> </span><span class="NLM_article-title">Purification and characterization of hepsin from rat liver microsomes</span>. <i>Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>1337</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1016/S0167-4838(96)00152-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2FS0167-4838%2896%2900152-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=9003440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADyaK28XntlKku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1337&publication_year=1997&pages=85-95&author=A.+Zhukovauthor=U.+Hellmanauthor=M.+IngelmanSundberg&title=Purification+and+characterization+of+hepsin+from+rat+liver+microsomes&doi=10.1016%2FS0167-4838%2896%2900152-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and characterization of hepsin from rat liver microsomes</span></div><div class="casAuthors">Zhukov, Andrei; Hellman, Ulf; Ingelman-Sundberg, Magnus</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure and Molecular Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1337</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-95</span>CODEN:
                <span class="NLM_cas:coden">BBAEDZ</span>;
        ISSN:<span class="NLM_cas:issn">0167-4838</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hepsin (I), a putative cell-surface serine proteinase, was isolated from the microsomal membranes of rat liver and purified to homogeneity by hydroxylapatite, DEAE-Sepharose, and benzamidine-Sepharose chromatogs.  The course of purifn. was monitored using antibodies raised against a 20-mer peptide at the C-terminus of rat I, and the identity of the purified protein was confirmed by partial amino acid sequencing.  A single-chain precursor of ∼50 kDa found in the microsomes underwent spontaneous maturation in the course of purifn. so that the last, affinity chromatog., step recovered only the mature form which dissocd. to subunits of 31 and 19 kDa under reducing SDS-PAGE.  Proteinase digestion expts. with microsomal vesicles were consistent with the luminal orientation of the precursor C-terminus, which would result in its extracellular orientation upon transportation to the cell surface.  [3H]Diisopropyl fluorophosphate covalently bound to the large subunit showing it to be the catalytic subunit.  N-terminal sequencing of this subunit demonstrated that the zymogen was converted to the active serine proteinase by cleavage at the Arg-161-Ile-162 site.  Activity measurements with short synthetic peptides showed that the enzyme cleaves after basic amino acid residues, Arg being preferable to Lys.  The inhibition pattern was typical of trypsin-like serine proteinases.  The pH-dependence of activity within the pH range of 6-9 had no max., with the activity increasing continuously with pH.  These results were consistent with the earlier predictions based on I amino acid sequence and elucidated the specificity and other earlier unknown enzymic and mol. properties of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ1d1KNa08RrVg90H21EOLACvtfcHk0lhiE7Yvt9w3SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntlKku70%253D&md5=50fc9780a600fe40691cda0fe81c0581</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2FS0167-4838%2896%2900152-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-4838%252896%252900152-5%26sid%3Dliteratum%253Aachs%26aulast%3DZhukov%26aufirst%3DA.%26aulast%3DHellman%26aufirst%3DU.%26aulast%3DIngelmanSundberg%26aufirst%3DM.%26atitle%3DPurification%2520and%2520characterization%2520of%2520hepsin%2520from%2520rat%2520liver%2520microsomes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Protein%2520Struct.%2520Mol.%2520Enzymol.%26date%3D1997%26volume%3D1337%26spage%3D85%26epage%3D95%26doi%3D10.1016%2FS0167-4838%2896%2900152-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pant, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukonoweshuro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramjee, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selway, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarver, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tervonen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klefstrom, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and testing of potent, selective hepsin inhibitors via application of an automated closed-loop optimization platform</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4335</span>– <span class="NLM_lpage">4347</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01698</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01698" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFOhurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4335-4347&author=S.+M.+Pantauthor=A.+Mukonoweshuroauthor=B.+Desaiauthor=M.+K.+Ramjeeauthor=C.+N.+Selwayauthor=G.+J.+Tarverauthor=A.+G.+Wrightauthor=K.+Birchallauthor=T.+M.+Chapmanauthor=T.+A.+Tervonenauthor=J.+Klefstrom&title=Design%2C+synthesis%2C+and+testing+of+potent%2C+selective+hepsin+inhibitors+via+application+of+an+automated+closed-loop+optimization+platform&doi=10.1021%2Facs.jmedchem.7b01698"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and testing of potent, selective hepsin inhibitors via application of an automated closed-loop optimization platform</span></div><div class="casAuthors">Pant, Shishir M.; Mukonoweshuro, Amanda; Desai, Bimbisar; Ramjee, Manoj K.; Selway, Christopher N.; Tarver, Gary J.; Wright, Adrian G.; Birchall, Kristian; Chapman, Timothy M.; Tervonen, Topi A.; Klefstrom, Juha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4335-4347</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepsin is a membrane-anchored serine protease whose role in hepatocyte growth factor (HGF) signaling and epithelial integrity makes it a target of therapeutic interest in carcinogenesis and metastasis.  Using an integrated design, synthesis, and screening platform, we were able to rapidly develop potent and selective inhibitors of hepsin.  In progressing from the initial hit (I) to compd. (II), the IC50 value against hepsin was improved from ∼1 μM to 22 nM, and the selectivity over urokinase-type plasminogen activator (uPA) was increased from 30-fold to >6000-fold.  Subsequent in vitro ADMET profiling and cellular studies confirmed that the leading compds. are useful tools for interrogating the role of hepsin in breast tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowUiuZrLxxeLVg90H21EOLACvtfcHk0lhiE7Yvt9w3SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFOhurs%253D&md5=7451e2ec2e276280136eecffe7cbd7dd</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01698%26sid%3Dliteratum%253Aachs%26aulast%3DPant%26aufirst%3DS.%2BM.%26aulast%3DMukonoweshuro%26aufirst%3DA.%26aulast%3DDesai%26aufirst%3DB.%26aulast%3DRamjee%26aufirst%3DM.%2BK.%26aulast%3DSelway%26aufirst%3DC.%2BN.%26aulast%3DTarver%26aufirst%3DG.%2BJ.%26aulast%3DWright%26aufirst%3DA.%2BG.%26aulast%3DBirchall%26aufirst%3DK.%26aulast%3DChapman%26aufirst%3DT.%2BM.%26aulast%3DTervonen%26aufirst%3DT.%2BA.%26aulast%3DKlefstrom%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520testing%2520of%2520potent%252C%2520selective%2520hepsin%2520inhibitors%2520via%2520application%2520of%2520an%2520automated%2520closed-loop%2520optimization%2520platform%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4335%26epage%3D4347%26doi%3D10.1021%2Facs.jmedchem.7b01698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongmok  Kwon</span>, <span class="hlFld-ContribAuthor ">Hyunsoo  Ha</span>, <span class="hlFld-ContribAuthor ">Hayoung  Jeon</span>, <span class="hlFld-ContribAuthor ">Jaebong  Jang</span>, <span class="hlFld-ContribAuthor ">Sang-Hyun  Son</span>, <span class="hlFld-ContribAuthor ">Kiho  Lee</span>, <span class="hlFld-ContribAuthor ">Song-Kyu  Park</span>, <span class="hlFld-ContribAuthor ">Youngjoo  Byun</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship studies of dipeptide-based hepsin inhibitors with Arg bioisosteres. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>107 </em>, 104521. <a href="https://doi.org/10.1016/j.bioorg.2020.104521" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104521</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104521%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DStructure-activity%252Brelationship%252Bstudies%252Bof%252Bdipeptide-based%252Bhepsin%252Binhibitors%252Bwith%252BArg%252Bbioisosteres%26aulast%3DKwon%26aufirst%3DHongmok%26date%3D2021%26volume%3D107%26spage%3D104521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandre  Murza</span>, <span class="hlFld-ContribAuthor ">Sébastien P.  Dion</span>, <span class="hlFld-ContribAuthor ">Pierre-Luc  Boudreault</span>, <span class="hlFld-ContribAuthor ">Antoine  Désilets</span>, <span class="hlFld-ContribAuthor ">Richard  Leduc</span>, <span class="hlFld-ContribAuthor ">Éric  Marsault</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of type II transmembrane serine proteases in the treatment of diseases of the respiratory tract – A review of patent literature. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (11)
                                     , 807-824. <a href="https://doi.org/10.1080/13543776.2020.1817390" title="DOI URL">https://doi.org/10.1080/13543776.2020.1817390</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1817390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1817390%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DInhibitors%252Bof%252Btype%252BII%252Btransmembrane%252Bserine%252Bproteases%252Bin%252Bthe%252Btreatment%252Bof%252Bdiseases%252Bof%252Bthe%252Brespiratory%252Btract%252B%2525E2%252580%252593%252BA%252Breview%252Bof%252Bpatent%252Bliterature%26aulast%3DMurza%26aufirst%3DAlexandre%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D11%26spage%3D807%26epage%3D824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shijin  Sun</span>, <span class="hlFld-ContribAuthor ">Lina  Wang</span>, <span class="hlFld-ContribAuthor ">Shengnan  Zhang</span>, <span class="hlFld-ContribAuthor ">Ce  Zhang</span>, <span class="hlFld-ContribAuthor ">Yue  Chen</span>, <span class="hlFld-ContribAuthor ">Qingyu  Wu</span>, <span class="hlFld-ContribAuthor ">Ningzheng  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">N-glycan in the scavenger receptor cysteine-rich domain of hepsin promotes intracellular trafficking and cell surface expression. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2020,</strong> <em>161 </em>, 818-827. <a href="https://doi.org/10.1016/j.ijbiomac.2020.06.109" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2020.06.109</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2020.06.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2020.06.109%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DN-glycan%252Bin%252Bthe%252Bscavenger%252Breceptor%252Bcysteine-rich%252Bdomain%252Bof%252Bhepsin%252Bpromotes%252Bintracellular%252Btrafficking%252Band%252Bcell%252Bsurface%252Bexpression%26aulast%3DSun%26aufirst%3DShijin%26date%3D2020%26volume%3D161%26spage%3D818%26epage%3D827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincent  Blay</span>, <span class="hlFld-ContribAuthor ">Mu-Chun  Li</span>, <span class="hlFld-ContribAuthor ">Sunita P.  Ho</span>, <span class="hlFld-ContribAuthor ">Mashall L.  Stoller</span>, <span class="hlFld-ContribAuthor ">Hsing-Pang  Hsieh</span>, <span class="hlFld-ContribAuthor ">Douglas R.  Houston</span>. </span><span class="cited-content_cbyCitation_article-title">Design of drug-like hepsin inhibitors against prostate cancer and kidney stones. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2020,</strong> <em>10 </em>
                                    (7)
                                     , 1309-1320. <a href="https://doi.org/10.1016/j.apsb.2019.09.008" title="DOI URL">https://doi.org/10.1016/j.apsb.2019.09.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2019.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2019.09.008%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDesign%252Bof%252Bdrug-like%252Bhepsin%252Binhibitors%252Bagainst%252Bprostate%252Bcancer%252Band%252Bkidney%252Bstones%26aulast%3DBlay%26aufirst%3DVincent%26date%3D2020%26volume%3D10%26issue%3D7%26spage%3D1309%26epage%3D1320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Jin</span>, <span class="hlFld-ContribAuthor ">Fan  Shen</span>, <span class="hlFld-ContribAuthor ">Michael  Weinfeld</span>, <span class="hlFld-ContribAuthor ">Consolato  Sergi</span>. </span><span class="cited-content_cbyCitation_article-title">Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.00727" title="DOI URL">https://doi.org/10.3389/fonc.2020.00727</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.00727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.00727%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DInsulin%252BGrowth%252BFactor%252BBinding%252BProtein%252B7%252B%252528IGFBP7%252529-Related%252BCancer%252Band%252BIGFBP3%252Band%252BIGFBP7%252BCrosstalk%26aulast%3DJin%26aufirst%3DLi%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiyu  Chen</span>, <span class="hlFld-ContribAuthor ">Joshua J.  Yim</span>, <span class="hlFld-ContribAuthor ">Matthew  Bogyo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic and biological approaches to map substrate specificities of proteases. </span><span class="cited-content_cbyCitation_journal-name">Biological Chemistry</span><span> <strong>2019,</strong> <em>401 </em>
                                    (1)
                                     , 165-182. <a href="https://doi.org/10.1515/hsz-2019-0332" title="DOI URL">https://doi.org/10.1515/hsz-2019-0332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hsz-2019-0332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhsz-2019-0332%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Chemistry%26atitle%3DSynthetic%252Band%252Bbiological%252Bapproaches%252Bto%252Bmap%252Bsubstrate%252Bspecificities%252Bof%252Bproteases%26aulast%3DChen%26aufirst%3DShiyu%26date%3D2019%26date%3D2019%26volume%3D401%26issue%3D1%26spage%3D165%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vishnu C.  Damalanka</span>, <span class="hlFld-ContribAuthor ">Scott A.  Wildman</span>, <span class="hlFld-ContribAuthor ">James W.  Janetka</span>. </span><span class="cited-content_cbyCitation_article-title">Piperidine carbamate peptidomimetic inhibitors of the serine proteases HGFA, matriptase and hepsin. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 1646-1655. <a href="https://doi.org/10.1039/C9MD00234K" title="DOI URL">https://doi.org/10.1039/C9MD00234K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00234K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00234K%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DPiperidine%252Bcarbamate%252Bpeptidomimetic%252Binhibitors%252Bof%252Bthe%252Bserine%252Bproteases%252BHGFA%25252C%252Bmatriptase%252Band%252Bhepsin%26aulast%3DDamalanka%26aufirst%3DVishnu%2BC.%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D9%26spage%3D1646%26epage%3D1655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carly E.  Martin</span>, <span class="hlFld-ContribAuthor ">Karin  List</span>. </span><span class="cited-content_cbyCitation_article-title">Cell surface–anchored serine proteases in cancer progression and metastasis. </span><span class="cited-content_cbyCitation_journal-name">Cancer and Metastasis Reviews</span><span> <strong>2019,</strong> <em>38 </em>
                                    (3)
                                     , 357-387. <a href="https://doi.org/10.1007/s10555-019-09811-7" title="DOI URL">https://doi.org/10.1007/s10555-019-09811-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10555-019-09811-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10555-019-09811-7%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520and%2520Metastasis%2520Reviews%26atitle%3DCell%252Bsurface%2525E2%252580%252593anchored%252Bserine%252Bproteases%252Bin%252Bcancer%252Bprogression%252Band%252Bmetastasis%26aulast%3DMartin%26aufirst%3DCarly%2BE.%26date%3D2019%26date%3D2019%26volume%3D38%26issue%3D3%26spage%3D357%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michele  Montaruli</span>, <span class="hlFld-ContribAuthor ">Domenico  Alberga</span>, <span class="hlFld-ContribAuthor ">Fulvio  Ciriaco</span>, <span class="hlFld-ContribAuthor ">Daniela  Trisciuzzi</span>, <span class="hlFld-ContribAuthor ">Anna Rita  Tondo</span>, <span class="hlFld-ContribAuthor ">Giuseppe Felice  Mangiatordi</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>. </span><span class="cited-content_cbyCitation_article-title">Accelerating Drug Discovery by Early Protein Drug Target Prediction Based on a Multi-Fingerprint Similarity Search †. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (12)
                                     , 2233. <a href="https://doi.org/10.3390/molecules24122233" title="DOI URL">https://doi.org/10.3390/molecules24122233</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24122233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24122233%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAccelerating%252BDrug%252BDiscovery%252Bby%252BEarly%252BProtein%252BDrug%252BTarget%252BPrediction%252BBased%252Bon%252Ba%252BMulti-Fingerprint%252BSimilarity%252BSearch%252B%2525E2%252580%2525A0%26aulast%3DMontaruli%26aufirst%3DMichele%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D12%26spage%3D2233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/medium/jm-2018-01536m_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01536&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/medium/jm-2018-01536m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Previously reported pro-HGF and pro-MSP substrate-based triplex ketobenzothiazole (kbt) inhibitors of HGFA, matriptase, and hepsin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01536&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/medium/jm-2018-01536m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. PS-SCL evaluation of HGFA substrate specificity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01536&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/medium/jm-2018-01536m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Matriptase, Hepsin, and HGFA Inhibitor Library of P1 Arg Dipeptide kbts<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01536&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HCl·HN(Me)OMe, HATU, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, DMF, RT; (b) benzothiazole, nBuLi in hexane, THF, −78 °C, 1.5 h, then <b>3</b>, −78 °C, 2 h; (c) 4 M HCl in dioxane, RT; (d) HATU, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, DMF, RT; (e) TFA/thioanisole/H<sub>2</sub>O (95:2.5:2.5 v/v/v), RT, 4 h.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/medium/jm-2018-01536m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docking model and binding orientations of <b>6a</b> to matriptase (A, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NCL">3NCL</a>, protein in light blue, ligand in gold) and hepsin (C, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z8G">1Z8G</a> protein in tan, ligand in green) with respective ligand interaction diagrams (B, matriptase numbering; D, hepsin numbering).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01536&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/medium/jm-2018-01536m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Docking model of <b>6k</b> bound to hepsin. (A) H-Bond capabilities of <b>6k</b> (cyan) with Asn99 of hepsin (tan, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z8G">1Z8G</a>). (B) Overlap of matriptase (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NCL">3NCL</a>) Phe99 and the inability of HGFA (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WUC">2WUC</a>) Ser99 indicate a greatly diminished ability to form favorable interactions in the S2 pocket when P2 is Asn. (C) Surface view of hepsin-bound <b>6k</b> with the P2 Asn residue fitting into the S2 pocket. This amide–amide interaction is likely weakened or lost in hepsin when introducing another carbon linker (Gln); see <b>6e</b> and <b>6f</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01536&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/medium/jm-2018-01536m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking model of <b>6b</b> to (A) matriptase (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NCL">3NCL</a>, blue) surface view with <b>6b</b> (purple) with the P2 position indicated with red circle. (B) Hepsin (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z8G">1Z8G</a>, tan) surface view with docked compo <b>6b</b> (green) and P2 position with clear pocket indicated with red circle. (C) Overlay of matriptase (blue ribbon, residues) and hepsin (tan ribbons, residues) showing the important Phe99 (chymotrypsin numbering) occupying the P2 pocket for matriptase, homologous residue Asn99 of Hepsin pointed away, to the left. (D) Ligand interaction diagram of <b>6b</b> with hepsin (residue numbering for hepsin).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01536&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/medium/jm-2018-01536m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0010.jpeg" id="rightTab-GRAPHIC-d7e1476-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibition of cell-based hepsin activity by <b>6k</b> and <b>6b</b>. (A) Inhibition of Boc-QRR-AMC cleavage in MCF10A cells with doxycycline inducible hepsin (MCF10A-Indu20-hepsin) by matriptase inhibitor <b>6b</b> and hepsin inhibitor <b>6k</b>. (B) Inhibition of hepsin-mediated loss of desmosomal cadherin desmoglein 2 by <b>6b</b> and <b>6k</b>. Representative confocal immunofluorescence microscopy images of MCF10A-indu20-hepsin cells without (−DOX) or with (+DOX) induction of hepsin and pretreated with indicated inhibitors. Asterisks denote cells with at least two sides bordering the neighboring cells staining positive for desmoglein 2. Scale bar is 10 μm. (C) Quantitation of desmosomal integrity. Cells expressing pericellular desmoglein 2 staining in at least two sides were counted positive from the immunofluorescent images. Cells were counted from 10 field of views per treatment from three biological repeats and shown as a percentage. Student’s <i>t</i> test was used for statistical analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01536/20190116/images/large/jm-2018-01536m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01536&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43728" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43728" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 79 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Otin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bond, J. S.</span></span> <span> </span><span class="NLM_article-title">Proteases: multifunctional enzymes in life and disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">30433</span>– <span class="NLM_lpage">30437</span>, <span class="refDoi"> DOI: 10.1074/jbc.R800035200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1074%2Fjbc.R800035200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=30433-30437&author=C.+Lopez-Otinauthor=J.+S.+Bond&title=Proteases%3A+multifunctional+enzymes+in+life+and+disease&doi=10.1074%2Fjbc.R800035200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R800035200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R800035200%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Otin%26aufirst%3DC.%26aulast%3DBond%26aufirst%3DJ.%2BS.%26atitle%3DProteases%253A%2520multifunctional%2520enzymes%2520in%2520life%2520and%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D30433%26epage%3D30437%26doi%3D10.1074%2Fjbc.R800035200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menssen, R.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of cell regulation–proteolysis, the big surprise</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>592</i></span>,  <span class="NLM_fpage">2515</span>– <span class="NLM_lpage">2524</span>, <span class="refDoi"> DOI: 10.1002/1873-3468.13109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1002%2F1873-3468.13109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=592&publication_year=2018&pages=2515-2524&author=D.+H.+Wolfauthor=R.+Menssen&title=Mechanisms+of+cell+regulation%E2%80%93proteolysis%2C+the+big+surprise&doi=10.1002%2F1873-3468.13109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2F1873-3468.13109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1873-3468.13109%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DD.%2BH.%26aulast%3DMenssen%26aufirst%3DR.%26atitle%3DMechanisms%2520of%2520cell%2520regulation%25E2%2580%2593proteolysis%252C%2520the%2520big%2520surprise%26jtitle%3DFEBS%2520Lett.%26date%3D2018%26volume%3D592%26spage%3D2515%26epage%3D2524%26doi%3D10.1002%2F1873-3468.13109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman-Vaughan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, J. V.</span></span> <span> </span><span class="NLM_article-title">Regulated intramembrane proteolysis: emergent role in cell signalling pathways</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1185</span>– <span class="NLM_lpage">1202</span>, <span class="refDoi"> DOI: 10.1042/BST20170002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1042%2FBST20170002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29079648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2jsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=1185-1202&author=A.+J.+McCarthyauthor=C.+Coleman-Vaughanauthor=J.+V.+McCarthy&title=Regulated+intramembrane+proteolysis%3A+emergent+role+in+cell+signalling+pathways&doi=10.1042%2FBST20170002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Regulated intramembrane proteolysis: emergent role in cell signalling pathways</span></div><div class="casAuthors">McCarthy, Aonghus J.; Coleman-Vaughan, Caroline; McCarthy, Justin V.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1185-1202</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Receptor signalling events including those initiated following activation of cytokine and growth factor receptors and the well-characterised death receptors (tumor necrosis factor receptor, type 1, FasR and TRAIL-R1/2) are initiated at the cell surface through the recruitment and formation of intracellular multiprotein signalling complexes that activate divergent signalling pathways.  Over the past decade, research studies reveal that many of these receptor-initiated signalling events involve the sequential proteolysis of specific receptors by membrane-bound proteases and the γ-secretase protease complexes.  Proteolysis enables the liberation of sol. receptor ectodomains and the generation of intracellular receptor cytoplasmic domain fragments.  The combined and sequential enzymic activity has been defined as regulated intramembrane proteolysis and is now a fundamental signal transduction process involved in the termination or propagation of receptor signalling events.  In this review, we discuss emerging evidence for a role of the γ-secretase protease complexes and regulated intramembrane proteolysis in cell- and immune-signalling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGPwlWk4YWfrVg90H21EOLACvtfcHk0liXOrA-w-mdhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2jsr%252FL&md5=0197606bd89179c5d071039b92e58f96</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1042%2FBST20170002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20170002%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarthy%26aufirst%3DA.%2BJ.%26aulast%3DColeman-Vaughan%26aufirst%3DC.%26aulast%3DMcCarthy%26aufirst%3DJ.%2BV.%26atitle%3DRegulated%2520intramembrane%2520proteolysis%253A%2520emergent%2520role%2520in%2520cell%2520signalling%2520pathways%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2017%26volume%3D45%26spage%3D1185%26epage%3D1202%26doi%3D10.1042%2FBST20170002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achen, M. G.</span></span> <span> </span><span class="NLM_article-title">The proteolytic activation of angiogenic and lymphangiogenic growth factors in cancer–its potential relevance for therapeutics and diagnostics</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1821</span>– <span class="NLM_lpage">1842</span>, <span class="refDoi"> DOI: 10.2174/0929867321666131217144550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.2174%2F0929867321666131217144550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=24350854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmt1Gqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1821-1842&author=N.+C.+Harrisauthor=M.+G.+Achen&title=The+proteolytic+activation+of+angiogenic+and+lymphangiogenic+growth+factors+in+cancer%E2%80%93its+potential+relevance+for+therapeutics+and+diagnostics&doi=10.2174%2F0929867321666131217144550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The Proteolytic Activation of Angiogenic and Lymphangiogenic Growth Factors in Cancer - Its Potential Relevance for Therapeutics and Diagnostics</span></div><div class="casAuthors">Harris, Nicole C.; Achen, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1821-1842</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The growth of blood vessels (angiogenesis) and lymphatic vessels (lymphangiogenesis) in and around solid tumors is central to the growth and metastatic spread of cancer.  The therapeutic targeting of angiogenesis has become an established modality of cancer treatment, however, more comprehensive targeting of angiogenic signaling pathways may be required to enhance the clin. benefits of this approach.  Angiogenesis and lymphangiogenesis are driven, or modulated, by a range of secreted glycoproteins including vascular endothelial growth factors, platelet-derived growth factors, and transforming growth factor-β.  These key regulatory growth factors are subject to proteolytic activation, involving highly specific cleavage events, which can occur at the cell surface or in the extracellular milieu.  These cleavage events are catalyzed by a variety of enzymes including proprotein convertases.  This proteolysis can regulate the activity of these growth factors by enhancing binding affinities for cell surface receptors and co-receptors, or by altering their interactions with heparan sulfate proteoglycans, thereby modulating bioavailability.  The proteolytic processing of these growth factors complicates strategies for targeting them for diagnostic and/or therapeutic purposes in cancer, as processing can generate various forms with distinct biol. properties.  Hence it has been important to det. which forms are biol. active for promoting angiogenesis and lymphangiogenesis in cancer, so as to indicate clin. relevance.  Here we review the regulation of tumor angiogenesis and lymphangiogenesis by proteolytic activation of growth factors, and the potential therapeutic and diagnostic strategies arising from our understanding of this process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8Dz41WYYQHbVg90H21EOLACvtfcHk0liXOrA-w-mdhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmt1Gqtr8%253D&md5=dc55abec7e0f1b1476809d96008471f9</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F0929867321666131217144550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666131217144550%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DN.%2BC.%26aulast%3DAchen%26aufirst%3DM.%2BG.%26atitle%3DThe%2520proteolytic%2520activation%2520of%2520angiogenic%2520and%2520lymphangiogenic%2520growth%2520factors%2520in%2520cancer%25E2%2580%2593its%2520potential%2520relevance%2520for%2520therapeutics%2520and%2520diagnostics%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1821%26epage%3D1842%26doi%3D10.2174%2F0929867321666131217144550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eatemadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiyelabegan, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negahdari, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazlomi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daraee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daraee, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eatemadi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadroddiny, E.</span></span> <span> </span><span class="NLM_article-title">Role of protease and protease inhibitors in cancer pathogenesis and treatment</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2016.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.biopha.2016.12.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=28006747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFWltrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2017&pages=221-231&author=A.+Eatemadiauthor=H.+T.+Aiyelabeganauthor=B.+Negahdariauthor=M.+A.+Mazlomiauthor=H.+Daraeeauthor=N.+Daraeeauthor=R.+Eatemadiauthor=E.+Sadroddiny&title=Role+of+protease+and+protease+inhibitors+in+cancer+pathogenesis+and+treatment&doi=10.1016%2Fj.biopha.2016.12.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Role of protease and protease inhibitors in cancer pathogenesis and treatment</span></div><div class="casAuthors">Eatemadi, Ali; Aiyelabegan, Hammed T.; Negahdari, Babak; Mazlomi, Mohammad Ali; Daraee, Hadis; Daraee, Nasim; Eatemadi, Razieh; Sadroddiny, Esmaeil</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">221-231</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Cancer is the second cause of death in 2015, and it has been estd. to surpass heart diseases as the leading cause of death in the next few years.  Several mechanisms are involved in cancer pathogenesis.  Studies have indicated that proteases are also implicated in tumor growth and progression which is highly dependent on nutrient and oxygen supply.  On the other hand, protease inhibitors could be considered as a potent strategy in cancer therapy.  On the basis of the type of the key amino acid in the active site of the protease and the mechanism of peptide bond cleavage, proteases can be classified into six groups: cysteine, serine, threonine, glutamic acid, aspartate proteases, as well as matrix metalloproteases.  In this review, we focus on the role of different types of proteases and protease inhibitors in cancer pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAT3oJ_gif8rVg90H21EOLACvtfcHk0lhymqBDhjJ6BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFWltrfL&md5=decfade2ecb7c383ba1de1535d25c3be</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2016.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2016.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DEatemadi%26aufirst%3DA.%26aulast%3DAiyelabegan%26aufirst%3DH.%2BT.%26aulast%3DNegahdari%26aufirst%3DB.%26aulast%3DMazlomi%26aufirst%3DM.%2BA.%26aulast%3DDaraee%26aufirst%3DH.%26aulast%3DDaraee%26aufirst%3DN.%26aulast%3DEatemadi%26aufirst%3DR.%26aulast%3DSadroddiny%26aufirst%3DE.%26atitle%3DRole%2520of%2520protease%2520and%2520protease%2520inhibitors%2520in%2520cancer%2520pathogenesis%2520and%2520treatment%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2017%26volume%3D86%26spage%3D221%26epage%3D231%26doi%3D10.1016%2Fj.biopha.2016.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mason, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, J. A.</span></span> <span> </span><span class="NLM_article-title">Proteolytic networks in cancer</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2010.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.tcb.2010.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=21232958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1Gnt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=228-237&author=S.+D.+Masonauthor=J.+A.+Joyce&title=Proteolytic+networks+in+cancer&doi=10.1016%2Fj.tcb.2010.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic networks in cancer</span></div><div class="casAuthors">Mason, Steven D.; Joyce, Johanna A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">228-237</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Proteases are important for multiple processes during malignant progression, including tumor angiogenesis, invasion and metastasis.  Recent evidence reveals that tumor-promoting proteases function as part of an extensive multidirectional network of proteolytic interactions, in contrast to the unidirectional caspase cascade.  These networks involve different constituents of the tumor microenvironment and key proteases, such as cathepsin B, urokinase-type plasminogen activator and several matrix metalloproteinases, occupy central nodes for amplifying proteolytic signals passing through the network.  The proteolytic network interacts with other important signaling pathways in tumor biol., involving chemokines, cytokines, and kinases.  Viewing these proteolytic interactions as a system of activating and inhibiting reactions provides insight into tumor biol. and reveals relevant pharmaceutical targets.  This review examines recent advances in understanding proteases in cancer and summarizes how the network of activity is co-opted to promote tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtZN81nyg0grVg90H21EOLACvtfcHk0lhymqBDhjJ6BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1Gnt78%253D&md5=60909797ce77bd59bed67d8b8dcfde87</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2010.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2010.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DS.%2BD.%26aulast%3DJoyce%26aufirst%3DJ.%2BA.%26atitle%3DProteolytic%2520networks%2520in%2520cancer%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2011%26volume%3D21%26spage%3D228%26epage%3D237%26doi%3D10.1016%2Fj.tcb.2010.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sevenich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, J. A.</span></span> <span> </span><span class="NLM_article-title">Pericellular proteolysis in cancer</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2331</span>– <span class="NLM_lpage">2347</span>, <span class="refDoi"> DOI: 10.1101/gad.250647.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1101%2Fgad.250647.114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=2331-2347&author=L.+Sevenichauthor=J.+A.+Joyce&title=Pericellular+proteolysis+in+cancer&doi=10.1101%2Fgad.250647.114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1101%2Fgad.250647.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.250647.114%26sid%3Dliteratum%253Aachs%26aulast%3DSevenich%26aufirst%3DL.%26aulast%3DJoyce%26aufirst%3DJ.%2BA.%26atitle%3DPericellular%2520proteolysis%2520in%2520cancer%26jtitle%3DGenes%2520Dev.%26date%3D2014%26volume%3D28%26spage%3D2331%26epage%3D2347%26doi%3D10.1101%2Fgad.250647.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eftekhari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lima, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saifeddine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noorbakhsh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarisbrick, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenberg, M. D.</span></span> <span> </span><span class="NLM_article-title">Microenvironment proteinases, proteinase-activated receptor regulation, cancer and inflammation</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>399</i></span>,  <span class="NLM_fpage">1023</span>– <span class="NLM_lpage">1039</span>, <span class="refDoi"> DOI: 10.1515/hsz-2018-0001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1515%2Fhsz-2018-0001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=2018&pages=1023-1039&author=R.+Eftekhariauthor=S.+G.+de+Limaauthor=Y.+Liuauthor=K.+Miharaauthor=M.+Saifeddineauthor=F.+Noorbakhshauthor=I.+A.+Scarisbrickauthor=M.+D.+Hollenberg&title=Microenvironment+proteinases%2C+proteinase-activated+receptor+regulation%2C+cancer+and+inflammation&doi=10.1515%2Fhsz-2018-0001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2018-0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2018-0001%26sid%3Dliteratum%253Aachs%26aulast%3DEftekhari%26aufirst%3DR.%26aulast%3Dde%2BLima%26aufirst%3DS.%2BG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMihara%26aufirst%3DK.%26aulast%3DSaifeddine%26aufirst%3DM.%26aulast%3DNoorbakhsh%26aufirst%3DF.%26aulast%3DScarisbrick%26aufirst%3DI.%2BA.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26atitle%3DMicroenvironment%2520proteinases%252C%2520proteinase-activated%2520receptor%2520regulation%252C%2520cancer%2520and%2520inflammation%26jtitle%3DBiol.%2520Chem.%26date%3D2018%26volume%3D399%26spage%3D1023%26epage%3D1039%26doi%3D10.1515%2Fhsz-2018-0001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oikonomopoulou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamandis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenberg, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandran, V.</span></span> <span> </span><span class="NLM_article-title">Proteinases and their receptors in inflammatory arthritis: an overview</span>. <i>Nat. Rev. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1038/nrrheum.2018.17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1038%2Fnrrheum.2018.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29416136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=170-180&author=K.+Oikonomopoulouauthor=E.+P.+Diamandisauthor=M.+D.+Hollenbergauthor=V.+Chandran&title=Proteinases+and+their+receptors+in+inflammatory+arthritis%3A+an+overview&doi=10.1038%2Fnrrheum.2018.17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Proteinases and their receptors in inflammatory arthritis: an overview</span></div><div class="casAuthors">Oikonomopoulou, Katerina; Diamandis, Eleftherios P.; Hollenberg, Morley D.; Chandran, Vinod</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Rheumatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">170-180</span>CODEN:
                <span class="NLM_cas:coden">NRRACB</span>;
        ISSN:<span class="NLM_cas:issn">1759-4790</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Proteinases are enzymes with established roles in physiol. and pathol. processes such as digestion and the homeostasis, destruction and repair of tissues.  Over the past few years, the hormone-like properties of circulating proteinases have become increasingly appreciated.  Some proteolytic enzymes trigger cell signalling via proteinase-activated receptors, a family of G protein-coupled receptors that have been implicated in inflammation and pain in inflammatory arthritis.  Proteinases can also regulate ion flux owing to the cross-sensitization of transient receptor potential cation channel subfamily V members 1 and 4, which are assocd. with mechanosensing and pain.  In this Review, the idea that proteinases have the potential to orchestrate inflammatory signals by interacting with receptors on cells within the synovial microenvironment of an inflamed joint is revisited in three arthritic diseases: osteoarthritis, spondyloarthritis and rheumatoid arthritis.  Unanswered questions are highlighted and the therapeutic potential of modulating this proteinase-receptor axis for the management of disease in patients with these types of arthritis is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyh0isavyOy7Vg90H21EOLACvtfcHk0lin2O3xB4T4mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKjs70%253D&md5=2b5b3abfd42385c916651acaea15efcb</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrrheum.2018.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrrheum.2018.17%26sid%3Dliteratum%253Aachs%26aulast%3DOikonomopoulou%26aufirst%3DK.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DChandran%26aufirst%3DV.%26atitle%3DProteinases%2520and%2520their%2520receptors%2520in%2520inflammatory%2520arthritis%253A%2520an%2520overview%26jtitle%3DNat.%2520Rev.%2520Rheumatol.%26date%3D2018%26volume%3D14%26spage%3D170%26epage%3D180%26doi%3D10.1038%2Fnrrheum.2018.17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanabe, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">List, K.</span></span> <span> </span><span class="NLM_article-title">The role of type II transmembrane serine protease-mediated signaling in cancer</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">1421</span>– <span class="NLM_lpage">1436</span>, <span class="refDoi"> DOI: 10.1111/febs.13971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1111%2Ffebs.13971" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2017&pages=1421-1436&author=L.+M.+Tanabeauthor=K.+List&title=The+role+of+type+II+transmembrane+serine+protease-mediated+signaling+in+cancer&doi=10.1111%2Ffebs.13971"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13971%26sid%3Dliteratum%253Aachs%26aulast%3DTanabe%26aufirst%3DL.%2BM.%26aulast%3DList%26aufirst%3DK.%26atitle%3DThe%2520role%2520of%2520type%2520II%2520transmembrane%2520serine%2520protease-mediated%2520signaling%2520in%2520cancer%26jtitle%3DFEBS%2520J.%26date%3D2017%26volume%3D284%26spage%3D1421%26epage%3D1436%26doi%3D10.1111%2Ffebs.13971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Owen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilpatrick, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, V.</span></span> <span> </span><span class="NLM_article-title">Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>426</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1042/BJ20091448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1042%2FBJ20091448" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2010&pages=219-228&author=K.+A.+Owenauthor=D.+Y.+Qiuauthor=J.+Alvesauthor=A.+M.+Schumacherauthor=L.+M.+Kilpatrickauthor=J.+Liauthor=J.+L.+Harrisauthor=V.+Ellis&title=Pericellular+activation+of+hepatocyte+growth+factor+by+the+transmembrane+serine+proteases+matriptase+and+hepsin%2C+but+not+by+the+membrane-associated+protease+uPA&doi=10.1042%2FBJ20091448"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1042%2FBJ20091448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20091448%26sid%3Dliteratum%253Aachs%26aulast%3DOwen%26aufirst%3DK.%2BA.%26aulast%3DQiu%26aufirst%3DD.%2BY.%26aulast%3DAlves%26aufirst%3DJ.%26aulast%3DSchumacher%26aufirst%3DA.%2BM.%26aulast%3DKilpatrick%26aufirst%3DL.%2BM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DJ.%2BL.%26aulast%3DEllis%26aufirst%3DV.%26atitle%3DPericellular%2520activation%2520of%2520hepatocyte%2520growth%2520factor%2520by%2520the%2520transmembrane%2520serine%2520proteases%2520matriptase%2520and%2520hepsin%252C%2520but%2520not%2520by%2520the%2520membrane-associated%2520protease%2520uPA%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D426%26spage%3D219%26epage%3D228%26doi%3D10.1042%2FBJ20091448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolumam, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarus, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhuri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchhofer, D.</span></span> <span> </span><span class="NLM_article-title">Proteolytic activation of pro-macrophage-stimulating protein by hepsin</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1186</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-11-0004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1158%2F1541-7786.MCR-11-0004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=21875933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKntb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=1175-1186&author=R.+Ganesanauthor=G.+A.+Kolumamauthor=S.+J.+Linauthor=M.+H.+Xieauthor=L.+Santellauthor=T.+D.+Wuauthor=R.+A.+Lazarusauthor=A.+Chaudhuriauthor=D.+Kirchhofer&title=Proteolytic+activation+of+pro-macrophage-stimulating+protein+by+hepsin&doi=10.1158%2F1541-7786.MCR-11-0004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic Activation of Pro-Macrophage-Stimulating Protein by Hepsin</span></div><div class="casAuthors">Ganesan, Rajkumar; Kolumam, Ganesh A.; Lin, S. Jack; Xie, Ming-Hong; Santell, Lydia; Wu, Thomas D.; Lazarus, Robert A.; Chaudhuri, Amitabha; Kirchhofer, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1175-1186</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Macrophage-stimulating protein (MSP) is a plasminogen-related growth factor and ligand for the receptor tyrosine kinase RON.  The MSP/RON system promotes wound healing and invasive tumor growth and suppresses proinflammatory immune response.  MSP binding to RON requires proteolytic conversion of the inactive single-chain form (pro-MSP) into the disulfide-linked α/β heterodimer.  The pro-MSP cleavage sequence (Ser-Lys-Leu-Arg483↓Val484) closely matches the substrate recognition sequences of hepsin, a type II transmembrane serine protease, that is overexpressed in several cancers.  Here, we show that recombinant hepsin cleaves pro-MSP at the consensus site Arg483-Val484 with superior efficiency compared with the known activators MT-SP1 and hepatocyte growth factor activator (HGFA).  At least 50% of pro-MSP was processed within 1 h at a hepsin concn. of 2.4 nmol/L and at a molar enzyme to substrate ratio of 1:500.  An uncleavable single-chain variant of MSP weakly bound to a RON-Fc fusion protein, whereas hepsin-cleaved MSP bound with a KD of 10.3 nmol/L, suggesting that the high-affinity binding site in MSP β-chain was properly formed.  LNCaP prostate cancer cells overexpressing hepsin on the cell surface efficiently activated pro-MSP, which was blocked by a specific anti-hepsin antibody.  Incubation of pro-MSP with hepsin led to robust RON-mediated phosphorylation of mitogen-activated protein kinase, ribosomal S6 protein, and Akt in human A2780 ovarian carcinoma cells stably expressing RON protein.  In macrophages, pro-MSP with hepsin induced chemotaxis and attenuated lipopolysaccharide-dependent prodn. of nitric oxide.  These findings suggest that the MSP/RON signaling pathway may be regulated by hepsin in tissue homeostasis and in disease pathologies, such as in cancer and immune disorders.  Mol Cancer Res; 9(9); 1175-86.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmBj9IV-D-j7Vg90H21EOLACvtfcHk0li_59sIiHFtYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKntb%252FM&md5=86805e168be676e7776550a0d817082d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-11-0004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-11-0004%26sid%3Dliteratum%253Aachs%26aulast%3DGanesan%26aufirst%3DR.%26aulast%3DKolumam%26aufirst%3DG.%2BA.%26aulast%3DLin%26aufirst%3DS.%2BJ.%26aulast%3DXie%26aufirst%3DM.%2BH.%26aulast%3DSantell%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DT.%2BD.%26aulast%3DLazarus%26aufirst%3DR.%2BA.%26aulast%3DChaudhuri%26aufirst%3DA.%26aulast%3DKirchhofer%26aufirst%3DD.%26atitle%3DProteolytic%2520activation%2520of%2520pro-macrophage-stimulating%2520protein%2520by%2520hepsin%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2011%26volume%3D9%26spage%3D1175%26epage%3D1186%26doi%3D10.1158%2F1541-7786.MCR-11-0004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, H.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of hepatocyte growth factor activation in cancer tissues</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1890</span>– <span class="NLM_lpage">1904</span>, <span class="refDoi"> DOI: 10.3390/cancers6041890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.3390%2Fcancers6041890" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1890-1904&author=M.+Kawaguchiauthor=H.+Kataoka&title=Mechanisms+of+hepatocyte+growth+factor+activation+in+cancer+tissues&doi=10.3390%2Fcancers6041890"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3390%2Fcancers6041890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers6041890%26sid%3Dliteratum%253Aachs%26aulast%3DKawaguchi%26aufirst%3DM.%26aulast%3DKataoka%26aufirst%3DH.%26atitle%3DMechanisms%2520of%2520hepatocyte%2520growth%2520factor%2520activation%2520in%2520cancer%2520tissues%26jtitle%3DCancers%26date%3D2014%26volume%3D6%26spage%3D1890%26epage%3D1904%26doi%3D10.3390%2Fcancers6041890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherle, P. A.</span></span> <span> </span><span class="NLM_article-title">Development of c-MET pathway inhibitors</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1241</span>, <span class="refDoi"> DOI: 10.1517/13543784.2011.600687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1517%2F13543784.2011.600687" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=1225-1241&author=X.+D.+Liuauthor=R.+C.+Newtonauthor=P.+A.+Scherle&title=Development+of+c-MET+pathway+inhibitors&doi=10.1517%2F13543784.2011.600687"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F13543784.2011.600687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2011.600687%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%2BD.%26aulast%3DNewton%26aufirst%3DR.%2BC.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26atitle%3DDevelopment%2520of%2520c-MET%2520pathway%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26spage%3D1225%26epage%3D1241%26doi%3D10.1517%2F13543784.2011.600687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J. J.</span></span> <span> </span><span class="NLM_article-title">Targeting receptor tyrosine kinase MET in cancer: small molecule inhibitors and clinical progress</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4427</span>– <span class="NLM_lpage">4453</span>, <span class="refDoi"> DOI: 10.1021/jm401427c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401427c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4427-4453&author=J.+J.+Cui&title=Targeting+receptor+tyrosine+kinase+MET+in+cancer%3A+small+molecule+inhibitors+and+clinical+progress&doi=10.1021%2Fjm401427c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress</span></div><div class="casAuthors">Cui, J. Jean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4427-4453</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The HGF/MET signaling pathway is crit. in mediating a wide range of normal physiol. functions including embryol. development, wound healing, and tissue regeneration.  Aberrant activation of the pathway has frequently been found in human cancers via protein overexpression, mutation, gene amplification, and also paracrine or autocrine up-regulation.  In addn., the activation of HGF/MET signaling confers resistance to the effects of cancer treatments.  Therefore, inhibition of the HGF/MET signaling pathway has great potential for therapeutic intervention in cancer.  Currently, there are three approaches toward modulating HGF/MET signaling in human clin. studies of cancer: anti-HGF monoclonal antibodies, MET monoclonal antibodies, and small mol. MET inhibitors.  Preliminary clin. benefit from inhibition of HGF or MET has been reported.  This Perspective will provide an overview of the HGF/MET signaling pathway in cancer and then will review the development of small mol. MET inhibitors and their progress in clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoARAsEnH4X5rVg90H21EOLACvtfcHk0li_59sIiHFtYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltbvE&md5=534fd1c6fd8b83be41251d0d556903d1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm401427c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401427c%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520receptor%2520tyrosine%2520kinase%2520MET%2520in%2520cancer%253A%2520small%2520molecule%2520inhibitors%2520and%2520clinical%2520progress%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4427%26epage%3D4453%26doi%3D10.1021%2Fjm401427c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span> <span> </span><span class="NLM_article-title">Hepatocyte growth factor and Met in drug discovery</span>. <i>J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1093/jb/mvv027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1093%2Fjb%2Fmvv027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=25770121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVOgtLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2015&pages=271-284&author=K.+Sakaiauthor=S.+Aokiauthor=K.+Matsumoto&title=Hepatocyte+growth+factor+and+Met+in+drug+discovery&doi=10.1093%2Fjb%2Fmvv027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor and Met in drug discovery</span></div><div class="casAuthors">Sakai, Katsuya; Aoki, Shunsuke; Matsumoto, Kunio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">271-284</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Activation of the hepatocyte growth factor (HGF) -Met pathway evokes dynamic biol. responses that support the morphogenesis, regeneration and survival of cells and tissues.  A characterization of conditional Met knockout mice indicates that the HGF-Met pathway plays important roles in the regeneration, protection and homeostasis of cells such as hepatocytes, renal tubular cells and neurons.  Preclin. studies in disease models have indicated that recombinant HGF protein and expression plasmid for HGF are biol. drug candidates for the treatment of patients with diseases or injuries that involve impaired tissue function.  The phase-I and phase-I/II clin. trials of the intrathecal administration of HGF protein for the treatment of patients with amyotrophic lateral sclerosis and spinal cord injury, resp., are ongoing.  Biol. actions of HGF that promote the dynamic movement, morphogenesis and survival of cells also closely participate in invasion-metastasis and resistance to the mol.-targeted drugs in tumor cells.  Different types of HGF-Met pathway inhibitors are now in clin. trials for treatment of malignant tumors.  Basic research on HGF and Met has lead to drug discoveries in regenerative medicine and tumor biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquPM_j6_c6trVg90H21EOLACvtfcHk0li_59sIiHFtYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVOgtLvK&md5=ad81f392981d02d76934cce53ac4d2f8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvv027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvv027%26sid%3Dliteratum%253Aachs%26aulast%3DSakai%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DS.%26aulast%3DMatsumoto%26aufirst%3DK.%26atitle%3DHepatocyte%2520growth%2520factor%2520and%2520Met%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Biochem.%26date%3D2015%26volume%3D157%26spage%3D271%26epage%3D284%26doi%3D10.1093%2Fjb%2Fmvv027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. S.</span></span> <span> </span><span class="NLM_article-title">Progress in cancer therapy targeting c-Met signaling pathway</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1007/s12272-012-0402-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1007%2Fs12272-012-0402-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=22553051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVGlu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=595-604&author=K.+H.+Jungauthor=B.+H.+Parkauthor=S.+S.+Hong&title=Progress+in+cancer+therapy+targeting+c-Met+signaling+pathway&doi=10.1007%2Fs12272-012-0402-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in cancer therapy targeting c-Met signaling pathway</span></div><div class="casAuthors">Jung, Kyung Hee; Park, Byung Hee; Hong, Soon-Sun</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">595-604</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  A primary hurdle in developing anticancer therapeutics is to selectively target cancer cells while sparing normal tissues.  Oncogenic protein kinases represent a class of biol. important targets for cancer intervention.  Among them, c-Met is a receptor tyrosine kinase (RTK) that has low activity in normal tissues but is dysregulated in many tumor types.  The c-Met is the prototype member of a subfamily of RTKs, which includes Ron, which is structurally distinct from other RTK families.  It is the only known high-affinity receptor for hepatocyte growth factor, also known as scatter factor.  HGF and c-Met are both required for normal mammalian development.  In adults, both are widely expressed in a variety of tissues; however, their expression is normally very low and is involved mainly in tissue damage, repair and regeneration.  The results of in vitro and in vivo expts. have shown that this receptor-growth factor pair is involved in multiple physiol. cellular responses, including cell proliferation, survival, differentiation, motility, and invasion.  Here, as well as presenting the biol. aspects of c-Met signaling regulation, we consider recent findings that have provided new knowledge at the mol., cellular, and animal study.  Also, we describe how the c-Met pathway is tuned by the functional cooperation between various signal transducers.  We then discuss the progress in the development of agents that target the c-Met pathway, with an emphasis on small mols. of c-Met kinase inhibitors.  Finally, we provide our perspective in terms of possible future trends and limitation in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2BhXJADEW8rVg90H21EOLACvtfcHk0lgbFhOy0gkHbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVGlu74%253D&md5=b3f70ac7f90458023abce87edc758396</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs12272-012-0402-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-012-0402-6%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DK.%2BH.%26aulast%3DPark%26aufirst%3DB.%2BH.%26aulast%3DHong%26aufirst%3DS.%2BS.%26atitle%3DProgress%2520in%2520cancer%2520therapy%2520targeting%2520c-Met%2520signaling%2520pathway%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2012%26volume%3D35%26spage%3D595%26epage%3D604%26doi%3D10.1007%2Fs12272-012-0402-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parikh, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghate, M. D.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the discovery of small molecule c-Met kinase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">1103</span>– <span class="NLM_lpage">1138</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.08.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.ejmech.2017.08.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29157685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVKitLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2018&pages=1103-1138&author=P.+K.+Parikhauthor=M.+D.+Ghate&title=Recent+advances+in+the+discovery+of+small+molecule+c-Met+kinase+inhibitors&doi=10.1016%2Fj.ejmech.2017.08.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the discovery of small molecule c-Met Kinase inhibitors</span></div><div class="casAuthors">Parikh, Palak K.; Ghate, Manjunath D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1103-1138</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">C-Met is a prototype member of a subfamily of heterodimeric receptor tyrosine kinases (RTKs) and is the receptor for hepatocyte growth factor (HGF).  Binding of HGF to its receptor c-Met, initiates a wide range of cellular signalling, including those involved in proliferation, motility, migration and invasion.  Importantly, dysregulated HGF/c-Met signalling is a driving factor for numerous malignancies and promotes tumor growth, invasion, dissemination and/or angiogenesis.  Dysregulated HGF/c-Met signalling has also been assocd. with poor clin. outcomes and resistance acquisition to some approved targeted therapies.  Thus, c-Met kinase has emerged as a promising target for cancer drug development.  Different therapeutic approaches targeting the HGF/c-Met signalling pathway are under development for targeted cancer therapy, among which small mol. inhibitors of c-Met kinase constitute the largest effort within the pharmaceutical industry.  The review is an effort to summarize recent advancements in medicinal chem. development of small mol. c-Met kinase inhibitors as potential anti-cancer agents which would certainly help future researchers to bring further developments in the discovery of small mol. c-Met kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcQHNqZtWRPLVg90H21EOLACvtfcHk0lgbFhOy0gkHbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVKitLbO&md5=d598a6ad21532adab52bff67a8bd8e01</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.08.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.08.044%26sid%3Dliteratum%253Aachs%26aulast%3DParikh%26aufirst%3DP.%2BK.%26aulast%3DGhate%26aufirst%3DM.%2BD.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520small%2520molecule%2520c-Met%2520kinase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D143%26spage%3D1103%26epage%3D1138%26doi%3D10.1016%2Fj.ejmech.2017.08.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Silva, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottaro, D. P.</span></span> <span> </span><span class="NLM_article-title">Targeting the hepatocyte growth factor/Met pathway in cancer</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">855</span>– <span class="NLM_lpage">870</span>, <span class="refDoi"> DOI: 10.1042/BST20160132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1042%2FBST20160132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=28673936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlaktbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=855-870&author=D.+M.+De%0ASilvaauthor=A.+Royauthor=T.+Katoauthor=F.+Cecchiauthor=Y.+H.+Leeauthor=K.+Matsumotoauthor=D.+P.+Bottaro&title=Targeting+the+hepatocyte+growth+factor%2FMet+pathway+in+cancer&doi=10.1042%2FBST20160132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the hepatocyte growth factor/Met pathway in cancer</span></div><div class="casAuthors">De Silva, Dinuka M.; Roy, Arpita; Kato, Takashi; Cecchi, Fabiola; Lee, Young H.; Matsumoto, Kunio; Bottaro, Donald P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">855-870</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Hepatocyte growth factor (HGF)-induced activation of its cell surface receptor, the Met tyrosine kinase, drives mitogenesis, motogenesis and morphogenesis in a wide spectrum of target cell types and embryol., developmental and homeostatic contexts.  Typical paracrine HGF/Met signaling is regulated by HGF activation at target cell surfaces, HGF binding-induced receptor activation, internalization and degrdn.  Despite these controls, HGF/Met signaling contributes to oncogenesis, tumor angiogenesis and invasiveness, and tumor metastasis in many types of cancer, leading to the rapid growth of pathway-targeted anticancer drug development programs.  We review here HGF and Met structure and function, basic properties of HGF/Met pathway antagonists now in clin. development, and recent clin. trial results.  Presently, the main challenges facing the effective use of HGF/Met-targeted antagonists for cancer treatment include optimal patient selection, diagnostic and pharmacodynamic biomarker development, and the identification and testing of effective therapy combinations.  The wealth of basic information, anal. reagents and model systems available regarding normal and oncogenic HGF/Met signaling will continue to be invaluable in meeting these challenges and moving expeditiously toward more effective cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqANiimskGdsrVg90H21EOLACvtfcHk0lgbFhOy0gkHbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlaktbbF&md5=8582f3c75774ccd2ca73db8869a9b347</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1042%2FBST20160132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20160132%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BSilva%26aufirst%3DD.%2BM.%26aulast%3DRoy%26aufirst%3DA.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DCecchi%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DY.%2BH.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DBottaro%26aufirst%3DD.%2BP.%26atitle%3DTargeting%2520the%2520hepatocyte%2520growth%2520factor%252FMet%2520pathway%2520in%2520cancer%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2017%26volume%3D45%26spage%3D855%26epage%3D870%26doi%3D10.1042%2FBST20160132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. H.</span></span> <span> </span><span class="NLM_article-title">MSP-RON signalling in cancer: pathogenesis and therapeutic potential</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">481</span>, <span class="refDoi"> DOI: 10.1038/nrc3545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1038%2Fnrc3545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=23792360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVykur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=466-481&issue=7&author=H.+P.+Yaoauthor=Y.+Q.+Zhouauthor=R.+Zhangauthor=M.+H.+Wang&title=MSP-RON+signalling+in+cancer%3A+pathogenesis+and+therapeutic+potential&doi=10.1038%2Fnrc3545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">MSP-RON signalling in cancer: pathogenesis and therapeutic potential</span></div><div class="casAuthors">Yao, Hang-Ping; Zhou, Yong-Qing; Zhang, Ruiwen; Wang, Ming-Hai</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">466-481</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the discovery of MSP (macrophage-stimulating protein; also known as MST1 and hepatocyte growth factor-like (HGFL)) as the ligand for the receptor tyrosine kinase RON (also known as MST1R) in the early 1990s, the roles of this signalling axis in cancer pathogenesis has been extensively studied in various model systems.  Both in vitro and in vivo evidence has revealed that MSP-RON signalling is important for the invasive growth of different types of cancers.  Currently, small-mol. inhibitors and antibodies blocking RON signalling are under investigation.  Substantial responses have been achieved in human tumor xenograft models, laying the foundation for clin. validation.  In this Review, we discuss recent advances that demonstrate the importance of MSP-RON signalling in cancer and its potential as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxZ7BjkQx6l7Vg90H21EOLACvtfcHk0lgbFhOy0gkHbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVykur8%253D&md5=e903663a2613485f0091e83611c3766a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrc3545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3545%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DH.%2BP.%26aulast%3DZhou%26aufirst%3DY.%2BQ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DM.%2BH.%26atitle%3DMSP-RON%2520signalling%2520in%2520cancer%253A%2520pathogenesis%2520and%2520therapeutic%2520potential%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2013%26volume%3D13%26issue%3D7%26spage%3D466%26epage%3D481%26doi%3D10.1038%2Fnrc3545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H. P.</span></span> <span> </span><span class="NLM_article-title">Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addiction</span>. <i>J Biomed. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.7555/JBR.27.20130038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.7555%2FJBR.27.20130038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=24086167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvFamu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=345-356&author=M.+H.+Wangauthor=R.+Zhangauthor=Y.+Q.+Zhouauthor=H.+P.+Yao&title=Pathogenesis+of+RON+receptor+tyrosine+kinase+in+cancer+cells%3A+activation+mechanism%2C+functional+crosstalk%2C+and+signaling+addiction&doi=10.7555%2FJBR.27.20130038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addiction</span></div><div class="casAuthors">Wang, Minghai; Zhang, Ruiwen; Zhou, Yongqing; Yao, Hangping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomedical Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">345-356</span>CODEN:
                <span class="NLM_cas:coden">JBROEZ</span>;
        ISSN:<span class="NLM_cas:issn">1674-8301</span>.
    
            (<span class="NLM_cas:orgname">Editorial Dep. of Journal of Biomedical Research</span>)
        </div><div class="casAbstract">A review.  The RON receptor tyrosine kinase, a member of the MET proto-oncogene family, is a pathogenic factor implicated in tumor malignancy.  Specifically, aberrations in RON signaling result in increased cancer cell growth, survival, invasion, angiogenesis, and drug resistance.  Biochem. events such as ligand binding, receptor overexpression, generation of structure-defected variants, and point mutations in the kinase domain contribute to RON signaling activation.  Recently, functional crosstalk between RON and signaling proteins such as MET and EFGR has emerged as an addnl. mechanism for RON activation, which is crit. for tumorigenic development.  The RON signaling crosstalk acts either as a regulatory feedback loop that strengthens or enhances tumorigenic phenotype of cancer cells or serves as a signaling compensatory pathway providing a growth/survival advantage for cancer cells to escape targeted therapy.  Moreover, viral oncoproteins derived from Friend leukemia or Epstein-Barr viruses interact with RON to drive viral oncogenesis.  In cancer cells, RON signaling is integrated into cellular signaling network essential for cancer cell growth and survival.  These activities provide the mol. basis of targeting RON for cancer treatment.  In this review, we will discuss recent data that uncover the mechanisms of RON activation in cancer cells, review evidence of RON signaling crosstalk relevant to cancer malignancy, and emphasize the significance of the RON signaling addiction by cancer cells for tumor therapy.  Understanding aberrant RON signaling will not only provide insight into the mechanisms of tumor pathogenesis, but also lead to the development of novel strategies for molecularly targeted cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS3TWJA95rurVg90H21EOLACvtfcHk0liubmQ3I9OrAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvFamu7g%253D&md5=905b8c4a4c6e162d02d33b064d517ccb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.7555%2FJBR.27.20130038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7555%252FJBR.27.20130038%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%2BH.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DY.%2BQ.%26aulast%3DYao%26aufirst%3DH.%2BP.%26atitle%3DPathogenesis%2520of%2520RON%2520receptor%2520tyrosine%2520kinase%2520in%2520cancer%2520cells%253A%2520activation%2520mechanism%252C%2520functional%2520crosstalk%252C%2520and%2520signaling%2520addiction%26jtitle%3DJ%2520Biomed.%2520Res.%26date%3D2013%26volume%3D27%26spage%3D345%26epage%3D356%26doi%3D10.7555%2FJBR.27.20130038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padhye, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Potential therapeutics specific to c-MET/RON receptor tyrosine kinases for molecular targeting in cancer therapy</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1181</span>– <span class="NLM_lpage">1188</span>, <span class="refDoi"> DOI: 10.1038/aps.2010.106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1038%2Faps.2010.106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=1181-1188&author=M.+H.+Wangauthor=S.+S.+Padhyeauthor=S.+Guinauthor=Q.+Maauthor=Y.+Q.+Zhou&title=Potential+therapeutics+specific+to+c-MET%2FRON+receptor+tyrosine+kinases+for+molecular+targeting+in+cancer+therapy&doi=10.1038%2Faps.2010.106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Faps.2010.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2010.106%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%2BH.%26aulast%3DPadhye%26aufirst%3DS.%2BS.%26aulast%3DGuin%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DY.%2BQ.%26atitle%3DPotential%2520therapeutics%2520specific%2520to%2520c-MET%252FRON%2520receptor%2520tyrosine%2520kinases%2520for%2520molecular%2520targeting%2520in%2520cancer%2520therapy%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2010%26volume%3D31%26spage%3D1181%26epage%3D1188%26doi%3D10.1038%2Faps.2010.106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Webb, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W. G.</span></span> <span> </span><span class="NLM_article-title">Type II transmembrane serine protease (TTSP) deregulation in cancer</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">552</span>, <span class="refDoi"> DOI: 10.2741/3704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.2741%2F3704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=21196187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVyltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=539-552&author=S.+L.+Webbauthor=A.+J.+Sandersauthor=M.+D.+Masonauthor=W.+G.+Jiang&title=Type+II+transmembrane+serine+protease+%28TTSP%29+deregulation+in+cancer&doi=10.2741%2F3704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Type II transmembrane serine protease (TTSP) deregulation in cancer</span></div><div class="casAuthors">Webb, Siobhan L.; Sanders, Andrew J.; Mason, Malcolm D.; Jiang, Wen G.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience, Landmark Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">539-552</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  The Type II transmembrane serine proteases (TTSP) are a relatively newly identified family of proteolytic enzymes that have become the subject of intense scrutiny in the field of cancer research.  Advances in genome screening technol. have enabled the identification of putative members and the further characterization of existing members.  The TTSPs are involved in a diverse range of physiol. functions and new roles continue to be discovered.  A large majority of these proteases appear to play crucial roles in the development of disease, esp. cancer development and progression.  This review presents the current knowledge of the biol. role of those TTSPs that have been identified in the development and progression of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5vmYxuDq1y7Vg90H21EOLACvtfcHk0liubmQ3I9OrAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVyltrk%253D&md5=d8f0bc72ad393fc20c0c149d15681f79</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2741%2F3704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3704%26sid%3Dliteratum%253Aachs%26aulast%3DWebb%26aufirst%3DS.%2BL.%26aulast%3DSanders%26aufirst%3DA.%2BJ.%26aulast%3DMason%26aufirst%3DM.%2BD.%26aulast%3DJiang%26aufirst%3DW.%2BG.%26atitle%3DType%2520II%2520transmembrane%2520serine%2520protease%2520%2528TTSP%2529%2520deregulation%2520in%2520cancer%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2011%26volume%3D16%26spage%3D539%26epage%3D552%26doi%3D10.2741%2F3704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Owusu, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galemmo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klampfer, L.</span></span> <span> </span><span class="NLM_article-title">Hepatocyte Growth factor, a key tumor-promoting factor in the tumor microenvironment</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">35</span>, <span class="refDoi"> DOI: 10.3390/cancers9040035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.3390%2Fcancers9040035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=35&author=B.+Y.+Owusuauthor=R.+Galemmoauthor=J.+Janetkaauthor=L.+Klampfer&title=Hepatocyte+Growth+factor%2C+a+key+tumor-promoting+factor+in+the+tumor+microenvironment&doi=10.3390%2Fcancers9040035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3390%2Fcancers9040035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers9040035%26sid%3Dliteratum%253Aachs%26aulast%3DOwusu%26aufirst%3DB.%2BY.%26aulast%3DGalemmo%26aufirst%3DR.%26aulast%3DJanetka%26aufirst%3DJ.%26aulast%3DKlampfer%26aufirst%3DL.%26atitle%3DHepatocyte%2520Growth%2520factor%252C%2520a%2520key%2520tumor-promoting%2520factor%2520in%2520the%2520tumor%2520microenvironment%26jtitle%3DCancers%26date%3D2017%26volume%3D9%26spage%3D35%26doi%3D10.3390%2Fcancers9040035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, W.</span></span> <span> </span><span class="NLM_article-title">Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">45</span>, <span class="refDoi"> DOI: 10.1186/s12943-018-0796-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1186%2Fs12943-018-0796-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29455668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitF2nt7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=45&author=Y.+Zhangauthor=M.+Xiaauthor=K.+Jinauthor=S.+Wangauthor=H.+Weiauthor=C.+Fanauthor=Y.+Wuauthor=X.+Liauthor=X.+Liauthor=G.+Liauthor=Z.+Zengauthor=W.+Xiong&title=Function+of+the+c-Met+receptor+tyrosine+kinase+in+carcinogenesis+and+associated+therapeutic+opportunities&doi=10.1186%2Fs12943-018-0796-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities</span></div><div class="casAuthors">Zhang, Yazhuo; Xia, Mengfang; Jin, Ke; Wang, Shufei; Wei, Hang; Fan, Chunmei; Wu, Yingfen; Li, Xiaoling; Li, Xiayu; Li, Guiyuan; Zeng, Zhaoyang; Xiong, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45/1-45/14</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">C-Met is a receptor tyrosine kinase belonging to the MET (MNNG HOS transforming gene) family, and is expressed on the surfaces of various cells.  Hepatocyte growth factor (HGF) is the ligand for this receptor.  The binding of HGF to c-Met initiates a series of intracellular signals that mediate embryogenesis and wound healing in normal cells.  However, in cancer cells, aberrant HGF/c-Met axis activation, which is closely related to c-Met gene mutations, overexpression, and amplification, promotes tumor development and progression by stimulating the PI3K/AKT, Ras/MAPK, JAK/STAT, SRC, Wnt/β-catenin, and other signaling pathways.  Thus, c-Met and its assocd. signaling pathways are clin. important therapeutic targets.  In this review, we elaborate on the mol. structure of c-Met and HGF and the mechanism through which their interaction activates the PI3K/AKT, Ras/MAPK, and Wnt signaling pathways.  We also summarize the connection between c-Met and RON and EGFR, which are also receptor tyrosine kinases.  Finally, we introduce the current therapeutic drugs that target c-Met in primary tumors, and their use in clin. research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxr1VpZ-qwwbVg90H21EOLACvtfcHk0lgLBrPpS9RC-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitF2nt7nE&md5=23db43661c4a23160dbed1ee1c26f8db</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1186%2Fs12943-018-0796-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12943-018-0796-y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DXiong%26aufirst%3DW.%26atitle%3DFunction%2520of%2520the%2520c-Met%2520receptor%2520tyrosine%2520kinase%2520in%2520carcinogenesis%2520and%2520associated%2520therapeutic%2520opportunities%26jtitle%3DMol.%2520Cancer%26date%3D2018%26volume%3D17%26spage%3D45%26doi%3D10.1186%2Fs12943-018-0796-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span>; <span class="NLM_string-name">Benson, R.</span></span> <i>Extracellular Targeting of Cell Signaling in Cancer: Strategies Directed at MET and RON Receptor Tyrosine Kinases</i>, <span class="NLM_edition">1st</span> ed.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2018</span>; p pages cm.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1002%2F9781119300229" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+W.+Janetka&author=R.+Benson&title=Extracellular+Targeting+of+Cell+Signaling+in+Cancer%3A+Strategies+Directed+at+MET+and+RON+Receptor+Tyrosine+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2F9781119300229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781119300229%26sid%3Dliteratum%253Aachs%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26btitle%3DExtracellular%2520Targeting%2520of%2520Cell%2520Signaling%2520in%2520Cancer%253A%2520Strategies%2520Directed%2520at%2520MET%2520and%2520RON%2520Receptor%2520Tyrosine%2520Kinases%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamibeppu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukino, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamoto, T.</span></span> <span> </span><span class="NLM_article-title">Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression</span>. <i>Hum. Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1007/s13577-015-0123-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1007%2Fs13577-015-0123-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=26250899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCjs7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=22-29&author=S.+Sugieauthor=S.+Mukaiauthor=K.+Yamasakiauthor=T.+Kamibeppuauthor=H.+Tsukinoauthor=T.+Kamoto&title=Plasma+macrophage-stimulating+protein+and+hepatocyte+growth+factor+levels+are+associated+with+prostate+cancer+progression&doi=10.1007%2Fs13577-015-0123-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression</span></div><div class="casAuthors">Sugie, Satoru; Mukai, Shoichiro; Yamasaki, Koji; Kamibeppu, Toyoharu; Tsukino, Hiromasa; Kamoto, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Human Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-29</span>CODEN:
                <span class="NLM_cas:coden">HUCEE7</span>;
        ISSN:<span class="NLM_cas:issn">1749-0774</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Hepatocyte growth factor (HGF) is a well-known multifunctional growth factor, and evidence has accumulated indicating that the HGF/MET (HGF receptor) signaling axis is involved in the progression of cancer.  Macrophage-stimulating protein (MSP) is also known as a growth factor which activates not only macrophages but also cancer cells and osteoclasts through the activation of the specific Receptor d'origine nantais (RON).  Pro-HGF and pro-MSP lack biol. activity and, therefore, require proteolytic activation for conversion to an active two-chain form by HGF activator (HGFA).  Although, there are several studies on HGF/MET signaling with castration-resistant prostate cancer (CRPC) and bone metastasis, reports on plasma protein are rare.  In addn., the MSP/RON signaling axis in PC is not well understood.  Here, we analyzed assocns. between PC progression and plasma HGF and MSP levels.  We tested plasma samples from 58 patients with PC: 36 with castration-resistant (CR) PC and 22 with pretreatment for PC as control.  We used ELISA (ELISA) kit to det. plasma levels of HGF, MSP and HGFA, and examd. correlations with clinicopathol. characteristics such as Gleason grade and bone metastasis.  PCR was used to evaluate HGF and MSP-related mols. in PC cell lines.  Plasma levels of HGF, MSP and HGFA in the CRPC group were higher than in the control group (HGF: P < 0.001; MSP: P = 0.008; HGFA: P < 0.001).  HGF and MSP levels were significantly correlated (P = 0.003).  In the CRPC group, plasma HGF and MSP levels and Gleason score were not correlated; however, high plasma MSP level correlated with bone metastasis.  (P = 0.016). In cell lines, PC3 expressed significantly more HGF, MET and RON than did LNCaP (P < 0.001), and both cell lines expressed MSP.  Plasma concns. of HGF, MSP and HGFA are significantly elevated in patients with CRPC.  Also, as plasma MSP levels are significantly assocd. with bone metastasis in CRPC patients, MSP may be a candidate for serum marker of bone metastasis.  Our results show the importance of the HGF/MET and MSP/RON signaling systems in CRPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogVts6n7zstrVg90H21EOLACvtfcHk0lgLBrPpS9RC-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCjs7jE&md5=27f51149484567eb0a3b70c8d5209667</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs13577-015-0123-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13577-015-0123-5%26sid%3Dliteratum%253Aachs%26aulast%3DSugie%26aufirst%3DS.%26aulast%3DMukai%26aufirst%3DS.%26aulast%3DYamasaki%26aufirst%3DK.%26aulast%3DKamibeppu%26aufirst%3DT.%26aulast%3DTsukino%26aufirst%3DH.%26aulast%3DKamoto%26aufirst%3DT.%26atitle%3DPlasma%2520macrophage-stimulating%2520protein%2520and%2520hepatocyte%2520growth%2520factor%2520levels%2520are%2520associated%2520with%2520prostate%2520cancer%2520progression%26jtitle%3DHum.%2520Cell%26date%3D2016%26volume%3D29%26spage%3D22%26epage%3D29%26doi%3D10.1007%2Fs13577-015-0123-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Q. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S. T.</span></span> <span> </span><span class="NLM_article-title">c-Met and RON expression levels in endometrial adenocarcinoma tissue and their relationship with prognosis</span>. <i>Eur. J. Gynaecol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=26189249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FkslajsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=255-259&author=X.+P.+Zhuangauthor=W.+W.+Jinauthor=X.+D.+Tengauthor=Z.+Z.+Yuanauthor=Q.+Q.+Linauthor=S.+T.+Xu&title=c-Met+and+RON+expression+levels+in+endometrial+adenocarcinoma+tissue+and+their+relationship+with+prognosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">c-Met and RON expression levels in endometrial adenocarcinoma tissue and their relationship with prognosis</span></div><div class="casAuthors">Zhuang X P; Jin W W; Teng X D; Yuan Z Z; Lin Q Q; Xu S T</div><div class="citationInfo"><span class="NLM_cas:title">European journal of gynaecological oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-9</span>
        ISSN:<span class="NLM_cas:issn">0392-2936</span>.
    </div><div class="casAbstract">OBJECTIVE:  To investigate the potential relevance of c-Met and RON gene expression in patients with adenocarcinoma of the endometrium and analyze the relationships among the c-Met and RON expression, clinicopathological characteristics, and patient survival.  MATERIALS AND METHODS:  The study included 60 cases diagnosed with endometrial adenocarcinoma with more than five-years follow-up.  Total RNA from formalin-fixed paraffin-embedded tissues of 60 adenocarcinomas of the endometrium and normal endometrium tissues were isolated for c-Met and RON quantitative analysis by real-time real-time polymerase chain reaction (RT-PCR).  RESULTS:  The c-Met and RON expression in endometrial adenocarcinoma was significantly higher than that in normal endometrial tissues (p < 0.01), with average up-regulated levels of 3.94 ± 1.88 and 2.74 ± 0.88, respectively.  Moreover, high c-Met expression was significantly correlated with the histological stage (p = 0.017), and high RON expression was related to histological stage (p = 0.035), muscle invasion (p = 0.006), and lymph node metastasis (p = 0.018).  Multivariate Cox regression analysis revealed that the co-expression of c-Met and RON was an independent prognostic factor for adenocarcinoma of the endometrium and was significantly associated with decreased overall survival (HR = 3.571, p = 0.014).  CONCLUSION:  The co-expression of c-Met and RON is associated with a poor prognosis in endometrial adenocarcinoma and is an independent prognostic marker for endometrioid adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTH_GNAkXtkKyA3UY9EwTNrfW6udTcc2ebS3fDnGP8gTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FkslajsA%253D%253D&md5=68430e788aa8f1ca8eaa088c56cd153f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DX.%2BP.%26aulast%3DJin%26aufirst%3DW.%2BW.%26aulast%3DTeng%26aufirst%3DX.%2BD.%26aulast%3DYuan%26aufirst%3DZ.%2BZ.%26aulast%3DLin%26aufirst%3DQ.%2BQ.%26aulast%3DXu%26aufirst%3DS.%2BT.%26atitle%3Dc-Met%2520and%2520RON%2520expression%2520levels%2520in%2520endometrial%2520adenocarcinoma%2520tissue%2520and%2520their%2520relationship%2520with%2520prognosis%26jtitle%3DEur.%2520J.%2520Gynaecol.%2520Oncol.%26date%3D2015%26volume%3D36%26spage%3D255%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karnad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, J. W.</span></span> <span> </span><span class="NLM_article-title">Roles of c-Met and RON kinases in tumor progression and their potential as therapeutic targets</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">3507</span>– <span class="NLM_lpage">3518</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.3420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.18632%2Foncotarget.3420" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=3507-3518&author=K.+Changauthor=A.+Karnadauthor=S.+Zhaoauthor=J.+W.+Freeman&title=Roles+of+c-Met+and+RON+kinases+in+tumor+progression+and+their+potential+as+therapeutic+targets&doi=10.18632%2Foncotarget.3420"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.3420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.3420%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DK.%26aulast%3DKarnad%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DFreeman%26aufirst%3DJ.%2BW.%26atitle%3DRoles%2520of%2520c-Met%2520and%2520RON%2520kinases%2520in%2520tumor%2520progression%2520and%2520their%2520potential%2520as%2520therapeutic%2520targets%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D3507%26epage%3D3518%26doi%3D10.18632%2Foncotarget.3420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maggiora, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fracchioli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagnaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arisio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsaros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massobrio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comoglio, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Renzo, M. F.</span></span> <span> </span><span class="NLM_article-title">The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1016/S0014-4827(03)00250-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2FS0014-4827%2803%2900250-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=12915129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1ehu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2003&pages=382-389&author=P.+Maggioraauthor=A.+Lorenzatoauthor=S.+Fracchioliauthor=B.+Costaauthor=M.+Castagnaroauthor=R.+Arisioauthor=D.+Katsarosauthor=M.+Massobrioauthor=P.+M.+Comoglioauthor=M.+F.+Di+Renzo&title=The+RON+and+MET+oncogenes+are+co-expressed+in+human+ovarian+carcinomas+and+cooperate+in+activating+invasiveness&doi=10.1016%2FS0014-4827%2803%2900250-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness</span></div><div class="casAuthors">Maggiora, Piera; Lorenzato, Annalisa; Fracchioli, Stefano; Costa, Barbara; Castagnaro, Massimo; Arisio, Riccardo; Katsaros, Dionyssios; Massobrio, Marco; Comoglio, Paolo M.; Flavia Di Renzo, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">382-389</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">RON is a member of the receptor tyrosine kinase gene family that includes the MET oncogene, whose germline mutations have been causally related to human tumorigenesis.  In vitro, RON and MET receptors cross-talk, synergize in intracellular signaling, and cooperate in inducing morphogenic responses.  Here the authors show that the RON and MET oncogenes were expressed in 55% and 56% of human ovarian carcinomas, resp., and were significantly coexpressed in 42% (P < 0.001).  In ovarian carcinoma samples and cell lines the authors did not find mutations in RON and MET gene kinase domain, nor coexpression of RON and MET receptor ligands (MSP and HGF, resp.).  We show that motility and invasiveness of ovarian cancer cells coexpressing MET and RON receptors were elicited by HGF and, to a lesser extent, by MSP.  More interestingly, invasion of both reconstituted basement membrane and collagen gel was greatly enhanced by the simultaneous addn. of the 2 ligands.  These data suggest that coexpression of the MET and RON receptors confer a selective advantage to ovarian cancer cells and might promote ovarian cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCY6UIVChzy7Vg90H21EOLACvtfcHk0livx5HDxl0IdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1ehu7w%253D&md5=b1905acc66d6f2dbaabd79870a33172b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0014-4827%2803%2900250-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-4827%252803%252900250-7%26sid%3Dliteratum%253Aachs%26aulast%3DMaggiora%26aufirst%3DP.%26aulast%3DLorenzato%26aufirst%3DA.%26aulast%3DFracchioli%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DB.%26aulast%3DCastagnaro%26aufirst%3DM.%26aulast%3DArisio%26aufirst%3DR.%26aulast%3DKatsaros%26aufirst%3DD.%26aulast%3DMassobrio%26aufirst%3DM.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3DDi%2BRenzo%26aufirst%3DM.%2BF.%26atitle%3DThe%2520RON%2520and%2520MET%2520oncogenes%2520are%2520co-expressed%2520in%2520human%2520ovarian%2520carcinomas%2520and%2520cooperate%2520in%2520activating%2520invasiveness%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2003%26volume%3D288%26spage%3D382%26epage%3D389%26doi%3D10.1016%2FS0014-4827%2803%2900250-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Z.</span></span> <span> </span><span class="NLM_article-title">RON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">3209</span>– <span class="NLM_lpage">3218</span>, <span class="refDoi"> DOI: 10.3892/or.2017.5585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.3892%2For.2017.5585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=28440432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOiu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=3209-3218&author=B.+Yinauthor=Z.+Liuauthor=Y.+Wangauthor=X.+Wangauthor=W.+Liuauthor=P.+Yuauthor=X.+Duanauthor=C.+Liuauthor=Y.+Chenauthor=Y.+Zhangauthor=X.+Panauthor=H.+Yaoauthor=Z.+Liaoauthor=Z.+Tao&title=RON+and+c-Met+facilitate+metastasis+through+the+ERK+signaling+pathway+in+prostate+cancer+cells&doi=10.3892%2For.2017.5585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">RON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells</span></div><div class="casAuthors">Yin, Binbin; Liu, Zhenping; Wang, Yiyun; Wang, Xuchu; Liu, Weiwei; Yu, Pan; Duan, Xiuzhi; Liu, Chunhua; Chen, Yuhua; Zhang, Yurong; Pan, Xiaoyan; Yao, Hangping; Liao, Zhaoping; Tao, Zhihua</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3209-3218</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1791-2431</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Prostate cancer (PCa) is a metastatic malignant cancer driven by complex pathol. mechanisms and characterized by poor long-term prognosis.  Metastasis is the main cause of death of PCa patients, yet the mol. mechanisms of this process are poorly understood.  In the present study, pos. co-expression of RON and c-Met was obsd. in human clin. PCa tissues (biopsy material), as detected by immunohistochem. staining and quant. real-time PCR.  We investigated this further in PCa cells, demonstrating that the inhibition of RON and c-Met with foretinib (GSK1363089) suppressed metastasis and promoted the reversal of the epithelial-to-mesenchymal transition (EMT) in PCa cells.  Furthermore, the invasion and migration of PCa cells were enhanced by the exogenous activation of RON with MSP and c-Met with HGF, whereas silencing of RON and c-Met attenuated the invasion and metastasis of the PCa cells.  Our data also demonstrated that HGF/c-Met, but not the MSP-RON signaling pathway may be the dominant mechanism for PCa EMT.  We further revealed that RON and c-Met facilitate metastasis via ERK1/2 signaling.  These findings indicate that RON and c-Met facilitate metastasis through ERK1/2 signaling and that targeting RON and c-Met with foretinib may be an attractive therapeutic option for suppressing PCa metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdySGcGmt017Vg90H21EOLACvtfcHk0livx5HDxl0IdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOiu7jI&md5=cda4b24641558f38f259f5f9a8bfc589</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3892%2For.2017.5585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2017.5585%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DDuan%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DLiao%26aufirst%3DZ.%26aulast%3DTao%26aufirst%3DZ.%26atitle%3DRON%2520and%2520c-Met%2520facilitate%2520metastasis%2520through%2520the%2520ERK%2520signaling%2520pathway%2520in%2520prostate%2520cancer%2520cells%26jtitle%3DOncol.%2520Rep.%26date%3D2017%26volume%3D37%26spage%3D3209%26epage%3D3218%26doi%3D10.3892%2For.2017.5585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1864</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2017.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.bbadis.2017.12.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29253515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVegtrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1864&publication_year=2018&pages=793-803&author=Y.+Yiauthor=S.+Zengauthor=Z.+Wangauthor=M.+Wuauthor=Y.+Maauthor=X.+Yeauthor=B.+Zhangauthor=H.+Liu&title=Cancer-associated+fibroblasts+promote+epithelial-mesenchymal+transition+and+EGFR-TKI+resistance+of+non-small+cell+lung+cancers+via+HGF%2FIGF-1%2FANXA2+signaling&doi=10.1016%2Fj.bbadis.2017.12.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling</span></div><div class="casAuthors">Yi, Yanmei; Zeng, Shanshan; Wang, Zhaotong; Wu, Minhua; Ma, Yuanhuan; Ye, Xiaoxia; Zhang, Biao; Liu, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1864</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">793-803</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The involvement of the tumor stromal cells in acquired resistance of non-small cell lung cancers (NSCLCs) to tyrosine kinase inhibitors (TKIs) has previously been reported, but the precise mechanism remains unclear.  In the present study, we investigated the role and mechanism underlying Cancer-assocd. fibroblasts (CAFs) in TKI resistance of NSCLCs.  In vitro and in vivo expts. showed that HCC827 and PC9 cells, non-small cell lung cancer cells with EGFR-activating mutations, became resistant to the EGFR-TKI gefitinib when cultured with CAFs isolated from NSCLC tissues.  Moreover, we showed that CAFs could induce epithelial-mesenchymal transition (EMT) phenotype of HCC827 and PC9 cells, with an assocd. change in the expression of epithelial to mesenchymal transition markers.  Using proteomics-based method, we identified that CAFs significantly increased the expression of the Annexin A2 (ANXA2).  More importantly, knockdown of ANXA2 completely reversed EMT phenotype and gefitinib resistance induced by CAFs.  Furthermore, we found that CAFs increased the expression and phosphorylation of ANXA2 by secretion of growth factors HGF and IGF-1 and by activation of the corresponding receptors c-met and IGF-1R.  Dual inhibition of HGF/c-met and IGF-1/IGF-1R pathways could significantly suppress ANXA2, and markedly reduced CAFs-induced EMT and gefitinib resistance.  Taken together, these findings indicate that CAFs promote EGFR-TKIs resistance through HGF/IGF-1/ANXA2/EMT signaling and may be an ideal therapeutic target in NSCLCs with EGFR-activating mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcSKkW5LtfQ7Vg90H21EOLACvtfcHk0ljnBko-E0xFnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVegtrzI&md5=5ce2254fbb4f8a8a7f91bda6b81190cc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2017.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2017.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DYi%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DCancer-associated%2520fibroblasts%2520promote%2520epithelial-mesenchymal%2520transition%2520and%2520EGFR-TKI%2520resistance%2520of%2520non-small%2520cell%2520lung%2520cancers%2520via%2520HGF%252FIGF-1%252FANXA2%2520signaling%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2018%26volume%3D1864%26spage%3D793%26epage%3D803%26doi%3D10.1016%2Fj.bbadis.2017.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sa, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joo, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, D. H.</span></span> <span> </span><span class="NLM_article-title">Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma</span>. <i>Neuro. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_fpage">noy105</span>, <span class="refDoi"> DOI: 10.1093/neuonc/noy105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1093%2Fneuonc%2Fnoy105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=noy105&author=J.+K.+Saauthor=S.+H.+Kimauthor=J.+K.+Leeauthor=H.+J.+Choauthor=Y.+J.+Shinauthor=H.+Shinauthor=H.+Kooauthor=D.+Kimauthor=M.+Leeauthor=W.+Kangauthor=S.+H.+Hongauthor=J.+Y.+Kimauthor=Y.+W.+Parkauthor=S.+W.+Songauthor=S.+J.+Leeauthor=K.+M.+Jooauthor=D.+H.+Nam&title=Identification+of+genomic+and+molecular+traits+that+present+therapeutic+vulnerability+to+HGF-targeted+therapy+in+glioblastoma&doi=10.1093%2Fneuonc%2Fnoy105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnoy105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnoy105%26sid%3Dliteratum%253Aachs%26aulast%3DSa%26aufirst%3DJ.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BK.%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DShin%26aufirst%3DY.%2BJ.%26aulast%3DShin%26aufirst%3DH.%26aulast%3DKoo%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DKang%26aufirst%3DW.%26aulast%3DHong%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DPark%26aufirst%3DY.%2BW.%26aulast%3DSong%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DJoo%26aufirst%3DK.%2BM.%26aulast%3DNam%26aufirst%3DD.%2BH.%26atitle%3DIdentification%2520of%2520genomic%2520and%2520molecular%2520traits%2520that%2520present%2520therapeutic%2520vulnerability%2520to%2520HGF-targeted%2520therapy%2520in%2520glioblastoma%26jtitle%3DNeuro.%2520Oncol.%26date%3D2018%26spage%3Dnoy105%26doi%3D10.1093%2Fneuonc%2Fnoy105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oba, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedo, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carapeto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKean, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Arnam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eterovic, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kale, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haymaker, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routbort, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydu, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernatchez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazar, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimm, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodman, S. E.</span></span> <span> </span><span class="NLM_article-title">Targeting the HGF/MET axis counters primary resistance to KIT inhibition in KIT-mutant melanoma</span>. <i>JCO Precis. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_fpage">55</span>, <span class="refDoi"> DOI: 10.1200/PO.18.00055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1200%2FPO.18.00055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=55&author=J.+Obaauthor=S.+H.+Kimauthor=W.+L.+Wangauthor=M.+P.+Macedoauthor=F.+Carapetoauthor=M.+A.+McKeanauthor=J.+Van+Arnamauthor=A.+K.+Eterovicauthor=S.+Senauthor=C.+R.+Kaleauthor=X.+Yuauthor=C.+L.+Haymakerauthor=M.+Routbortauthor=L.+E.+Hayduauthor=C.+Bernatchezauthor=A.+J.+Lazarauthor=E.+A.+Grimmauthor=D.+S.+Hongauthor=S.+E.+Woodman&title=Targeting+the+HGF%2FMET+axis+counters+primary+resistance+to+KIT+inhibition+in+KIT-mutant+melanoma&doi=10.1200%2FPO.18.00055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1200%2FPO.18.00055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FPO.18.00055%26sid%3Dliteratum%253Aachs%26aulast%3DOba%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DWang%26aufirst%3DW.%2BL.%26aulast%3DMacedo%26aufirst%3DM.%2BP.%26aulast%3DCarapeto%26aufirst%3DF.%26aulast%3DMcKean%26aufirst%3DM.%2BA.%26aulast%3DVan%2BArnam%26aufirst%3DJ.%26aulast%3DEterovic%26aufirst%3DA.%2BK.%26aulast%3DSen%26aufirst%3DS.%26aulast%3DKale%26aufirst%3DC.%2BR.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DHaymaker%26aufirst%3DC.%2BL.%26aulast%3DRoutbort%26aufirst%3DM.%26aulast%3DHaydu%26aufirst%3DL.%2BE.%26aulast%3DBernatchez%26aufirst%3DC.%26aulast%3DLazar%26aufirst%3DA.%2BJ.%26aulast%3DGrimm%26aufirst%3DE.%2BA.%26aulast%3DHong%26aufirst%3DD.%2BS.%26aulast%3DWoodman%26aufirst%3DS.%2BE.%26atitle%3DTargeting%2520the%2520HGF%252FMET%2520axis%2520counters%2520primary%2520resistance%2520to%2520KIT%2520inhibition%2520in%2520KIT-mutant%2520melanoma%26jtitle%3DJCO%2520Precis.%2520Oncol.%26date%3D2018%26spage%3D55%26doi%3D10.1200%2FPO.18.00055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knauf, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luckett, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voza, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Socci, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghossein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagin, J. A.</span></span> <span> </span><span class="NLM_article-title">Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">4086</span>– <span class="NLM_lpage">4097</span>, <span class="refDoi"> DOI: 10.1172/JCI120966</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1172%2FJCI120966" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2018&pages=4086-4097&author=J.+A.+Knaufauthor=K.+A.+Luckettauthor=K.+Y.+Chenauthor=F.+Vozaauthor=N.+D.+Socciauthor=R.+Ghosseinauthor=J.+A.+Fagin&title=Hgf%2FMet+activation+mediates+resistance+to+BRAF+inhibition+in+murine+anaplastic+thyroid+cancers&doi=10.1172%2FJCI120966"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1172%2FJCI120966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI120966%26sid%3Dliteratum%253Aachs%26aulast%3DKnauf%26aufirst%3DJ.%2BA.%26aulast%3DLuckett%26aufirst%3DK.%2BA.%26aulast%3DChen%26aufirst%3DK.%2BY.%26aulast%3DVoza%26aufirst%3DF.%26aulast%3DSocci%26aufirst%3DN.%2BD.%26aulast%3DGhossein%26aufirst%3DR.%26aulast%3DFagin%26aufirst%3DJ.%2BA.%26atitle%3DHgf%252FMet%2520activation%2520mediates%2520resistance%2520to%2520BRAF%2520inhibition%2520in%2520murine%2520anaplastic%2520thyroid%2520cancers%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2018%26volume%3D128%26spage%3D4086%26epage%3D4097%26doi%3D10.1172%2FJCI120966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1864</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2017.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.bbadis.2017.12.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29253515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVegtrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1864&publication_year=2018&pages=793-803&author=Y.+Yiauthor=S.+Zengauthor=Z.+Wangauthor=M.+Wuauthor=Y.+Maauthor=X.+Yeauthor=B.+Zhangauthor=H.+Liu&title=Cancer-associated+fibroblasts+promote+epithelial-mesenchymal+transition+and+EGFR-TKI+resistance+of+non-small+cell+lung+cancers+via+HGF%2FIGF-1%2FANXA2+signaling&doi=10.1016%2Fj.bbadis.2017.12.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling</span></div><div class="casAuthors">Yi, Yanmei; Zeng, Shanshan; Wang, Zhaotong; Wu, Minhua; Ma, Yuanhuan; Ye, Xiaoxia; Zhang, Biao; Liu, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1864</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">793-803</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The involvement of the tumor stromal cells in acquired resistance of non-small cell lung cancers (NSCLCs) to tyrosine kinase inhibitors (TKIs) has previously been reported, but the precise mechanism remains unclear.  In the present study, we investigated the role and mechanism underlying Cancer-assocd. fibroblasts (CAFs) in TKI resistance of NSCLCs.  In vitro and in vivo expts. showed that HCC827 and PC9 cells, non-small cell lung cancer cells with EGFR-activating mutations, became resistant to the EGFR-TKI gefitinib when cultured with CAFs isolated from NSCLC tissues.  Moreover, we showed that CAFs could induce epithelial-mesenchymal transition (EMT) phenotype of HCC827 and PC9 cells, with an assocd. change in the expression of epithelial to mesenchymal transition markers.  Using proteomics-based method, we identified that CAFs significantly increased the expression of the Annexin A2 (ANXA2).  More importantly, knockdown of ANXA2 completely reversed EMT phenotype and gefitinib resistance induced by CAFs.  Furthermore, we found that CAFs increased the expression and phosphorylation of ANXA2 by secretion of growth factors HGF and IGF-1 and by activation of the corresponding receptors c-met and IGF-1R.  Dual inhibition of HGF/c-met and IGF-1/IGF-1R pathways could significantly suppress ANXA2, and markedly reduced CAFs-induced EMT and gefitinib resistance.  Taken together, these findings indicate that CAFs promote EGFR-TKIs resistance through HGF/IGF-1/ANXA2/EMT signaling and may be an ideal therapeutic target in NSCLCs with EGFR-activating mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcSKkW5LtfQ7Vg90H21EOLACvtfcHk0ljnBko-E0xFnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVegtrzI&md5=5ce2254fbb4f8a8a7f91bda6b81190cc</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2017.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2017.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DYi%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DCancer-associated%2520fibroblasts%2520promote%2520epithelial-mesenchymal%2520transition%2520and%2520EGFR-TKI%2520resistance%2520of%2520non-small%2520cell%2520lung%2520cancers%2520via%2520HGF%252FIGF-1%252FANXA2%2520signaling%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2018%26volume%3D1864%26spage%3D793%26epage%3D803%26doi%3D10.1016%2Fj.bbadis.2017.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locatelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stammberger, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scagliotti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.</span></span> <span> </span><span class="NLM_article-title">Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer?</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2017.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.ctrv.2017.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29121501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGht7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=70-81&author=Y.+L.+Wuauthor=R.+A.+Sooauthor=G.+Locatelliauthor=U.+Stammbergerauthor=G.+Scagliottiauthor=K.+Park&title=Does+c-Met+remain+a+rational+target+for+therapy+in+patients+with+EGFR+TKI-resistant+non-small+cell+lung+cancer%3F&doi=10.1016%2Fj.ctrv.2017.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer?</span></div><div class="casAuthors">Wu, Yi-Long; Soo, Ross Andrew; Locatelli, Giuseppe; Stammberger, Uz; Scagliotti, Giorgio; Park, Keunchil</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">70-81</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Non-small cell lung cancer (NSCLC) inevitably develops resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) treatment.  In 5-20% of cases, this can be attributed to aberrant c-Met activity, providing a clear rationale for the use of c-Met inhibitors in these patients.  EGFR TKI-resistant tumors often remain sensitive to EGFR signaling, such that c-Met inhibitors are likely to be most effective when combined with continued EGFR TKI therapy.  The phase III trials of the c-Met inhibitors onartuzumab and tivantinib, which failed to demonstrate significant benefit in patients with NSCLC but excluded patients with EGFR TKI-resistant disease, do not allow c-Met to be dismissed as a rational target in EGFR TKI-resistant NSCLC.  Selective c-Met TKIs exhibit more favorable properties, targeting both hepatocyte growth factor (HGF)-dependent and -independent c-Met activity, with a reduced risk of toxicity compared to non-selective c-Met TKIs.  Phase Ib/II trials of the selective c-Met TKIs capmatinib and tepotinib have shown encouraging signs of efficacy.  Factors affecting the success of ongoing and future trials of c-Met inhibitors in patients with EGFR TKI-resistant, c-Met-pos. NSCLC are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpAvtCcmYXzLVg90H21EOLACvtfcHk0lih-JA23-nesA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGht7rJ&md5=88a27ba738f83f5933cf1de113406414</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2017.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2017.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%2BL.%26aulast%3DSoo%26aufirst%3DR.%2BA.%26aulast%3DLocatelli%26aufirst%3DG.%26aulast%3DStammberger%26aufirst%3DU.%26aulast%3DScagliotti%26aufirst%3DG.%26aulast%3DPark%26aufirst%3DK.%26atitle%3DDoes%2520c-Met%2520remain%2520a%2520rational%2520target%2520for%2520therapy%2520in%2520patients%2520with%2520EGFR%2520TKI-resistant%2520non-small%2520cell%2520lung%2520cancer%253F%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2017%26volume%3D61%26spage%3D70%26epage%3D81%26doi%3D10.1016%2Fj.ctrv.2017.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Owusu, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venukadasula, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galemmo, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klampfer, L.</span></span> <span> </span><span class="NLM_article-title">Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">63014</span>– <span class="NLM_lpage">63025</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.18260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.18632%2Foncotarget.18260" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=63014-63025&author=B.+Y.+Owusuauthor=S.+Thomasauthor=P.+Venukadasulaauthor=Z.+Hanauthor=J.+W.+Janetkaauthor=R.+A.+Galemmoauthor=L.+Klampfer&title=Targeting+the+tumor-promoting+microenvironment+in+MET-amplified+NSCLC+cells+with+a+novel+inhibitor+of+pro-HGF+activation&doi=10.18632%2Foncotarget.18260"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.18260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.18260%26sid%3Dliteratum%253Aachs%26aulast%3DOwusu%26aufirst%3DB.%2BY.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DVenukadasula%26aufirst%3DP.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26aulast%3DKlampfer%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520tumor-promoting%2520microenvironment%2520in%2520MET-amplified%2520NSCLC%2520cells%2520with%2520a%2520novel%2520inhibitor%2520of%2520pro-HGF%2520activation%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D63014%26epage%3D63025%26doi%3D10.18632%2Foncotarget.18260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ko, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadgeel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, B.</span></span> <span> </span><span class="NLM_article-title">MET/HGF pathway activation as a paradigm of resistance to targeted therapies</span>. <i>Ann. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">4</span>, <span class="refDoi"> DOI: 10.21037/atm.2016.12.09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.21037%2Fatm.2016.12.09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=28164089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVGqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=4&author=B.+Koauthor=T.+Heauthor=S.+Gadgeelauthor=B.+Halmos&title=MET%2FHGF+pathway+activation+as+a+paradigm+of+resistance+to+targeted+therapies&doi=10.21037%2Fatm.2016.12.09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">MET/HGF pathway activation as a paradigm of resistance to targeted therapies</span></div><div class="casAuthors">Ko, Brian; He, Tianfang; Gadgeel, Shirish; Halmos, Balazs</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Translational Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4/1-4/16</span>CODEN:
                <span class="NLM_cas:coden">ATMNDX</span>;
        ISSN:<span class="NLM_cas:issn">2305-5847</span>.
    
            (<span class="NLM_cas:orgname">AME Publishing Co.</span>)
        </div><div class="casAbstract">Resistance to targeted therapeutics is a key issue limiting the long-term utility of these medications in the management of molecularly selected subsets of cancer patients, including patients with non-small cell lung cancer harboring oncogenic alterations affecting EGFR, ALK and other genes.  Bypass resistance mediated by activation of MET kinase has emerged as a frequent, validated and pivotal resistance mechanism in multiple types of cancers.  Biochem. understanding is accumulating to explain the unique role of MET in such bypass pathways, providing alternate downstream activation opportunities and intricate interactions during epithelial-mesenchymal transitions.  Multiple diagnostic testing platforms have become available for selecting appropriate patients for MET targeting in a variety of settings.  Importantly, in light of the failures of several earlier clin. studies of MET targeting agents, a large array of recent and current MET-focused trials are incorporating stricter patient selection and more robust predictive biomarkers providing hope for validation of MET targeting as a clin. impactful strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZmcMfkcO3dbVg90H21EOLACvtfcHk0lih-JA23-nesA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVGqsrc%253D&md5=481e6d34488004735582f9ebdf308f27</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.21037%2Fatm.2016.12.09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.21037%252Fatm.2016.12.09%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DGadgeel%26aufirst%3DS.%26aulast%3DHalmos%26aufirst%3DB.%26atitle%3DMET%252FHGF%2520pathway%2520activation%2520as%2520a%2520paradigm%2520of%2520resistance%2520to%2520targeted%2520therapies%26jtitle%3DAnn.%2520Transl.%2520Med.%26date%3D2017%26volume%3D5%26spage%3D4%26doi%3D10.21037%2Fatm.2016.12.09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friese-Hamim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bladt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locatelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stammberger, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaukat, A.</span></span> <span> </span><span class="NLM_article-title">The selective c-Met inhibitor tepotinib can overcome epidermal growth factor receptor inhibitor resistance mediated by aberrant c-Met activation in NSCLC models</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">972</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=28469968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFOntLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=962-972&author=M.+Friese-Hamimauthor=F.+Bladtauthor=G.+Locatelliauthor=U.+Stammbergerauthor=A.+Blaukat&title=The+selective+c-Met+inhibitor+tepotinib+can+overcome+epidermal+growth+factor+receptor+inhibitor+resistance+mediated+by+aberrant+c-Met+activation+in+NSCLC+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The selective c-Met inhibitor tepotinib can overcome epidermal growth factor receptor inhibitor resistance mediated by aberrant c-Met activation in NSCLC models</span></div><div class="casAuthors">Friese-Hamim, Manja; Bladt, Friedhelm; Locatelli, Giuseppe; Stammberger, Uz; Blaukat, Andree</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">962-972</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Non-small cell lung cancer (NSCLC) sensitive to first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) often acquires resistance through secondary EGFR mutations, including the T790M mutation, aberrant c-Met receptor activity, or both.  We assessed the ability of the highly selective c-Met inhibitor tepotinib to overcome EGFR TKI resistance in various xenograft models of NSCLC.  In models with EGFR-activating mutations and low c-Met expression (patient explant-derived LU342, cell line PC-9), EGFR TKIs caused tumors to shrink, but growth resumed upon cessation of treatment.  Tepotinib combined with EGFR TKIs delayed tumor regrowth, while tepotinib alone was ineffective.  In patient explant-derived LU858, which has an EGFR-activating mutation and expresses high levels of c-Met/HGF, EGFR TKIs had no effect on tumor growth.  Tepotinib combined with EGFR TKIs caused complete tumor regression and tepotinib alone caused tumor stasis.  In cell line DFCI081 (activating EGFR mutation, c-Met amplification), EGFR TKIs were ineffective, whereas tepotinib alone induced com- plete tumor regression.  Finally, in a 'double resistant' EGFR T790M-pos., high c-Met model (cell line HCC827-GR- T790M), the EGFR TKIs erlotinib, afatinib, and rociletinib, as well as tepotinib as a single agent or in combination with erlotinib or afatinib, slowed tumor growth, but only tepotinib in combination with rociletinib induced complete tumor regression.  We conclude that tepotinib can overcome acquired resistance to EGFR TKIs.  Based on these data, clin. trials of tepotinib in combination with EGFR TKIs in patients with NSCLC with acquired resistance to first-generation EGFR TKIs are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzmtl8W9HgD7Vg90H21EOLACvtfcHk0lhB4r4aIiZfbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFOntLbI&md5=332fbd51f81c57cfefb0aa301d1ebd73</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriese-Hamim%26aufirst%3DM.%26aulast%3DBladt%26aufirst%3DF.%26aulast%3DLocatelli%26aufirst%3DG.%26aulast%3DStammberger%26aufirst%3DU.%26aulast%3DBlaukat%26aufirst%3DA.%26atitle%3DThe%2520selective%2520c-Met%2520inhibitor%2520tepotinib%2520can%2520overcome%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitor%2520resistance%2520mediated%2520by%2520aberrant%2520c-Met%2520activation%2520in%2520NSCLC%2520models%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2017%26volume%3D7%26spage%3D962%26epage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cascone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howells, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddad, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanrahan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortez, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giri, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saigal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jüergensmeier, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbst, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wistuba, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heymach, J. V.</span></span> <span> </span><span class="NLM_article-title">The HGF/c-MET pathway is a driver and biomarker of VEGFR-inhibitor resistance and vascular remodeling in non-small cell lung cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5489</span>– <span class="NLM_lpage">5501</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-3216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1158%2F1078-0432.CCR-16-3216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=28559461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsV2mu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=5489-5501&author=T.+Casconeauthor=L.+Xuauthor=H.+Y.+Linauthor=W.+Liuauthor=H.+T.+Tranauthor=Y.+Liuauthor=K.+Howellsauthor=V.+Haddadauthor=E.+Hanrahanauthor=M.+B.+Nilssonauthor=M.+A.+Cortezauthor=U.+Giriauthor=H.+Kadaraauthor=B.+Saigalauthor=Y.+Y.+Parkauthor=W.+Pengauthor=J.+S.+Leeauthor=A.+J.+Ryanauthor=J.+M.+J%C3%BCergensmeierauthor=R.+S.+Herbstauthor=J.+Wangauthor=R.+R.+Langleyauthor=I.+I.+Wistubaauthor=J.+J.+Leeauthor=J.+V.+Heymach&title=The+HGF%2Fc-MET+pathway+is+a+driver+and+biomarker+of+VEGFR-inhibitor+resistance+and+vascular+remodeling+in+non-small+cell+lung+cancer&doi=10.1158%2F1078-0432.CCR-16-3216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non-Small Cell Lung Cancer</span></div><div class="casAuthors">Cascone, Tina; Xu, Li; Lin, Heather Y.; Liu, Wenbin; Tran, Hai T.; Liu, Yuan; Howells, Kathryn; Haddad, Vincent; Hanrahan, Emer; Nilsson, Monique B.; Cortez, Maria A.; Giri, Uma; Kadara, Humam; Saigal, Babita; Park, Yun-Yong; Peng, Weiyi; Lee, Ju-Seog; Ryan, Anderson J.; Juergensmeier, Juliane M.; Herbst, Roy S.; Wang, Jing; Langley, Robert R.; Wistuba, Ignacio I.; Lee, Jack J.; Heymach, John V.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5489-5501</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Resistance to VEGFR inhibitors is a major obstacle in the treatment of non-small cell lung cancer (NSCLC).  We investigated the cellular mechanisms mediating resistance of NSCLCs to VEGFR tyrosine kinase inhibitors.  Exptl. Design: We generated murine models of human NSCLC and performed targeted inhibition studies with the VEGFR TKIs cediranib and vandetanib.  We used species-specific hybridization of microarrays to compare cancer (human) and stromal (mouse) cell transcriptomes of TKI-sensitive and -resistant tumors.  We measured tumor microvascular d. and vessel tortuosity to characterize the effects of therapy on the tumor vascular bed.  Circulating cytokine and angiogenic factor levels in patients enrolled in VEGFR TKI trials were correlated with clin. outcomes.  Results: Murine xenograft models of human lung adenocarcinoma were initially sensitive to VEGFR TKIs, but developed resistance to treatment.  Species-specific microarray anal. identified increased expression of stromal-derived hepatocyte growth factor (HGF) as a candidate mediator of TKI resistance and its receptor, c-MET, was activated in cancer cells and tumor-assocd. stroma.  A transient increase in hypoxia-regulated mols. in the initial response phase was followed by adaptive changes resulting in a more tortuous vasculature.  Forced HGF expression in cancer cells reduced tumor sensitivity to VEGFR TKIs and produced tumors with tortuous blood vessels.  Dual VEGFR/c-MET signaling inhibition delayed the onset of the resistant phenotype and prevented the vascular morphol. alterations.  In patients with cancer receiving VEGFR TKIs, high pretreatment HGF plasma levels correlated with poorer survival.  Conclusions: HGF/c-MET pathway mediates VEGFR inhibitor resistance and vascular remodeling in NSCLC.  Clin Cancer Res; 23(18); 5489-501. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxqt2NPffHZrVg90H21EOLACvtfcHk0lhB4r4aIiZfbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2mu7bN&md5=9fe1f48d84c2087476122e0ea83fff39</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-3216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-3216%26sid%3Dliteratum%253Aachs%26aulast%3DCascone%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DH.%2BY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DTran%26aufirst%3DH.%2BT.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHowells%26aufirst%3DK.%26aulast%3DHaddad%26aufirst%3DV.%26aulast%3DHanrahan%26aufirst%3DE.%26aulast%3DNilsson%26aufirst%3DM.%2BB.%26aulast%3DCortez%26aufirst%3DM.%2BA.%26aulast%3DGiri%26aufirst%3DU.%26aulast%3DKadara%26aufirst%3DH.%26aulast%3DSaigal%26aufirst%3DB.%26aulast%3DPark%26aufirst%3DY.%2BY.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DRyan%26aufirst%3DA.%2BJ.%26aulast%3DJ%25C3%25BCergensmeier%26aufirst%3DJ.%2BM.%26aulast%3DHerbst%26aufirst%3DR.%2BS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLangley%26aufirst%3DR.%2BR.%26aulast%3DWistuba%26aufirst%3DI.%2BI.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DHeymach%26aufirst%3DJ.%2BV.%26atitle%3DThe%2520HGF%252Fc-MET%2520pathway%2520is%2520a%2520driver%2520and%2520biomarker%2520of%2520VEGFR-inhibitor%2520resistance%2520and%2520vascular%2520remodeling%2520in%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26spage%3D5489%26epage%3D5501%26doi%3D10.1158%2F1078-0432.CCR-16-3216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W. H.</span></span> <span> </span><span class="NLM_article-title">Increased HGF expression induces resistance to c-MET tyrosine kinase inhibitors in gastric cancer</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1127</span>– <span class="NLM_lpage">1138</span>, <span class="refDoi"> DOI: 10.21873/anticanres.11426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.21873%2Fanticanres.11426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=28314274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlWqt7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=1127-1138&author=S.+Y.+Ahnauthor=J.+Kimauthor=M.+A.+Kimauthor=J.+Choiauthor=W.+H.+Kim&title=Increased+HGF+expression+induces+resistance+to+c-MET+tyrosine+kinase+inhibitors+in+gastric+cancer&doi=10.21873%2Fanticanres.11426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Increased HGF expression induces resistance to c-MET tyrosine kinase inhibitors in gastric cancer</span></div><div class="casAuthors">Ahn, So Yeong; Kim, Jin; Kim, Min A.; Choi, Jiwoon; Kim, Woo Ho</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1127-1138</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: Increased expression of hepatocyte growth factor (HGF) and MET proto-oncogene (c-MET) is assocd. with poor prognosis in various cancer types.  Recently, it was reported that the expression of HGF induces resistance to tyrosine kinase inhibitors (TKIs) targeting epidermal growth factor receptor, human epidermal receptor receptor 2, and b-raf proto-oncogene.  Here, we investigated the effects of HGF overexpression in gastric cancer cells in the absence or presence of c-MET TKIs.  Materials and Methods: The effects of c-MET TKIs in gastric cancer cells with and without c-MET overexpression were detd. in gastric cancer cell lines with various cell biol. methods.  Results: Compared to the control, cells with induced expression of HGF showed increase in anchorage-independent colony formation (p<0.001).  The c-MET TKIs inhibited HGF/c-MET downstream signaling, cell proliferation, migration and invasion, and triggered cell-cycle arrest in Hs746T cells.  However, HGF-transfected cells were less affected.  Conclusion: c-MET TKIs had inhibitory effects only on cells overexpressing c-MET.  Furthermore, overexpression of HGF resulted in resistance to c-MET TKIs through an autocrine manner in gastric cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEL-NHb_Qbz7Vg90H21EOLACvtfcHk0lhB4r4aIiZfbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlWqt7bE&md5=c8b178dfc8fa4c2102a5f54aa025fabb</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.21873%2Fanticanres.11426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.21873%252Fanticanres.11426%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DM.%2BA.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DW.%2BH.%26atitle%3DIncreased%2520HGF%2520expression%2520induces%2520resistance%2520to%2520c-MET%2520tyrosine%2520kinase%2520inhibitors%2520in%2520gastric%2520cancer%26jtitle%3DAnticancer%2520Res.%26date%3D2017%26volume%3D37%26spage%3D1127%26epage%3D1138%26doi%3D10.21873%2Fanticanres.11426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwasa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashima, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamaguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, Y.</span></span> <span> </span><span class="NLM_article-title">Serum level of hepatocyte growth factor is a novel marker of predicting the outcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">4925</span>– <span class="NLM_lpage">4938</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.6753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.18632%2Foncotarget.6753" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=4925-4938&author=N.+Takahashiauthor=K.+Furutaauthor=H.+Taniguchiauthor=Y.+Sasakiauthor=H.+Shojiauthor=Y.+Honmaauthor=S.+Iwasaauthor=N.+Okitaauthor=A.+Takashimaauthor=K.+Katoauthor=T.+Hamaguchiauthor=Y.+Shimadaauthor=Y.+Yamada&title=Serum+level+of+hepatocyte+growth+factor+is+a+novel+marker+of+predicting+the+outcome+and+resistance+to+the+treatment+with+trastuzumab+in+HER2-positive+patients+with+metastatic+gastric+cancer&doi=10.18632%2Foncotarget.6753"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.6753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.6753%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DFuruta%26aufirst%3DK.%26aulast%3DTaniguchi%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DShoji%26aufirst%3DH.%26aulast%3DHonma%26aufirst%3DY.%26aulast%3DIwasa%26aufirst%3DS.%26aulast%3DOkita%26aufirst%3DN.%26aulast%3DTakashima%26aufirst%3DA.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DHamaguchi%26aufirst%3DT.%26aulast%3DShimada%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DY.%26atitle%3DSerum%2520level%2520of%2520hepatocyte%2520growth%2520factor%2520is%2520a%2520novel%2520marker%2520of%2520predicting%2520the%2520outcome%2520and%2520resistance%2520to%2520the%2520treatment%2520with%2520trastuzumab%2520in%2520HER2-positive%2520patients%2520with%2520metastatic%2520gastric%2520cancer%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D4925%26epage%3D4938%26doi%3D10.18632%2Foncotarget.6753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koseki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marubashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, H.</span></span> <span> </span><span class="NLM_article-title">c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1892</span>– <span class="NLM_lpage">1898</span>, <span class="refDoi"> DOI: 10.3892/ol.2018.8793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.3892%2Fol.2018.8793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=30008881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252Fot1Oitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=1892-1898&author=K.+Noguchiauthor=M.+Konnoauthor=H.+Eguchiauthor=K.+Kawamotoauthor=R.+Mukaiauthor=N.+Nishidaauthor=J.+Kosekiauthor=H.+Wadaauthor=H.+Akitaauthor=T.+Satohauthor=S.+Marubashiauthor=H.+Naganoauthor=Y.+Dokiauthor=M.+Moriauthor=H.+Ishii&title=c-Met+affects+gemcitabine+resistance+during+carcinogenesis+in+a+mouse+model+of+pancreatic+cancer&doi=10.3892%2Fol.2018.8793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer</span></div><div class="casAuthors">Noguchi Kozo; Eguchi Hidetoshi; Kawamoto Koichi; Mukai Ryouta; Wada Hiroshi; Akita Hirofumi; Marubashi Shigeru; Nagano Hiroaki; Doki Yuichiro; Mori Masaki; Noguchi Kozo; Konno Masamitsu; Nishida Naohiro; Satoh Taroh; Ishii Hideshi; Koseki Jun; Ishii Hideshi</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1892-1898</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">Pancreatic adenocarcinoma is thought to develop from histologically identifiable intraductal lesions known as pancreatic intraepithelial neoplasias (PanINs), which exhibit similar morphological and genetic features to pancreatic ductal adenocarcinoma (PDAC).  Therefore, a better understanding of the biological features underlying the progression of PanIN is essential to development more effective therapeutic interventions for PDAC.  In recent years, numerous studies have reported that MET proto-oncogene receptor tyrosine kinase (c-MET) is a potential marker of pancreatic cancer stem cells (CSCs).  CSCs have been revealed to initiate and propagate tumors in vitro and in vivo, and are associated with a chemoresistant phenotype.  However, in vivo models using a xenograft approach are limited.  In the present study, the morphological phenotype, molecular alteration and biological behavior of neoplasia in Pdx-1Cre/+, KrasLSL-G12D/+ and Metflox/flox and wild-type mice was analyzed.  The results demonstrated that while oncogenic KrasLSL-G12D/+ increased PanIN initiation and significantly decreased survival rate compared with wild-type mice, no additive effect of c-Met receptor signaling on PanIN progression or prognosis was observed.  Following gemcitabine administration, c-Met inhibition in Kras LSL-G12D/+ mice significantly decreased the total surface area of PanIN lesions and the number of anti-proliferation marker protein Ki-67 positive cells occupying PanIN lesions compared with Met+/+ mice.  In conclusion, complete inhibition of the c-Met signaling pathway with chemotherapy may be useful for the treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfpOBgcGQpVV1C8OJBvdfbfW6udTcc2eZA55H8NI6Gwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252Fot1Oitg%253D%253D&md5=15a5e95a6c508b521637baf730cccd9f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3892%2Fol.2018.8793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2018.8793%26sid%3Dliteratum%253Aachs%26aulast%3DNoguchi%26aufirst%3DK.%26aulast%3DKonno%26aufirst%3DM.%26aulast%3DEguchi%26aufirst%3DH.%26aulast%3DKawamoto%26aufirst%3DK.%26aulast%3DMukai%26aufirst%3DR.%26aulast%3DNishida%26aufirst%3DN.%26aulast%3DKoseki%26aufirst%3DJ.%26aulast%3DWada%26aufirst%3DH.%26aulast%3DAkita%26aufirst%3DH.%26aulast%3DSatoh%26aufirst%3DT.%26aulast%3DMarubashi%26aufirst%3DS.%26aulast%3DNagano%26aufirst%3DH.%26aulast%3DDoki%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DH.%26atitle%3Dc-Met%2520affects%2520gemcitabine%2520resistance%2520during%2520carcinogenesis%2520in%2520a%2520mouse%2520model%2520of%2520pancreatic%2520cancer%26jtitle%3DOncol.%2520Lett.%26date%3D2018%26volume%3D16%26spage%3D1892%26epage%3D1898%26doi%3D10.3892%2Fol.2018.8793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Della
Corte, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papaccio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciardiello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgillo, F.</span></span> <span> </span><span class="NLM_article-title">Role of HGF-MET signaling in primary and acquired resistance to targeted therapies in cancer</span>. <i>Biomedicines</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.3390/biomedicines2040345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.3390%2Fbiomedicines2040345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=28548075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A280%3ADC%252BC1cnhs1Cqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=345-358&author=C.+M.+Della%0ACorteauthor=M.+Fasanoauthor=F.+Papaccioauthor=F.+Ciardielloauthor=F.+Morgillo&title=Role+of+HGF-MET+signaling+in+primary+and+acquired+resistance+to+targeted+therapies+in+cancer&doi=10.3390%2Fbiomedicines2040345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Role of HGF-MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer</span></div><div class="casAuthors">Della Corte Carminia Maria; Fasano Morena; Papaccio Federica; Ciardiello Fortunato; Morgillo Floriana</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicines</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">345-358</span>
        ISSN:<span class="NLM_cas:issn">2227-9059</span>.
    </div><div class="casAbstract">The Hepatocyte growth factor (HGF)-mesenchymal-epithelial transition (MET) pathway is deregulated in several cancers and is associated with aggressive phenotype and worse prognosis.  MET, a tyrosine kinase receptor activated by HGF, plays a physiological role in embryogenesis, promoting cell growth, survival and motility.  HGF-MET aberrant activation in tumorigenesis acts through various mechanisms: paracrine/autocrine HGF production, MET overexpression, MET germ-line and sporadic mutations and cross-talk with other growth factor receptors.  In addition, MET activation could represent a mechanism of escape from other targeted therapies, through receptor amplification or over-stimulation by the ligand, as demonstrated in non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) models with acquired resistance to epidermal growth factor receptor (EGFR) inhibitors and also in models of melanoma resistant to the BRAF inhibitor vemurafenib.  As a consequence, a lot of molecules targeting MET signaling are under clinical investigation as single agent or in combination with other targeted drugs.  Patient selection, based on MET expression on tumor samples (eventually, by re-biopsy of new metastatic sites), and pharmacokinetic/pharmacodynamic markers are needed.  Authors review the latest data on the role of MET and the molecular mechanism underlying primary or acquired resistance to biological agents, focusing on NSCLC, CRC and melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTv7dhNFbIrIpSWdIdmEou5fW6udTcc2eZA55H8NI6Gwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnhs1Cqsw%253D%253D&md5=bbb1bd966dfe08f4a790b264ad3402b4</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.3390%2Fbiomedicines2040345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiomedicines2040345%26sid%3Dliteratum%253Aachs%26aulast%3DDella%2BCorte%26aufirst%3DC.%2BM.%26aulast%3DFasano%26aufirst%3DM.%26aulast%3DPapaccio%26aufirst%3DF.%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DMorgillo%26aufirst%3DF.%26atitle%3DRole%2520of%2520HGF-MET%2520signaling%2520in%2520primary%2520and%2520acquired%2520resistance%2520to%2520targeted%2520therapies%2520in%2520cancer%26jtitle%3DBiomedicines%26date%3D2014%26volume%3D2%26spage%3D345%26epage%3D358%26doi%3D10.3390%2Fbiomedicines2040345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of cancer: the next generation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+the+next+generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0lhwSmTuwAAfDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520the%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Partanen, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tervonen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klefstrom, J.</span></span> <span> </span><span class="NLM_article-title">Breaking the epithelial polarity barrier in cancer: the strange case of LKB1/PAR-4</span>. <i>Philos. Trans. R. Soc., B</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">20130111</span>, <span class="refDoi"> DOI: 10.1098/rstb.2013.0111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1098%2Frstb.2013.0111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=24062587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslarsr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2013&pages=20130111&author=J.+I.+Partanenauthor=T.+A.+Tervonenauthor=J.+Klefstrom&title=Breaking+the+epithelial+polarity+barrier+in+cancer%3A+the+strange+case+of+LKB1%2FPAR-4&doi=10.1098%2Frstb.2013.0111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Breaking the epithelial polarity barrier in cancer: the strange case of LKB1/PAR-4</span></div><div class="casAuthors">Partanen, Johanna I.; Tervonen, Topi A.; Klefstrom, Juha</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical Transactions of the Royal Society, B: Biological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">1629</span>),
    <span class="NLM_cas:pages">20130111/1-20130111/12</span>CODEN:
                <span class="NLM_cas:coden">PTRBAE</span>;
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">A review.  The PAR clan of polarity regulating genes was initially discovered in a genetic screen searching for genes involved in asym. cell divisions in the Caenorhabditis elegans embryo.  Today, investigations in worms, flies and mammals have established PAR proteins as conserved and fundamental regulators of animal cell polarization in a broad range of biol. phenomena requiring cellular asymmetries.  The human homolog of invertebrate PAR-4, a serine-threonine kinase LKB1/STK11, has caught attention as a gene behind Peutz-Jeghers polyposis syndrome and as a bona fide tumor suppressor gene commonly mutated in sporadic cancer.  LKB1 functions as a master regulator of AMP-activated protein kinase (AMPK) and 12 other kinases referred to as the AMPK-related kinases, including four human homologues of PAR-1.  The role of LKB1 as part of the energy sensing LKB1-AMPK module has been intensively studied, whereas the polarity function of LKB1, in the context of homoeostasis or cancer, has gained less attention.  Here, we focus on the PAR-4 identity of LKB1, discussing the wt. of evidence indicating a role for LKB1 in regulation of cell polarity and epithelial integrity across species and highlight recent investigations providing new insight into the old question: does the PAR-4 identity of LKB1 matter in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohoudKDkyUQbVg90H21EOLACvtfcHk0lj3PBO0ydaIVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslarsr%252FF&md5=c0e81854cdbf072069df76fb4bc5013d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1098%2Frstb.2013.0111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2013.0111%26sid%3Dliteratum%253Aachs%26aulast%3DPartanen%26aufirst%3DJ.%2BI.%26aulast%3DTervonen%26aufirst%3DT.%2BA.%26aulast%3DKlefstrom%26aufirst%3DJ.%26atitle%3DBreaking%2520the%2520epithelial%2520polarity%2520barrier%2520in%2520cancer%253A%2520the%2520strange%2520case%2520of%2520LKB1%252FPAR-4%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2013%26volume%3D368%26spage%3D20130111%26doi%3D10.1098%2Frstb.2013.0111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gumbiner, B. M.</span></span> <span> </span><span class="NLM_article-title">Cell adhesion: the molecular basis of tissue architecture and morphogenesis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81279-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2FS0092-8674%2800%2981279-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=8608588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADyaK28XhtFWqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1996&pages=345-357&author=B.+M.+Gumbiner&title=Cell+adhesion%3A+the+molecular+basis+of+tissue+architecture+and+morphogenesis&doi=10.1016%2FS0092-8674%2800%2981279-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Cell adhesion: the molecular basis of tissue architecture and morphogenesis</span></div><div class="casAuthors">Gumbiner, Barry M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-57</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with 73 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyBq4qZqr6ArVg90H21EOLACvtfcHk0lj3PBO0ydaIVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtFWqtr4%253D&md5=4bea75fb17918173afdbc25ca896e523</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981279-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981279-9%26sid%3Dliteratum%253Aachs%26aulast%3DGumbiner%26aufirst%3DB.%2BM.%26atitle%3DCell%2520adhesion%253A%2520the%2520molecular%2520basis%2520of%2520tissue%2520architecture%2520and%2520morphogenesis%26jtitle%3DCell%26date%3D1996%26volume%3D84%26spage%3D345%26epage%3D357%26doi%3D10.1016%2FS0092-8674%2800%2981279-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Effing, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourbeau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vercoulen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coultas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palen, J.</span></span> <span> </span><span class="NLM_article-title">Self-management programmes for COPD: moving forward</span>. <i>Chron. Resp. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1177/1479972311433574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1177%2F1479972311433574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=22308551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A280%3ADC%252BC383gsFOmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=27-35&author=T.+W.+Effingauthor=J.+Bourbeauauthor=J.+Vercoulenauthor=A.+J.+Apterauthor=D.+Coultasauthor=P.+Meekauthor=P.+Valkauthor=M.+R.+Partridgeauthor=J.+Palen&title=Self-management+programmes+for+COPD%3A+moving+forward&doi=10.1177%2F1479972311433574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Self-management programmes for COPD: moving forward</span></div><div class="casAuthors">Effing Tanja W; Bourbeau Jean; Vercoulen Jan; Apter Andrea J; Coultas David; Meek Paula; Valk Paul van der; Partridge Martyn R; Palen Job van der</div><div class="citationInfo"><span class="NLM_cas:title">Chronic respiratory disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Self-management is of increasing importance in chronic obstructive pulmonary disease (COPD) management.  However, there is confusion over what processes are involved, how the value of self-management should be determined, and about the research priorities.  To gain more insight into and agreement about the content of programmes, outcomes, and future directions of COPD self-management, a group of interested researchers and physicians, all of whom had previously published on this subject and who had previously collaborated on other projects, convened a workshop.  This article summarises their initial findings.  Self-management programmes aim at structural behaviour change to sustain treatment effects after programmes have been completed.  The programmes should include techniques aimed at behavioural change, be tailored individually, take the patient's perspective into account, and may vary with the course of the patient's disease and co-morbidities.  Assessment should include process variables.  This report is a step towards greater conformity in the field of self-management.  To enhance clarity regarding effectiveness, future studies should clearly describe their intervention, be properly designed and powered, and include outcomes that focus more on the acquisition and practice of new skills.  In this way more evidence and a better comprehension on self-management programmes will be obtained, and more specific formulation of guidelines on self-management made possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSlsoHkMF-1VWyYR5VtavbzfW6udTcc2eZsmePssgFWH7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383gsFOmsg%253D%253D&md5=e14a1c60a1b360cf1dcd93beef57225c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1177%2F1479972311433574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1479972311433574%26sid%3Dliteratum%253Aachs%26aulast%3DEffing%26aufirst%3DT.%2BW.%26aulast%3DBourbeau%26aufirst%3DJ.%26aulast%3DVercoulen%26aufirst%3DJ.%26aulast%3DApter%26aufirst%3DA.%2BJ.%26aulast%3DCoultas%26aufirst%3DD.%26aulast%3DMeek%26aufirst%3DP.%26aulast%3DValk%26aufirst%3DP.%26aulast%3DPartridge%26aufirst%3DM.%2BR.%26aulast%3DPalen%26aufirst%3DJ.%26atitle%3DSelf-management%2520programmes%2520for%2520COPD%253A%2520moving%2520forward%26jtitle%3DChron.%2520Resp.%2520Dis.%26date%3D2012%26volume%3D9%26spage%3D27%26epage%3D35%26doi%3D10.1177%2F1479972311433574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ergel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singavarapu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orsulic, S.</span></span> <span> </span><span class="NLM_article-title">Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">2041</span>– <span class="NLM_lpage">2047</span>, <span class="refDoi"> DOI: 10.1002/ijc.23726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1002%2Fijc.23726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=18726901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Chs73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2008&pages=2041-2047&author=J.+Miaoauthor=D.+Muauthor=B.+Ergelauthor=R.+Singavarapuauthor=Z.+Duanauthor=S.+Powersauthor=E.+Olivaauthor=S.+Orsulic&title=Hepsin+colocalizes+with+desmosomes+and+induces+progression+of+ovarian+cancer+in+a+mouse+model&doi=10.1002%2Fijc.23726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model</span></div><div class="casAuthors">Miao, Jiangyong; Mu, David; Ergel, Burce; Singavarapu, Rajasekhar; Duan, Zhenfeng; Powers, Scott; Oliva, Esther; Orsulic, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2041-2047</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Hepsin is a serine protease that is widely expressed in different tissues and cell types, most prominently in the normal liver and kidney.  Overexpression of hepsin has been assocd. with prostate cancers, ovarian cancers and renal cell carcinomas.  The physiol. functions of hepsin in normal tissues and tumors are poorly understood.  To gain insight into its function in ovarian cancer, we analyzed the expression and subcellular localization of hepsin protein in ovarian cancer cell lines and tumors.  We showed that the membrane-assocd. hepsin protein is present at desmosomal junctions, where it colocalizes with its putative proteolytic substrate hepatocyte growth factor.  Consistent with the growing evidence that desmosomal junctions and their constituents play a role in cancer progression, we demonstrated that overexpression of hepsin promotes ovarian tumor growth in a mouse model.  The ability of ectopic hepsin to induce tumor growth in mice is abrogated by the mutation of 3 crit. residues in the catalytic domain, thus implicating the enzymic activity of hepsin in promoting tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLAGCqOpssILVg90H21EOLACvtfcHk0lj4CLKJwfw10w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Chs73E&md5=3b7b8ce6c7458011cc1a685e21050f2e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fijc.23726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.23726%26sid%3Dliteratum%253Aachs%26aulast%3DMiao%26aufirst%3DJ.%26aulast%3DMu%26aufirst%3DD.%26aulast%3DErgel%26aufirst%3DB.%26aulast%3DSingavarapu%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DZ.%26aulast%3DPowers%26aufirst%3DS.%26aulast%3DOliva%26aufirst%3DE.%26aulast%3DOrsulic%26aufirst%3DS.%26atitle%3DHepsin%2520colocalizes%2520with%2520desmosomes%2520and%2520induces%2520progression%2520of%2520ovarian%2520cancer%2520in%2520a%2520mouse%2520model%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2008%26volume%3D123%26spage%3D2041%26epage%3D2047%26doi%3D10.1002%2Fijc.23726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klezovitch, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevillet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirosevich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matusik, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasioukhin, V.</span></span> <span> </span><span class="NLM_article-title">Hepsin promotes prostate cancer progression and metastasis</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2004.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.ccr.2004.07.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=185-195&author=O.+Klezovitchauthor=J.+Chevilletauthor=J.+Mirosevichauthor=R.+L.+Robertsauthor=R.+J.+Matusikauthor=V.+Vasioukhin&title=Hepsin+promotes+prostate+cancer+progression+and+metastasis&doi=10.1016%2Fj.ccr.2004.07.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2004.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2004.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DKlezovitch%26aufirst%3DO.%26aulast%3DChevillet%26aufirst%3DJ.%26aulast%3DMirosevich%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DR.%2BL.%26aulast%3DMatusik%26aufirst%3DR.%2BJ.%26aulast%3DVasioukhin%26aufirst%3DV.%26atitle%3DHepsin%2520promotes%2520prostate%2520cancer%2520progression%2520and%2520metastasis%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26spage%3D185%26epage%3D195%26doi%3D10.1016%2Fj.ccr.2004.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tervonen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belitskin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pant, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englund, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ala-Hongisto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevalaita, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sihto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heikkila, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leidenius, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moilanen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joensuu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovanen, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klefstrom, J.</span></span> <span> </span><span class="NLM_article-title">Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1832</span>– <span class="NLM_lpage">1846</span>, <span class="refDoi"> DOI: 10.1038/onc.2015.248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1038%2Fonc.2015.248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=26165838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsFSru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=1832-1846&author=T.+A.+Tervonenauthor=D.+Belitskinauthor=S.+M.+Pantauthor=J.+I.+Englundauthor=E.+Marquesauthor=H.+Ala-Hongistoauthor=L.+Nevalaitaauthor=H.+Sihtoauthor=P.+Heikkilaauthor=M.+Leideniusauthor=K.+Hewitsonauthor=M.+Ramachandraauthor=A.+Moilanenauthor=H.+Joensuuauthor=P.+E.+Kovanenauthor=A.+Posoauthor=J.+Klefstrom&title=Deregulated+hepsin+protease+activity+confers+oncogenicity+by+concomitantly+augmenting+HGF%2FMET+signalling+and+disrupting+epithelial+cohesion&doi=10.1038%2Fonc.2015.248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion</span></div><div class="casAuthors">Tervonen, T. A.; Belitskin, D.; Pant, S. M.; Englund, J. I.; Marques, E.; Ala-Hongisto, H.; Nevalaita, L.; Sihto, H.; Heikkila, P.; Leidenius, M.; Hewitson, K.; Ramachandra, M.; Moilanen, A.; Joensuu, H.; Kovanen, P. E.; Poso, A.; Klefstrom, J.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1832-1846</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepsin belongs to a family of cell-surface serine proteases, which have sparked interest as therapeutic targets because of the accessibility of extracellular protease domain for inhibitors.  Hepsin is frequently amplified and/or overexpressed in epithelial cancers, but it is not clear how enhanced hepsin expression confers a potential for oncogenicity.  The authors show that hepsin is consistently overexpressed in more than 40% of examd. breast cancers, including all major biol. subtypes.  The effects of doxycycline-induced hepsin overexpression were examd. in mammary epithelial organoids, and the authors found that induced hepsin acutely downmodulates its cognate inhibitor, hepatocyte growth factor (HGF) activator inhibitor type 1 (HAI-1).  Hepsin-induced depletion of cellular HAI-1 led to a sharp increase in pericellular serine protease activity.  The derepressed hepsin proteolytically activated downstream serine proteases, augmented HGF/MET signaling and caused deterioration of desmosomes and hemidesmosomes; structures important for cell cohesion and cell-basement membrane interaction.  Moreover, chronic induction of hepsin considerably shortened the latency of Myc-dependent tumorigenesis in the mouse mammary gland.  The serine protease and uPA system inhibitor WX-UK1, identified as a micromolar range hepsin inhibitor, prevented hepsin from augmenting HGF/MET signaling and disrupting desmosomes and hemidesmosomes.  The findings suggest that the oncogenic activity of hepsin arises not only from elevated expression level but also from depletion of HAI-1, events which together trigger gain-of-function activity impacting HGF/MET signaling and epithelial cohesion.  Thus, hepsin overexpression is a major oncogenic conferrer to a serine protease activity involved in breast cancer dissemination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8Y0QR91QE0rVg90H21EOLACvtfcHk0lj4CLKJwfw10w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsFSru7w%253D&md5=76153fb74378464915e3a22e60c2c152</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.248%26sid%3Dliteratum%253Aachs%26aulast%3DTervonen%26aufirst%3DT.%2BA.%26aulast%3DBelitskin%26aufirst%3DD.%26aulast%3DPant%26aufirst%3DS.%2BM.%26aulast%3DEnglund%26aufirst%3DJ.%2BI.%26aulast%3DMarques%26aufirst%3DE.%26aulast%3DAla-Hongisto%26aufirst%3DH.%26aulast%3DNevalaita%26aufirst%3DL.%26aulast%3DSihto%26aufirst%3DH.%26aulast%3DHeikkila%26aufirst%3DP.%26aulast%3DLeidenius%26aufirst%3DM.%26aulast%3DHewitson%26aufirst%3DK.%26aulast%3DRamachandra%26aufirst%3DM.%26aulast%3DMoilanen%26aufirst%3DA.%26aulast%3DJoensuu%26aufirst%3DH.%26aulast%3DKovanen%26aufirst%3DP.%2BE.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DKlefstrom%26aufirst%3DJ.%26atitle%3DDeregulated%2520hepsin%2520protease%2520activity%2520confers%2520oncogenicity%2520by%2520concomitantly%2520augmenting%2520HGF%252FMET%2520signalling%2520and%2520disrupting%2520epithelial%2520cohesion%26jtitle%3DOncogene%26date%3D2016%26volume%3D35%26spage%3D1832%26epage%3D1846%26doi%3D10.1038%2Fonc.2015.248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raghav, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loree, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopetz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holla, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yap, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salgia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, D.</span></span> <span> </span><span class="NLM_article-title">Untying the gordion knot of targeting MET in cancer</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2018.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.ctrv.2018.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29730462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXoslSit7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2018&pages=95-103&author=K.+Raghavauthor=A.+M.+Baileyauthor=J.+M.+Loreeauthor=S.+Kopetzauthor=V.+Hollaauthor=T.+A.+Yapauthor=F.+Wangauthor=K.+Chenauthor=R.+Salgiaauthor=D.+Hong&title=Untying+the+gordion+knot+of+targeting+MET+in+cancer&doi=10.1016%2Fj.ctrv.2018.04.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Untying the gordion knot of targeting MET in cancer</span></div><div class="casAuthors">Raghav, Kanwal; Bailey, Ann Marie; Loree, Jonathan M.; Kopetz, Scott; Holla, Vijaykumar; Yap, Timothy Anthony; Wang, Fang; Chen, Ken; Salgia, Ravi; Hong, David</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95-103</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Despite compelling evidence backing the crucial role of a dysregulated MET axis in cancer and a myriad of agents targeting this pathway in active clin. development, the therapeutic value of MET inhibition in cancer oncol. remains to be established.  Although a series of disappointing clin. trials, at first, lessened fervor for targeting this pathway, investigations continue unabated with a no. of novel active compds. entering clin. trials.  Suboptimal designs which lacked biomarker selection have been the main reason for these early failures and this has stimulated a more biomarker enriched approach lately.  Fresh insights into the mechanics of diverse MET aberrations (amplifications and mutations) have allowed trial enrichment for appropriate patients in appropriate disease settings.  Development of MET inhibition as a therapeutic strategy in cancer has been a lesson in itself reflecting the challenging opportunities enclosed in the genetic landscape of cancer.  Here, we will review the status of MET targeted therapy in development as it stands today, discuss emerging paradigms in MET inhibition and theorize on concepts for future development.  We venture to propose that in spite of early disappointments, the future of this therapeutic strategy is promising with use of appropriate predictive biomarker in the right clin. context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpszv9uz_eUgrVg90H21EOLACvtfcHk0lj4CLKJwfw10w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXoslSit7c%253D&md5=8769ec4cc88cafb61f8f58a1a7647ae4</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2018.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2018.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DRaghav%26aufirst%3DK.%26aulast%3DBailey%26aufirst%3DA.%2BM.%26aulast%3DLoree%26aufirst%3DJ.%2BM.%26aulast%3DKopetz%26aufirst%3DS.%26aulast%3DHolla%26aufirst%3DV.%26aulast%3DYap%26aufirst%3DT.%2BA.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DSalgia%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DD.%26atitle%3DUntying%2520the%2520gordion%2520knot%2520of%2520targeting%2520MET%2520in%2520cancer%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2018%26volume%3D66%26spage%3D95%26epage%3D103%26doi%3D10.1016%2Fj.ctrv.2018.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Owen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilpatrick, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, V.</span></span> <span> </span><span class="NLM_article-title">Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>426</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1042/BJ20091448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1042%2FBJ20091448" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2010&pages=219-228&author=K.+A.+Owenauthor=D.+Qiuauthor=J.+Alvesauthor=A.+M.+Schumacherauthor=L.+M.+Kilpatrickauthor=J.+Liauthor=J.+L.+Harrisauthor=V.+Ellis&title=Pericellular+activation+of+hepatocyte+growth+factor+by+the+transmembrane+serine+proteases+matriptase+and+hepsin%2C+but+not+by+the+membrane-associated+protease+uPA&doi=10.1042%2FBJ20091448"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1042%2FBJ20091448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20091448%26sid%3Dliteratum%253Aachs%26aulast%3DOwen%26aufirst%3DK.%2BA.%26aulast%3DQiu%26aufirst%3DD.%26aulast%3DAlves%26aufirst%3DJ.%26aulast%3DSchumacher%26aufirst%3DA.%2BM.%26aulast%3DKilpatrick%26aufirst%3DL.%2BM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DJ.%2BL.%26aulast%3DEllis%26aufirst%3DV.%26atitle%3DPericellular%2520activation%2520of%2520hepatocyte%2520growth%2520factor%2520by%2520the%2520transmembrane%2520serine%2520proteases%2520matriptase%2520and%2520hepsin%252C%2520but%2520not%2520by%2520the%2520membrane-associated%2520protease%2520uPA%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D426%26spage%3D219%26epage%3D228%26doi%3D10.1042%2FBJ20091448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimomura, T.</span></span> <span> </span><span class="NLM_article-title">Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2): Emerging key players in epithelial integrity and cancer</span>. <i>Pathol. Int.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1111/pin.12647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1111%2Fpin.12647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29431273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvVKqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2018&pages=145-158&author=H.+Kataokaauthor=M.+Kawaguchiauthor=T.+Fukushimaauthor=T.+Shimomura&title=Hepatocyte+growth+factor+activator+inhibitors+%28HAI-1+and+HAI-2%29%3A+Emerging+key+players+in+epithelial+integrity+and+cancer&doi=10.1111%2Fpin.12647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2): Emerging key players in epithelial integrity and cancer</span></div><div class="casAuthors">Kataoka, Hiroaki; Kawaguchi, Makiko; Fukushima, Tsuyoshi; Shimomura, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Pathology International</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">145-158</span>CODEN:
                <span class="NLM_cas:coden">PITEES</span>;
        ISSN:<span class="NLM_cas:issn">1320-5463</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The growth, survival, and metabolic activities of multicellular organisms at the cellular level are regulated by intracellular signaling, systemic homeostasis and the pericellular microenvironment.  Pericellular proteolysis has a crucial role in processing bioactive mols. in the microenvironment and thereby has profound effects on cellular functions.  Hepatocyte growth factor activator inhibitor type 1 (HAI-1) and HAI-2 are type I transmembrane serine protease inhibitors expressed by most epithelial cells.  They regulate the pericellular activities of circulating hepatocyte growth factor activator and cellular type II transmembrane serine proteases (TTSPs), proteases required for the activation of hepatocyte growth factor (HGF)/scatter factor (SF).  Activated HGF/SF transduces pleiotropic signals through its receptor tyrosine kinase, MET (coded by the proto-oncogene MET), which are necessary for cellular migration, survival, growth and triggering stem cells for accelerated healing.  HAI-1 and HAI-2 are also required for normal epithelial functions through regulation of TTSP-mediated activation of other proteases and protease-activated receptor 2, and also through suppressing excess degrdn. of epithelial junctional proteins.  This review summarizes current knowledge regarding the mechanism of pericellular HGF/SF activation and highlights emerging roles of HAIs in epithelial development and integrity, as well as tumorigenesis and progression of transformed epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYGfh8FgAOz7Vg90H21EOLACvtfcHk0lhvemmWZvr9Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvVKqsLw%253D&md5=f828322366d79c101fea4f6508f34ba6</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fpin.12647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpin.12647%26sid%3Dliteratum%253Aachs%26aulast%3DKataoka%26aufirst%3DH.%26aulast%3DKawaguchi%26aufirst%3DM.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DShimomura%26aufirst%3DT.%26atitle%3DHepatocyte%2520growth%2520factor%2520activator%2520inhibitors%2520%2528HAI-1%2520and%2520HAI-2%2529%253A%2520Emerging%2520key%2520players%2520in%2520epithelial%2520integrity%2520and%2520cancer%26jtitle%3DPathol.%2520Int.%26date%3D2018%26volume%3D68%26spage%3D145%26epage%3D158%26doi%3D10.1111%2Fpin.12647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J.</span></span> <span> </span><span class="NLM_article-title">Hepatocyte growth factor activator inhibitor type1 in cancer: Advances and perspectives (Review)</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2779</span>– <span class="NLM_lpage">2785</span>, <span class="refDoi"> DOI: 10.3892/mmr.2014.2628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.3892%2Fmmr.2014.2628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=25310042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWnsbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=2779-2785&author=Q.+Zhengauthor=H.+Wuauthor=J.+Caoauthor=J.+Ye&title=Hepatocyte+growth+factor+activator+inhibitor+type1+in+cancer%3A+Advances+and+perspectives+%28Review%29&doi=10.3892%2Fmmr.2014.2628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor activator inhibitor type-1 in cancer: advances and perspectives (Review)</span></div><div class="casAuthors">Zheng, Qiaoli; Wu, Haijian; Cao, Jiang; Ye, Jingjia</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2779-2785</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-2997</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Cancer is one of the most common diseases, with high morbidity and mortality rates.  Large-scale efforts have been made to understand the pathogenesis of the disease, particularly in the advanced stages, in order to develop effective therapeutic approaches.  Hepatocyte growth factor activator inhibitor type-1 (HAI-1), also known as serine protease inhibitor Kunitz type 1, inhibits the activity of several trypsin-like serine proteases.  In particular, HAI-1 suppresses hepatocyte growth factor (HGF) activator and matriptase, resulting in subsequent inhibition of HGF/scatter factor and macrophage-stimulating protein (MSP).  HGF and MSP are involved in cancer development and progression, via the receptors Met receptor tyrosine kinase (RTK) and Ron RTK, resp.  Therefore, HAI-1-mediated downregulation of HGF and MSP signaling may suppress tumorigenesis and progression in certain types of cancers.  Abnormal HAI-1 expression levels have been obsd. in various types of human cancer.  The exact function of HAI-1 in cancer pathogenesis, however, has not been fully elucidated.  In this review, the focus is on the potential impact of aberrant HAI-1 expression levels on tumorigenesis and progression, the underlying mechanisms, and areas that require further investigation to clarify the precise role of HAI-1 in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfCZdhwYJ70LVg90H21EOLACvtfcHk0lhvemmWZvr9Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWnsbfP&md5=93e1e489eed74d2bae545a9e22d0012e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2014.2628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2014.2628%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DJ.%26atitle%3DHepatocyte%2520growth%2520factor%2520activator%2520inhibitor%2520type1%2520in%2520cancer%253A%2520Advances%2520and%2520perspectives%2520%2528Review%2529%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2014%26volume%3D10%26spage%3D2779%26epage%3D2785%26doi%3D10.3892%2Fmmr.2014.2628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. Y.</span></span> <span> </span><span class="NLM_article-title">Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0120489</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0120489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1371%2Fjournal.pone.0120489" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=H.+H.+Changauthor=Y.+Xuauthor=H.+Laiauthor=X.+Yangauthor=C.+C.+Tsengauthor=Y.+J.+Laiauthor=Y.+Panauthor=E.+Zhouauthor=M.+D.+Johnsonauthor=J.+K.+Wangauthor=C.+Y.+Lin&title=Differential+subcellular+localization+renders+HAI-2+a+matriptase+inhibitor+in+breast+cancer+cells+but+not+in+mammary+epithelial+cells&doi=10.1371%2Fjournal.pone.0120489"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0120489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0120489%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DH.%2BH.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DTseng%26aufirst%3DC.%2BC.%26aulast%3DLai%26aufirst%3DY.%2BJ.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DM.%2BD.%26aulast%3DWang%26aufirst%3DJ.%2BK.%26aulast%3DLin%26aufirst%3DC.%2BY.%26atitle%3DDifferential%2520subcellular%2520localization%2520renders%2520HAI-2%2520a%2520matriptase%2520inhibitor%2520in%2520breast%2520cancer%2520cells%2520but%2520not%2520in%2520mammary%2520epithelial%2520cells%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0120489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Generali, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berruti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brizzi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allevi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonardi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguggini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bersiga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogliotti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span> <span> </span><span class="NLM_article-title">Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">550</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-1266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1158%2F1078-0432.CCR-06-1266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=17255277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslSksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=550-558&author=D.+Generaliauthor=S.+B.+Foxauthor=A.+Berrutiauthor=J.+W.+Mooreauthor=M.+P.+Brizziauthor=N.+Patelauthor=G.+Alleviauthor=S.+Bonardiauthor=S.+Agugginiauthor=A.+Bersigaauthor=L.+Campoauthor=L.+Dogliottiauthor=A.+Bottiniauthor=A.+L.+Harris&title=Regulation+of+hepatocyte+growth+factor+activator+inhibitor+2+by+hypoxia+in+breast+cancer&doi=10.1158%2F1078-0432.CCR-06-1266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Hepatocyte Growth Factor Activator Inhibitor 2 by Hypoxia in Breast Cancer</span></div><div class="casAuthors">Generali, Daniele; Fox, Stephen B.; Berruti, Alfredo; Moore, John W.; Brizzi, Maria Pia; Patel, Nilay; Allevi, Giovanni; Bonardi, Simone; Aguggini, Sergio; Bersiga, Alessandra; Campo, Leticia; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2, Pt. 1</span>),
    <span class="NLM_cas:pages">550-558</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The in vitro regulation of hepatocyte growth factor activator inhibitor type 2 (HAI-2) in breast cancer cells and the in vivo predictive role for the efficacy of chemoendocrine primary therapy in patients with breast cancer were examd.  HAI-2 regulation was studied in a panel of breast cancer cell lines comparing normoxia to hypoxia.  The effect of HIF-1α RNAi on HAI-2 expression was evaluated in these cells.  HAI-2 was examd. in breast cancer using in situ hybridization and immunohistochem.  The HAI-2 predictive role was assessed in T2-4 N0-1 breast cancers (n = 177) enrolled in a neoadjuvant randomized trial comparing epirubicin vs. epirubicin + tamoxifen.  HAI-2 mRNA and protein were regulated by hypoxia in the c-erbB2-pos. cell lines, SKBR3 and BT474, and controlled by HIF-1α in these cells.  Immunohistochem. confirmed this profile with high expression of HAI-2 in c-erbB2-pos. breast cancer.  HAI-2 was correlated with T status (P < 0.004), node involvement (P = 0.01), and c-erbB2 expression (P = 0.05).  HAI-2 also correlated with hypoxia markers such as carbonic anhydrase IX expression (P = 0.01) and HIF-1α.  Addnl., high levels of HAI-2 were a significant predictor for poor clin. complete response to preoperative epirubicin in univariate (P = 0.01) and multivariate analyses (P = 0.016).  No correlation with disease-free survival and survival was obsd.  HAI-2 expression in breast cancer correlated with tumor aggressiveness in vivo.  It is a HIF target in c-erbB2-pos. cells and it is an independent neg. predictive factor of efficacy of anthracycline therapy.  The interaction of HAI-2 with the hepatocyte growth factor activation pathway may be a useful site for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4iW5ipIu3fbVg90H21EOLACvtfcHk0lgoAe9v5CjRvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslSksQ%253D%253D&md5=01b6c32e957161f0a1566a7cb8b65339</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1266%26sid%3Dliteratum%253Aachs%26aulast%3DGenerali%26aufirst%3DD.%26aulast%3DFox%26aufirst%3DS.%2BB.%26aulast%3DBerruti%26aufirst%3DA.%26aulast%3DMoore%26aufirst%3DJ.%2BW.%26aulast%3DBrizzi%26aufirst%3DM.%2BP.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DAllevi%26aufirst%3DG.%26aulast%3DBonardi%26aufirst%3DS.%26aulast%3DAguggini%26aufirst%3DS.%26aulast%3DBersiga%26aufirst%3DA.%26aulast%3DCampo%26aufirst%3DL.%26aulast%3DDogliotti%26aufirst%3DL.%26aulast%3DBottini%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DRegulation%2520of%2520hepatocyte%2520growth%2520factor%2520activator%2520inhibitor%25202%2520by%2520hypoxia%2520in%2520breast%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D550%26epage%3D558%26doi%3D10.1158%2F1078-0432.CCR-06-1266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W. G.</span></span> <span> </span><span class="NLM_article-title">Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">1176</span>– <span class="NLM_lpage">1183</span>, <span class="refDoi"> DOI: 10.1002/ijc.21881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1002%2Fijc.21881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=16557597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1Cmsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2006&pages=1176-1183&author=C.+Parrauthor=W.+G.+Jiang&title=Hepatocyte+growth+factor+activation+inhibitors+%28HAI-1+and+HAI-2%29+regulate+HGF-induced+invasion+of+human+breast+cancer+cells&doi=10.1002%2Fijc.21881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells</span></div><div class="casAuthors">Parr, Christian; Jiang, Wen G.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1176-1183</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Hepatocyte growth factor (HGF) plays a plethora of roles in cancer metastasis and tumor growth.  The interaction between tumor cells and their surrounding stromal environment is a crucial factor regulating tumor invasion and metastasis.  Stromal fibroblasts are the main source of HGF in the body, and release HGF as an inactive precursor (pro-HGF).  HGF activator (HGFA), matriptase, urokinase-type plasminogen activator and hepsin are the main factors responsible for converting pro-HGF into active HGF.  HAI-1 and HAI-2 are 2 novel Kunitz-type serine protease inhibitors that regulate HGF activity through inhibition of HGFA, matriptase and hepsin action.  Recent studies demonstrate that HAI-1 and HAI-2 may also potently inhibit a no. of other pro-metastatic serine proteases and therefore have direct bearing on the spread of tumors.  Our study examd. the potential of these HAI's to suppress the influence of HGF and regulate cancer metastasis.  We generated a retroviral expression system that induced HAI expression in a human fibroblast cell line.  Forced expression of either HAI-1 or HAI-2 in these fibroblasts resulted in a dramatic decrease in the prodn. of bioactive hepatocyte growth factor (HGF).  This redn. in HGF activity subsequently suppressed HGF's metastatic influence on breast cancer cells.  To further assess the anti-cancer properties of HAI-1 and HAI-2 we generated recombinant HAI proteins.  These recombinant HAI proteins possessed the ability to potently quench HGF activity.  We also demonstrate that these recombinant HAI's suppressed fibroblast-mediated breast cancer invasion.  An addnl. ribozyme transgenes study revealed that elimination of HAI-1 and HAI-2 expression, in an MDA-MB-231 breast cancer cell line, significantly enhanced the migratory, proliferative and invasive nature of these breast cancer cells.  Overall, our data demonstrates the important roles of HAI-1 and HAI-2 in cancer metastasis, and reveals that these serine protease inhibitors display strong therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqmM4Gs-NQurVg90H21EOLACvtfcHk0lgoAe9v5CjRvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1Cmsbg%253D&md5=e38f295a24311b5c976aacb7912575f9</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Fijc.21881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.21881%26sid%3Dliteratum%253Aachs%26aulast%3DParr%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DW.%2BG.%26atitle%3DHepatocyte%2520growth%2520factor%2520activation%2520inhibitors%2520%2528HAI-1%2520and%2520HAI-2%2529%2520regulate%2520HGF-induced%2520invasion%2520of%2520human%2520breast%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2006%26volume%3D119%26spage%3D1176%26epage%3D1183%26doi%3D10.1002%2Fijc.21881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansel, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W. G.</span></span> <span> </span><span class="NLM_article-title">The hepatocyte growth factor regulatory factors in human breast cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-0553-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1158%2F1078-0432.CCR-0553-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=14734471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvF2mtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=202-211&author=C.+Parrauthor=G.+Watkinsauthor=R.+E.+Manselauthor=W.+G.+Jiang&title=The+hepatocyte+growth+factor+regulatory+factors+in+human+breast+cancer&doi=10.1158%2F1078-0432.CCR-0553-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">The Hepatocyte Growth Factor Regulatory Factors in Human Breast Cancer</span></div><div class="casAuthors">Parr, Christian; Watkins, Gareth; Mansel, Robert E.; Jiang, Wen G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1, Pt. 1</span>),
    <span class="NLM_cas:pages">202-211</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hepatocyte growth factor (HGF) stimulates tumor cell-cell interactions, matrix adhesion, migration, invasion, and angiogenesis.  This factor is produced as an inactive precursor called pro-HGF, which requires proteolytic conversion, by HGF activator (HGFA) and matriptase, to evoke a biol. response.  Two new HGFA inhibitors, HAI-1 and HAI-2, inhibit the generation of biol. active HGF, through their interaction with HGFA.  This study detd. the expression of this HGF regulatory system in breast cancer.  We examd. HGF, the HGF receptor (c-Met), HGFA, matriptase, and the activation inhibitors (HAI-1 and HAI-2), tissues from patients with breast cancer.  Breast cancer tissue (n = 100) and normal background tissue (n = 20) was obtained immediately after surgery.  The median follow-up for the patients was 72 mo.  HGF, c-Met, HGFA, matriptase-1, HAI-1, and HAI-2 expression was quantified using real-time quant. PCR.  The distribution of these factors in mammary tissues was also examd. through immunohistochem.  The breast cancer specimens expressed a significantly higher level of HGF, c-Met, HGFA, HAI-1, and HAI-2, but not matriptase, compared with the normal background tissues.  Tumor tissues from node-pos. patients expressed a higher level of HGFA than from the patients without nodal involvement.  Interestingly, HAI-2 was expressed to a lower degree in pos. nodes than that of the node-neg. breast cancer tissues.  HAI-1 and HAI-2 were both significantly reduced in grade 3 tumors compared with the well-differentiated tumors.  In addn., on comparison of Tumor-Node-Metastasis (TNM) classification groups, HAI-2 was also found to be statistically lower in the TNM 3 breast cancer group when compared with TNM groups 1 and 2, thus assocd. with a poor prognosis.  This study shows that there are aberrant levels of HGF, c-Met, HGFA, HAI-1, and HAI-2 expressed in breast cancer tissues compared with background breast tissue.  HAI-1 and HAI-2 are expressed to a significantly lower level in poorly differentiated breast tumors, and HAI-2 is also inversely correlated with nodal involvement and tumor spread.  Overall a low level of HAI-2 in the breast cancer tissues was assocd. with an overall poor outlook.  Therefore, the HGF regulatory system may have an important role in the progression of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJFpNGyq1zVrVg90H21EOLACvtfcHk0lgoAe9v5CjRvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvF2mtg%253D%253D&md5=6d08f437f0917d61960a028a60cc8c64</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-0553-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-0553-3%26sid%3Dliteratum%253Aachs%26aulast%3DParr%26aufirst%3DC.%26aulast%3DWatkins%26aufirst%3DG.%26aulast%3DMansel%26aufirst%3DR.%2BE.%26aulast%3DJiang%26aufirst%3DW.%2BG.%26atitle%3DThe%2520hepatocyte%2520growth%2520factor%2520regulatory%2520factors%2520in%2520human%2520breast%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D202%26epage%3D211%26doi%3D10.1158%2F1078-0432.CCR-0553-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haruyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanemaru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, H.</span></span> <span> </span><span class="NLM_article-title">Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1111/cas.12306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1111%2Fcas.12306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=24147538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1emt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2014&pages=44-51&author=J.+J.+Yeauthor=M.+Kawaguchiauthor=Y.+Haruyamaauthor=A.+Kanemaruauthor=T.+Fukushimaauthor=K.+Yamamotoauthor=C.+Y.+Linauthor=H.+Kataoka&title=Loss+of+hepatocyte+growth+factor+activator+inhibitor+type+1+participates+in+metastatic+spreading+of+human+pancreatic+cancer+cells+in+a+mouse+orthotopic+transplantation+model&doi=10.1111%2Fcas.12306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model</span></div><div class="casAuthors">Ye, Jingjia; Kawaguchi, Makiko; Haruyama, Yukihiro; Kanemaru, Ai; Fukushima, Tsuyoshi; Yamamoto, Koji; Lin, Chen-Yong; Kataoka, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-51</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is a membrane-bound serine protease inhibitor that is expressed on the surface of epithelial and carcinoma cells.  On the cell surface, HAI-1 regulates membrane-anchored serine proteases, with matriptase being the most crit. target.  Matriptase is involved in pericellular processing of biol. active mols., including protease-activated receptor-2 (PAR-2).  Previously we reported that S2-CP8 cells, a metastatic variant of the SUIT-2 human pancreatic adenocarcinoma cell line, showed markedly decreased HAI-1 expression.  To assess the significance of HAI-1 loss in invasion and spontaneous metastasis of S2-CP8 cells, we established stable S2-CP8 sublines that expressed HAI-1 under the control of a tetracycline-regulated promoter.  In vitro migration and invasion assays revealed inhibitory effects of HAI-1 on S2-CP8 cell migration and invasion.  Matriptase activity was suppressed by the expression of HAI-1.  As the enhanced invasiveness in the absence of HAI-1 was alleviated by knockdown of matriptase by 81% and of PAR-2 completely, and PAR-2 antagonist also suppressed the invasion, matriptase-mediated PAR-2 activation is involved in HAI-1 loss-induced invasion of S2-CP8 cells.  We then analyzed the effect of HAI-1 expression on metastasis of S2-CP8 cells in vivo using a nude mouse orthotopic xenograft model.  Although approx. 50% of the control mice developed distant metastasis, mice treated with doxycycline to induce HAI-1 expression did not develop metastasis.  These data indicate that HAI-1 loss contributes to invasion and dissemination of a highly metastatic subline of SUIT-2, suggesting crucial roles for the balance of pericellular serine proteases/inhibitors in pancreatic cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQkXcHG-e_arVg90H21EOLACvtfcHk0lgLg11afJU0rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1emt7Y%253D&md5=2f31be04c86b90c559d5036dd74ebca3</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1111%2Fcas.12306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.12306%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DJ.%2BJ.%26aulast%3DKawaguchi%26aufirst%3DM.%26aulast%3DHaruyama%26aufirst%3DY.%26aulast%3DKanemaru%26aufirst%3DA.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DC.%2BY.%26aulast%3DKataoka%26aufirst%3DH.%26atitle%3DLoss%2520of%2520hepatocyte%2520growth%2520factor%2520activator%2520inhibitor%2520type%25201%2520participates%2520in%2520metastatic%2520spreading%2520of%2520human%2520pancreatic%2520cancer%2520cells%2520in%2520a%2520mouse%2520orthotopic%2520transplantation%2520model%26jtitle%3DCancer%2520Sci.%26date%3D2014%26volume%3D105%26spage%3D44%26epage%3D51%26doi%3D10.1111%2Fcas.12306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span> <span> </span><span class="NLM_article-title">Down-regulation of HAI-1 is associated with poor-differentiation status of colorectal cancer</span>. <i>Hum. Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1007/s13577-013-0074-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1007%2Fs13577-013-0074-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=23979832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyitLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2013&pages=162-169&author=J.+J.+Yeauthor=H.+X.+Chengauthor=Y.+Wangauthor=J.+Cao&title=Down-regulation+of+HAI-1+is+associated+with+poor-differentiation+status+of+colorectal+cancer&doi=10.1007%2Fs13577-013-0074-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Down-regulation of HAI-1 is associated with poor-differentiation status of colorectal cancer</span></div><div class="casAuthors">Ye, Jingjia; Cheng, Haixia; Wang, Yi; Cao, Jiang</div><div class="citationInfo"><span class="NLM_cas:title">Human Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">162-169</span>CODEN:
                <span class="NLM_cas:coden">HUCEE7</span>;
        ISSN:<span class="NLM_cas:issn">1749-0774</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is a Kunitz-type serine protease inhibitor which is widely expressed in epithelial cells.  The purpose of this study is to investigate the relationship between HAI-1 expression and differentiation status of colorectal epithelia.  The expression of HAI-1 in clin. samples of both cancerous and normal colorectal tissues was evaluated by immunohistochem. staining.  An in vitro epithelial differentiation model of Caco-2 cell was established, and the characteristics of differentiation of Caco-2 cells were obsd. by transmission electron microscopy.  The expression of HAI-1 in Caco-2 cells at different differentiation stages was examd. by western blot.  Immunohistochem. staining of 52 human colorectal cancer tissues showed a definite correlation between HAI-1 expression and differentiation status: IHC score (mean ± SE) of HAI-1 was higher for well- or moderately-differentiated colorectal cancer tissues than for poorly-differentiated colorectal cancer tissues, with significant differences in HAI-1 pos. rate (P < 0.01 and P < 0.05 for well-differentiated vs. poorly-differentiated and moderately-differentiated vs. poorly-differentiated, resp.).  Immunohistochem. staining of normal colorectal tissues showed pos. HAI-1 expression in well-differentiated epithelial cells whereas the under-differentiated crypt cells showed very weak HAI-1 staining signals.  The result of western blot also showed the gradual increasing of HAI-1 expression during the process of Caco-2 differentiation in vitro.  HAI-1 expression correlates with the differentiation status of colorectal epithelia and could serve as a differentiation marker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVUtCI3pt1ZbVg90H21EOLACvtfcHk0lgLg11afJU0rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyitLbE&md5=c13038b3998ef114e9f946f1cab22e63</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2Fs13577-013-0074-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13577-013-0074-7%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DJ.%2BJ.%26aulast%3DCheng%26aufirst%3DH.%2BX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DJ.%26atitle%3DDown-regulation%2520of%2520HAI-1%2520is%2520associated%2520with%2520poor-differentiation%2520status%2520of%2520colorectal%2520cancer%26jtitle%3DHum.%2520Cell%26date%3D2013%26volume%3D26%26spage%3D162%26epage%3D169%26doi%3D10.1007%2Fs13577-013-0074-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaieda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takezaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeshima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, H.</span></span> <span> </span><span class="NLM_article-title">Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>109</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2970</span>– <span class="NLM_lpage">2979</span>, <span class="refDoi"> DOI: 10.1111/cas.13732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1111%2Fcas.13732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=29987920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFanu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2018&pages=2970-2979&issue=9&author=T.+Fukushimaauthor=M.+Kawaguchiauthor=K.+Yamamotoauthor=F.+Yamashitaauthor=A.+Izumiauthor=T.+Kaiedaauthor=Y.+Takezakiauthor=H.+Itohauthor=H.+Takeshimaauthor=H.+Kataoka&title=Aberrant+methylation+and+silencing+of+the+SPINT2+gene+in+high-grade+gliomas&doi=10.1111%2Fcas.13732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas</span></div><div class="casAuthors">Fukushima, Tsuyoshi; Kawaguchi, Makiko; Yamamoto, Koji; Yamashita, Fumiki; Izumi, Aya; Kaieda, Takashi; Takezaki, Yuka; Itoh, Hiroshi; Takeshima, Hideo; Kataoka, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2970-2979</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Hepatocyte growth factor activator inhibitor type 2 (HAI-2), encoded by the SPINT2 gene, is a membrane-anchored protein that inhibits proteases involved in the activation of hepatocyte growth factor (HGF), a ligand of MET receptor.  Epigenetic silencing of the SPINT2 gene has been reported in a human glioblastoma cell line (U87) and glioblastoma-derived cancer stem cells.  However, the incidence of SPINT2 methylation in tumor tissues obtained from glioma patients is unknown.  In this study, we analyzed the methylation status of the SPINT2 gene of eight human glioblastoma cell lines and surgically resected glioma tissues of different grades (II, III, and IV) by bisulfite sequence anal. and methylation-specific PCR.  Most glioblastoma lines (7/8) showed methylation of the SPINT2 gene with a significantly reduced level of SPINT2mRNA compared to cultured astrocytes and normal brain tissues.  However, all glioblastoma lines expressed mRNA for HGF activator (HGFAC), a target protease of HAI-2/SPINT2.  Forced expression of SPINT2 reduced MET phosphorylation of U87 glioblastoma cells both in vitro and in intracranial xenografts in nude mice.  Methylation-specific PCR anal. of the resected glioma tissues indicated notable methylation of the SPINT2 gene in 33.3% (2/6), 71.4% (10/14), and 74.3% (26/35) of grade II, III, and IV gliomas, resp.  Anal. of RNA sequencing data in a public database indicated an increased HGFAC/SPINT2 expression ratio in high-grade compared to low-grade gliomas (P = .01).  In summary, aberrant methylation of the SPINT2 gene is frequently obsd. in high-grade gliomas and might confer MET signaling in the glioma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmUH_ACH3-nbVg90H21EOLACvtfcHk0lgLg11afJU0rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFanu7rF&md5=fd5319e9bdd89a003b1488addc55bb5b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1111%2Fcas.13732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13732%26sid%3Dliteratum%253Aachs%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DKawaguchi%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DYamashita%26aufirst%3DF.%26aulast%3DIzumi%26aufirst%3DA.%26aulast%3DKaieda%26aufirst%3DT.%26aulast%3DTakezaki%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DH.%26aulast%3DTakeshima%26aufirst%3DH.%26aulast%3DKataoka%26aufirst%3DH.%26atitle%3DAberrant%2520methylation%2520and%2520silencing%2520of%2520the%2520SPINT2%2520gene%2520in%2520high-grade%2520gliomas%26jtitle%3DCancer%2520Sci.%26date%3D2018%26volume%3D109%26issue%3D9%26spage%3D2970%26epage%3D2979%26doi%3D10.1111%2Fcas.13732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karmakar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owusu, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klampfer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span> <span> </span><span class="NLM_article-title">alpha-Ketobenzothiazole serine protease inhibitors of aberrant HGF/c-MET and MSP/RON kinase pathway signaling in cancer</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">599</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1002%2Fcmdc.201500600" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=585-599&author=Z.+Hanauthor=P.+K.+Harrisauthor=P.+Karmakarauthor=T.+Kimauthor=B.+Y.+Owusuauthor=S.+A.+Wildmanauthor=L.+Klampferauthor=J.+W.+Janetka&title=alpha-Ketobenzothiazole+serine+protease+inhibitors+of+aberrant+HGF%2Fc-MET+and+MSP%2FRON+kinase+pathway+signaling+in+cancer&doi=10.1002%2Fcmdc.201500600"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500600%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DHarris%26aufirst%3DP.%2BK.%26aulast%3DKarmakar%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DT.%26aulast%3DOwusu%26aufirst%3DB.%2BY.%26aulast%3DWildman%26aufirst%3DS.%2BA.%26aulast%3DKlampfer%26aufirst%3DL.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3Dalpha-Ketobenzothiazole%2520serine%2520protease%2520inhibitors%2520of%2520aberrant%2520HGF%252Fc-MET%2520and%2520MSP%252FRON%2520kinase%2520pathway%2520signaling%2520in%2520cancer%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D585%26epage%3D599%26doi%3D10.1002%2Fcmdc.201500600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chugani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of HGFA, matriptase, and hepsin serine proteases: a nonkinase strategy to block cell signaling in cancer</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1219</span>– <span class="NLM_lpage">1224</span>, <span class="refDoi"> DOI: 10.1021/ml500254r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500254r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1219-1224&author=Z.+Hanauthor=P.+K.+Harrisauthor=D.+E.+Jonesauthor=R.+Chuganiauthor=T.+Kimauthor=M.+Agarwalauthor=W.+Shenauthor=S.+A.+Wildmanauthor=J.+W.+Janetka&title=Inhibitors+of+HGFA%2C+matriptase%2C+and+hepsin+serine+proteases%3A+a+nonkinase+strategy+to+block+cell+signaling+in+cancer&doi=10.1021%2Fml500254r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fml500254r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500254r%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DHarris%26aufirst%3DP.%2BK.%26aulast%3DJones%26aufirst%3DD.%2BE.%26aulast%3DChugani%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DT.%26aulast%3DAgarwal%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DWildman%26aufirst%3DS.%2BA.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DInhibitors%2520of%2520HGFA%252C%2520matriptase%252C%2520and%2520hepsin%2520serine%2520proteases%253A%2520a%2520nonkinase%2520strategy%2520to%2520block%2520cell%2520signaling%2520in%2520cancer%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1219%26epage%3D1224%26doi%3D10.1021%2Fml500254r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Franco, F.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvis, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span> <span> </span><span class="NLM_article-title">Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: evaluation of potency and selectivity derived from distinct binding pockets</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2328</span>– <span class="NLM_lpage">2343</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.03.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.bmc.2015.03.072" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2328-2343&author=F.%0AM.+Francoauthor=D.+E.+Jonesauthor=P.+K.+Harrisauthor=Z.+Hanauthor=S.+A.+Wildmanauthor=C.+M.+Jarvisauthor=J.+W.+Janetka&title=Structure-based+discovery+of+small+molecule+hepsin+and+HGFA+protease+inhibitors%3A+evaluation+of+potency+and+selectivity+derived+from+distinct+binding+pockets&doi=10.1016%2Fj.bmc.2015.03.072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.03.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.03.072%26sid%3Dliteratum%253Aachs%26aulast%3DFranco%26aufirst%3DF.%2BM.%26aulast%3DJones%26aufirst%3DD.%2BE.%26aulast%3DHarris%26aufirst%3DP.%2BK.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DWildman%26aufirst%3DS.%2BA.%26aulast%3DJarvis%26aufirst%3DC.%2BM.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DStructure-based%2520discovery%2520of%2520small%2520molecule%2520hepsin%2520and%2520HGFA%2520protease%2520inhibitors%253A%2520evaluation%2520of%2520potency%2520and%2520selectivity%2520derived%2520from%2520distinct%2520binding%2520pockets%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D2328%26epage%3D2343%26doi%3D10.1016%2Fj.bmc.2015.03.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venukadasula, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owusu, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobrath, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truss, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stackhouse, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messick, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klampfer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galemmo, R. A.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of nonpeptide inhibitors of hepatocyte growth factor activation</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00357</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00357" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=177-181&author=P.+K.+Venukadasulaauthor=B.+Y.+Owusuauthor=N.+Bansalauthor=L.+J.+Rossauthor=J.+V.+Hobrathauthor=D.+Baoauthor=J.+W.+Trussauthor=M.+Stackhouseauthor=T.+E.+Messickauthor=L.+Klampferauthor=R.+A.+Galemmo&title=Design+and+synthesis+of+nonpeptide+inhibitors+of+hepatocyte+growth+factor+activation&doi=10.1021%2Facsmedchemlett.5b00357"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00357%26sid%3Dliteratum%253Aachs%26aulast%3DVenukadasula%26aufirst%3DP.%2BK.%26aulast%3DOwusu%26aufirst%3DB.%2BY.%26aulast%3DBansal%26aufirst%3DN.%26aulast%3DRoss%26aufirst%3DL.%2BJ.%26aulast%3DHobrath%26aufirst%3DJ.%2BV.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DTruss%26aufirst%3DJ.%2BW.%26aulast%3DStackhouse%26aufirst%3DM.%26aulast%3DMessick%26aufirst%3DT.%2BE.%26aulast%3DKlampfer%26aufirst%3DL.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520nonpeptide%2520inhibitors%2520of%2520hepatocyte%2520growth%2520factor%2520activation%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D177%26epage%3D181%26doi%3D10.1021%2Facsmedchemlett.5b00357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Owusu, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venukadasula, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messick, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galemmo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klampfer, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">29492</span>– <span class="NLM_lpage">29506</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.8785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.18632%2Foncotarget.8785" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=29492-29506&author=B.+Y.+Owusuauthor=N.+Bansalauthor=P.+K.+Venukadasulaauthor=L.+J.+Rossauthor=T.+E.+Messickauthor=S.+Goelauthor=R.+A.+Galemmoauthor=L.+Klampfer&title=Inhibition+of+pro-HGF+activation+by+SRI31215%2C+a+novel+approach+to+block+oncogenic+HGF%2FMET+signaling&doi=10.18632%2Foncotarget.8785"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8785%26sid%3Dliteratum%253Aachs%26aulast%3DOwusu%26aufirst%3DB.%2BY.%26aulast%3DBansal%26aufirst%3DN.%26aulast%3DVenukadasula%26aufirst%3DP.%2BK.%26aulast%3DRoss%26aufirst%3DL.%2BJ.%26aulast%3DMessick%26aufirst%3DT.%2BE.%26aulast%3DGoel%26aufirst%3DS.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26aulast%3DKlampfer%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520pro-HGF%2520activation%2520by%2520SRI31215%252C%2520a%2520novel%2520approach%2520to%2520block%2520oncogenic%2520HGF%252FMET%2520signaling%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D29492%26epage%3D29506%26doi%3D10.18632%2Foncotarget.8785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piper, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaron, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriele, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meininger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, R. J.</span></span> <span> </span><span class="NLM_article-title">Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>390</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1042/BJ20041955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1042%2FBJ20041955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=15839837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntFGmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2005&pages=125-136&author=S.+Herterauthor=D.+E.+Piperauthor=W.+Aaronauthor=T.+Gabrieleauthor=G.+Cutlerauthor=P.+Caoauthor=A.+S.+Bhattauthor=Y.+Choeauthor=C.+S.+Craikauthor=N.+Walkerauthor=D.+Meiningerauthor=T.+Hoeyauthor=R.+J.+Austin&title=Hepatocyte+growth+factor+is+a+preferred+in+vitro+substrate+for+human+hepsin%2C+a+membrane-anchored+serine+protease+implicated+in+prostate+and+ovarian+cancers&doi=10.1042%2FBJ20041955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers</span></div><div class="casAuthors">Herter, Sylvia; Piper, Derek E.; Aaron, Wade; Gabriele, Timothy; Cutler, Gene; Cao, Ping; Bhatt, Ami S.; Choe, Youngchool; Craik, Charles S.; Walker, Nigel; Meininger, David; Hoey, Timothy; Austin, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">390</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-136</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Hepsin is a membrane-anchored, trypsin-like serine protease with prominent expression in the human liver and tumors of the prostate and ovaries.  To better understand the biol. functions of hepsin, we identified macromol. substrates employing a tetrapeptide PS-SCL (positional scanning-synthetic combinatorial library) screen that rapidly dets. the P1-P4 substrate specificity.  Hepsin exhibited strong preference at the P1 position for arginine over lysine, and favored threonine, leucine or asparagine at the P2, glutamine or lysine at the P3, and proline or lysine at the P4 position.  The relative activity of hepsin toward individual AMC (7-amino-4-methylcoumarin)-tetrapeptides was generally consistent with the overall peptide profiling results derived from the PC-SCL screen.  The most active tetrapeptide substrate Ac (acetyl)-KQLR-AMC matched with the activation cleavage site of the hepatocyte growth factor precursor s.c.-HGF (single-chain HGF), KQLR↓VVNG (where ↓ denotes the cleavage site), as identified by a database anal. of trypsin-like precursors.  X-ray crystallog. studies with KQLR chloromethylketone showed that the KQLR peptide fits well into the substrate-binding cleft of hepsin.  This hepsin-processed HGF induced c-Met receptor tyrosine phosphorylation in SKOV-3 ovarian cancer cells, indicating that the hepsin-cleaved HGF is biol. active.  Activation cleavage site mutants of s.c.-HGF with predicted non-preferred sequences, DPGR↓VVNG or KQLQ↓VVNG, were not processed, illustrating that the P4-P1 residues can be important determinants for substrate specificity.  In addn. to finding macromol. hepsin substrates, the extracellular inhibitors of the HGF activator, HAI-1 and HAI-2, were potent inhibitors of hepsin activity (IC50 4±0.2 nM and 12±0.5 nM resp.).  Together, our findings suggest that the HGF precursor is a potential in vivo substrate for hepsin in tumors, where hepsin expression is dysregulated and may influence tumorigenesis through inappropriate activation and/or regulation of HGF receptor (c-Met) functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra-Cmy0jAqULVg90H21EOLACvtfcHk0ljnMUbj7W2wAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntFGmsrg%253D&md5=2ac65cd9f3bcdb72bfdd9856e005f415</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1042%2FBJ20041955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20041955%26sid%3Dliteratum%253Aachs%26aulast%3DHerter%26aufirst%3DS.%26aulast%3DPiper%26aufirst%3DD.%2BE.%26aulast%3DAaron%26aufirst%3DW.%26aulast%3DGabriele%26aufirst%3DT.%26aulast%3DCutler%26aufirst%3DG.%26aulast%3DCao%26aufirst%3DP.%26aulast%3DBhatt%26aufirst%3DA.%2BS.%26aulast%3DChoe%26aufirst%3DY.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DWalker%26aufirst%3DN.%26aulast%3DMeininger%26aufirst%3DD.%26aulast%3DHoey%26aufirst%3DT.%26aulast%3DAustin%26aufirst%3DR.%2BJ.%26atitle%3DHepatocyte%2520growth%2520factor%2520is%2520a%2520preferred%2520in%2520vitro%2520substrate%2520for%2520human%2520hepsin%252C%2520a%2520membrane-anchored%2520serine%2520protease%2520implicated%2520in%2520prostate%2520and%2520ovarian%2520cancers%26jtitle%3DBiochem.%2520J.%26date%3D2005%26volume%3D390%26spage%3D125%26epage%3D136%26doi%3D10.1042%2FBJ20041955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beliveau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desilets, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span> <span> </span><span class="NLM_article-title">Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">2213</span>– <span class="NLM_lpage">2226</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.06950.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1111%2Fj.1742-4658.2009.06950.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=2213-2226&author=F.+Beliveauauthor=A.+Desiletsauthor=R.+Leduc&title=Probing+the+substrate+specificities+of+matriptase%2C+matriptase-2%2C+hepsin+and+DESC1+with+internally+quenched+fluorescent+peptides&doi=10.1111%2Fj.1742-4658.2009.06950.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.06950.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.06950.x%26sid%3Dliteratum%253Aachs%26aulast%3DBeliveau%26aufirst%3DF.%26aulast%3DDesilets%26aufirst%3DA.%26aulast%3DLeduc%26aufirst%3DR.%26atitle%3DProbing%2520the%2520substrate%2520specificities%2520of%2520matriptase%252C%2520matriptase-2%252C%2520hepsin%2520and%2520DESC1%2520with%2520internally%2520quenched%2520fluorescent%2520peptides%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D2213%26epage%3D2226%26doi%3D10.1111%2Fj.1742-4658.2009.06950.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhatt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farady, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasquez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">5771</span>– <span class="NLM_lpage">5776</span>, <span class="refDoi"> DOI: 10.1073/pnas.0606514104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1073%2Fpnas.0606514104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=5771-5776&author=A.+S.+Bhattauthor=A.+Welmauthor=C.+J.+Faradyauthor=M.+Vasquezauthor=K.+Wilsonauthor=C.+S.+Craik&title=Coordinate+expression+and+functional+profiling+identify+an+extracellular+proteolytic+signaling+pathway&doi=10.1073%2Fpnas.0606514104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0606514104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0606514104%26sid%3Dliteratum%253Aachs%26aulast%3DBhatt%26aufirst%3DA.%2BS.%26aulast%3DWelm%26aufirst%3DA.%26aulast%3DFarady%26aufirst%3DC.%2BJ.%26aulast%3DVasquez%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DK.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DCoordinate%2520expression%2520and%2520functional%2520profiling%2520identify%2520an%2520extracellular%2520proteolytic%2520signaling%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D5771%26epage%3D5776%26doi%3D10.1073%2Fpnas.0606514104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barre, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhard, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappelhoff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beliveau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span> <span> </span><span class="NLM_article-title">Cleavage specificity analysis of six type II transmembrane serine proteases (TTSPs) using PICS with proteome-derived peptide libraries</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e105984</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0105984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1371%2Fjournal.pone.0105984" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=O.+Barreauthor=A.+Dufourauthor=U.+Eckhardauthor=R.+Kappelhoffauthor=F.+Beliveauauthor=R.+Leducauthor=C.+M.+Overall&title=Cleavage+specificity+analysis+of+six+type+II+transmembrane+serine+proteases+%28TTSPs%29+using+PICS+with+proteome-derived+peptide+libraries&doi=10.1371%2Fjournal.pone.0105984"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0105984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0105984%26sid%3Dliteratum%253Aachs%26aulast%3DBarre%26aufirst%3DO.%26aulast%3DDufour%26aufirst%3DA.%26aulast%3DEckhard%26aufirst%3DU.%26aulast%3DKappelhoff%26aufirst%3DR.%26aulast%3DBeliveau%26aufirst%3DF.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26atitle%3DCleavage%2520specificity%2520analysis%2520of%2520six%2520type%2520II%2520transmembrane%2520serine%2520proteases%2520%2528TTSPs%2529%2520using%2520PICS%2520with%2520proteome-derived%2520peptide%2520libraries%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0105984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duchene, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desilets, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boudreault, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najmanovich, R.</span></span> <span> </span><span class="NLM_article-title">Analysis of subpocket selectivity and identification of potent selective inhibitors for matriptase and matriptase-2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10198</span>– <span class="NLM_lpage">10204</span>, <span class="refDoi"> DOI: 10.1021/jm5015633</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5015633" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2nt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10198-10204&author=D.+Ducheneauthor=E.+Colomboauthor=A.+Desiletsauthor=P.+L.+Boudreaultauthor=R.+Leducauthor=E.+Marsaultauthor=R.+Najmanovich&title=Analysis+of+subpocket+selectivity+and+identification+of+potent+selective+inhibitors+for+matriptase+and+matriptase-2&doi=10.1021%2Fjm5015633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of Subpocket Selectivity and Identification of Potent Selective Inhibitors for Matriptase and Matriptase-2</span></div><div class="casAuthors">Duchene, Dominic; Colombo, Eloic; Desilets, Antoine; Boudreault, Pierre-Luc; Leduc, Richard; Marsault, Eric; Najmanovich, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10198-10204</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We studied the factors affecting the selectivity of peptidomimetic inhibitors of the highly homologous proteases matriptase (also known as ST-14, for suppressor of tumorigenicity 14 protein) and matriptase-2 (also known as TMPRSS6) across subpockets using docking simulations.  We obsd. that the farther away a subpocket is located from the catalytic site, the more pronounced its role in selectivity.  As a result of our exhaustive virtual screening, we biochem. validated novel potent and selective inhibitors of both enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJgZtgEt4i17Vg90H21EOLACvtfcHk0lh2railsw-inA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2nt7vI&md5=3e33bc97debaddf8129c04d722c3ea11</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm5015633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5015633%26sid%3Dliteratum%253Aachs%26aulast%3DDuchene%26aufirst%3DD.%26aulast%3DColombo%26aufirst%3DE.%26aulast%3DDesilets%26aufirst%3DA.%26aulast%3DBoudreault%26aufirst%3DP.%2BL.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DMarsault%26aufirst%3DE.%26aulast%3DNajmanovich%26aufirst%3DR.%26atitle%3DAnalysis%2520of%2520subpocket%2520selectivity%2520and%2520identification%2520of%2520potent%2520selective%2520inhibitors%2520for%2520matriptase%2520and%2520matriptase-2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10198%26epage%3D10204%26doi%3D10.1021%2Fjm5015633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desilets, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duchene, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chagnon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najmanovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, E.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of potent, selective inhibitors of matriptase</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">530</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1021/ml3000534</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3000534" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1OntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=530-534&author=E.+Colomboauthor=A.+Desiletsauthor=D.+Ducheneauthor=F.+Chagnonauthor=R.+Najmanovichauthor=R.+Leducauthor=E.+Marsault&title=Design+and+synthesis+of+potent%2C+selective+inhibitors+of+matriptase&doi=10.1021%2Fml3000534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Potent, Selective Inhibitors of Matriptase</span></div><div class="casAuthors">Colombo, Eloic; Desilets, Antoine; Duchene, Dominic; Chagnon, Felix; Najmanovich, Rafael; Leduc, Richard; Marsault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">530-534</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Matriptase is a member of the type II transmembrane serine protease family.  Several studies have reported deregulated matriptase expression in several types of epithelial cancers, suggesting that matriptase constitutes a potential target for cancer therapy.  We report herein a new series of slow, tight-binding inhibitors of matriptase, which mimic the P1-P4 substrate recognition sequence of the enzyme.  Preliminary structure-activity relationships indicate that this benzothiazole-contg. RQAR-peptidomimetic is a very potent inhibitor and possesses a good selectivity for matriptase vs. other serine proteases.  A mol. model was generated to elucidate the key contacts between inhibitor (I) and matriptase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlqkegeO0GdbVg90H21EOLACvtfcHk0lh2railsw-inA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1OntrY%253D&md5=560a72862038f32c57c829618fdd28aa</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fml3000534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3000534%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DE.%26aulast%3DDesilets%26aufirst%3DA.%26aulast%3DDuchene%26aufirst%3DD.%26aulast%3DChagnon%26aufirst%3DF.%26aulast%3DNajmanovich%26aufirst%3DR.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DMarsault%26aufirst%3DE.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%252C%2520selective%2520inhibitors%2520of%2520matriptase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D530%26epage%3D534%26doi%3D10.1021%2Fml3000534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28K1%29+and+the+concentration+of+inhibitor+which+causes+50%25+inhibition+%28I50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0liOV8v3Efiv9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528K1%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byun, Y.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis, and biological evaluation of Leu-Arg dipeptide analogs as novel hepsin inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2Fj.bmcl.2015.12.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=310-314&author=H.+Kwonauthor=Y.+Kimauthor=K.+Parkauthor=S.+A.+Choiauthor=S.-H.+Sonauthor=Y.+Byun&title=Structure-based+design%2C+synthesis%2C+and+biological+evaluation+of+Leu-Arg+dipeptide+analogs+as+novel+hepsin+inhibitors&doi=10.1016%2Fj.bmcl.2015.12.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DS.%2BA.%26aulast%3DSon%26aufirst%3DS.-H.%26aulast%3DByun%26aufirst%3DY.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520Leu-Arg%2520dipeptide%2520analogs%2520as%2520novel%2520hepsin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D310%26epage%3D314%26doi%3D10.1016%2Fj.bmcl.2015.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ergel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singavarapu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orsulic, S.</span></span> <span> </span><span class="NLM_article-title">Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">2041</span>– <span class="NLM_lpage">2047</span>, <span class="refDoi"> DOI: 10.1002/ijc.23726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1002%2Fijc.23726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=18726901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Chs73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2008&pages=2041-2047&author=J.+Miaoauthor=D.+Muauthor=B.+Ergelauthor=R.+Singavarapuauthor=Z.+Duanauthor=S.+Powersauthor=E.+Olivaauthor=S.+Orsulic&title=Hepsin+colocalizes+with+desmosomes+and+induces+progression+of+ovarian+cancer+in+a+mouse+model&doi=10.1002%2Fijc.23726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model</span></div><div class="casAuthors">Miao, Jiangyong; Mu, David; Ergel, Burce; Singavarapu, Rajasekhar; Duan, Zhenfeng; Powers, Scott; Oliva, Esther; Orsulic, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2041-2047</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Hepsin is a serine protease that is widely expressed in different tissues and cell types, most prominently in the normal liver and kidney.  Overexpression of hepsin has been assocd. with prostate cancers, ovarian cancers and renal cell carcinomas.  The physiol. functions of hepsin in normal tissues and tumors are poorly understood.  To gain insight into its function in ovarian cancer, we analyzed the expression and subcellular localization of hepsin protein in ovarian cancer cell lines and tumors.  We showed that the membrane-assocd. hepsin protein is present at desmosomal junctions, where it colocalizes with its putative proteolytic substrate hepatocyte growth factor.  Consistent with the growing evidence that desmosomal junctions and their constituents play a role in cancer progression, we demonstrated that overexpression of hepsin promotes ovarian tumor growth in a mouse model.  The ability of ectopic hepsin to induce tumor growth in mice is abrogated by the mutation of 3 crit. residues in the catalytic domain, thus implicating the enzymic activity of hepsin in promoting tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLAGCqOpssILVg90H21EOLACvtfcHk0liOV8v3Efiv9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Chs73E&md5=3b7b8ce6c7458011cc1a685e21050f2e</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Fijc.23726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.23726%26sid%3Dliteratum%253Aachs%26aulast%3DMiao%26aufirst%3DJ.%26aulast%3DMu%26aufirst%3DD.%26aulast%3DErgel%26aufirst%3DB.%26aulast%3DSingavarapu%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DZ.%26aulast%3DPowers%26aufirst%3DS.%26aulast%3DOliva%26aufirst%3DE.%26aulast%3DOrsulic%26aufirst%3DS.%26atitle%3DHepsin%2520colocalizes%2520with%2520desmosomes%2520and%2520induces%2520progression%2520of%2520ovarian%2520cancer%2520in%2520a%2520mouse%2520model%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2008%26volume%3D123%26spage%3D2041%26epage%3D2047%26doi%3D10.1002%2Fijc.23726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhukov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellman, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">IngelmanSundberg, M.</span></span> <span> </span><span class="NLM_article-title">Purification and characterization of hepsin from rat liver microsomes</span>. <i>Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>1337</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1016/S0167-4838(96)00152-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=10.1016%2FS0167-4838%2896%2900152-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=9003440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADyaK28XntlKku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1337&publication_year=1997&pages=85-95&author=A.+Zhukovauthor=U.+Hellmanauthor=M.+IngelmanSundberg&title=Purification+and+characterization+of+hepsin+from+rat+liver+microsomes&doi=10.1016%2FS0167-4838%2896%2900152-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and characterization of hepsin from rat liver microsomes</span></div><div class="casAuthors">Zhukov, Andrei; Hellman, Ulf; Ingelman-Sundberg, Magnus</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure and Molecular Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1337</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-95</span>CODEN:
                <span class="NLM_cas:coden">BBAEDZ</span>;
        ISSN:<span class="NLM_cas:issn">0167-4838</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hepsin (I), a putative cell-surface serine proteinase, was isolated from the microsomal membranes of rat liver and purified to homogeneity by hydroxylapatite, DEAE-Sepharose, and benzamidine-Sepharose chromatogs.  The course of purifn. was monitored using antibodies raised against a 20-mer peptide at the C-terminus of rat I, and the identity of the purified protein was confirmed by partial amino acid sequencing.  A single-chain precursor of ∼50 kDa found in the microsomes underwent spontaneous maturation in the course of purifn. so that the last, affinity chromatog., step recovered only the mature form which dissocd. to subunits of 31 and 19 kDa under reducing SDS-PAGE.  Proteinase digestion expts. with microsomal vesicles were consistent with the luminal orientation of the precursor C-terminus, which would result in its extracellular orientation upon transportation to the cell surface.  [3H]Diisopropyl fluorophosphate covalently bound to the large subunit showing it to be the catalytic subunit.  N-terminal sequencing of this subunit demonstrated that the zymogen was converted to the active serine proteinase by cleavage at the Arg-161-Ile-162 site.  Activity measurements with short synthetic peptides showed that the enzyme cleaves after basic amino acid residues, Arg being preferable to Lys.  The inhibition pattern was typical of trypsin-like serine proteinases.  The pH-dependence of activity within the pH range of 6-9 had no max., with the activity increasing continuously with pH.  These results were consistent with the earlier predictions based on I amino acid sequence and elucidated the specificity and other earlier unknown enzymic and mol. properties of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ1d1KNa08RrVg90H21EOLACvtfcHk0liOV8v3Efiv9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntlKku70%253D&md5=50fc9780a600fe40691cda0fe81c0581</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2FS0167-4838%2896%2900152-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-4838%252896%252900152-5%26sid%3Dliteratum%253Aachs%26aulast%3DZhukov%26aufirst%3DA.%26aulast%3DHellman%26aufirst%3DU.%26aulast%3DIngelmanSundberg%26aufirst%3DM.%26atitle%3DPurification%2520and%2520characterization%2520of%2520hepsin%2520from%2520rat%2520liver%2520microsomes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Protein%2520Struct.%2520Mol.%2520Enzymol.%26date%3D1997%26volume%3D1337%26spage%3D85%26epage%3D95%26doi%3D10.1016%2FS0167-4838%2896%2900152-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pant, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukonoweshuro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramjee, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selway, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarver, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tervonen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klefstrom, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and testing of potent, selective hepsin inhibitors via application of an automated closed-loop optimization platform</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4335</span>– <span class="NLM_lpage">4347</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01698</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01698" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFOhurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4335-4347&author=S.+M.+Pantauthor=A.+Mukonoweshuroauthor=B.+Desaiauthor=M.+K.+Ramjeeauthor=C.+N.+Selwayauthor=G.+J.+Tarverauthor=A.+G.+Wrightauthor=K.+Birchallauthor=T.+M.+Chapmanauthor=T.+A.+Tervonenauthor=J.+Klefstrom&title=Design%2C+synthesis%2C+and+testing+of+potent%2C+selective+hepsin+inhibitors+via+application+of+an+automated+closed-loop+optimization+platform&doi=10.1021%2Facs.jmedchem.7b01698"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and testing of potent, selective hepsin inhibitors via application of an automated closed-loop optimization platform</span></div><div class="casAuthors">Pant, Shishir M.; Mukonoweshuro, Amanda; Desai, Bimbisar; Ramjee, Manoj K.; Selway, Christopher N.; Tarver, Gary J.; Wright, Adrian G.; Birchall, Kristian; Chapman, Timothy M.; Tervonen, Topi A.; Klefstrom, Juha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4335-4347</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepsin is a membrane-anchored serine protease whose role in hepatocyte growth factor (HGF) signaling and epithelial integrity makes it a target of therapeutic interest in carcinogenesis and metastasis.  Using an integrated design, synthesis, and screening platform, we were able to rapidly develop potent and selective inhibitors of hepsin.  In progressing from the initial hit (I) to compd. (II), the IC50 value against hepsin was improved from ∼1 μM to 22 nM, and the selectivity over urokinase-type plasminogen activator (uPA) was increased from 30-fold to >6000-fold.  Subsequent in vitro ADMET profiling and cellular studies confirmed that the leading compds. are useful tools for interrogating the role of hepsin in breast tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowUiuZrLxxeLVg90H21EOLACvtfcHk0li69pPYCGom6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFOhurs%253D&md5=7451e2ec2e276280136eecffe7cbd7dd</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01698%26sid%3Dliteratum%253Aachs%26aulast%3DPant%26aufirst%3DS.%2BM.%26aulast%3DMukonoweshuro%26aufirst%3DA.%26aulast%3DDesai%26aufirst%3DB.%26aulast%3DRamjee%26aufirst%3DM.%2BK.%26aulast%3DSelway%26aufirst%3DC.%2BN.%26aulast%3DTarver%26aufirst%3DG.%2BJ.%26aulast%3DWright%26aufirst%3DA.%2BG.%26aulast%3DBirchall%26aufirst%3DK.%26aulast%3DChapman%26aufirst%3DT.%2BM.%26aulast%3DTervonen%26aufirst%3DT.%2BA.%26aulast%3DKlefstrom%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520testing%2520of%2520potent%252C%2520selective%2520hepsin%2520inhibitors%2520via%2520application%2520of%2520an%2520automated%2520closed-loop%2520optimization%2520platform%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4335%26epage%3D4347%26doi%3D10.1021%2Facs.jmedchem.7b01698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NCL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NCL','PDB','3NCL'); return false;">PDB: 3NCL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z8G" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z8G','PDB','1Z8G'); return false;">PDB: 1Z8G</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WUC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WUC','PDB','2WUC'); return false;">PDB: 2WUC</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i40"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01536">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_34021"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01536">10.1021/acs.jmedchem.8b01536</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H NMR, HPLC purity and MS spectral data for all compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01536/suppl_file/jm8b01536_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01536/suppl_file/jm8b01536_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01536/suppl_file/jm8b01536_si_001.pdf">jm8b01536_si_001.pdf (2.37 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01536/suppl_file/jm8b01536_si_002.csv">jm8b01536_si_002.csv (2.36 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01536&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01536%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-2%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01536" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996c064c7f1239","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
